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Abstract
This thesis presents a full cost-benefit analysis of In-Vitro-Fertilisation (IVF) from a 
societal perspective. It is based on a contingent valuation survey administered 
through internet to a sample of the Italian population. A referendum format and a 
payment scale were used to elicit willingness-to-pay (WTP) for a publicly funded 
program providing IVF to infertile couples. WTP was also elicited for a hypothetical 
situation in which the respondent was asked to imagine being infertile and willing to 
have a baby.
Overall, results show the feasibility of using this new method of administration of 
contingent valuation questionnaires. Responses reveal consistent patterns and the 
number of inconsistent answers is limited. WTP for private use (in case of infertility) 
and for a public program are positively associated with income, education, being 
within the fertility age range and being informed about infertility and IVF.
The take-it-or-leave-it format and a variant of the payment scale method result in 
different mean WTP estimates, but simulated and actual referendum WTP are very 
similar. There is evidence of an anchoring effect since the values presented in the 
take-it-or-leave-it question had an impact on the answers to the modified payment 
card questions that followed.
Mean WTP estimated from the different questions are consistently above the mean 
cost of providing IVF, as estimated on the basis of a full costing methodology. The 
IVF program shows net welfare benefits under several assumptions. The study 
shows that the societal benefits of an IVF program mainly derives from the high WTP 
of a minority of citizens who tend to be the most affluent, educated and familiar with 
infertility and IVF.
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Chapter 1
Introduction
1.1. The purpose of the study
The aim of this thesis is to present a full cost-benefit analysis of In-Vitro-Fertilisation 
(herein referred to as IVF). The research was designed and implemented to offer 
guidance on policy making for public funding of this form of intervention. Basically, 
we wanted to shed some light on the economic rationality for using government 
resources to provide IVF, a relatively sophisticated and expensive procedure that 
increases the chances of infertile couples of having a baby. Therefore our study 
deals with the allocation of resources in public health care systems and aims at 
illustrating how cost-benefit analysis may concretely help in making decisions about 
rationing.
The concepts of rationing and priority setting applied to healthcare are now receiving 
greater attention in many industrialised countries. In the Netherlands, Italy, New 
Zealand, Norway, Sweden, United Kingdom and the United States of America 
various initiatives have openly recognised that diverse forms of rationing take place 
in healthcare systems and that, at least potentially, there are merits in taking some 
steps towards more explicit, systematic and democratic rationing.
Although it is increasingly recognised that implicit rationing is becoming less 
sustainable, so far only a few concrete initiatives have made rationing more explicit. 
Very often the policy debate tends to remain on the ground of principles and general 
criteria. However, economic evidence is required for reimbursement or coverage of 
pharmaceuticals in many countries (Taylor et al., 2004). The National Institute of 
Health and Clinical Excellence (NICE) in England and Wales and the Scottish 
Medicines Consortium (SMC) in Scotland regularly produce guidance based on 
economic evidence (Cairns, 2006). In Italy, the Netherlands, Canada, Australia and 
Sweden economic evidence is often required by regulatory bodies, but the process 
according to which economic data are analysed and assessed appear less well
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established than in the United Kingdom. Over the last ten years there have been a 
significant moves towards making governments’ decisions about funding medicines 
and, to a lesser extent, other technologies and interventions based on evidence of 
effectiveness and cost-effectiveness.
Despite the advances in explicit and systematic approaches to rationing and a wider 
use of economic evaluation studies to guide policy making, we are aware of a few 
explicit exclusions from public coverage in Europe. Despite clear evidence that 
resources made available by governments do not suffice to meet demand, rationing 
decisions are often left at organisational level and at the point of service delivery 
(Klein et al., 1996).
Nevertheless, there are some services that represent exceptions, as they tend to be 
a preferred target for explicit exclusion from public coverage - IVF is one of these 
exceptions. In 1994, almost a quarter of the Health Authorities in Britain refused to 
purchase IVF services (Evans, 1995). President Clinton’s ill-fated Health Security Act 
specifically excluded IVF services from the minimum package of services to be 
covered by insurance plans. In the Netherlands, the Dunning Committee (a 
committee set up to define the legal responsibilities of insurance schemes), argued 
that IVF should not be considered necessary, since childlessness does not interfere 
with the normal functioning of Dutch society.
Despite IVF having been targeted by explicit rationing in several situations, little is 
known about what IVF is worth to patients and to society. In particular, very few 
studies have been carried out to measure the value generated by the money spent 
on IVF treatment. This study aims to investigate the value generated by resources 
used on this intervention, which increases the probability of couples with fertility 
problems to have a child.
The concepts of rationing and priority setting applied to healthcare are now receiving 
greater attention in many industrialised countries. In the Netherlands, Italy, New 
Zealand, Norway, Sweden, United Kingdom and the United States of America 
various initiatives have openly recognised that some forms of rationing take place in
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the healthcare systems and that, at least potentially, there are merits in taking some 
steps towards more explicit, systematic and democratic rationing.
Although it is increasingly recognised that implicit rationing is becoming less 
sustainable, so far only a few concrete initiatives have made rationing more explicit. 
Very often the policy debate tends to remain on the ground of principles and general 
criteria. However, economic evidence is required for reimbursement or coverage of 
pharmaceuticals in many countries (Taylor et al., 2004). The National Institute of 
Health and Clinical Excellence (NICE) in England and Wales and the Scottish 
Medicines Consortium (SMC) in Scotland regularly produce guidance based on 
economic evidence (Cairns, 2006). In Italy, the Netherlands, Canada, Australia and 
Sweden economic evidence is often required by regulatory bodies, but the process 
according to which economic data are analysed and assessed appear less well 
established than in the United Kingdom. Over the last ten years there have been a 
significant moves towards making governments’ decisions about funding medicines 
and, to a lesser extent, other technologies and interventions based on evidence of 
effectiveness and cost-effectiveness.
Despite the advances in explicit and systematic approaches to rationing and a wider 
use of economic evaluation studies to guide policy making, we are aware of a few 
explicit exclusions from public coverage in Europe. Despite clear evidence that 
resources made available by governments do not suffice to meet demand, rationing 
decisions are often left at organisational level and at the point of service delivery 
(Klein et al., 1996).
Nevertheless, there are some services that represent exceptions, as they tend to be 
a preferred target for explicit exclusion from public coverage - IVF is one of these 
exceptions. In 1994, almost a quarter of the Health Authorities in Britain refused to 
purchase IVF services (Evans, 1995). President Clinton’s ill-fated Health Security Act 
specifically excluded IVF services from the minimum package of services to be 
covered by insurance plans. In the Netherlands, the Dunning Committee (a 
committee set up to define the legal responsibilities of insurance schemes), argued 
that IVF should not be considered necessary, since childlessness does not interfere 
with the normal functioning of Dutch society.
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Despite IVF having been targeted by explicit rationing in several situations, little is 
known about what IVF is worth to patients and to society. In particular, very few 
studies have been carried out to measure the value generated by the money spent 
on IVF treatment. This study aims to investigate the value generated by resources 
used on this intervention, which increases the probability of couples with fertility 
problems to have a child.
1.2. Why Cost-benefit Analysis?
As argued by New and Le Grand (1996) moving towards more explicit, systematic 
and democratic forms of rationing is fraught with danger. In the areas where there is 
explicit rationing, decisions are made on the basis of facts rather than hypotheses. 
There is a clear need to identify rational approaches. One way to offer guidance to 
decision makers on a specific rationing decision is to perform an economic 
evaluation. In this type of evaluation, healthcare decisions are assessed by 
comparing costs of alternatives with their consequences or outcomes (Drummond et 
al., 1997). Traditionally, economic evaluations in the healthcare field have been 
carried out as either cost effectiveness-analysis or cost-utility analysis (ACU). In cost- 
effectiveness analysis (ACE) the cost per unit of health effects (i.e. life-years) gained 
by the adoption of the programme is estimated. In cost—utility analysis health effects 
are measured in terms of utility, in order to capture and combine in a single measure 
the different health benefits according to individuals’ judgement. Both cost- 
effectiveness and cost-utility analysis are inappropriate in the context of IVF. While it 
is theoretically possible to estimate the cost per new life or even the cost per Quality 
Adjusted Life Year (QALY) attributable to this technology, it is likely that these 
approaches will miss the real benefit of IVF: is the increase in welfare of giving an 
infertile couple a chance to have a baby.
Cost-effectiveness analysis may provide important economic insights about IVF and 
other Assisted Reproduction Technologies (ARTs). The incremental cost- 
effectiveness ratios, where effectiveness is measured in terms of live births or 
pregnancies, may be used to make a preliminary assessment about the “value” of the 
intervention and can be used to compare different ARTs or different categories of 
patients undergoing ARTs. Indeed, later in this thesis we present a cost-effective ness 
analysis of IVF and use it to make sense of the data obtained in the contingent
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valuation (CV) survey. However, the cost per live birth of using IVF or other ARTs 
cannot be compared to the cost per life saved or per year of life gained. Simply, new 
babies and saved lives are not commensurable as they refer to two completely 
different categories of benefits. Despite that both concern with life, there are no 
reason to assume that the contribution to the wellbeing of a new life is similar to that 
of a saved life. Therefore, cost-effectiveness data provide weak evidence, if any, to 
make decision about public coverage of IVF.
Cost-utility of healthcare intervention is becoming increasingly popular. In this type of 
study, health consequences of interventions are evaluated according to indexes 
(Quality Adjusted Life Years to mention the most widespread) that should represent a 
summary of patients’ preferences for different health states. In theory, the QALY 
construct could be used to measure the intensity of preference of a person (or a 
couple) for having a child in the case of infertility. For example, standard gamble 
exercises could be designed to ask respondents to trade between their years of life 
and the probability of having a child using IVF treatment. However, asking a person 
to trade her personal years of life with the probability of a newborn from IVF is 
logically far away from the QALY concept and the way it can be elicited.
An alternative approach to assess IVF from an economic perspective is to carry out a 
cost-benefit analysis (CBA). The main difference between CBA and the other 
techniques mentioned above is that the former seeks to place monetary values on 
both the inputs (costs) and outcomes (benefits) of the programme being evaluated, 
while the latter provides monetary measures of only the costs.
CBA is more appropriate than ACE and ACU because it allows one to capture the full 
value that IVF treatment holds for people. In the other two techniques, the value of 
programmes is strictly related to the contribution to the health improvements that the 
beneficiaries enjoy. Even in ACU, that makes use of the utility concept, the basic idea 
is to measure health-related quality of life rather than quality of life in general. 
Infertility is a medical condition; IVF is a medical intervention, being childless can be 
a very distressful condition - childlessness can sometimes lead to psychological 
disorders. Nevertheless, the gain that people derive from IVF is not mainly related to 
the health of the parents. It derives from fulfilling the desire of becoming a parent and 
its impact is on the overall wellbeing of the person/couple.
17
Cost-benefit analysis is more appropriate that ACE and ACU because it is more 
flexible and can thus go beyond the narrow health implications of procreating babies 
through IVF. It can measure the value of obtaining a child when one is infertile as 
well as also capture the benefits of undergoing the entire process, which can be 
associated with avoiding regret feelings (Ryan, 1999). In addition, CBA appears 
better grounded in welfare economics theory and provides clearer decision rules than 
ACE and ACU.
There are three steps in conducting a CBA for this specific medical intervention: a) to 
perform a cost-analysis to estimate the cost per cycle of treatment; b) to review 
effectiveness evidence to calculate the cost per unit of success, that is the cost per 
delivered baby; c) to compare the cost per delivered baby with the monetary value 
placed by society to have a baby from IVF. This study covers all the three steps and 
tries to provide some innovative advancements in terms of methodology on both 
costing and benefit measuring systems.
In order to measure the benefits of the treatment, one option is to refer to the human 
capital concept. According to this concept, the benefits of a health care intervention 
can be measured in terms of the future flow of income that is freed by the 
intervention (Robinson, 1993). The human capital approach has several limitations 
(Robinson, 1993; Johannesson 1996a). From a pragmatic point of view it has the 
disturbing consequence of assigning very small values to poor people and to 
individuals who are not in the labour force. From a theoretical point of view, the 
approach is not consistent with welfare economics because it is not rooted in the 
proper concept of willingness to pay (WTP), as measured by Kaldor and Hicks. 
Finally, at an intuitive level, the fallacy of the human capital approach derives from 
the fact that better health is measured in terms of enhanced productivity only, thus 
neglecting that individuals value good health per se. As a consequence, the human 
capital approach is no longer popular among economists and standard cost-benefit 
analysis is now generally carried out using the WTP approach. In this approach, 
monetary values are placed by observing or eliciting how much money individuals 
are prepared to pay for a particular good.
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WTP can be measured using two main approaches: revealed preferences or 
expressed preferences. The revealed preference approach is based on the 
observation of actual behaviour, while the expressed preference approach is based 
on the direct elicitation of WTP from individuals through the use of carefully designed 
and administered sample surveys. This approach is usually named the contingent 
valuation (CV) method.
In this thesis we use the CV method to perform a full cost-benefit analysis of a 
government programme providing IVF to infertile couples. The CBA aims to provide 
solid evidence to policy makers. In particular, it aims to use economic analysis to 
inform decisions relating to government coverage of a major medical intervention that 
has been specifically targeted by explicit rationing decisions. More specifically, two 
main research questions are addressed by this empirical study:
1. Can a contingent valuation survey conducted via the internet be a feasible method 
to measure benefits of a health care programme in general, and of a programme 
providing IVF in particular?
2. Taking into account the experimental state of the methodology, is the expressed 
WTP of Italians for a public programme providing IVF to infertile couples greater than 
costs of implementing the programme? In other words, would the benefits of such 
programme exceed its costs?
These research questions are strongly connected with four broader issues that are 
discussed in the subsequent chapters. The first issue pertains to IVF. Through the 
survey we have collected evidence to broaden our knowledge concerning the attitude 
towards this particular service. IVF, despite absorbing relatively small amounts of 
resources, well represents the new medical technologies that raise exceptional 
ethical problems and in which treatments aim at improving human functioning and 
general wellbeing rather than curing diseases.
The second aspect concerns the relationship between economics and health policy. 
By investigating the feasibility of a specific economic tool we expect to better 
understand how economic “rationality” can establish a fruitful dialogue with the
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multitude of perspectives that influence decision making processes within the health 
care sector. The IVF case is analysed in the broader context of the problem of the 
scarcity of resources in the healthcare system. The specific focus of the empirical 
part of the thesis is on the feasibility of using economic analysis to offer guidance to 
rationing decisions.
Previous contingent valuation studies have mainly investigated the perspective of IVF 
users. Given that our research measured the willingness-to-pay (WTP) of a sample 
of the general population we were able to investigate the role of caring externalities. 
Therefore, the third aspect discussed in the thesis concerns the distinction between 
egoism and altruism in the context of reproductive medicine.
Finally, this thesis investigates a thorny issue in contingent valuation studies: the 
format to elicit WTP. Since our sample was asked three WTP questions we could 
compare the referendum to the Payment Card formats and investigate how they 
differ.
1.3. Structure of the thesis
A full understanding of a cost-benefit analysis of IVF requires some understanding 
about infertility, its treatment and a variety of issues that makes this medical 
intervention rather special. Chapter 2 deals with these issues thus presenting the 
background of the rest of the thesis. It also mentions some policy issues raised by 
the use of this intervention and its government funding.
In a full cost-benefit analysis both estimates of costs and benefits are important. 
Therefore we paid attention to both of these issues in the thesis. Chapter 3 reviews 
the literature on contingent valuation and specifically investigates previous contingent 
valuation studies on ARTs. The review of the vast literature review on CV in 
healthcare has provided us with important elements to design the survey and has 
been used to make sense of our results.
To provide a solid background to the costing part of the study we used a rather 
different approach. We went through the literature on cost accounting, generally 
considered a sub-discipline of management, and we tried to learn from this literature
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how to conduct a cost study for the purpose of a cost-benefit analysis aimed at 
providing guidance about public coverage of an intervention (chapter 4). Briefly, we 
reached the conclusion that cost-benefit analysis should be based on solid cost 
studies, rather than on the use of tariffs and prices, and that the full costing 
methodology has to be used.
Chapter 5 presents the methods used in the cost-benefit analysis and details the 
source of the data. The measurement of benefits is based on a large survey 
conducted via internet that was specifically designed for the purpose of this research. 
The survey collected information about the knowledge, attitude and willingness to 
pay for IVF of a sample of the Italian population. The sample is not probabilistic but it 
was built to make a representative picture of adult Italians with respect to age, 
gender, education and residence. To our knowledge, this is the first attempt to 
investigate WTP for a medical intervention through a CV survey administered via 
internet to a large national sample. The last part of chapter 4 presents the methods 
used to estimate the cost of IVF. It explains how we calculated the cost of an IVF 
cycle according to a full costing procedure and how we used it in the context of the 
CBA. The cost analysis presented in the thesis is based on data collected in two 
Assisted Reproduction Centres located in northern Italy, one run by the Italian 
National Health Service and the other private.
Presentation of results is split into two chapters. Chapter 6 reports the results of the 
survey to provide a picture of the information about infertility and IVF, attitude 
towards this technology and willingness-to-pay. The purpose of this chapter is to 
provide a picture of what the people in the sample think about these issues and to 
assess possible correlations. In this chapter, we present results of several regression 
analyses that try to explain how demographic and socio-economic variables influence 
knowledge, attitude and willingness to pay for IVF. In addition to improve our 
understanding of what people think about IVF, this chapter provides some important 
insights about the validity of the survey and the contingent valuation method.
Chapter 7 focuses on the economic results of the study strictu sensu. It presents the 
estimates of mean WTP for personal use of IVF in case of infertility on the basis of 
the data of the Payment Card questions. It also presents WTP for a national 
programme providing IVF to infertile couple with public funding on the basis of the
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answers to a referendum format question and to a second Payment Card battery of 
questions. Results are then compared, discussed and used to investigate their 
validity. The chapter then reports results of the cost analysis and briefly reports 
results of a cost-effectiveness analysis. Finally, estimates of benefits and costs are 
assembled to perform the cost-benefit analysis of a programme providing IVF to 
infertile couples in Italy. On the basis of reasonable assumptions, our study shows 
that such a programme would generate net benefit and thus should be endorsed by 
the government.
We conclude our thesis with a discussion of several methodological issues 
encountered and raised by the study (chapter 8). Overall, the study is encouraging as 
it shows that collecting information for cost-benefit analysis in population surveys is 
feasible and valid, at least to a certain extent. We do think that the spectacular 
advancements of Information and Communication Technologies create more 
opportunities to use public opinion to make collective choices, including public 
opinion data that can be used in the framework of rigorous economic analysis.
Overall, this study provides evidence in favour of the public funding of IVF. This 
funding is consistent with recent trends in many affluent countries where IVF to 
infertile couples has become part of the benefits of statutory coverage. Nevertheless, 
it is important to underline that the results of our study are mainly driven by a minority 
of respondents that have high willingness-to-pay for the programme. This study 
confirms that measurement of benefits in cost-benefit analysis may favour the point 
of view of those who are more affluent and thus have higher willingness to pay.
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Chapter 2
Infertility and Assisted Reproduction Techniques
2.1. Introduction
This chapter provides a background to the rest of the thesis on infertility, the 
treatments to overcome it and some relevant ethical issues that influence policy 
making in this field of medicine. The chapter does not intend to cover in detail all the 
technical, ethical and legal aspects related to Assisted Reproduction Techniques 
(ARTs). Nevertheless it is written with the intention to give the reader a sufficient 
background to understand the rest of the thesis and to contextualise the use of 
economic analysis to offer guidance on public coverage of In Vitro Fertilisation (IVF) 
services.
The first two sections define infertility and its main treatments and provide a brief 
history of IVF, which was pioneered in the UK in the late 1970s. The following two 
sections concisely report the available evidence on the effectiveness and the 
possible side effects of IVF: it is now clear that this treatment does help infertile 
people to conceive but also presents a serious clinical side effect that is multiple 
births.
Section six briefly reports the main ethical problems at stake with ARTs. The aim of 
this section is to provide the reader with a summary of the issues that can influence 
public opinion and, in particular, attitudes towards public funding. The ethical and 
social issues arisen by IVF and other ARTs motivated European governments to 
enact specific legislation to regulate the matter. A summary of the regulation and 
public funding of IVF in the major EU member states are reported in section 7 and 8.
2.2. Infertility and its treatments
Infertility is generally defined as the inability to conceive after 12 months of 
unprotected sexual intercourse (Udoff and Adashi, 1999). However, the National 
Institute for Clinical Excellence (NICE) in the UK suggests a more stringent definition:
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that is, failing to get pregnant after two years of regular unprotected sexual 
intercourse. Infertility can be classified as either primary or secondary. Primary 
infertility is diagnosed if the couple has never had a conception, while secondary 
infertility is the term applied to couples that have a history of at least one documented 
conception but who currently have not been able to conceive for at least twelve 
months (if the less stringent definition of infertility is applied).
It should be noted that the definitions of infertility are based on evidence of 
pregnancy over a period of time, rather than on a physiological status of the couple. 
The probability of a normal couple conceiving in a given menstrual cycle is called 
fecundability and is estimated to be 25%. Taking into account that a fraction of 
conceptions results in spontaneous abortion, it is estimated that over 90% of normal 
couples will have conceived at the end of one year of unprotected sexual intercourse. 
Therefore, for those who fail to conceive the diagnosis of infertility (as defined above) 
does not necessarily mean that conception cannot occur, but rather that the couple 
have been unable to conceive naturally over a twelve month period. These couples 
belong to a medically defined group that is less likely to conceive. Some of them may 
be able to conceive naturally after a few more attempts while others may be affected 
by various conditions that make natural conception either highly unlikely or 
impossible.
Infertility is thought to affect 10-15% of all couples of reproductive age. Infertility 
increases with the age of both the woman and the man. The aetiology of infertility 
can be divided into three major categories: (i) male factors, (ii) female factors and (iii) 
undetermined aetiology. Men and women equally contribute to couple infertility. In 
approximately 40% of couples the aetiology is primarily male factor. Female factor 
accounts for another 40% while the remaining 20% of couples’ infertility is attributed 
to a combination of male and female factors.
The investigation of an infertile couple is a rather long process beginning with the 
analysis of a complete medical history and including a physical exam and laboratory 
testing. The aim of the evaluation is to make a specific diagnosis, which is helpful to 
decide the appropriate course of treatment. For male infertility approximately 50% of 
cases have no specific aetiology and for 75% there is no treatment that can directly 
improve the abnormality. The advent of Assisted Reproductive Technologies (ARTs)
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greatly benefited couples affected by male infertility as in almost all cases it can 
overcome the disfunction.
In approximately 40% of infertile women, the main aetiological factor is the failure to 
ovulate and in another 40% is related to tubal damage or other pelvic pathologies. 
Unusual causes and unexplained infertility account for the remaining 20%.
Treatment strategies for infertility depend on the specific aetiology of the infertility. 
The main strategies are surgery for anatomical defects and other specific conditions, 
ovulation induction with various drugs including compounds made through 
recombinant technology and ARTs, including sperm or egg donation. Indications for 
ARTs include tubal factor infertility, endometriosis, male factor infertility, immunologic 
infertility, and unexplained infertility. IVF is not the only or the most important 
intervention to overcome infertility. It is important to bear in mind that more simple 
techniques like artificial insemination are frequently used. Furthermore, it should be 
noted that pharmaceutical therapies increase the probability of pregnancy in many 
categories of patients. Scientists and clinicians suggest following a gradual approach 
to treating infertility and recommend the use of complicated (and often invasive) 
techniques only if the more simple ones fail.
IVF consists of a sequence of steps that, by overcoming possible male and female 
dysfunctions, make conception more likely than through the natural way. In the 
natural cycle an oocyte (egg) leaves an ovary and is transported through a fallopian 
tube. There it can be fertilized by a spermatozoon and become an embryo. The 
embryo may settle in the uterus and grow into a foetus. In an IVF cycle this sequence 
is altered by medical intervention. First, medication is given in order to obtain more 
oocytes. Then, if stimulation is successful, the oocytes are aspired from the ovaries. 
Here the in vitro phase begins. Basically, spermatozoa (previously collected) and 
oocytes are brought together in order to obtain embryos. These embryos are then 
transferred into the woman’s uterus three or five days after the aspiration. From this 
stage on, natural and assisted conceptions return to follow the same course.
ZIFT (Zygote intra-Fallopian transfer), GIFT (Gamete intra-Fallopian transfer) and 
ICSI (Introcytoplasmic injection) are variants of IVF. ZIFT is the same procedure as
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IVF except that embryos are transferred into the Fallopian tubes rather than into the 
uterus. GIFT utilizes the same oocyte stimulation protocol as IVF; however, once the 
eggs are retrieved, they are mixed with sperm and immediately transferred into the 
tubes. GIFT and ZIFT techniques are not widely used and, according to the NICE 
Clinical Guideline issued in 2004, there is insufficient scientific evidence to 
recommend their use in preference to conventional IVF (National Collaborating 
Centres, 2004). ICSI is a micromanipulation technique. This sophisticated procedure 
introduces a single sperm directly into the cytoplasm of the egg and can produce 
fertilization even in cases with very poor-quality sperm. This technique overcomes 
almost all the causes of male infertility (Edwards, 1998), improves fertilisation rates 
and represents more than 50% of all IVF treatment in many countries (HFEA, 2006).
2.3. IVF and infertility treatments: a brief history
For centuries, human reproduction was a mystery and, in many societies, birth was 
considered as a miracle. Those who were unable to conceive could not receive 
significant help and were often stigmatised. Until the beginning of the last century, a 
variety of rites and primitive medicines, including ingredients such as pig’s teeth, 
frogs and spiders were the only hope for infertile couples (Edwards, 1998). Indeed, 
infertility, up until recently, was believed to be a female problem, although it is now 
undisputed that both female and male infertility cause couple infertility (see above).
IVF has diverse origins (Edwards, 1998) and the history of the technique may be 
characterised by three related periods of development (Iglesias, 1990). The first 
phase dates from the late nineteen century until the late 1960s - it was in the hands 
of research scientists. Dr. Heape is the person generally attributed as being the first 
researcher to make a significant contribution to the development of IVF. Heape 
transferred genetically marked embryos from one rabbit to another and obtained 
offspring. In the thirties the first attempts were made to culture mammalian embryos 
in vitro. Approximately during the same period various hormones influencing and 
regulating the gonads were discovered and in the following two decades they were 
tested on mice to induce ovarian stimulation.
The second phase, from 1968 to 1978, is characterised by the collaboration between 
scientists and clinicians. In 1968 the first medico-scientific research team was set up 
under the leadership of Dr. Edwards (a physiologist who is considered the father of
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IVF) in England. The team set up a very ambitious agenda: “to attempt (human) 
fertilisation in vitro and the culture of embryos in order to alleviate some forms of 
infertility, and to study the origin of inherited defects" (Edwards, 1983). In effect, this 
ten-year period led to the acquisition of all the fundamental steps required to 
implement IVF. They included the basic understanding and control of the maturation 
of a) the human egg, follicle growth and the process of ovulation, b) the fertilising 
capacitation of sperm, c) the aspiration of the pre-ovulatory egg, d) the replacement 
of the embryo in the womb, d) the implantation on the embryo in the womb and the 
continuation of pregnancy (Iglesias, 1990). Mastering these steps has made it 
possible to replace embryos into infertile mothers since 1972. The birth of the first 
baby successfully conceived in vitro, Louise Brown, was in July 1978.
The third phase (1978 to present), has seen significant technological developments 
and very rapid widespread use of the technique in industrialised countries. In the 
1980s new drugs were introduced, the IVF technique was refined and variants of IVF 
were developed (gamete intra-fallopian transfer -GIFT- and zygote intra-fallopian 
transfer -  ZIFT). In 1986 the diagnosis of genetic disease in human pre-implantation 
embryos was introduced. More recently, ICSI (intracytoplasmic sperm injection) has 
opened the era of direct manipulation of the human gamete. ICSI has significantly 
improved assisted reproduction by improving fertilisation rates in general and by 
extending the treatment population to include patients with male sub-fertility - 
previously not considered viable for classic IVF.
Since their first clinical success, IVF and other assisted reproductive techniques were 
rapidly adopted in many countries. At Bourn Hall, the private clinic established in 
England by the pioneers of IVF, from October 1980 to April 1983 139 babies were 
born as a result of IVF. In 2000 in the United Kingdom (UK), 72 IVF clinics were 
operating and about 6,500 babies were born after IVF or ICSI cycles (HFEA, 2000). 
Between April 2003 and March 2004 10,242 children were born through IVF (HFEA, 
2006). They are approximately 1.5% of all the newborns in UK. These babies were 
procreated as a result of the commitment of 30,000 patients who underwent IVF for a 
total of about 38,000 cycles of IVF treatment.
A survey conducted by Shenker (1997) shows that in 1995/96 IVF was available in 
516 centres in 39 European countries. According to a similar survey carried out on
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Asian centres, approximately 267 ART centres (half of which in Japan) were 
operating in Asia (Shenker and Shushan, 1996). However, these centres were 
concentrated in only 16 countries, where the standard of living is relatively high. In 
the United States of America, where IVF was introduced in 1982, the market for IVF, 
excluding fertility drugs, is estimated at 1 trillions US $ (Spar, 2006). In 1986, there 
were roughly 100 fertility clinics, performing about 10,000 cycles of ARTs. In 2002, 
there were 428 clinics performing as many as 115,000 cycles.
2.4. Effectiveness of IVF
Despite the impressive development of IVF, the documentation of its effects has not 
been supported by large randomised clinical trials. Effectiveness is mainly 
documented by success rates reported by clinics and by national and international 
registries. Only recently, a few relatively small trials have reported significantly higher 
live birth rates with IVF/ICSI cycles when compared with no treatment in some 
categories of patients (National Collaborating Centres, 2004). Despite the lack of 
large clinical trials, however, it appears now undisputable that IVF is an effective 
procedure.
Since IVF is a chain of several treatment phases, success rates can be presented in 
several ways. The two main most meaningful measures are the pregnancy-per-cycle 
rate and the live birth-per-cycle rate. The pregnancy-per-cycle rate is the percentage 
of IVF cycles started that produced a pregnancy. This rate is higher than the live birth 
per cycle rate because some pregnancies end in miscarriage, therapeutic abortion, 
or stillbirth.
The live birth-per-cycle rate is the percentage of IVF cycles started that result in a live 
birth (a delivery of one or more babies). In terms of overall benefits, this is the most 
significant rate as it represents the average chance of having a live-born infant by 
using IVF. This rate is the main measure that will be used in this thesis.
The first significant statistics collected in the second half of the ‘80s reported a live 
birth-per-cycle rate around 10% (Haan, 1991; Medical Research International, 1989). 
Since then the success rate has significantly improved. In the early ‘90s patients 
undergoing IVF could expect pregnancy rates of 17% to 23% per cycle and
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corresponding delivery rates of 13 to 18% per cycle. Data from 49 countries for 2002 
show that the delivery rate per initiated cycle is now 18.6% for conventional IVF and 
20.4% for ICSI -  the data refers to non donated material only (Adamson et al., 2006).
More recent data appear even more favourable. In the USA the 2003 Assisted 
Reproductive Technology Report shows basic statistics of almost all the clinics (399 
of the 429 clinics) operating in the USA in that year (Centers for Disease Control and 
Prevention, 2005). Results reported in table 1 refer to all ART (IVF, GIFT and ZIFT) 
cycles that used fresh, non-donor eggs or embryos. Results mainly refer to IVF as 
GIFT and ZIFT were performed rarely (about 0.5% of treatments), while 56% of IVF 
cycles were performed using the micromanipulation technique ICSI (success rates in 
IVF cycles with and without ICSI appear similar). In 2003, according to the Report, 
91,032 cycles were initiated with fresh non-donor eggs or embryos. They were 
responsible for 31,348 pregnancies and 15,367 live births. Consequently, pregnancy 
rates and live birth rates were 34.4% and 28.3%, respectively.
Table 2.1. Outcome of ART cycles using fresh, non-donor eggs or embryos in 2003 in the United States___________
#
Cycle initiated (1) 91,032 Pregnancy per cycle (4/1) 34,4%
Egg retrieval (2) 79,602 Live birth per cycle (5/1) 28,3%
Embryo transfers (3) 74,296 Live birth per retrieval (5/2) 32,4%
Pregnancies (4) 31,348 Live birth per transfer (5/3) 34,7%
Live births (5) 25,775 Live birth per pregnancy (4/5) 82,2%
Source: Centers for Disease Control and Prevention, 2005.
A similar registry is kept in the United Kingdom by the Human Fertilisation and 
Embriology Authority (HFEA, 2006). During the period 2003/04 the Authority 
collected data on 38,264 IVF cycles administered to 29,688 patients (the all cycles 
legally performed in the UK). In the 92/93 period there were reported 17,301 initiated 
cycles with a live birth per initiated cycle of 13.2%. In the late nineties the number of 
cycles performed in the UK almost doubled (28,689) and live birth rated reached 
19.6. Data based on treatments carried out between April 2003 and March 2004 
show that about 29,700 patients underwent IVF, that 38,264 cycles were initiated and 
that they facilitated 8,251 successful births (success rate = 21.6%).
There are various factors that are supposed to affect IVF pregnancies and live birth 
rates. The most significant one for the purpose of this dissertation is the age of the
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woman. It is now clearly recognised that the woman’s age has a crucial effect on IVF 
success rate -  this is clearly demonstrated by the American and the British registries. 
The evidence illustrates that pregnancy rates, live birth rates for ART Cycles using 
fresh non-donor eggs or embryos decrease with age. In the USA, while live birth 
rates for women who are 30 years old or less is above 40%, the average chance of 
live birth is 15.1% for women aged 40 (Centers for Disease Control, 2005).
The strong impact of age on IVF success rate is also reported in the UK (HFEA, 
2006). Table 2 shows live birth rates by woman age. The live birth rates remain 
above 28% for women less than 35 years old. For older women this rate sharply 
declines, especially for those who are above forty. Out of 836 cycles performed in 
women aged 43 or above only 3.2% of the treatments resulted in a live birth. As we 
will see later in this thesis, these data have a very strong impact on the cost- 
effectiveness of IVF: older women, who are also often those who feel more 
compelled to procreate, present much less favourably in the cost-effectiveness ratios 
due to the limited effectiveness of the procedure on them.
Table 2.2. Live birth rates by age of woman in the United Kingdom (non-donor fresh 
eggs only)________________________
Woman age Treatment cycles Live birth rate per 
treatment cycle
Under 35 13,489 28.2%
35-37 7,077 23.6%
38-39 3,984 18.3%
40-42 2,965 10.6%
43 and over 836 3.2%
A ll patients 28,351 23.3%
Source: HFEA, 2006
2.5. Clinical side effects of IVF: the problem of multiple births
Although IVF and other ARTs have brought hope to many couples suffering from 
infertility, these procedures have important shortcomings (Serour et al., 1999). The 
whole experience that couples have to undergo whilst on IVF programmes is 
emotionally taxing and stressful. From the clinical point of view, various side effects 
are associated to the procedure itself. Daily injections are required, tests have to be 
repeatedly carried out to monitor hormone levels, furthermore oocyte recovery and 
embryo transfer have some relevant side effects. The side effects that can result can 
be as a consequence of the medication; it increases the risk the Ovarian
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Hyperstimulation Syndrome, as well as the risk of infection and bleeding during 
oocye collection (Serour et al., 1999). Moreover, women undergoing IVF experience 
higher rates of miscarriage, ectopic pregnancy and heterotopic pregnancy. However, 
it is unclear if the higher rates can be attributed to the interventions or simply to the 
baseline condition of the woman (for example some of these side effects could be 
attributed solely to being older). Despite a long list of problems that can be 
associated with IVF, at present there is no strong evidence that side effects of IVF 
are so relevant and/or widespread to restrict its use in healthy couples.
The major clinical problem with IVF is somehow related to its effectiveness, which is 
multiple pregnancies and births. Multiple pregnancies are associated with greater 
risks for both mother and foetuses compared with a singleton pregnancy (Edwards, 
1998). These include higher rates of caesarean section, low birth weight, and infant 
death and disability. In the USA in 2003, among the 31,348 pregnancies that resulted 
from ART cycles using fresh, non-donor eggs or embryos, 59% of pregnancies were 
singleton, 29% were twin pregnancies, and 6% were triplet or greater pregnancies 
(Centers for Disease Control, 2003). Thus, overall, about 35% of the pregnancies 
included more than one foetus.
The high rate of multiple foetus pregnancies results in multiple live births. Thirty-four 
percent of live births from ART involved more than one infant (31% twins and 3% 
triplets). This compares with a multiple-infant birth rate of less than 3% in the general 
US population. The multiple birth rates for IVF are also high in the United Kingdom. 
In the period 1998/99 about 24% of births were multiple, with almost 3% triplets or 
more (HFEA, 2006).
There is much discussion in clinical literature about the high rate of multiple 
pregnancies. The main point of this discussion concerns the positive association 
between multiple pregnancies and the number of embryos replaced. The HFEA 
figures for 1998/99 show that the pregnancy rate per cycle with one, two, or three 
embryos replaced was 9.5%, 26.1% and 26.4%, respectively (table 3). 
Corresponding multiple pregnancy rates were 3.2%, 26.4% and 33.1%, respectively. 
Basically, patients and clinicians face a trade-off when they decide how many 
embryos should be transferred - the higher number of embryos they transfer, the
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higher the chance of live birth. However, the higher the number of embryos 
transferred, the higher the risk of there being a multiple pregnancy.
Table 2.3. IVF clinical pregnancy and multiple clinical pregnancy by the number of embryos 
transferred in the United Kingdom________________________ ____________ _____________
Embryos
transferred
Number 
o f cycles
Number o f clinical 
pregnancies
Clinical
pregnancy
rate
Multiple clinical 
pregnancy rate
Singleton Twin Triplet or 
greater
One 2,977 276 8 1 9.5% 3.2%
Two 14,144 2,721 959 15 26.1% 26.4%
Three 13,399 2,398 924 248 26.4% 33.1%
Total 30,520 5,395 1,891 264 24.6% 28.7%
Source: HFEA, 2000
In the early nineties UK legislation limited the maximum number of embryos to be 
transferred to three. Similar rules are enforced in other European countries. Recently, 
the Human Embryology and Fertilisation Authority lowered the maximum to two. In 
the USA there is no such limitation thus meaning that almost 50% of cycles involve 
the transfer of more than three embryos. This may partially explain why the success 
rate in the USA is higher.
2.6. Ethical and social issues related to IVF
This dissertation focuses on the economic dimension of IVF, using economic 
analysis to assess whether this technology should be publicly funded. Therefore, a 
thorough analysis of the ethical and social implications of IVF and other ARTs is 
beyond the scope of the present study. However, as health policy process 
concerning reimbursement can be affected by the ethical and social concerns, this 
section will briefly present the main ethical issues raised by the use of ARTs.
These technologies have made possible to change reproduction in four ways (Koch, 
1998). First, technology can be used to substitute, repair or circumvent physical 
elements of the reproductive process. This is the technology option mainly referred in 
this dissertation. The technical process is one in which non-donor fresh eggs and 
sperm are manipulated in vitro with the sole purpose of overcoming infertility.
Second, technology can be used to exchange actors in the reproductive process, 
making possible the creation of family types that would not otherwise have existed. 
With IVF using father’s spermatozoa and the mother’s egg, the child is genetically
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related to both parents, whereas children conceived with donated sperm are 
genetically related to the mother but not to the father. Likewise, children conceived 
using donated eggs are genetically related to the father but not the mother. When 
both eggs and spermatozoa are donated, the child is not genetically related to either 
parent. This latter group of children is similar to adopted ones in that they are 
genetically unrelated to both parents, but differ in that parents experience pregnancy 
and develop a relationship with the child at the prenatal stage and subsequently birth. 
Moreover, the exchange of actors in the reproductive process may involve surrogacy: 
this is when a woman accepts to carry out a pregnancy to deliver a baby that it is 
immediately given to someone else (the child may be genetically related to neither, 
one or both parents).
The third class of technical options refers to the possibility to space out the elements 
of reproductive process by freezing. At present it is technically possible to freeze 
sperm, eggs and fertilised eggs (embryos). These options make possible to 
procreate post-mortem. In theory, a baby can be delivered years after the death of 
both their genetic parents.
The fourth class concerns pre-implantation genetic diagnosis and germ line therapy. 
Pre-implantation genetic diagnosis is a very early form of prenatal diagnosis aimed at 
eliminating embryos carrying serious genetic disorders. It can also be used to carry 
out gender selection. Although not feasible yet, gene therapy may soon allow to fix 
some genetic diseases at the embryonic stage.
As mentioned above, a systematic discussion of the implications of each of these 
technical options is beyond the scope of the dissertation. We only briefly present the 
main issues related to the first typology, which is directly involved by the economic 
evaluation presented in the following chapters. Before doing this, however, it appears 
appropriate to make a few general considerations on the overall advancements in 
human reproduction technology.
In order to neutralise the ethical issues as much as possible, we designed the cost 
benefit analysis making reference to infertile married couples using their own 
gametes. Therefore, the economic analysis disregards programmes where donated
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genetic material is used, that makes use of surrogacy and that include diagnostic 
activities, embryo selection and cryoconservation. This should have minimised the 
risk that surveyed individuals were influenced by ethical considerations that are not 
necessarily involved in conventional IVF (first typology described above). 
Nevertheless, it should be recognized that such an attempt to counterbalance the 
ethical issues raised by the other typologies of ARTs cannot be complete. We do 
expect that some of the respondents were influenced by the overall debate 
concerning new advancements in human procreation and the ethical issues it raises
The second consideration concerns the relationship between the new advancements 
in reproduction technology and public funding. The aim of this research is to assess 
if, from an economic point of view, traditional IVF deserves public funding. Here IVF 
is seen merely as a way of overcoming infertility. Consequently, we focused on 
traditional IVF because it is very relevant in economic terms and because it involves 
few of the ethical problems raised by the other typologies. However, it should be 
clarified that even more advanced techniques urgently require explicit decision 
regarding public funding. Let’s take for example pre-implantation gene diagnosis and 
gene therapy. They are extremely controversial as they may take relevant steps 
towards designing children and eugenics. However, it is also clear that the potential 
benefits are very relevant as certain diseases can be avoided or somehow made less 
distressing. In other words, these technologies pose serious ethical problems but 
also have the potential to provide great health benefits. At present, ARTs are not 
simply a way of overcoming infertility but also a potential way in which to promote 
health at the prenatal stage. If the use of ARTs expands as a means to improve 
people health it will be very important to carefully assess the costs and benefits of 
public funding. The risk we see in this area is that relevant ethical issues may 
encourage lesser government involvement in public funding resulting in health 
inequalities increasing.
Returning to traditional IVF, various ethical issues have been raised. The first, more 
radical one, concerns the separation of sexual intercourse from procreation. The 
prime argument against IVF presented by the Catholic Church refers to this 
separation. According to Donum Vitae (Congregazione per la Fede, 1987), the main 
Catholic Church document on human procreation, God defined an indissoluble 
connection between the two meanings of marital life (sexual life): marital union (that
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is something spiritual) and procreation. As contraception denies the procreative 
dimension of the marital life and thus it is unethical, in a similar way IVF is unethical 
too because denies the marital (spiritual) union during the act of procreation. 
According to the official position of the Catholic Church, sex and procreation are 
necessarily linked and technology cannot be used to separate them.
This rather radical position appeals mainly to the Catholic community and does not 
exert sufficient influence at a political level to forbid traditional IVF in virtually all 
industrialised Christian countries. Indeed, this position was not even endorsed by 
Italian catholic parties during the parliamentary discussion on IVF in 2004. The 
Catholic Church, other religions, and also various non-religious cultural and 
ideological movements appear more rigid with regard to another critical issue related 
to IVF interventions: the generation and the use of embryos. The in-vitro phase of the 
procedure aims at producing more than one embryo to facilitate the choice of the 
best ones to be re-implanted and thus possibly re-implanting more than one embryo 
and, in some case, cryoconserving them for possible future use. The ethical focus 
here is on the nature of embryos. Those who consider embryos as a form of life 
harshly criticise IVF, as in many cases it requires suppressing some of them. In 
effect, even those who do not recognise embryos as a form of human life generally 
agree that some form of protection should be granted to embryos and that their 
handling should be regulated.
Related to the “overproduction” of embryos is also multi-foetal pregnancy reduction. 
As seen above, in order to increase the chance of obtaining a live birth, very often 
numerous embryos are transferred to the woman’s uterus. This results in a very high 
incidence of multiple gestations (about 30%) carrying with it increased frequency of 
complications for the mother as well as a higher perinatal morbidity and mortality. 
Multi-foetal pregnancy reduction is therefore prescribed to protect the mother, to 
increase the chance of at least one live birth and sometimes just because the mother 
is not willing to manage multiple births. To a certain extent multi-foetal pregnancy 
reduction resembles a type of abortion a can thus criticised and justified on the same 
ground. However, at least two differences distinguish normal abortion from multi- 
foetal reduction. The first relates to the origin of the problem. While, "normal" abortion 
is related to an unwanted pregnancy, multi-foetal reduction derives from a clear 
desire to have a baby (although it is not necessarily the case that more than one
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child is desired at a given time). From this point of view multi-foetal reduction may be 
considered even worse than a "normal" abortion as it contrasts procreation after a 
series of acts aimed at making it possible. On the other hand, some clinicians claim 
that multi-foetal reduction should not be considered as an abortion since the purpose 
of selective termination is the continuation of life, and not the termination of the 
pregnancy (Fasouliotis and Shenker, 1999). If selective termination is carried out to 
protect the other foetuses or the mother, it can be argued that the termination is 
carried out in order to protect life.
The last main ethical issue raised by traditional IVF is the generation of spare 
embryos that are usually obtained by the method of induced super-ovulation in the 
woman. The practice of inducing super-ovulation is performed for two main reasons: 
it avoids subjecting the woman to the trauma and the risks of repeated laparoscopies 
to recover oocytes (in the case more than one cycle is attempted) and it facilitates 
the selection of embryos prior to implantation (Shenker, 1997). In addition, the 
generation of spare embryos may be pursued in order to make spare "material" 
available for donation or scientific research. Although super-ovulation and thus the 
generation of spare embryos is not strictly a part of an IVF programme, this is a 
commonly diffused practice. The generation and use of spare embryos raises the 
issues of their destiny and their protection and are subjected to a lot of ethical 
disputes.
2.7. IVF regulation in Italy and other major European countries
IVF and other ARTs are practised in all European countries with the exception of 
Luxembourg (Shenker, 1997; Spar, 2006). In most countries the practice of IVF 
commenced in the '80s before specific legislation was enacted. However, major EU 
members, with the exception of Italy, enacted specific regulation in the late 1980s or 
in the first half of the 1990s. In France, Germany, Spain and UK specific pieces of 
legislation authorise and regulate ARTs (Human Fertilisation and Embriology Act, 
1990; Lansac, 1996; Beier and Beckman, 1991; Shenker, 1997). In all of the above- 
mentioned countries FIVET, GIFT, ZIFT and ICSI are legal and can be administered 
for a therapeutic reason (i.e. to help the couple to conceive if they are infertile). 
Differences across the various pieces of legislation arise on a number of issues. The 
United Kingdom and Spain appear more liberal than France and Germany. In the 
former two countries, in addition to married couples, co-habitant couples and single
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women can have access to ARTs. In France, access to the techniques is restricted to 
couples (including those who co-habit), while in Germany assisted reproduction is 
allowed only to married couples. Legislation in these countries also differs as far as 
genetic material donation is concerned. The United Kingdom and Spain allow sperm, 
ovum and also embryo donation; France forbids embryo donation but permits sperm 
and ovum donation; Germany appears more restrictive as it forbids IVF with donated 
material. Germany is also more restrictive compared to the other mentioned 
countries concerning cryopreservation; it is illegal. Whereas, in France, Spain and 
UK cryopreservation is legal if aimed at making available extra embryos for transfer 
in a future cycle. In Spain and UK cryopreservation is also allowed for the purposes 
of pre-embryo research (pre-embryo refers to the first 14 days after fertilization).
In all of the above-mentioned countries selective foetal reduction of multiple 
pregnancies is practised. However, in order to avoid foetal reduction, all of the four 
countries’ medical guidelines suggest that no more than 3 or 4 embryos are 
transferred - the UK limits the number of transferred embryos to 2. Another 
commonality that these countries share is that the national government, regional 
governments or a specific national authority (like the HFEA in the UK) specifically 
regulate the activities of the centres that are licensed to provide ART services.
In contrast to the situation of these members of the European Union, Italy has kept 
infertility services provisionally regulated for a long period. It was only in 2004 that a 
piece of legislation was passed by the Italian Parliament that related to the regulation 
of ARTs. The matter was initially regulated by a Circular enacted by the Ministry of 
Health that was conceived as a provisional measure, further it was targeted only to 
the NHS. However, due to the lack of legislation, the Circular became the judicial 
reference for the practice of ARTs in the NHS and the private sector was left without 
regulation. As a result, until 2004, the practice of IVF in the NHS was strictly limited, 
while the private sector could act well beyond what is legal in most of the other EU 
member states.
The Circular, while introducing the principle that infertility treatment is part of the 
duties of the NHS (thus implying that public coverage was assured), clearly limited 
the availability of the treatment to married couples and excluded the use of donated 
material. At the same time, the lack of explicit regulation on the matter in the private
37
sector left ample room for the establishment of private practices that performed an 
array of services, including services to unmarried couples and single women, IVF 
and other ARTs with donated material, cryopreservation, and even gender selection.
Although there is insufficient evidence is, it appears likely that Italy was not a safe 
environment for couples (and individuals) seeking infertility treatments. The lack of 
legislation and the strict rules imposed, limited the provision of IVF and other ARTs in 
the public sector, whilst paradoxically it promoted the establishment of private clinics 
that could operate with minimal surveillance and control. Although professional 
associations established codes of practice (CECOS, EFRA Italia), they were not 
mandatory and many private practices operated at their discretion, with no obligation 
to respect standards and no explicit accountability systems. Despite a National 
registry of ART centres being established by a government directive, registration was 
not made compulsory therefore there were many centres that were not even known 
by the Ministry of Health and Regional Health Authorities.
This situation has been highly criticised by professional associations, patients' 
advocates and all political parties. However, for many years the Parliament was not 
been able to pass legislation, despite the fact that many members of Parliament had 
officially stated that legislation was absolutely required to stop the "Italian Wild West" 
of reproductive services.
Indeed, in 1999 it looked as though legislation would have been enacted. The 
"Camera dei Deputati" (the Lower House) approved an act covering all the main 
issues and in the "Senato" (the Upper House) major political parties stated that they 
would have voted in favour of this piece of legislation as it was the result of a 
reasonable compromise between different instances. Instead however, members of 
the Senate claimed autonomy from the official party positions on the grounds that, on 
such vital issues as those raised by ARTs - personal value judgements were more 
important than party discipline. Consequently, the equilibrium reached in the Lower 
House dissolved and thus the proposed legislation was not approved.
Legislation was finally passed in 2004, after fierce parliamentary discussion (Legge 
40, 2004). It clearly states that Assisted Reproduction Technologies are allowed only 
to overcome fertility problems and only once other therapeutic methods (e.g. artificial
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insemination) have failed. It permits IVF and other ARTs to married and stable 
heterosexual couples, but only using the couples’ genetic material. Donation of eggs, 
sperm or other genetic material is not allowed and severely punished. The legislation 
also bans the freezing of embryos, limits the number of embryos that can be 
implanted in the woman’s womb to three and forbids embryo research. Opponents to 
the legislation tried to cancel it through a national referendum held in June 2005. The 
referendum failed because only 34% of adult Italians (automatically registered to 
vote) went to the polls. Basically, those who favoured the approved legislation 
campaigned against going to the polls. As a consequence, despite a sweeping 
majority among voters, abolishers did not reach the quorum of the majority of Italians 
registered to vote and hence the legislation was not abolished.
2.8. Public funding of IVF
In the past IVF was often used to discuss criteria for rationing (Klein et al. 1996, 
Giacomini et al., 2000). The Dunning committee in the Netherlands suggested that 
IVF was not necessary and thus should be excluded from public coverage because 
childlessness does not interfere with normal functioning in the Dutch society (Van de 
Ven, 1995). President Clinton’s ill-fated Health Security Act specifically excluded IVF 
services from the minimum package of services to be covered by insurance plans 
(Spar, 2006). In the early nineties, in a UK study of 114 purchasing plans, the 
majority of Health Authorities stated that they were purchasing some IVF (Redmayne 
et al., 2003). However, six health authorities explicitly stated they did not want to buy 
IVF or other similar ARTs. This old study clearly showed that the public funding of 
IVF was not consistent across the UK. More recently, a Canadian study used the 
case of IVF to study the multiplicity of meanings of not insuring services and to show 
the complexity of rationing decisions.
In the early days of ARTs many governments tried to exclude them from public 
coverage on several different grounds. These included the claim that infertility is not 
a disease, that IVF is not a cure but only a way to bypass infertility problems, that IVF 
is not really needed because some people decide to be childless, or that, in those 
days, IVF was still experimental. Indeed, IVF was an interesting object of rationing 
because it is peculiar for the “need” it addresses and for the outcome it promises. 
Obviously, procreating babies is different from saving lives or improving the quality of 
life of people suffering because of a disease. It is not denied that people with
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infertility may live in stressful conditions, but it is argued that it is purely subjective as 
some people prefer not to have babies and are happy about that. Generally, 
diseases do not work this way. We could not find other examples in which people are 
not negatively affected by having a pathological condition and may be even pleased 
by that. Also, ARTs interfere with procreation rather than with existing lives and this, 
as seen earlier, may pose ethical problems. Whatever the reason, IVF was a 
preferred target for discussion and for explicit decisions about rationing.
At the moment, IVF is provided, although with limitations, with some government or 
social insurance funds in the four largest EU member states (France, Germany, Italy 
and the UK). None of these countries entirely excludes IVF from public or statutory 
coverage, even if different rules may apply about eligibility criteria (e.g. the age of the 
woman), types of ARTs offered and maximum number of cycles per patient. 
Nevertheless, it appears likely that publicly funded supply falls short of demand. 
There is some evidence to suggest a lack of access to treatment within the British 
and the Italian NHS, the two largest tax-funded systems in Europe. The HFEA (2006) 
reports that about 25% of IVF treatments are funded by the NHS. This low 
percentage contrasts with NICE recommendations that couples should be offered up 
to three cycles of IVF on the NHS if the woman is aged 23-39 and the couple has an 
identified cause for their infertility, or have not conceived after three years. There are 
no reliable data in Italy about the use if IVF, as at June 2006 a list of all the centres 
nationwide that the Italian regions have authorised to provide IVF treatments was not 
available. Nevertheless, three clinicians that we met when collecting cost data 
reported that the number of NHS centres is rather limited and that the majority of 
treatments are performed by private institutions and are paid for directly by patients.
It appears that IVF treatments are not denied by official government positions in 
major European countries, but rationing may take place in the form of short supply 
and lack of compliance with the recommendations. In this respect, NICE in England 
and Wales took a clear stand, as it made specific recommendations about the use of 
IVF treatments, while the Italian NHS appears generic in the way it includes them in 
its basic package. The following chapters will present and discuss methods and 
results of a cost-benefit study designed to offer guidance on the issue of public 
coverage of this treatment. From an economic perspective it is based on the 
assumption that a thorough computation of costs and benefits according to a welfare
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economics model may allow us to discern whether the programme makes a positive 
contribution to the welfare of a defined population. While we recognise that there may 
be merits in some forms of uncertainty and ambiguity in NHS coverage (Mechanic, 
1995), we strongly believe that systems need to be more “rational” in the way they 
use scarce resources. We agree with New and Le Grand (1996) that there is a real 
danger that moving too fast towards explicit, systematic and democratic forms of 
rationing may be problematic because the “NHS is about more than simply producing 
health ...(as) it acts as a mechanism, and a symbol, of reassurance and social 
stability to that sound economic analyses may help decision making”. We have not 
designed and conducted this study with the intent to offer policy-makers the final 
solution about IVF coverage. We simply think that a sound economic analysis, 
designed to help decision-making, may be a relevant input to make better choices in 
health care systems.
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Chapter 3
The contingent valuation method for measuring the benefits of
health care
3.1. Introduction
Since the seminal work by Mishan published in 1971 applications of cost-benefit- 
analysis (CBA) have been mainly based on the estimation of individuals’ willingness- 
to-pay (WTP) or willingness-to-accept (WTA). The former refers to the maximum 
amount of money that individuals are willing to pay for a set of benefits, while the 
latter refers to the minimum amount of money that individuals are willing to accept as 
compensation for a set of losses. There are two main empirical approaches that can 
be used to measure WTP or WTA for benefits attributable to healthcare programmes: 
revealed preferences and expressed preferences. Revealed preference studies 
indirectly measure WTP or WTA through the observation of actual behaviour. 
Choices concerning occupation, housing, diet and driving behaviour can reveal 
people’s attitude towards their health and, hence, can provide data to estimate WTP 
or WTA for some health hazards. The most common type of revealed preference 
studies related to health refers to wage-risk trade-offs on the labour market 
(Johannesson 1996a; Viscusi 1993).
Expressed preferences studies derive WTP or WTA from survey questions referring 
to hypothetical markets. This approach circumvents the absence of markets for some 
goods and can capture elements that are not present in private market decisions. 
Surveys can be designed to reflect either a private goods market or a political market 
(Mitchell and Carson 1989; Smith, 2006 see below). Since the values elicited from 
these surveys are contingent upon the particular hypothetical market described to the 
respondent, this approach has been called the Contingent Valuation (CV) method.
The first trace of the idea to elicit monetary benefits from hypothetical surveys and to 
use them in cost-benefit analysis dates back to 1947, when Ciriacy-Wantrup wrote 
that:
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“Individuals of a sample or of a social group as a whole may be asked 
how much money they are willing to pay for successive additional
quantities of a collective extra-market good.  If every individual o f the
whole social group is interrogated, all individual values (not quantities) 
are added. The results correspond to a market-demand schedule... In 
combination with a corresponding cost schedule the socially desirable 
supply of the collective extra-market good can be determined."
Starting from the mid 1960s the CV method has been developed both at the 
conceptual and empirical levels (Smith, 2006). The development of the method has 
mainly taken place in two areas: transport economics and, more recently, 
environment economics. In transport economics the main applications of the CV 
method have focused on measuring safety benefits and the value of travelling time. 
In environment economics, instead, studies have focused on the non-user values of 
environmental habitat and resources and, to a lesser extent, health benefits 
stemming from improved quality of the environment.
Davis (1963) is the first person who used the method. He made a contingent 
valuation survey in Maine in order to measure the value of a recreational area. Since 
then, several hundreds of papers have applied the Ciriacy-Wantrup intuition in the 
environment field. The first contingent valuation survey related to the provision of 
health care was performed by Acton (1973) in the United States. The analysis 
focused on a programme making available mobile coronary care units that would 
reduce the risk of death after a heart attack. Acton designed a survey with various 
types of WTP questions and administered it to three different samples: one that was 
a randomly stratified sample of households living in the Boston area (36 households) 
and the others that comprised union leaders (21) and business executives (160). The 
response rate was very low with only 36 individuals returning the questionnaire. 
Moreover, 11 questionnaires reported a willingness-to-pay of zero and were 
considered by Acton as protest answers. On the basis of these and other elements 
Acton concluded that the validity of the study was unclear.
Either because of the problems of Acton’s study or because researchers were more 
attracted by the development of cost-effectiveness and cost-utility analysis, for many 
years no other studies used the CV method for valuing health care. The second 
attempt to use the method was made by other Harvard scholars ten years later:
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Thompson, Read and Liang (1984). They investigated WTP for a hypothetical cure of 
chronic arthritis. Since then the CV method had not been substantially developed in 
the health sector for many years. It is only in the last 10/15 years that papers using 
contingent valuation techniques have become more frequent in health economics, 
public health and clinical journals (figure 3.1).
Figure 3.1. Number of contingent valuation studies by year of publication and type of journal
Figure 1
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In fact, the number of contingent valuation studies in health care is growing. This is 
probably due to a number of factors, including the evident limitations of cost- 
effectiveness and cost-utility analysis, the consistency of the CV methods with 
welfare economics theory, and the improvement of the techniques of surveying 
people and of sampling individuals. In addition to these reasons, one merit of CV 
methods is the possibility to investigate directly the preferences of members of the 
community. These surveys mimic procedures of hypothecation of government 
spending. If hypothecation is desirable because it turns pawns into queens (or at 
least it goes some way towards doing so) (Le Grand, 2003), eliciting preferences for 
specific health programmes is expected to offer guidance to policy makers making 
them aligned to individual preferences.
Contingent valuation is now performed by economists and other specialists in 
different areas, and it is used by government agencies and international 
organisations for the economic evaluation of a variety of investments. Carson’s 
(1994) bibliography listed about 1,000 studies over 40 countries in several fields, 
including the environment, transportation, the art and education, sanitation and
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health. However, until the end of the ‘90s very few contingent valuation studies 
concerned health services. By the means of a search strategy based on the two most 
popular computerised databases in medicine (Medline) and economics (Econlit), and 
bibliographies of some of the retrieved studies, we collected only 33 papers 
published from 1984 to 1996 which report results of empirical contingent valuation 
studies. Nowadays, the production of CV studies is more significant with about 30 
papers published annually.
This chapter reviews studies that have directly elicited WTP or WTA for healthcare 
services through the CV method. Over the past ten years it has become increasingly 
popular in the health economics literature to elicit WTP through an indirect method 
labelled Discrete Choice Experiment (DCE). DCE belongs to the family of conjoint 
analysis (CA) techniques. These techniques have their origin in market research and 
are used to establish the relative importance of different attributes in the provision of 
a good (Ryan, 1999). They have been used by non-economists to investigate factors 
that explain patients’ preferences for attributes of health services and by economists 
to derive the monetary value of benefits associated to the use of health services and, 
more generally, to measure preferences. When CA is used within the framework of 
economic theory it is generally labelled DCE or sometimes CE (Choice Experiment). 
DCEs have been used in health economics to estimate WTP to undergo IVF 
treatments (Ryan, 1999), to reduce time spent on waiting lists (Propper, 1990), to 
investigate preferences and to test WTA measures for blood transfusion services 
(van der Pol and Cairns, 1998), to elicit patient preferences in the doctor-patient 
relationship (Vick and Scott, 1998), to estimate time preferences for health (van der 
Pol and Cairns, 2001; Cairns and van der Pol, 2004), and as a method of deriving 
preference-based values for process of care and health state outcomes (McKenzie et 
al., 2001, Hakim et al., 1999).
This chapter focuses in CV studies only and reviews the literature concerning health 
services. In addition, it selectively reviews the environmental econonomics literature 
on three specific issues: the possible formats to elicit WTP, the use of internet to 
conduct CV studies and the assumptions about the probability distribution functions 
of WTP in case of zero WTP. In these specific areas the CV literature in the 
environmental field could provide us with relevant material to understand the nature 
of the data that we collected and to identify the appropriate econometric models. We
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also checked other fields such as the art and transports, but we realised that 
developments in contingent valuations have taken mainly place in environmental 
studies.
3.2. A framework to review contingent valuation studies
There appears to be large methodological differences in the health care contingent 
valuation literature on important issues such as the content of the WTP questions, 
the way they are asked and the choice of the sample (O’Brien and Gafni, 1996). This 
is because the CV method is a young research field and thus it is very far from being 
well established from a theoretical point of view. Nevertheless, in order to carry out a 
literature review of contingent valuation studies in the health care field, it is necessary 
to have a classification framework from which to start.
The growing number of empirical studies in the health care field has been critically 
discussed by a few methodological reviews (Diener et al., 1998, Klose, 1999; Olsen 
and Smith, 2001; Smith, 2003). Some of these contributions are discussed later in 
this chapter. In this study, the framework proposed by O’Brien and Gafni (1996) is 
used to classify and review the contingent valuation literature in health care. This 
critical appraisal framework presents eleven specific considerations grouped in five 
general questions aiming to help in the interpretation of the design of the contingent 
valuation studies. This framework does not discuss the advantages or disadvantages 
using the method, nor does it address the theoretical foundations of CBA because it 
accepts that as given. It presents some basic questions whose answers may help to 
understand the main conceptual and methodological issues related to the use of 
contingent valuation method in the health care field. In addition to this contribution, 
the analysis of the literature is based on an important contribution specific to the 
environment field: the document prepared by a panel of economic experts to 
evaluate the use of the CV method in determining non-use values of environmental 
resources and provide comment to the National Oceanic and Atmospheric 
Administration (NOAA) of the USA Federal Government (Arrow et al., 1993).
The conceptual framework suggested by O’Brien and Gafni (1996) (Diener et. al, 
1998) is structured around eleven considerations grouped into five general questions 
(table 3.1):
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1) What questions do we want to answer?
2) What type of measure can we use?
3) What do we need to ask of whom?
4) What characteristics of the programme are important to determine how it is 
valued?
5) What question formats minimise bias and increase precision?
Questions and considerations are presented and discussed below according to the 
original paper.
Table 3.1. Questions and considerations for a contingent valuation study of a health care programme 
(O’Brien and Gafhi, 1996)._________________________________________________________________
1. What question do we want to 
answer?
Problem definition
Pricing and demand studies
Project appraisal for resource allocation
Current status of the programme 
Programme currently exists 
Programme does not currently exist
Utility and disutility of programme to respondent 
Gain in utility from programme 
Loss in utility from programme
2. What type of measure can we 
use?
Money measure of utility change 
Compensating Variation (CV) 
Equivalent Variation (EV)
“Direction” of measurement 
Willingness-to-pay (WTP) 
Willingness-to-accept (W TA)
3. What do we need to ask of 
whom?
Framing of programme consumption and payment 
Ex-post user-based question 
Ex-ante insurance-based question
4. What characteristics of the 
programme are important for 
determining how it is valued?
Programme outcome description 
Certain outcomes 
Uncertain outcomes
Nature of the “market” for valuation scenario 
Private goods market 
Political market
5. What question formats minimize 
bias and increase precision
Valuation scenario 
Holistic versus decomposed 
Degree of realism
Value elicitation method 
Open-ended questions 
Bidding games 
Payment cards
Take-it-or-leave-it (with follow-up)
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3.2.1. What question do we want to answer?
Problem definition.
WTP may be studied for a variety of reasons and from a number of different 
perspectives. Not all studies trying to elicit WTP for health services are carried out as 
part of a cost-benefit-analysis. Some monetary valuation studies are carried out to 
estimate private demand curves and, hence, to support a variety of policy decisions 
including the use of co-payments. More broadly, there are some studies that are 
concerned with marketing decisions rather than with collective decision-making about 
health care programmes.
Although there are some WTP questions that may be unrelated to economic 
evaluation, we found it conceptually difficult to disntiguish whether the underlying 
question is one of marketing or evaluation. Marketing is more than pricing or 
promotion; it involves studying the expectations and other characteristics of 
consumers. As economic evaluation techniques are applicable to any collectively- 
funded delivery system (Pauly, 1995), the possibility that private insurance 
companies use CBA or other economic evaluation techniques to offer guidance to 
the definition of insured risks and services should not be excluded. Also, strategic 
marketing decisions in the pharmaceutical industry and other industries related to 
healthcare can be supported by economic evaluations according to different 
perspectives. In addition, marketing is developing in non-profit organisations as well 
in the public sector. Organisations whose main aim is not the generation of profit are 
increasingly putting more effort into better understand their “consumers” and to use 
“market” information to support their decision-making. As a consequence, in public 
and non-profit organisations economic evaluation can be considered as a “social 
marketing” technique.
Many published papers are focused on methodological issues such as the validity of 
different elicitation formats or the characteristics of the scenarios presented. These 
studies deserve to be considered separately from the others. Therefore, for the 
purpose of the literature review presented in this chapter, we have reformulated the 
classification suggested by Gafni and O’Brien (1996, Diener et al. 1998) on the 
problem definition of the studies. We prefer to classify studies according to four
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categories: a) economic evaluation (the contingent valuation method is used as part 
of a cost-benefit analysis); b) analysis of demand (the method is used to investigate 
the characteristics of the demand for the programme); c) cost-of-ilness studies (the 
analysis is used to estimate the economic burden of the disease, d) methodological 
studies (the study is focused on testing the contingent valuation method).
Current status of programme
Some studies regard programmes that currently exist, others refer to programmes 
that are hypothetical. The utility gain of a project perceived by the respondents of the 
CV survey may be different in the two scenarios. It is thus useful to distinguish the 
studies according to the following classification: a) existing programmes (the object of 
the evaluation is available or could be available to the respondents); b) hypothetical 
programmes (the survey presents a programme that is hypothetical).
Utility and disutility of the programme to respondents
It was argued that in the case of health care, negative bids can be excluded 
(Johannesson and Jonsson, 1991). However, not all individuals will be affected or will 
be better off from the introduction of a new health care programme. Similarly, the 
cessation of an existing programme may be a source of utility for some people. The 
removal of public coverage of voluntary abortion would represent a utility gain for 
some people. Also, some programmes prolonging the life of individuals with 
infectious diseases bring disutility to many members of the society that may face an 
increased risk of infection (Villari et al, 1996). With particular reference to our study, it 
is possible that some reproductive techniques face ethical opposition and are thus 
associated with utility losses (for example the introduction of a new programme) or 
gains (in the case of removal).
It is therefore important to check whether the decision under evaluation brings about 
losses or gains. In a situation where they are both present, appropriate devices have 
to be used to elicit the monetary equivalent of both positive and negative utility 
changes. Unfortunately, it proved very difficult to derive information in this respect 
from the paper because this issue has been neglected by many authors, even where 
it was evident that potential losers were likely. Therefore, we decided not to include
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this issue in the systematic analysis of the health papers and to discuss it in the final 
part of the chapter.
3.2.2. What type of measure can we use?
Monetary measure of utility change
Theoretically, it is possible to measure willingness-to-pay (WTP) or willingness-to- 
accept (WTA) on the basis of two monetary measures of utility change: 
compensating variation and equivalent variation. The distinction depends on whether 
the utility level is held constant before or after the decision is implemented. If the 
analysis is based on the starting utility level (the utility level before the change), WTP 
and WTA measures are usually referred to as compensating variations. On the 
contrary, if WTP and WTA are measured according to the new level of utility (the 
level of the utility after the change), the monetary measures are usually called 
equivalent variations. It should be noted that, although they are equivalent measures 
of consumer surplus if income effects are irrelevant, they do differ in perspective: 
compensating variation is evaluated from the original level of welfare and equivalent 
variation from the anticipated new level of welfare (O’Brien and Gafni, 1996; Diener 
et al., 1998).
Direction of measurement
The distinction between equivalent variation and compensating variation is further 
complicated by the distinction between WTP and WTA. As mentioned above, WTP is 
the maximum amount of money that individuals are willing to pay for a set of benefits, 
while WTA is the minimum amount of money that individuals are willing to accept as 
compensation for a set of losses. WTP questions are generally framed as “How 
much would you pay to have this set of benefits?’’, while WTA questions are framed 
as “How much would you accept as compensation for giving up these benefits?” The 
two measures are not equivalent if the marginal utility of income is assumed 
declining. As WTP and WTA are utility measures they are affected by the direction of 
change in income (Brent, 2003). If the utility of income is decreasing, for a given 
good WTP is greater than WTA because the consumer is available to sacrify more 
income to get the good that she is available to receive as compensation. If the 
marginal utility of income were constant, then there would be no difference between 
WTP and WTA.
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3.2.3. What do we need to ask of whom?
Externality and option value
The framework suggested by O’Brien and Gafni (1996) comprises three types of 
individuals whose WTP or WTA can be measured: individuals who have the disease; 
individuals who have not the disease, but they are at risk of acquiring it; individuals 
who have not got the disease and who are not at risk of acquiring it. The first group of 
individuals are the immediate beneficiaries of the health care programmes. They are 
expected to express a strong preference for programmes which are in their favour. 
Accordingly, they are generally expected to state a higher WTP than people without 
the disease. The second group of individuals refer to the option value concept 
(Weisbrod, 1964). People may be willing to pay an amount to ensure that the health 
care programme will be available at a later time. This option increases people welfare 
because, by acting like an insurance policy, it reduces uncertainty. The third type 
refers to individuals who are not and will not be affected by the disease but are 
somehow affected by its consequences. Externaility is the economic concept 
involved here (Culyer, 1976). Two types of externalities can be distinguished: 
physical externalities and altruistic externalities. The first type of externality refers to 
situations where some individuals are physically affected by the programme even if 
they are not the direct beneficiaries. Examples of programmes bringing about such 
externalities include prevention programmes for infectious diseases targeted to 
specific population groups (the community at large benefits as a result of lower 
incidence rates), wide and systematic use of antibiotics (the community at large 
develops resistance to the drug), treatment of individuals affected by certain mental 
disorders (keeping these individuals on treatment can decrease the risk of criminal 
offences). This type of externality is only concerned with the individual’s well-being.
The second concept of externality assumes a broader perspective - that individuals 
can derive utility from the fact that other individuals have access to specific goods. 
Altruistic externalities are probably very relevant in health care since public funding is 
often motivated on the basis of solidarity principles. In addition to positive altruistic 
externalities, it is conceivable that people may suffer from the others’ consumption of 
specific goods which raise serious ethical problems, such as voluntary abortion, IVF 
or even organ donation (see later in the chapter).
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It should be clear that these three “groups” of beneficiaries reflect three components 
of benefits of health care programmes that may co-exist in the same individual. A 
patient affected by a disease may reveal herself as being willing to pay for the care 
she needs (patient value), thus ensuring that the option is available for her in the 
case of future personal need (option value) and for making it available to other 
people in state of need (altruistic value).
As far as the classification of the paper is concerned it proved difficult to detect 
whether the option value component was present. Thus, we simplified the 
classification originally proposed by O’Brien and Gafni (1996) focussing on whether 
there was any altruistic component on the measuered WTP/WTA.
Framing of programme consumption and payment
There are two general approaches that can be used in a CV study: the ex-ante 
insurance-based and the ex-post user-based. In the ex-post approach, respondents 
are asked to assume that they are at the point of using the service being evaluated. 
Under this hypothetical scenario they are asked to state their WTP or WTA. In the 
second approach, respondents are asked to express their WTP or WTA for an 
insurance that covers the service being evaluated. Obviously, the second approach 
requires providing the person with relevant information about the probability that the 
service will be used.
In an earlier paper, Gafni (1991) suggested that in the context of public decision­
making the ex-ante insurance based approach has to be followed. This suggestion 
stems from the consideration that users of health services do not generally pay at the 
point of consumption for the services they use. Also, by definition public funding of 
goods whose future utilisation is uncertain is a form of insurance. In spite of this 
position, however, the conceptual framework presented here recognises that there 
are some circumstances where asking insurance-based questions may not be 
appropriate. For example, most individual and collective prevention programmes 
cannot be insured because their consumption is not influenced by any uncertain 
events. However, for all the services that can be subjected to an insurance service, 
O’Brien and Gafni (1996) suggest using the ex-ante perspective because the “user
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approach is not consistent with the theory CBA, which is based on the sum of the 
compensating (or equivalent) variations from the population affected’.
The ex-ante approach is also preferable because it allows the detection of 
respondents’ altruism. However, there are relevant problems with eliciting WTP from 
individuals who are not experiencing the disease: probabilities are difficult to 
understand by most people and the general population has less information about a 
specific disease and treatment than a member of the patient population. One way to 
overcome these problems is to use an ex-post user-based perspective and to 
multiply elicited WTP (or WTA) by the probability of becoming a patient. Following 
this procedure, the expected WTP indirectly measures non-user value (but it does 
not detect any externalities and does not include any valuation of the “option value”).
As shown by Johannesson (1996b) if the individual is risk neutral, ex-ante WTP and 
expected WTP coincide; while if the individual is risk averse with respect to income, 
expected WTP is a lower bound of ex-ante WTP, provided that the marginal utility of 
income does not vary with health status. These results should be taken into account 
when empirical studies are interpreted. Under the assumption that individuals are risk 
averse, if costs are lower than expected WTP the programme also passes the cost- 
benefit test from an insurance perspective.
Unfortunately, it cannot be assumed that expected WTP is a lower bound. First, as 
mentioned above, questions directed to users do not capture externalities, as in 
some cases the sign of the externalities can be uncertain. Second and more 
important, the assumption that the marginal utility of income does not vary with 
changes in the health status appears strong. Our knowledge about the interaction 
between marginal utility of income and health status is limited (Johannesson, 1991). 
A study conducted by Viscusi and Evans (1990) shows that the marginal utility of 
income increases with better health status. However, it may be the case, especially 
for certain diseases, that individuals perceive income as a substitute for health. Thus, 
health improvements are associated with lower marginal utility of income. Given that 
health is a very broad concept, often involving psychological aspects specific to the 
type of disease, it is probably difficult to identify general regularities between health 
status and marginal utility of income. Consequently, the possibility that WTP is a
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lower bound for ex ante WTP, even if externalities are ruled out, should be 
investigated in the specific context of the programme being evaluated.
While the insurance perspective may be theoretically relevant, in practice very few 
studies are framed according to this perspective. It appears to be important to 
distinguish between patients with and without experience of the intervention being 
evaluated. Hence, we classified studies according to three categories: ex-ante user 
based (the respondent has not experienced the intervention yet, but she is in need of 
it), ex-ante insurance based (the question refers to paying for insurance for the 
intervention), ex-post insurance based (the respondents were interviewed after they 
had experienced the intervention being evaluated) (Diener et al., 1998).
3.2.4. What characteristics of the programme are important for determining 
how it is valued?
Programme-outcome description
Under this consideration a distinction is proposed between certain and uncertain 
outcomes presented in the survey. The distinction was suggested by Gafni (1991) 
who argued that contributions to health (both positive and negative) attributable to 
the programme should be described in probability terms. However, it has to be taken 
into account that it may be very difficult to present uncertain outcomes, especially in 
ex-ante surveys were the presentation of the uncertainty of the outcome is added to 
the information concerning the probability of acquiring the condition for which the 
treatment is used.
Adequate presentation of the uncertainty surrounding events is one of the elements 
which have to be carefully thought about in designing the CV study. Other important 
aspects to be carefully described in the programme-outcome presentation include 
time and space specification, available alternatives to the programme, and a precise 
description of how the programme is funded.
Nature of the “market” for the valuation scenario
Scenarios used in contingent valuation studies should be consistent with the nature 
of the decision being evaluated. Guidelines with regard to the use of contingent 
valuation for the measurement of environmental damage suggest adopting a political
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market perspective: CV scenarios should be built in such a way that the respondent 
is asked whether he/she accepts to be taxed a certain amount (or a percentage of 
income) to fund a specific project (if WTP is measured) (Arrow et al, 1993). The 
decision to refer to political markets is mainly due to the technical nature of 
environmental goods. Being non-rival and non-excludable, they are subjected to free­
riding in the private market, hence meaning that they require government intervention 
to be adequately funded.
For certain health services the same argument applies. Most of health services, 
however, are private goods in nature because they do not conform to non-rivalry and 
non-excludability criteria. Therefore, for health services, it is generally possible to 
design CV surveys that describe private market scenarios. These scenarios mimic a 
private market asking respondent whether he/she is willing to pay (or accept) to have 
access to a specific good (including insurance). Indeed, these scenarios are probably 
preferable if the aim of the study is to measure user WTP or WTA. But, as noted 
earlier, often economic evaluations assume a public decision-making perspective 
and, consequently, aim to measure externalities, both physical and altruistic. In these 
economic evaluations the use of private market scenarios would not allow for the 
capture of the altruistic value of programmes being evaluated.
3.2.5. What question formats minimise bias and increase precision?
The survey instrument in a CV study is of the utmost importance (Johannesson and 
Jonsson, 1991). There are a number of sources of potential bias that are important 
(Mitchell and Carson, 1989). O’Brien and Gafni (1996) focus on two aspects that 
involve tradeoffs between precision and bias.
Valuation Scenario
The scenario presented in the survey can be holistic or decomposed. The former 
type of scenario needs to present the entire complexity of the programme. 
Consequently, WTP (or WTA) elicitation derives from a very complex process of 
evaluation which is largely unknown to the authors of the study. For complicated 
programmes this process can be very demanding from a cognitive point of view. On 
the contrary, in decomposed scenarios, the components of the programme are 
evaluated separately so that respondents may be presented simpler questions.
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There is no algorithm for aggregating decomposed WTP. In fact, they report one of 
the author’s experiences in carrying out a CV survey to measure benefits of a new 
antidepressant therapy (O’Brien et al, 1995). A decomposed scenario was presented 
to respondents because in the pilot study the holistic approach was found to be too 
cognitively demanding. However, despite the fact that the questions were easier to 
understand, the result of the survey was inconclusive on the value of the new drug 
because it is unknown how to aggregate single elicited WTP. Empirical studies 
generally show that the holistic WTP is sub-additive: adding up decomposed WTPs 
overestimates elicited values (Klose, 1999; Hammerschmidt et al., 2004).
In our opinion, decomposing scenarios is rarely a viable option in the CV 
methodology. The fact that some scenarios can be too cognitively demanding does 
not derive from the hypothetical nature of CV, but rather by the fact that complexity is 
a normal characteristic of real markets. Real purchasing or referendum decisions are 
often cognitively very demanding. In spite of this, decisions are taken and economic 
theory assumes that they are rational. In order to deal with cognitively demanding 
scenarios it is thus preferable to make the hypothetical markets closer to reality, 
rather than simpler but imaginative. Accordingly, it is suggested that the way the 
scenario is presented should be as realistic as possible. In particular it is suggested 
that scenarios should make sense in the context of the health care system and 
method of funding with which the respondent is familiar.
Whether the scenario is holistic or decomposed and the degree of realism are 
important characteristics of the CV survey. In addition, other elements are important 
to improve its validity and reliability.
Valuation-elicitation method
Gafni and O’Brien (1996) described five elicitation methods used in CV surveys: 
open-ended questions, bidding games, payment cards, and take-it-or-leave-it 
questions with or without follow-up. Recently, there have been attempts to use 
payment ladders (Hanley et al., 2003) and it has proposed a new elicitation method 
termed “structured haggling” that is assumed to better reflect the bargaining nature of 
purchasing decisions in the context of a sub-Saharan country (Onwujeckwe, 2004).
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Open-Ended Valuation Questions
In open-ended (OE) valuation questions each respondent is simply asked his/her 
maximum WTP for the programme. The approach is efficient, in the sense that it 
produces a large amount of information with simple and easy to administer 
questions. However, open-ended questions pose a large cognitive task and produce 
large number of non-responses or protest zero responses. It was described by the 
NOAA panel as “ulikely to provide the most reliable valuations” because it poses an 
exptremely difficult task, is unrealistic and is prone to strategic overstatements. In 
effect, in the real world goods are priced and consumers rarely formulate in their 
mind a maximum willingness-to-pay amount for goods. The OE format has been 
largely dismissed after the publication of the NOAA guidelines. However, its inferiority 
to other formats has been contested (e.g. Ready et al., 1996).
Bidding Games
The second elicitation method -bidding games- resembles auctions. An initial starting 
money bid is made to the respondent who accepts or rejects it. The bid is then raised 
or lowered depending on the answer. If the answer is “yes” the bid is raised and if the 
answer is “no” the bid is lowered. Bids are presented to the respondent until his/her 
willingness-to-pay is reached, that is when a lower/bound is reached or when there is 
a switch (from "yes” to “no” or viceversa). The method is more realistic than the open- 
ended format because each bid level requires only a yes/no response. Its main 
disadvantage is the potential for a starting bias, as the initial bid tends to imply a 
value for the good. One solution may be to vary initial bids across the sample or to let 
the respondent choosing the starting value (Bennet et al., 1996; Bennet & Trantert,
1998).
Payment Card
The payment card method visually presents to the respondent a range of values to 
choose from. This method can be conceived as a facilitated open-ended format. 
Respondents have to decide a value (or a range of values), but these are somehow 
presented by the questionnaire or the interviewer. In this way the potential for a 
starting bias is reduced. Nonetheless, the unrealistic nature of the open-ended 
question remains.
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Take-it-or-leave-it (dichotomous choice or referendum)
In the take-it-or-leave-it (TIOLI) approach each respondent is asked whether he or 
she is willing to accept a single bid. By varying the bid in different sub-samples, the 
proportion of respondents who are willing to pay different bids (prices) can be 
calculated so to identify a relationship between bids and fractions of the sample. This 
curve can be interpreted as an aggregate demand curve (Johannesson, 1996a). The 
TIOLI approach is also named dichotomous choice or referendum format. There are 
three main problems with this approach. First, it is inefficient because, compared to 
other elicitation methods - a much larger sample size for the same level of statistical 
precision is required. Second, it requires important assumptions about how to specify 
the demand curve (Mitchell and Carson 1989; Donaldson et al., 1998). Third, it may 
result in an inflation of mean WTP amounts as respondents may favour “yes 
answers” simply to please the interviewer or because they feel good about revealing 
their willingness-to-pay (warm-glow effect) (Desvousges et al., 1993; Hanley et al., 
2003; Ryan et al., 2004). Nevertheless, this elicitation method appears to be close to 
actual behaviour (we generally decide whether to buy at given prices) and is very 
easy to understand by respondents. The NOAA panel for the evaluation of 
environmental damages suggested adopting this approach (Arrow et al., 1993) and is 
still widely used.
The take-it-or-leave-it question can be followed by one or more bids. The respondent 
is asked a question requiring a “yes” or “no” answer about whether she/he would pay 
a specific price. If the respondent states “yes”, another WTP question is asked using 
a higher price chosen. If the answer is “no”, the follow-up question presents a lower 
price. By collecting more answers from each respondent, the method improves 
statistical efficiency of the simple binary approach and resembles a bidding game.
More recently, there has been an interest in using payment ladders (Hanley et al, 
2003). Such ladders suggest a range of uncertainty over the value respondents 
express on the commodity being valued. The rationale for using this elicitation 
method is based on the assumption that while respondents may know for sure 
whether they would or would not be willing to pay a given amount for a good, there 
are other amounts that they would not be sure about. For instance, a respondent 
may be sure that she would pay 20 and that she would not pay 100, but she could be
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unsure about whether she would pay 50. This method although little used in 
evaluating health care has used and tested in environmental studies and is often 
lable “multiple bounded” (Welsh and Poe, 1998; Cameron et al., 2002).
The Structured Haggling Technique (SH) was developed by Onwujekwe (2004) with 
specific reference to the sub-Saharan context. Price-taking in many African and 
other developing countries differs considerably from the context in which binary 
questions or payment cards have been suggested. Question format is a major 
element of contingent valuation surveys which is unlikely to be transferred 
successfully without paying attention to the environment circumstances. Onwujekwe
(2004) argues that the elicitation format needs to be indigenous to the area in which it 
is used. According to the proposed SH technique, the interviewer initiates the 
haggling process by offering the good to the respondent at a price that is well above 
the expected sale price. Then the method tries to simulate a real bargaining process 
that is expected to terminate with a value that reflects respondent’s maximum 
willingness to pay. This method appears closer to the way markets function in many 
countries; it also has the merit to guide the respondent in constructing his/her WTP. 
Psychologists, behavioural theorists and recently economists have argued that 
preferences are not generally “ready” to be discovered; on the contrary, they are 
constructed by individuals in response to stimuli (Cookson, 2000; Ryan et al., 2004).
3.3. A literature review of contingent valuation studies in the health care 
field
3.3.1. General information on the search strategy and the collected studies
We reviewed the literature following three main strategies. First, we collected 
empirical articles published in major journals, methodological contributions and 
reviews to understand the debate upon the CV method and its critical issues. This 
part of the literature review aimed to provide the background for the empirical study 
presented in the thesis. Then, we systematically collected studies published from 
1984 to 2005. This review allowed us to investigate how CV empirical studies have 
changed over time and to implement the framework presented in the previous 
section. Finally, we reviewed in depth all CV studies that deal with IVF, the focus of 
our empirical research.
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We performed the literature review in two different moments and we used two 
different research strategies. We collected the contingent valuation literature for the 
1984-1996 in 1998 according to three different strategies. First, the English-language 
literature was searched in two health and medicine computerised databases: Medline 
and Health Plan. Articles were identified according to there being present one of the 
following keywords in the title or in the abstract: willingness-to-pay, willingness-to 
accept and contingent valuation. The medical and health literature search was 
complemented with a literature review on Econlit, the main computerised economics 
literature database, using the keywords health and one of the following: contingent 
valuation, willingness-to-pay and willingness to accept. Retrieved titles and abstracts 
from medical and economics databases were then reviewed to select the articles that 
reported results from an empirical contingent valuation. Therefore, methodological 
and review articles, including letters and editorials were excluded. Finally, the 
bibliography of each collected article was systematically reviewed to identify 
additional studies of interest.
For the period 1997-2005 a similar, but somehow simplified, approach was deemed 
necessary because of the much larger number of studies in the area of cost-benefit 
analysis. Using the same strategy adopted for the period 1984-1996 we obtained 
21,262 articles, too many to be processed and selected. Therefore, for the latter 
period we only retrieved abstracts that contained the expression “contingent 
valuation” in the title or in the abstract and then we reviewed each abstract to see 
whether the article included the inclusion criteria, namely to report a CV empirical 
study. Abstracts of studies were retrieved from both Medline and Econlit. For the 
Econlit database contingent valuation was associated to the world health in any 
possible field.
Some of the identified articles report empirical studies on WTP or WTA for mortality 
risk reduction or health improvement that are not related to health care services. For 
example, Jones-Lee et al. (1985) investigated the value of reductions in the risk of 
traffic death surveying a random sample of 1,150 individuals and Shechter and Kim 
(1991) surveyed individuals living in the Haifa metropolitan area to measure their 
willingness-to-pay for pollution abatement. These and other retrieved studies used 
contingent valuation to measure willingness-to-pay (or willingness-to-accept) for 
decisions affecting people’s health that are undertaken outside the health care
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sector. Although these studies may provide useful experience and evidence to 
construct a contingent valuation survey for IVF, we decided to focus the literature 
review on published studies that involve the use of health services and, 
consequently, to exclude those that are unrelated to decisions made in the health 
care system.
According to these criteria, we identified 141 studies. For four studies it was not 
possible to find a copy of the entire article. As a consequence we analysed 136 
studies, 32 published between January 1984 and December 1996 and 105 published 
between January 1997 and December 2005 (table 3.2). The number of contingent 
valuation studies is growing. The number of published studies in the last two year 
(2004-05) is higher than those published in the previous two-year period and the 
growth appears linear or even exponential. Various systematic literature reviews 
found a similar pattern (Diener et al. 1998; Klose, 1999; Olsen and Smith, 2001; 
Smith, 2003).
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Table 3.2. Contingent valuation studies by purpose and type o f problem investigated (1984-2005).
First Author Journal Year of 
Pub.
Purpose of the 
study
Problem investigated Existing/
Hypothetical
treatment
1 Thompson Med Dec Mak 1984 Method/ Demand Rheumatoid Arthritis Hypothetical
2 Berwick Med Care 1985 Method Diagnostics (antenatal 
care)
Existing
3 Fisher J Paediat 1985 Method/ Demand Paediatric confidential 
care
Exiting
4 Thompson AJ Public Health 1986 Demand Rheumatoid Arthritis Hypothetical
5 Grimes BMJ 1988 CBA Diagnostic (screening for 
cancer)
Existing
6 Appel Med Care 1990 Method/ Demand Diagnostic (contrasting 
agents)
Existing
7 Donaldson J Health Econ 1990 CBA Hospital care vs. nursing 
home
Existing
8 Reis J Nursing Admin 1990 Demand Insurance plans Not applicable
9 Eastaugh I J Tech Ass H C 1991 Demand Blood transfusion Existing
10 Johannesson J Health Econ 1991 Method Hypertension Existing
11 Pennie Can J Public 
Health
1991 Demand Vaccine for Hepatitis B Existing
12 Johannesson J Hypert 1992 CBA Hypertension Existing
13 Golan Med Dec Mak 1993 Method/Demand Supplementary health 
insurance
Not applicable
14 Johannesson J Health Econ 1993 Method Hypertension Existing
15 Johannesson Applied Econ 1993 Method Lipid lowering Existing
16 Lindholm I J Tech Ass H C 1994 CBA Prevention of 
cardiovascular diseases
Existing
17 Mills J Trop Med Hyg 1994 CBA Bed-net impregnation for 
malaria
Existing
18 Neumann Med Care 1994 Method In-Vitro-Fertilisation Existing
19 O’Brien Med Dec Mak 1994 Method Chronic lung diseases Hypothetical
20 Donaldson Health Econ 1995 Method/Demand Diagnostic (screening fro 
cystic fibrosis)
Existing
21 Eckerlund Health Policy 1995 Demand Health care budget Not applicable
22 Granberg Acta Gyn Ob Sc 1995 CBA In-Vitro-Fertilisation Existing
23 Miedzybrodzka J med Genet 1995 Demand Diagnostic (screening fro 
cystic fibrosis)
Existing
24 O’Brien Pharmacoecon 1995 CBA Antidepressant drug Existing
25 Osmond J Paed 1995 CBA Paediatric sutures Existing
26 Ross Med Care 1995 Method Ambulatory services Existing
27 Chestnut Med Dec Mak 1996 Method Drug for angina Hypothetical
28 Kartman Health Econ 1996 Method Drug for oesophagitis Hypothetical
29 Kartman Med Dec Mak 1996 Method Drug for angina Hypothetical
30 Ryan Health Econ 1996 Method In-Vitro-Fertilisation Existing
31 Stalhammar Med Dec Mak 1996 Method Drug for ulcer Hypothetical
32 Weaver Soc Sc & Med 1996 Demand Quality improvement Not applicable
33 Asenso-Okyere Health Policy 1997 Demand Private Health Insurance Not applicable
34 Kartman Health Econ 1997 Method Drug for oesophagitis Hypothetical
35 Lee Health Policy 1997 Demand Autologous blood 
donation
Existing
36 O’Conor J Health Econ 1997 Method Asthma Hypothetical
37 Olsen Health Econ 1997 Method Cancer, heart interv., 
helicopter services
Hypothetical
38 Zethreaus Brit J Ob & 
Gynaec
1997 CBA Hormone Replacement 
Therapy
Existing
39 Donaldson Birth 1998 Method Location of giving birth Existing
40 Lee Medical Care 1998 Method/CBA Autologous blood 
donation
Existing
41 Mathiyazhagan IJ Tech Ass H C 1998 Demand Community Health 
Insurance
Not applicable
42 O’Brien Medical Care 1998 Method Cancer treatment Existing
43 Onwujeckwe Trop Med and Int 
H
1998 Demand Ivermectin distribution Existing
44 Ortega Cancer 1998 CBA Prophylactic Eiopoietin Existing
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alpha treatment
45 Tambour Med Dec Mak 1998 Method/CBA Hormone Replacement 
Therapy
Existing
46 Chiu Health Policy 1999 Demand In-home respite care Hypothetical
Al Donaldson Soc Sc & Med 1999 Method Location of giving birth Existing
48 Dranitsaris I J Tech Ass H C 1999 CBA Adjunct therapy for 
multiple myeloma
Existing
49 Matthews Public Health Dent 1999 Method Periodontal therapy Existing
50 Onwujekwe Public Health 1999 Demand Equity in
ivermectin distribution
Existing
51 Sorum Med Dec Mak 1999 Method/Demand Prevention of acute otitis Hypothetical
52 Torrance Pharmacoecon 1999 CBA Treatment of chronic 
bronchitis
Existing
53 Cho-Min-Naing S Asian J Trop 
Med
2000 Method/Demand ICT Malaria Pf/Pv test kit Existing
54 Clarke Applied Econ 2000 Method Mammographic
screening
Existing
55 Dranitsaris Pharmacoecon 2000 CBA Insuline treatment Existing
56 Estaugh I J Tech Ass H C 2000 Method/Demand Treatment of Von 
Willebrand’s Disease
Existing
57 Liu Health Econ 2000 Demand Cold prevention Hypothetical
58 Narbro I J Tech Ass H C 2000 Demand Obesity treatments Hypothetical
69 Onwujekwe Trop Med & Int 
Health
2000 Method/Demand Re-treatment of 
Insecticide-treated nets
Existing
60 Papatheofanis Q JNucI Med 2000 Demand PET in suspected lung 
cancer
Existing
61 Slothuus 1 J Tech Ass H C 2000 Method Arthritis symptom 
alleviation
Existing
62 Suh J Am Pharma 
Assoc
2000 Demand Pharmacy services Existing
63 Thomas J H Res & Policy 2000 Method Bone mineral density 
screening
Existing
64 Wagner Health Policy 2000 Method Mammographic screen. Existing
65 Zarkin J Sub Abuse Treat 2000 Demand Substance Abuse 
treatment
Hypothetical
66 Blumenschein J Health Econ 2001 Method Asthma management 
programme
Existing
67 Dalmau-
Matarrodona
Health Econ 2001 Method Home care Existing
68 Gyldmark Soc Sc & Med 2001 Method/Demand Insurance for 4 
interventions
Existing
69 Morris Med Dec Mak 2001 Method Pneumonia Vaccine Hypothetical
70 Onwujekwe Tro Med & Int 
Health
2001 Method/Demand Insecticide-treated nets Existing
71 Onwujekwe Health Econ 2001 Method/Demand Insecticide-treated nets Existing
72 Wagner Health Policy 2001 Method/Demand Mammographic screen. Existing
73 Arana Health Econ 2002 Method Influenza vaccine Existing
74 Bhatia Health Pol 
Planning
2002 Demand/method Insecticide-treated nets Existing
75 Clarke Health Econ 2002 Method Mammographic
screening
Existing
76 Forsythe Health Pol and 
Plan
2002 Demand HIV counselling and 
testing
Existing
77 Nocera Int of H C Fin and 
Econ
2002 Method/CBA Alzheimer Disease Hypothetical
78 Onwujekwe Soc Sc & Med 2002 Method Insecticide-treated nets Existing
89 Stewart J Health Econ 2002 Method Hypothetical
80 Taylor Health expect 2002 Method Delivery Existing
81 Wagner Health Policy 2002 Method/Demand Mammography Existing
82 Whittington Vaccine 2002 Demand HIV/AIDS vaccine Hypothetical
83 Zillich Pharmac 2002 Method Asthma Hypothetical
84 Bhatia App Ec Lett 2003 Method/Demand Insecticide-treated nets Existing
85 Borisova Health
Econ
2003 Methods Travel time for 
methadone treatment
Not applicable
86 Dong Soc Sc & Med 2003 Demand Community insurance Not applicable
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87 Dong Health Econ 2003 Demand Community insurance Not applicable
88 Foreit Health Policy 2003 Method/Demand Reprod ucti ve/fam i I y 
planning
Existing
89 Hammerschmidt IJ H Care Fin 
Econ
2003 Method Diabetes Hypothetical
90 Luchini Health Econ 2003 Method Cancer, heart interv., 
helicopter services
Hypothetical
91 Onwujekwue Health policy plan 2003 Method/ Demand Insecticide-treated nets Existing
92 Shiell Health Econ 2003 Method Vaccine Hypothetical
93 Tarasiuk Sleep 2003 CBA Obstructive sleeping 
apnea syndrome
Existing
94 Whynes J Health Econ 2003 Method Colorectal screening Existing
95 Amin H Res Pol &  Syst 2004 Demand Childhood diarrhoea Existing
96 Asgary Eur J Health Ec 2004 Demand Health Insurance Not applicable
97 Bissai Bull of WHO 2004 Demand AIDS vaccine Hypothetical
98 Bradford J Telemed 2004 Demand Telemedicine Existing
99 Carlsson Haemophilia 2004 CBA Treatment of haemophilia Existing
100 Dong H Pol & Planning 2004 Demand Community-based health 
insurance
Hypothetical
101 Dranitsaris Pharmacoecon 2004 CBA Pharmac. treatment of 
advances cancer
Existing
102 Greenberg Health Policy 2004 Method Prevention of Restenosis Hypothetical
103 Hammerschmidt Health Econ 2004 Method Diabetes Hypothetical
104 M atari a J Health Econ 2004 Demand Quality o f care Not applicable
105 Olsen J Econ Psychology 2004 Method Cancer, heart interv., 
helicopter services
Existing
106 Olsen Health Policy 2004 Method Heart operations, hip 
replacement, cataract
Hypothetical
107 Onwujekwe J H Serv Res Pol 2004 Demand Insecticide-treated nets Existing
108 Onwujekwe Health Econ 2004 Demand Insecticide-treated nets Existing
109 Onwujekwe Soc Sc & Med 2004 Method Insecticide-treated nets Existing
110 Pavlova App Econ 2004 Demand Health services Not applicable
111 Protiere Soc Sc & Med 2004 Method Cancer, heart interv., 
helicopter services
Existing
112 Rheingans Filaria J 2004 Demand Lymphatic filariasis Existing
113 Ryan J Health Econ 2004 Method Cancer, heart interv., 
helicopter services
Existing
114 Ryan Health Econ 2004 Method In Vitro Fertilisation Existing
115 Whynes Health Econ 2004 Method Colorectal Screening Existing
116 Asfaw Int J H Care Fin 
Econ
2005 Demand Health services Existing
117 Barner Res in Soc A 
Pharma
2005 Demand Pharmacist’s counselling 
for menopausal 
symptoms
Existing
118 Bradford Telemedice and e- 
Health '
2005 Demand Telemedice Existing
119 De Ridder Eur J Health Ec 2005 Method Attention disorder Hypothetical
120 Dong Health Policy 2005 Demand Community-based health 
insurance
Not applicable
121 F autre 1 J of Rheumat 2005 Cost of illness Rheumatoid Arthritis Hypothetical
122 Finkelstein Am J of Man Care 2005 Demand Bariatric surgery Existing
123 Hackl Health Econ 2005 Method Red Cross services Existing
124 Hamelsky Cephalgia 2005 Cost of illness Migraine Hypothetical
125 Ho Acc Anal & Prev 2005 Demand Pain-killing pill Hypothetical
126 Lee H and Q of Life 
Outcome
2005 Demand Pertussis treatment and 
vaccination
Hypothetical
127 Liu Health Econ 2005 Demand SARS Vaccine Hypothetical
128 Masiye Malaria Journal 2005 CBA Malaria vaccination and 
treatment
Hypothetical
129 Olsen J Health Econ 2005 Method Cancer, heart interv., 
helicopter services
Existing
130 Onwujekwe Soc Sc & Med 2005 Method/Demand Insecticide-treated nets Existing
131 Onwujekwe Health Econ 2005 Method Insecticide-treated nets Existing
132 Sadri Pharmacoecon 2005 Demand Inhaled Insulin Existing
133 Smith J Health Econ 2005 Method Hypothetical pill Hypothetical
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134 Suraratdecha Health Policy 2005 Demand AIDS vaccine Hypothetical
135 Takemura Health Econ 2005 Method X-ray for gastric cancer Existing
136 Whynes Health Econ 2005 Method Screening (cervical and 
colorectal)
Existing
The contingent valuation method has received a lot of attention from health 
economics journals, as it is clearly demonstrated by the high number of studies 
published in these journals. However these studies remain a marginal component of 
economic evaluation literature; cost-effectiveness and cost-utility analysis are largely 
the preferred method for evaluating medical and other health care decisions.
Contingent valuation studies benefit from a multidisciplinary effort. Although the 
method is rooted in welfare economics, well designed studies also require survey 
research skills and advise from medical experts. The audience of contingent 
valuation studies are heterogeneous as well. From the scientific point of view this 
includes welfare applied economists, health service researchers as well as policy 
analysts. But as a method to offer guidance on decisions about resource allocation, 
contingent valuation research is also expected to be of great interest to policy 
makers, managers, public health officials and clinicians. Consequently, it is not 
surprising that contingent valuation studies have been published in various types of 
journals: from public health to general applied economics, from health service 
research to clinical medicine.
We have classified the literature according to three broad categories of scientific 
journals: economics and policy, health service research, and medical and public 
health (figure 3.1). Surprisingly, the first article published in an economic or health 
policy journal is dated 1990, seventeen years after the paper by Acton (1973) 
reporting the first attempt to use the contingent valuation method in health care. 
However, since 1990 the number of studies published in the economics and policy 
literature has increased substantially and it is now much higher than the number of 
studies published in public health and medical journals. Data for 2004-2005 clearly 
illustrates that the trend observed in the ‘90s has accentuated in most recent years. 
CV studies mainly appear in policy and, even more frequently, in health economics 
journals. In only two years 8 studies were published in Health Economics and 4 
studies in Journal of Health Economics, the two most important scientific journals in 
the field.
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The identification of the journal where contingent valuation studies are published is 
important for two main reasons. First, it is likely that the skills of referees differ across 
journal types, with economics and policy journals having the most experienced 
reviewers in the area of applied welfare economics. To the other side, medical 
journals are much more likely to have experienced reviewers in the specific context 
of the study but little knowledge on methodological issues. The second reason to 
monitor where contingent valuation studies are published concerns their audience. 
Although still at an experimental stage, these studies are aimed at offering guidance 
to decision making. Publications in policy, public health and medical journals are thus 
more suitable to inform decision-making as their audience include health care 
professionals and policy advisors.
However, publications of contingent valuation studies in medical and public health 
journals, those that tend to have a larger audience and a greater impact on decision 
making, should raise some concern. The lack of experienced reviewers, as well as 
the lack of established guidelines on how to conduct these studies, may result in a 
weak review process and, consequently, in poor quality publications that may affect 
decision-making at policy, management and clinical level.
The relatively small number of empirical studies is associated with a limited number 
of researchers committed to the contingent valuation method. Although 78 authors 
appear in the 33 studies included in the analysis for the period 1984-1996, only 16 of 
them have published more than one paper and only three have published more than 
two papers. It is thus possible to assume that very few researchers were mainly 
focused on this type of studies and that performing a contingent valuation in the 
health care field was, at that time, occasional for the vast majority of researchers. In 
that period, the only exception was represented by Magnus Johannesson, a Swedish 
economist, who is first author in four studies and co-author in other five. Now the 
situation appears slightly different. About a dozen scientists published more than one 
article in the period 2004-2005 (Cairns, Donaldson, Dong, Fox-Rushby, Hanson, 
Onwujekwe, Olsen, Protiere, Ryan, Shackley, Smith). Some of them are also the 
authors of critical reviews of the existing literature (Olsen and Smith, 2001; Smith, 
2003; Hanley et al., 2003). Some of them have participated to the Eurowill project 
sponsored by the European Commission to test the use of willingness-to-pay to elicit 
community preferences in 6 EU member states. While until the end of the ‘90s the
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scientific interest for contingent valuation studies in the health field appeared limited 
to very few researchers, in most recent years a more structured community has 
emerged and a few scientists have clearly made contingent valuation and related 
techniques their major area of research. These scientists are mainly based in UK 
and, to a lesser extent, in Scandinavia and France. Interestingly, US researchers 
show a limited interest in this area of research. We were not able to identify any 
contingent valuation study published by Italians.
In the period 1984-1996, the commitment of Magnus Johannesson and the 
Stockholm School of Economics to the use of contingent valuation is witnessed by 
the relatively high number of studies performed in Sweden. In the same period other 
countries where these studies have been carried out were the United States of 
America, United Kingdom, Canada, Australia and Israel. The location of the studies 
clearly suggests that surveying people about their willingness-to-pay for health care 
has been mainly attempted in English speaking countries and Sweden. While the 
concentration of the studies in these countries may reflect a wider diffusion of 
economic evaluation of health care programmes in general and an easier access to 
international journals, it cannot be excluded that cultural characteristics of these 
countries can have contributed to make monetary evaluation of health benefits more 
acceptable to surveys’ respondents and decision-makers.
English speaking countries maintained their leading role in experimenting contingent 
valuation. In 2005, 45% of studies were performed in UK, Australia or the USA. 
However, a major novelty emerges from the analysis of the countries where the 
surveys were performed. Thirty-nine percent of studies published in the 2004-05 
period present data collected in developing countries. It appears that contingent 
valuation is an attractive method to investigate the demand for health care services 
and to develop co-payment strategies in these countries. Interestingly, few WTP 
studies performed in low and medium income countries are part of full cost-benefit 
analyses of specific health care interventions.
3.3.2. Methodological studies
Over the entire 1984-2005 period 55 studies (40%) were methodological as they 
tested feasibility, validity and reliability of the contingent valuation method (table 3.1).
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Contingent valuation has gained importance and prestige in the scientific community 
but methodological issues are still the focal point of empirical research.
Feasibility and face validity of the contingent valuation method
The first methodology studies focused on testing the feasibility of asking patients or 
healthy people WTP questions, the feasibility of different value elicitation methods 
and the association between WTP amounts and some expected explanatory 
variables. Thompson et al. (1984) and Thompson (1986) investigated WTP for a 
hypothetical cure for arthritis. In the former study the rate of plausible response was 
27%, while in the latter it was 84%. According to the author (Thompson, 1986), the 
increased response rate of the second study was attributable to improved 
questionnaire design, to the performance of the interviewers and to having no 
subjects older than sixty-six.
Johannesson et al. (1991) compared open-ended and take-or-leave-it contingent 
valuation questions in a mail questionnaire sent to 481 hypertension patients enrolled 
in a Swedish primary care centre. Patients were divided in two groups. The first sub­
sample received and open-ended question in which they were asked to state their 
maximum willingness-to-pay for their current treatment. The other sub-sample 
received a yes/no question in which respondents were asked to accept or reject a 
specified increase in user fees for their current treatment. Usable responses 
measured as percent of population were much higher with the take-it-or-leave-it 
question (56%) than with the open-ended question (27%). This study clearly 
indicates that respondents found the discrete valuation question easier to answer.
In two later studies conducted in the early ‘90s (Johannesson et al. 1993a; 
Johannesson et al. 1993b) other value elicitation methods were tested. The former 
study surveyed hypertensive patients in a primary care centre using a new type of 
binary WTP questions that allowed for different degrees of certainty with respect to 
the responses. The overall response rate was about 64% and the item non-response 
rate on the willingness-to-pay question was about 5%. In the latter study concerning 
treatment of high lipid levels, a combination of open-ended and closed-ended 
contingent valuation questions were asked to patients enrolled in a clinical trial. The 
response rate to the WTP question was 94%, suggesting the possibility of obtaining
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very high response rates by using the contingent valuation method in clinical trials. 
Both these studies provided an indirect test of validity as they assessed whether 
hypothesised theoretical relationship between WTP and some explanatory variables 
were supported by data. Accordingly to theoretical expectations, the survey on 
patients with hypertension found that higher prices reduced the demand for the 
treatment and that a larger difference in perceived health status between treatment 
and no treatment increased willingness to pay. However, no association was found 
between socio-economic variables and willingness to pay. Results of the lipid 
lowering study provided a stronger validity test: increased difference in perceived 
health status between treatment and no treatment increased WTP, income elasticity 
was positive and the correlation between WTP and willingness to give up time to take 
part to the lipid lowering programme was high.
Regression analyses to verify internal validity has always been a basic feature of 
contingent valuation studies and generally indicate that WTP questions are not 
answered randomly by respondents (Neumann and Johannesson, 1994; O’Brien and 
Viramontes, 1994; Kartman et al., 1996a; Kartman et al., 1996b; Ryan, 1996; 
Stalhammar 1996; Ryan et al., 1997; Zilich et al., 2002). In more recent contributions 
more sophisticated statistical techniques have become a regular companion of 
contingent valuation studies. Important theoretical contributions have focused on the 
search for appropriate techniques for econometric analysis of WTP data elicited in 
contingent valuation studies (Donaldson et al., 1998). It is now generally recognised 
that Ordinary Least Square (OLS) estimates are not appropriate because censoring, 
truncation or the elicitation format used (Maddala, 1983; Long, 1997). For TIOLI 
questions probabilistic models are generally appropriate (logit and probit). Similarly, 
when data contain a large proportion of zeros tobit or spike models are expected to 
perform better than OLS (Donaldson et al., 1998; Long 1997) or to make 
assumptions more consistent with the nature of data (Kristrom, 1997). In general, 
most recent studies appear to take statistical analysis more seriously. In addition to 
using limited dependent variable models; they present various measures to test 
homoscedasticity, normality of estimated residuals and functional specification (see 
for example Dong et al., 2003a). Finally, an increasing number of studies use non 
parametric approaches that allow to avoid to make assumption about the distribution 
underlying the data sample (Hanley, 2003).
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While early studies proved that respondents living in affluent countries, and often with 
relatively high levels of education, understand WTP questions and provide 
reasonable answers, more recent studies have tested the feasibility of contingent 
valuation in developing countries (Amin, 2004; Asfaw and von Braun 2005; Bhatia 
and Fox-Rushby 2001 and 2003; Dong et al., 2004 and 2005; Mataria, 2004; 
Onwujeckwe et al., 2004; Onwujeckwe et al. 2005a and 2005b; Masiye 2005; 
Suraratdecha 2005; Onwujekwe et al., 2008). The method seems to perform well 
even in these contexts, especially in personal interviews conducted by well trained 
interviewers and with carefully designed questions. Unsuprisingly, evidence clearly 
shows that surveys should be designed to fit cultural contexts (Wagner et al, 2000 
and 2001; Onwujekwe et al., 2008).
Convergent and criterion validity
In the early 1990s two studies attempted more conclusive validity tests. In addition to 
investigate the association between household income and WTP, O’Brien and 
Viramontes (1994) tried to explore the validity of their study by measuring the 
correlation between WTP elicited by a bidding game and utility values derived from a 
standard gamble exercise. A relatively high correlation was found between the two 
measures, indicating that there was some evidence of convergent validity for WTP 
with preferences measured by standard gamble. It is worth noting, however, that this 
validity test does not appear very strong because it just suggests that two different 
ways to measure expressed preferences in a hypothetical situation provide 
consistent results. This issue has been partly addressed only recently (see below).
The second validity study performed by Chestnut et al. (1996) compared two 
approaches for measuring heart patients’ WTP for changes in their angina 
symptoms. First, they asked patients to report actual expenditure and perceived 
angina episodes avoided. From these elements an averting-behaviour measurement 
of WTP was derived. Second, contingent valuation questions were asked to measure 
WTP for a hypothetical medical treatment that could avoid increases in angina 
episodes. Results of this small study (only 35 respondents provided data for the 
comparison) show that the average WTP to avoid additional angina episodes derived 
from the actual expenditure questions was comparable to the WTP directly elicited. 
According to the authors, these results provide a new test of validity of the contingent 
valuation approach. Unfortunately, the article is quite obscure in many crucial parts
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so that a complete analysis of the methodology used is not always possible. 
Moreover, the sample size is very small and some methodological choices are not 
clearly justified.
Both of these studies tried to produce a convergent validity test. This is a test to 
measure whether two or more measurement tools, that are expected to measure 
similar concepts, provide high correlated values (Carmines and Zeller, 1979). In the 
late ‘90s, in a study investigating three different health care programmes, Olsen and 
Donaldson (1998) found that there was a substantial discrepancy between the 
explicit ranking and the ranking implied from the partial WTP values. More recently, 
in a study conducted in 6 different countries on 1,240 subjects Olsen et al. (2005) 
found similar evidence. “The most consistent result of the study is the inconsistency 
of WTP and explicit ranking in all six countries” (Olsen et al., 2005, 994). The authors 
claim that their findings seriously challenge the use of contingent valuation to elicit 
people’s preferences in priority setting contexts.
Several studies have tested convergent validity by comparing different WTP 
elicitation methods. As already reported, Johannesson et al. 1991 compared the 
open-ended (OE) method with the dichotomous choice (DC) method and Donaldson 
et al. (1997a) compared the OE with the payment card (PC) method. Both DC and 
PC approaches to eliciting WTP for health care interventions appear superior to the 
OE method. With respect of expected determinants of WTP (e.g. that income is 
positively associated with willingness to pay) and completion rates both the DC and 
PC approaches are better than OE. In addition, there is concern about face validity of 
OE questions as they are too hypothetical, they do not reflect the way people 
generally behave in real markets and they do not provide any guidance to 
respondents on how to think about their willingness to pay for the good (Donaldson et 
al., 1997a; Ryan et al., 2004). However, a study on the screening for colorectal 
cancer has recently provided a different picture (Whynes et al., 2003). In comparison 
with the open-ended method, the payment scale generated higher evaluations. In 
addition, it is argued that open-ended questions are closer to how donations are 
solicited and decided than dichotomous choice questions (Onwujekwe, 2002; 
Onwujekwe and Uzochukwu, 2004). While people generally take or leave fixed prices 
in most markets, they are generally asked to give and then it is up to them to define 
the amount of the donation.
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Ryan et al. (2004) have compared WTP estimates generated from PC and DC and 
have compared stated WTP with preferences elicited from ordinal ranking and 
cardinal person-trade-offs; they obtained that the DC WTP approach resulted in 
welfare estimates substantially higher than those produced by the PC approach. 
They argue that this may be partly explained by “yea-saying”. Consistently with DC 
studies in the environmental economics literature, the DC method results in higher 
WTP because people bias their answers towards “yea-saying” when this is thought to 
be the socially desirable response. Neither the DC nor the PC method demonstrated 
to be convergent with ranking and person-trade-offs exercises. Nevertheless, the 
authors attributed this result to the fact that preferences are constructed in response 
to stimuli rather than revealed. Therefore, it can be expected that different methods 
result in different preferences. These results are partly backed by Shiell and Gold 
(2003) who have shown that preferences are not well formed and ready to be 
revealed in contingent valuation surveys. They also found that the payment card 
method failed to reveal respondents maximum WTP and provided vague estimates of 
preferences. In a major study conducted in the USA to compare 7 different value- 
elicitation methods it was obtain a similar result: 4 out of the seven methods did not 
produced data consistent with different indirect utility functions and the three methods 
that generated inconsistent estimates with the other were OE and PC (Cameron et 
al, 2002). It can be argued that these two methods may lead respondents to think 
about CV questions in rather different ways (Hanemann, 1996)
Coming back to healthcare studies, another important convergent validity test was 
performed by comparing CV method and travel cost method for improved access to 
mammographic screening in Australia (Clarke, 2002). The travel cost method 
measures revealed preferences and estimates the benefits of the good by using 
travel costs to have access to it. Based on information collected through telephone 
interviews of 372 women, the study by Clarke (2002) estimated that WTP based on 
the CV method was significantly higher than the WTP based on the travel cost 
method.
Tests of convergence provide valuable evidence on the validity of the CV method. 
Even if it is accepted that different cognitive processes may results in different 
preferences, a certain degree of convergence is to be found to make the contingent
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valuation method credible. If two elicitation approaches provide two unrelated 
estimates, at least one of them is not valid (that is it does not measure what it is 
designed to measure). However, a better validity test of the CV method is to compare 
hypothetical with real WTP.
To our knowledge three studies performed such a criterion validity test in the health 
care field (Blumenschein et al., 2001; Bhatia and Fox-Rushby, 2003; Onwujekwe and 
Uzochukwu, 2004; Onwujekwe et al., 2005). In the first study subjects received either 
a dichotomous choice WTP question or were given the opportunity to actually 
purchase an asthma management program (Blumenschein et al., 2001). In the 
hypothetical group, 38% of subjects stated that they would purchase the program at 
the stated price, but only 12% of subjects in the real group purchased the program. 
However, if in the hypothetical group only responders who stated to be “definitely 
sure” about their willingness-to-pay were considered “purchasers”, the fraction of 
hypothetical (14%) and real purchasers (12%) would be very similar. This study 
clearly indicates that the DC method overestimates WTP. However, it also suggests 
that it may be possible to correct this overestimation by sorting out the “definitely 
sure” and “yes” responses.
The second study was carried out in Gujarat (India) and involved three hundred 
households in 20 villages (Bhatia and Fox-Rushby, 2003). Respondents were first 
interviewed twice and then asked whether they would be willing to buy a treated 
mosquito net for a fixed price (equal to the modal value revealed in the interviews). 
The authors found that at an aggregate level there was no statistically significant 
difference between hypothetical WTP and actual demand. However, there was 
considerable variation among individuals. The authors concluded that CV-based 
WTP estimates are robust at the population level but less so at the individual level.
The third study compared three elicitation CV methods with actual willingness-to-pay 
for insecticide-treated bed nets in Nigeria and investigated the factors that cause 
divergences (Onwujekwe et al., 2005b). For all the three question formats there were 
divergences between stated and actual WTP: 69.4% of respondents in the bidding 
game group, 78.8% in the binary with follow-up group and 48.8% in the structured 
haggling group behaved differently from what they stated in the contingent valuation 
survey. Actual behaviour diverged from stated WTP for both the people willing to pay 
(who then did not purchase the net) and those unwilling to pay (who then did
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purchase the net). The authors found that there were genuine causes of divergence 
between stated and actual WTP across the question formats and argued that it is 
important to detect whether the divergence in WTP occurs because of bias or 
because of legitimate changes in consumers’ values or circumstances.
The same study investigated an issue that is probably even more crucial to 
understand the validity of the contingent valuation method in health care: the 
comparison of stated and actual altruistic WTP (Onwujekwe and Uzochukwu, 2004). 
First of all, the authors investigated the appropriate format to ask altruistic WTP 
questions. In general, it can be argued that question formats that better mimic price- 
taking in a particular context will generate more valid WTP estimates. However, 
according to the authors it is unclear whether the same question format should be 
used to value the three aspects of WTP (use, option and altruistic values). The 
dichotomous choice (yes/no to a proposed value) generally resembles the real 
market decisions of individuals for valuing use or option values, but it may not 
resemble the people’s normal altruistic decisions for goods and services. In general, 
dichotomous choice, bidding game and payment card formats do not reflect how 
individuals make altruistic contributions. These “payments” are usually made freely 
and voluntarily in an open-ended way.
To determine the best valid estimates of altruistic WTP the authors randomized the 
respondents either to the take-it-or-leave-it (TIOLI) with follow-up format or to open- 
ended (OE) questions. They then compared elicited WTP to provide insecticide- 
treated nets to low income households in Nigeria to actual voluntary contributions. 
More than 57% of the respondents were hypothetically willing to pay for altruism in 
both groups. A total of 27% and 33% of the respondents with positive hypothetical 
WTP in the TIOLI with follow-up and OE actually contributed. This study shows that 
only about one third of respondents willing to pay then actually paid the stated 
amount. It is also shows that the open-ended format elicits better valid estimates of 
altruistic WTP than the dichotomous choice format.
Overall, there is too little evidence available on the validity of the different formats to 
elicit WTP for health services. So far the following provisional conclusions can be 
formulated. First, different elicitation methods provide different stimuli and thus 
produce different results. Consequently, there is no “right” method to elicit WTP.
Second, there is evidence of “yea-saying” and this tends to generate overestimates 
of WTP when the take-it-or-leave-it format is used. The most precious experiments, 
which are those that compare stated WTP to actual WTP, clearly suggest that the 
former is larger than the latter. This is very important from a policy perspective and 
suggests that it may be useful to measure the degree of certainty of the respondents. 
Finally, to provide valid measures, altruistic WTP may require special elicitation 
formats that reflect the way in which altruistic payments occur in reality.
Reliability
In assessing reliability, it is necessary to investigate whether measuring the same 
object or the same phenomenon with the same measurement instrument will give 
similar results (Carmines and Zeller, 1979). Correlations between duplicated or 
reproduced measurements of the same object or phenomenon, using the same 
instrument, need to be calculated. This duplication can be carried out either by the 
same observer at different times (test-retest reliability), or by different observers 
simultaneously (inter-rater reliability).
The evidence on the reliability of willingness-to-pay elicited using the contingent 
valuation method is growing. The first study included in our review, that used open- 
ended questions, performed a test-retest reliability check on about 50 patients and 
found a correlation of 0.25 (Thompson et al., 1984). Studies performed in the ‘90s 
(mainly bidding games) suggested moderate-to-high reliability; reliability test-retest 
coefficients ranged between 0.5 and 0.8 (O’Brien and Viramontes, 1994; Cho et al., 
2000; Sorum, 1999). More recently, Onwujecke et al. (2005) retested bidding game, 
closed-ended and structure haggling questions one month after the first face-to-face 
interview and got relatively low Pearson’s coefficient of correlation (0.3-0.5). In this 
study structured haggling performed satisfactorily but it was not clear which format 
was superior. In a larger study in Africa conducted with face-to-face interviews, Dong 
et al. (2003) found that the reliability of both the dichotomous choice and the bidding 
game formats were moderate to good (Pearson and Spearman correlations between 
5.9 and 7.0). In addition, the study shows that the bidding game format was more 
reliable than the closed-ended format.
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To our knowledge the best evidence on reliability comes from the Nigerian study on 
insecticide-treated nets carried out at the London School of Hygiene and Tropical 
Medicine (Onwujekwe et al., 2004). Inter-rater reliability was evaluated by having two 
sets of interviewers administer questionnaires to randomly selected household 
heads. Inter-rater reliability coefficients were high at 0.77, 0.75 and 0.74 for the 
bidding game, the binary with follow-up and the structure haggling technique, 
respectively. Test-retest reliability was investigated by repeating interviews one 
month after the initial survey. Test-retest coefficients were low-to-moderate, ranging 
from 0.4 to 0.56. According to the authors, however, the lower coefficients in the test- 
retest reliability were due to the influence of factors affecting demand that had 
changed in the intervening period. This study also shows that the three different 
question formats have similar levels of reliability.
Random assignment of bids, range bias and prominent numbers
Four studies published recently investigated specific technical issues related to the 
choice of numbers to present in contingent valuation questions. Takemura et al.
(2005) investigated the influence of poor random assignment of bids in the discrete- 
choice WTP elicitation format. They show that if the survey fails to assign the bid 
randomly according to characteristics that are expected to be correlated with WTP, 
results are biased. It is thus necessary to check if bids are randomly assigned to the 
respondent’s characteristics and, if they are not, to adjust their interaction effects.
The other two problems are specific to the payment card format, that is the method 
where respondents are presented a card with possible WTP values and then they are 
asked to state if they are or they are not willing to pay for each of them (Whynes et 
al., 2004; Whynes et al., 2005). Probably, the most disturbing problem concerns the 
existence of range bias (Whynes et al., 2004). The authors report the findings of a 
contingent valuation survey of colorectal cancer screening, wherein different subjects 
were provided with payment scales of different lengths. The long scale presented 
values up to UK £ 1,000, while the short scale version extended only to UK £ 100. It 
emerged that the long scale produced a mean WTP more than 30% higher than that 
resulting from the short scale. The authors concluded that their findings are strongly 
supportive of the existence of range bias in payment card instruments -  scales which 
extend to higher values and generate even higher values.
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The other problem was discovered by observing the distribution of WTP values in 
three contingent valuation studies that elicited WTP from samples drawn from the 
general population of east-central England (Whynes et al., 2004). The studies elicited 
WTP using a payment scale, completed without supervision (self-administered). 
Subjects were asked to encircle their maximum value out of 29 different values, 
having obtained these by placing ticks against amounts they were sure they would 
pay and crosses against amounts they were sure they would not. The majority of the 
3,000 respondents indicated one of a limited number of values from the range 
available to them (£ 1,2, 5, 10, 20, 50, 100). These “prominent numbers” has been 
observed previously in circumstances where respondents were uncertain about their 
choices and are suggestive of bias in contingent valuation.
Scope sensitivity, “warm-glow” and free riding
In the ‘90s another major problem, widely debated in environmental economics, was 
addressed in the health care contingent valuation literature: scope sensitivity. The 
scope effect refers to the fact that, to be theoretically and intuitively valid, the 
contingent valuation method has to be sensitive to changes in scope of the 
programme being evaluated, i.e. that WTP increases with the size of benefits. An 
often mentioned study illustrates the problem. Boyle et al (1994) found that the 
average WTP to prevent 2,000 migratory birds from dying in oil-filled ponds was as 
great as that for 20,000 or 200,000 birds from dying. Marginal WTP is expected to 
decrease as the units of benefit of the programme increases. However, a drop to 
zero in WTP for additional benefits is hard to explain as the expression of a 
consistent, rational set of choices (Arrow et al., 1993).
Kartman et al. (1996b) tested the scope effect using a split sample approach. 
Different sub-samples were asked to answer a yes/no WTP question for different 
probabilities of successful treatments for reflux oesophagitis. Therefore, in this 
context (as in most of health care programmes) the size of the commodity being 
evaluated was measured in terms of probability of success. In this study the 
contingent valuation method proved sensitive to changes in scope in that the higher 
the probability of success, the higher the elicited WTP. Similarly, Neumann and
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Johannesson (1994) consistently found that WTP for IVF increased with the 
probability a success (measured in terms of at least one delivered baby).
A few recent studies have further investigated whether the contingent valuation 
method is sensitive to change in the scale of the programme. Liu et al. (2005) found 
that the WTP of two samples of the Taiwanese population were sensitive to the 
scope of the risk reduction of SARS. WTP was positively correlated (i) to the amount 
of risk avoided by the intervention, (ii) to the mortality rate attributable to the disease, 
(iii) to the duration of the efficacy of the preventive measure. Differently, a contingent 
valuation survey conducted in Uganda to understand the determinants of personal 
demand for an AIDS vaccine showed that respondents were little sensitive to the 
efficacy of the vaccine (Bishai, 2004). In a sample of more than 1,000 individuals the 
fraction of “yes” responses was not different for a 50% or a 95% efficacy vaccine. 
Respondents were not scope sensitive.
Greenberg et al. (2004) found slightly different evidence in a study conducted in the 
USA among patients enrolled in two percutaneous coronary interventions trials. The 
study measured patients’ WTP to reduce the risk of restenosis and repeat 
revascularisation. The baseline scenario described a 30% probability of repeat 
revascularisation. The median WTP was US $1162, US $ 366 and US $273 for 30%, 
20% and 10% absolute risk reductions, respectively. Here respondents were scope 
sensitive as they revealed higher WTP for higher risk reductions. However, they 
showed that they were willing to pay an additional amount of almost US $800 to 
reduce the risk from 10% to 0% and only US $ 87 to reduce the risk from 20% to 
10%. This study suggests that patients are willing to pay higher amounts for 
therapies that completely eliminate the risk of a negative event. One possible 
explanation may be that many individuals have a poor appreciation for numerical 
differences in magnitude (Greenberg et al., 2004).
Overall these studies suggest that respondents may have difficulties with fully 
appreciating numbers, especially if they refer to probabilities (Hammit & Graham,
1999). Our personal experience with people, even with highly educated ones, is that 
they rarely understand probabilistic reasoning. Obviously, this is a major problem 
with contingent valuation; monetary valuation should reflect the magnitude of the 
benefits to be usable and meaningful. However, it is worth noting that these
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difficulties with numbers and probabilities occur also when people make real choices. 
The fact that people have serious problems with probabilistic reasoning poses a 
serious challenge to all economic analysis based on rational choices, not only to 
contingent valuation studies.
But scope insensitiveness may have a different cause. It is argued that stated 
willingness-to-pay may be insensitive to variations in scope because respondents do 
not report real economic preferences, but rather derive moral satisfaction (warm 
glow) from the act of giving per se (Kahneman & Knetsch, 1992; Hackl & Pruckner, 
2005). Therefore, when asked WTP questions, respondents would signal their “warm 
glow” disregarding the scope (size) of the intervention. We are aware of one study 
only that intentionally tested the warm glow effect for health care services. Hackl and 
Pruckner (2005), through a contingent valuation survey of Red Cross services in 
Austria, found no evidence of the warm glow phenomena. Additionally, they did not 
find any evidence of respondents’ strategic behaviour (that is to give false signals). 
Both results were consistent across different payment vehicles (donations and 
insurance premiums). New studies are required to test the hypothesis of warm glow 
effects in health care; nevertheless, the existing evidence appears in favour of the 
validity of the method as far this effect is concerned.
Three recent studies have explored the cause of scale insensitivity of WTP and have 
shown that it tends to decrease as the size of the health benefit being valued 
increases (Smith, 2001; Yeung et al., 2003; Smith, 2005). They suggest that this may 
be due to an increasing relevance of the budget constraint as the value of the 
programme increases. As the benefit generated by the programme increases, WTP 
for that benefit rises and consequently the budget constraint becomes more 
determinant. Accordingly to standard economic theory, more of a good is consumed 
the more utility is gained, but each successive increment in the good yields lower 
amounts of additional utility (because of diminishing marginal utility). Consequently, 
in the indirect estimation of utility WTP should also increase at a decreasing rate for 
successive increases in health status (Smith, 2005).
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Starting and order bias
The Nigerian study on insecticide-treated nets provides uncertain evidence on 
another critical feature of contingent valuation: the possibility that, when asked more 
than one WTP question, respondents tend to be influenced by the initial proposed 
value (Onwujekwe and Nwagbo, 2002). This problem is a cause of systematic errors 
in the elicited WTP and is normally called starting-point bias. O’Brien and Viramontes 
(1994) found no association between starting bids and final bids when they analysed 
mean WTP adjusted by income and health status. However, in a different analysis 
that considered median values there was some evidence of a starting-point bias, but 
this did not reach conventional statistical significance (p=0.07).
Stalhammar (1996) has provided evidence on this problem by conducting a bidding 
game with 82 patients affected by duodenal ulcer or reflux oesophagitis. He found 
that the average WTP among the 42 patients who started at the low bid and the 40 
patients who were initially offered a high bid were 70 Swedish Crowns (SEK) (C 60- 
79) and 289 SEK (Cl 214-364), respectively. Consequently, the study indicated the 
presence of a relevant starting bias. This bias was found in other studies (Chestnut et 
al. 1996; Liu et al., 2000; Dong et al., 2003a). The study by Dong et al. (2003a) 
performed in Burkina Faso provides strong evidence in favour of the existence of a 
starting point bias in the bidding game process. The starting price offered to 
respondents was significantly associated to the elicited WTP. The higher the initial 
bid, the higher the elicited WTP. In a more recent study for telemedicine services 
Bradford et al. (2004) did not find similar evidence. However, the study may have had 
insufficient power to detect the effect due to the limited sample size (126 answers).
The study by Kartman et al. (1996b) on reflux oesophagitis also investigated the 
presence of question order effect: changing the sequence of questions in a multiple 
valuation questionnaire results in significant differences in elicited WTP. To test this 
potential shortcoming of contingent valuation, patients were randomly assigned to 
one of six possible sequences of questions. Whether the probability of accepting a 
certain proposed WTP was affected by the question order was then assessed in 
logistic regression analyses by using dummy variables. The results of the regression 
analyses did not prove any impact of question order on WTP.
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A few studies have further investigated whether the order in which the programmes 
(goods) are presented to respondents has an influence on the WTP values obtained. 
In a study presenting three health care programmes, Stewart et al. observed ordering 
effects in the ranking of the programmes; in the proportion of zero values reported 
and in the WTP for one of the programmes (Stewart et al., 2002). According to the 
authors, the best explanation for the ordering effects is one of warm glow, whereby 
the first programme in any sequence captures much of the utility associated with 
giving. Ordering effects are confirmed by De Ridder and De Graeve (2005) and, only 
to a limited extent, by Carlsson et al. (2004). In the former study a split sample was 
used to test order bias. The results show that WTP for a new drug varies according 
to the order in which the alternatives are presented. Respondents stated a higher 
WTP for the new drug only if the standard therapy (the comparator) was presented 
first. The latter study, based on a representative sample of the Swedish population, 
found that there was an order bias for one of the two treatments for which WTP was 
elicited.
Scenario description
Many healthcare technologies have several effects on the individuals’ health. In 
addition, these effects are not uncertain and thus require probability reasoning to be 
appreciated. For cost-benefit analysis they should theoretically be valued in a single 
scenario covering all relevant effects; this approach is called holistic measurement. 
However, a few studies presented decomposed scenarios in which respondents 
stated their WTP for each individual effect separately (O’Brien et al., 1995; 
Dranitsaris, 1997; Luchini et al., 2003). This approach is often preferred because it 
poses a smaller cognitive burden to respondents. Holistic WTP measures can be too 
complex especially when a large number of health effects have to be valued at once. 
As the capacity to process information appears to be limited, a holistic valuation of a 
technology with several effects can result in being too cognitively demanding. Often, 
respondents focus on a few effects (most likely to be those presented first).
An early contingent valuation study that measured WTP for an ultrasound in normal 
pregnancy provided evidence for the existence of sub-additivity: the sum of WTP for 
each individual effect measured separately exceeded WTP elicited for the holistic 
scenario (Berwick and Weinstein, 1985). Sub-additivity was confirmed by a recent 
study by Hammerschmidt et al. (2004) who tested the two approaches on diabetic
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patients. The authors also suggested a theory-based aggregation of individual effects 
that could considerably reduce the degree of overestimation generated by the 
aggregation WTP elicited in decomposed scenarios.
The complicated issue of how to describe the scenarios for WTP questions have 
been investigated by a group of French health economists who took part of the 
Eurowill project. This project was designed to assess the feasibility of the CV method 
as a tool for measuring preferences of members of the general public about health 
care programmes (Protiere et al., 2004). The project investigated three health 
programmes: more heart operations, a new breast cancer treatment and helicopter 
ambulance services. The authors show that performing separate evaluations of 
different programmes result in WTP estimates that are different from those derived 
from joint evaluations (that is when more programmes are assessed in the same 
study) (Luchini et al., 2003). They conclude that separate estimations may lead to 
misspecifications, as the estimations cannot take into account the fact that joint 
evaluation exogenously provides a reference structure to the respondent which 
affects the estimates of WTP for each programme. In another study using the same 
dataset the authors investigated the effects that providing additional information to 
respondents had on their WTP values. Although the statistically significant level of 
5% was not reached (probably due to the limited power of the study), the value 
associated with some additional “neutral” information on the process of care was 
positive. In addition, when the scenario was complemented by unambiguously 
“positive” information, the increase in the mean WTP became statistically significant. 
Interestingly, WTP for all three programmes tended to be significantly higher for 
respondents who were provided additional positive information about only one of the 
programmes. The fact that providing additional positive information on one 
programme affected WTP values for the other two programmes needs to be 
explained. It may be that respondents who received positive signals about a health 
programme tended to interpret such information as a signal about a general 
improvement in the quality of health care in general. Alternatively, the cause of this 
unexpected result may be attributed to a type of “starting-point” bias whereby the 
elicited WTP values for the two programmes for which additional information was not 
given simply derived by the previous evaluation. The first programme presented, 
whatever the amount of information it contained, was a reference point for the other 
two. Therefore, if the first programme contained more information and thus had a
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higher WTP, the subsequent programmes would be better evaluated simply because 
their assessment followed one that was better perceived.
These studies indicate that any attempt to measure preferences for health 
programmes in the general population should present respondents with descriptions 
of care containing attributes which are “legitimate” (from the decision maker’s point of 
view) and, potentially utility-generating. Overall, the description of the scenarios to be 
presented in contingent valuation surveys is probably the most critical element. So 
far, it has received limited attention and often empirical studies do not carefully 
design this element of the questionnaire (Diener et al., 1998; Olsen and Smith, 
2001). Future studies should further investigate this issue and should identify devices 
to increase the validity of contingent valuation in this respect.
3.3.3. Non cost-benefit studies providing inputs to decision makers
In the period 1984-1996, seventeen articles (56%) openly used the contingent 
valuation method to offer guidance to policy, managerial or clinical decisions (table
3.2). However, not all these articles make reference to costs of the programme being 
evaluated and most of them used the methods outside the framework of cost-benefit 
analysis. Miedzybroclzka et al. (1995) elicited WTP for two methods of carrier 
screening for cystic fibrosis from women attending a Maternity Hospital Clinic in 
Aberdeen. They found that the stepwise method (the mother is tested first and if she 
is positive the test is administered to the partner) was preferred by more women than 
the couple method (both future parents are tested simultaneously), although the 
intensity of the preference (the mean WTP in the two groups) was similar. On the 
basis of this evidence and on the result of a randomised trial showing that the 
stepwise method of screening was associated with less anxiety and false 
reassurance, the authors concluded that step-wise screening was the better 
approach for implementation. In this study WTP was an instrument used to measure 
the intensity of preference and was not used in a cost benefit analysis.
Two older studies used the contingent valuation method to investigate WTP for 
changes in the health care system. Golan and Shechter (1993) elicited willingness- 
to-pay for a programme that would allow interested patients to receive a variety of 
services otherwise unavailable through the statutory Israeli health care system. 
Under the programme; patients would be able to choose a consulting physician or
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surgeon from among the hospital’s senior staff, and to schedule operations or at least 
reduce waiting times. The availability of these options would be allowed by an 
extension of senior doctors’ working time. It was found that the WTP elicited from a 
random sample of Haifa residents was reasonable and that as a policy implication a 
complementary health care programme was favourable. However, no cost data of the 
programme was reported in the article; it was only mentioned that a parallel study on 
the supply of senior physicians suggested that adequate compensation could be 
generated by the activation of the programme.
A similar study was carried out by Eckerlund et al. (1995) to analyse how much 
Swedish residents are willing to spend in the form of taxes for health care. WTP was 
elicited by the means of a take-it-or-leave-it contingent valuation question that was 
included in a telephone survey of a national random sample of 1260 households. 
Respondents were asked if their households were prepared to pay X more per month 
in order to improve the medical care in their own county. Five possible answers were 
given: “yes, definitely”; “yes, probably”; “no, probably not”; “no, definitely not”; “don’t 
know”. Using a conservative interpretation of the yes answer to the proposed bids 
(only respondents who answered “yes, definitely”) mean WTP was estimated at 284 
Swedish Crowns (SEK) per month (€1 = SEK8), while in the standard interpretation 
(“yes, definitely” and “yes probably”) mean WTP was estimated at 635 SEK per 
month (health care expenditure per household in Sweden was about 2600 SEK per 
month at that time). This study interpreted results as a referendum. The authors 
report that the majority of respondents were prepared to increase the tax payment to 
health care, although the size of the increase appeared relatively modest (50% of the 
sample voted in favour of an increase in the tax payment of SEK 64 and SEK 237 per 
month using conservative and standard yes answers, respectively).
In the period 1997-2005 63 studies (43%) provided management or policy evidence 
and were not purely methodological. Most of them are not cost-benefit analysis as 
they investigated the determinants of the demand for specific services or for quality 
of care characteristics. It is interesting to notice that many studies conducted in 
developing countries were focussed on willingness-to-pay for personal or family’s use 
of services and aimed at understanding if co-payment schemes were feasible and 
affordable by the population (Amin and Khondoker, 2004; Bishai et al., 2004; Asfaw 
and von Braun, 2005; Asgary et al., 2004; Suraratdecha et, 2005; Onwujekwe, 2004;
84
Onwujekwe, 2004, 2005a, 2005b). It appears that in developing countries, and also 
to a certain extent also in affluent economies, contingent valuation is mainly used to 
investigate the characteristics of demand for health services, to set prices and, more 
generally, to improve market knowledge (see for example the large study on 
community health insurance in Burkina Faso; Dong et al. 2003a, 2003b, 2004 and 
2005).
The paper by Weaver and colleagues on WTP for child survival in Central African 
Republic is somehow representative of this type of studies (Weaver et al., 1996). The 
survey addressed two major issues: a) to what extent the user fee finances the costs 
of quality improvement and b) whether a uniform program could be implemented 
throughout the country or should the user fees be different across health regions. For 
each element of the hypothetical quality improvement programme the authors could 
estimate the percentage of the population that was willing to pay the costs and could 
assess that WTP in rural and urban areas was substantially different. According to 
these results the authors concluded that the proposed national user fee/quality 
improvement program was feasible and appropriate.
More recently, similar studies were conducted in Iran to assess if health care 
insurance currently operating in urban areas can be expanded to rural areas (Asgary 
et al, 2004), in Burkina Faso and Ethiopia to measure WTP for community based 
health insurance schemes (Dong et al. 2004 and 2005; Asfaw and von Braun, 2005), 
in Uganda to assess the factors affecting demand for an HIV/AIDS vaccine among 
adults (Bishai et al, 2004), in Bulgaria for measuring population attitudes towards 
paying for quality improvements of and quick access to public health care facilities 
(Pavlova et al., 2004) and in Nigeria to elicit WTP for insecticide-treated bednets 
(Onwujekwe, 2004; Onwujekwe 2005). Other studies that mainly investigated 
determinants of demand for health care were conducted in India, Thailand, Haiti, 
Zambia and Palestine. Indeed, the contingent valuation method appears increasingly 
used to investigate the characteristics of personal demand for services and to 
estimate the impact of user fees or private health insurance, rather than to assess 
whether government sponsored programmes produce net economic benefits.
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3.3.4. Cost-Benefit studies
Between 1984 and 1996 seven published studies (21%) can be classified as cost- 
benefit. However, most of these studies do not provide accurate cost analyses of the 
programme being evaluated. The Donaldson (1990) paper was the first contingent 
valuation study published in a health economics journal. This British study attempted 
to determine WTP for two alternative publicly-provided goods, namely continuing- 
care for elderly people in either hospital or National Health Service (NHS) nursing 
homes. Respondents were relatives of residents in both types of accommodations. 
After having provided them with a factual summary comparing hospital and NHS 
nursing home accommodation, relatives were asked which of the two types of care 
they preferred. They were then told how much per week the government spends on a 
continuing-care hospital bed and a NHS nursing-home place (British £215 and £225 
respectively at 1985 prices). They were then asked whether they thought a place in 
the preferred type of care was worth more than the cost of the other. Those who 
replied "yes” were asked how much more their preferred place was worth and those 
who gave a negative answer were asked how much less it was worth. Finally, for any 
valuation over £215 per week (the cost of the cheapest accommodation), 
respondents were asked whether they would be willing to accept the tax increases 
relative to such valuation. The household increase in taxes was calculated from a 
“ready reckoner” made available to interviewers. Seventy-one per cent of 
respondents provided valuations which could contribute to the analysis. Results show 
that the group that preferred NHS nursing-home care could potentially compensate 
the group which preferred hospital care and still remain better off. The technique 
used in the study is very interesting as it is an attempt to measure WTA and WTP to 
quantify benefits and costs, respectively, of a change in resource allocation (Gafni, 
1991).
To elicit WTP and WTA Donaldson (1990) used a sample of relatives of residents in 
NHS hospitals and NHS nursing homes and not the residents themselves. Similarly, 
Mills et al. (1994) surveyed two local informants (headman or religious leader) in 53 
villages in Gambia to ask about WTP for insecticide for bednet impregnation and 
preferred means of paying. During informal interviews the Medical Research Council 
fieldworkers administered a questionnaire that included an open-ended question on 
what respondents thought would be the maximum and the minimum amounts 
compounds would be willing to pay for the insecticide. The comparison of stated 
WTP with the likely cost of impregnating nets indicated a substantial gap between the
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two, the actual cost being far greater in the vast majority of the villages. However, the 
study was probably affected by a strategic bias, as it is likely that respondents 
understood WTP in the hope that subsidies could be forthcoming.
O’Brien et al (1995) used the contingent valuation method to assess the value of a 
new antidepressant as an alternative to four products belonging to the same 
pharmacological category, with different prices, but the same adverse effect profile. 
From a published meta-analysis of controlled clinical trials, they identified seven 
adverse effects and asked patients to express their WTP for a new drug that reduced 
each adverse effect by the specified probability. However, the authors could not 
derive a precise estimate from the WTP questions because there was uncertainty 
about the aggregation of WTP for multiple risks. Consequently, they reported that 
WTP was expected to be between Can $ 36 per month (the highest mean WTP 
among the 7 elicited values) and Can $ 118 (the sum of the 7 mean WTP values). 
They then compared this range with the additional costs required to substitute the old 
treatments with the new one and concluded that the net benefit of the new 
antidepressant (WTP minus cost) was greater when it was compared with the two 
most inexpensive treatments, but it was found ambiguous.
Osmond et al. (1995) performed an economic comparison of three methods 
commonly used to repair paediatric facial lacerations: non-dissolving sutures, 
dissolving sutures and tissue adhesive. First, they performed a cost analysis taking 
into account equipment utilisation, health care workers’ time and loss of both parents’ 
income for follow-up visits. The authors reported that the cost analysis was based on 
a healthy child being treated for a simple facial laceration in a tertiary-care paediatric 
hospital emergency department. According to the cost study, their conclusion was 
that the tissue adhesive was cheaper than both dissolving and non-dissolving 
sutures. Second, they approached a convenient sample of thirty parents who were 
visiting the emergency department with a child who had a problem other than a 
laceration. The sample was provided with an outline of the three repair techniques 
and with a description, based on previous studies, of the cosmetic outcome, 
complications, and level of pain to be expected with each. It was then asked parents 
to name the first, second and third choice of treatment method they would prefer for 
their child and how much they would be willing to pay for their first and second 
choice, if only their third choice was provided by the health care system. Twenty-
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seven parents named the tissue adhesive method as their first choice. Median WTP 
was Can $40 and Can $25 for tissue adhesive and dissolving sutures, respectively. 
Both cost analysis and WTP show that the tissue adhesive method was superior to 
the other two, so that the authors could conclude that this method was the preferred 
one of closure paediatric lacerations. It should be noted, however, that performing a 
cost analysis on just one case is clearly unsatisfactory, that the assumption that both 
parents lose income for the follow-up visit (required for non-dissolving sutures) 
appears questionable and that it is likely that the analysis suffered from double 
counting as WTP is expected to include parents’ valuation of their loss of income 
because of follow-up visits.
Surprisingly, out of the 102 studies published in the 1997-2005 period only twelve 
can be considered full cost benefit analysis (11.4%). In the clinical literature, from the 
last two years of the review we identified only two CBA based on contingent 
valuation. The paucity of cost benefit studies suggests that, in spite of the increasing 
popularity of the contingent valuation method, scientific interest for its use in the 
context of cost-benefit analysis is modest. As suggested earlier, the contingent 
valuation studies recently published either address methodological issues or aimed 
at investigated the determinants of demand focussing on the user value of services. 
However, it is also possible that in recent years more CBA studies than 
methodological ones have been missed. This is because methodological studies 
general apper in economics journals and “substantive” studies appear in medical and 
public health journals; and in medical journal it may be more frequent that the term 
“contingent valuation” is not used in abstracts and titles.
The first of the two latest published studies considered in this review concerned 
prevention and treatment of lymphatic filariasis (LF) conducted in Haiti (Rheingans et 
al., 2004) and reports both WTP estimates and provisional cost data of the 
programmes being evaluated. The authors assert that the estimated WTP for LF 
prevention in the surveyed community is likely to exceed actual medical expenses 
and productivity losses. However, details are not given and it is not appropriate to 
include productivity costs if benefits are calculated through a contingent valuation 
eliciting WTP for preventing the disease. As it is likely that respondents take into 
account productivity losses when they provided their answers, productivity losses are 
counted twice in the analysis. Although a formal quality assessment of the reviewed
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studies is not presented, it should be noted that this is one of the most obscure and 
most methodologically questionable studies of the entire sample.
Fortunately, the other cost-benefit study is clearly presented and appears 
methodologically sound. Carlsson et al. (2004) selected a representative sample of 
1080 Swedish adults, mailed them information about two different treatments for 
Haemophilia and asked them in a telephone interview to answers to two dichotomous 
choice (yes/no) WTP questions. Different respondents were randomly offered 
different bids ranging from 0.71 € to € 130. The mean estimated WTP was € 39 for 
the on-demand treatment and € 65 for prophylaxis treatment. Results were robust 
although it was detected a bias due to the order in which the two treatments were 
presented. We would like to point out that WTP for treating haemophilia was elicited 
from a sample representative of the general population. The survey asked whether 
people were willing to pay a specific amount so that patients with severe haemophilia 
would obtain on-demand treatment and another specific amount for prophylaxis. 
Therefore, the elicited WTP included the altruistic component.
The authors performed a cost benefit analysis as they compared the estimated 
average WTP per Swedish person (€ 39 to €65 for on-demand and prophylaxis 
treatment, respectively) to their share of the total cost of treating all patients with 
severe haemophilia in Sweden (€ 1.97 and € 5.56 for on-demand and prophylaxis 
treatment, respectively). On the basis of these estimates, the authors argued a) that 
the study gives support for both treatments strategies (compared with no treatment), 
since the estimated mean WTP exceeds costs of treatment b) gives firm support for 
prophylactic treatment, as the additional cost per taxpayer of prophylactic treatment 
was covered more than sevenfold by the additional WTP. Although this study was not 
available at the time the contingent valuation presented in this thesis was 
undertaken, the two studies have a very similar design as both elicit WTP from the 
general population, estimate the costs of providing a national programme and 
compared costs and benefit to assess the net economic benefit of the programme.
3.3.5. Health care issues investigated by contingent valuation studies
Table 3.2 also reports specific aspects investigated in the health care contingent 
valuation literature. In the 1984-1996 period twenty-five studies could be grouped in 6 
broad classes. The largest class comprises studies where respondents are
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presented with hypothetical treatments. All of them are methodological and refer to 
chronic diseases.
Five studies focus on existing programmes to prevent cardiovascular diseases and 
refer to pharmacological treatments to lower lipid levels and hypertension, as well as 
to a community-based primary care prevention programmes that involved the 
mobilisation of health workers, schools, voluntary associations, educational 
institutions, food producers, the retail trade, and the media (Lindholm et al 1994). 
One of these studies, published in a medical journal, was carried out in the context of 
a randomised clinical trial and compared dietary and obese drug treatment in obese 
men with mild hypertension (Johannesson and Fagerberg, 1992). In the 1984-1996 
period, all the studies on existing programmes to prevent cardiovascular diseases 
were carried out in Sweden.
Five studies concern diagnostic procedures and highlight the merits of contingent 
valuation in capturing benefits that cost-effectiveness analysis can hardly consider. 
Two studies elicited WTP for different methods of antenatal carrier screening for 
cystic fibrosis (Donaldson et al 1995; Miedzybrodzlca et al 1995), while the other 
three investigated the value of a low osmolality contrast media that reduces risk of 
minor side effects (Appel et al., 1990), the value of ultrasound in normal pregnancy 
(Berwick and Weinstein, 1985) and the value of a negative cervical smear (Grimes, 
1988).
The low osmolality contrast study asked patients to imagine a situation in which they 
required to have a radiography involving intravascular injection of a contrast agent. 
Patients were presented specific possible side effects of a low and a high contrast 
media and were provided with the risk of having each side effect with each contrast 
media. Of the 95 patients (out of 100) who completed the study questionnaire, a 
majority were unwilling to pay the extra cost of USA $ 50 to reduce the risk of minor 
side effects. The authors concluded that the use of the new contrast media was 
questionable. Gafni (1991) criticised several aspects of this paper, including the fact 
that it did not present the problem in the context of purchasing an additional 
insurance policy. He further criticised the choice of a convenient sample of patients 
(clearly belonging to low social classes) as it hindered any reasonable generalisation. 
The ultrasound in normal pregnancy (Berwick and Weinstein, 1985) and the cervical
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smear (Grimes 1988) papers investigated a common problem. Both papers found 
that decisional uses of test information may greatly overlook the value that patients 
attach to the test. A similar evidence comes from a survey that attempted to establish 
the importance of factors beyond some medical definition of success in the provision 
of Assisted Reproductive Techniques (Ryan 1996 and 1998). Results of the studies 
suggest that there is some value in going through the service, even if couples leave it 
childless.
Returning to the classification of studies for the period 1984-1996, a fourth class 
includes three articles on assisted reproductive techniques that will be discussed 
later in the chapter (Neumann and Johannesson 1994; Granberg et al 1995; Ryan 
1996), and a fifth class comprises two papers on WTP far autologous blood donation 
(Eastaugh, 1991; Lee et al., 1996). Finally, three papers form a special class of the 
contingent valuation literature in the health care field because they investigate 
general policies rather than specific medical procedures: Golan et al (1993) elicited 
WTP for supplementary insurance in the Israeli health care system, Eckerlund et al 
(1995) performed a contingent valuation study of the optimal size of the Swedish 
health care budget and Reis et al. (1990) investigated WTP of USA inner-city medical 
insured adults for a co-payment plan.
We were unable to classify the remaining seven studies published in the first period 
of the literature review. They concern paediatric confidential care (Fisher et al., 
1985), hospital accommodation versus NHS nursing home accommodation 
(Donaldson, 1990), factors influencing the acceptance of hepatitis B vaccine by 
students (Pennie et al. 1991), bednet impregnation to protect against malaria (Mills et 
al 1994), a new antidepressant drug (O’Brien et al., 1995), repair of paediatric 
lacerations (Osmond, 1995) and satisfaction for ambulatory services (Ross et al., 
1995).
A meaningful classification of the studies published between 1997 and 2005 
according to the type of health problem investigated is even more difficult. 
Cardiovascular interventions are still frequent: one study referred to measures to 
reduce restenosis (Greenberg et al., 2004), one was on inhaled insulin for diabetic 
patients (Sadri et al., 2005), one estimated benefits of treating haemophilia (Carlsson 
et al., 2004), one estimated WTP for telemedicine services to patients with heart
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failure (Bradford et al., 2004) and a few studies investigated an hypothetical increase 
in heart interventions (Stewart et al. 2002; Luchini et al., 2003; Olsen et al., 2004a; 
Olsen et al., 2004b; Protiere et al., 2004; Ryan et al., 2004; Olsen et al., 2005). 
Twelve publications investigated screening/diagnostic services (Clarke, 2000; Liu et 
al., 2000; Papatheofanis, 2000; Wagner et al., 2001; Wagner et al., 2002; Thomas et 
al., 2000; Clarke, 2002; Forsythe et al., 2002; Takemura, 2005; Whynes et al., 2004; 
Whynes et al., 2005) but in contrast with previous papers the focus was not on 
eliciting WTP for non health related outcomes (e.g. the value of reassurance).
Nineteen papers derived from three major projects that deserve attention. Six papers 
reported results of the Eurowill project that was designed to assess the feasibility of 
the CV method as an instrument for investigating and measuring preferences of the 
general public about health care programmes (Stewart et al. 2002; Luchini et al., 
2003; Ryan, 2004; Olsen et al., 2004a; Protiere et al., 2004; Olsen et al., 2005). The 
project investigated three health programmes: more heart operations, a new breast 
cancer treatment and helicopter ambulance service. These papers have severely 
challenged the validity of the contingent valuation method to offer guidance to policy 
making. Most of the work of the Eurowill project has underlined the inconsistencies of 
the answers that people provide to WTP questions.
The other project concerns the elicitation of WTP and its determinants for insecticide- 
treated bednets to prevent malaria in Nigeria (table 3.2) (Onwujekwe et al., 2001a; 
Onwujekwe et al., 2001b; Onwujekwe et al., 2002; Onwujekwe et al., 2003; 
Onwujekwe, 2004; Onwujekwe, Uzochukwu 2004; Onwujekwe et al., 2004; 
Onwujekwe et al., 2005a; Onwujekwe et al., 2005b). The papers derived from this 
project present a more optimistic picture of contingent evaluation. Overall, these 
ambitious and carefully designed surveys, that produced several methodological 
papers but at the same time gave valuable guidance to policy making, found the CV 
method reasonably valid and reliable.
Also the third major project was conducted in Africa and the WTP studies were part 
of a larger international cooperation project. However, in this study WTP was used to 
investigate community health insurance rather than a specific intervention. The study 
had a large sample size (almost 2,500 face-to-face interviews), allowed to make 
relevant methodological contributions (see above) and have been reported in four
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papers published in major international journals (Dong et al., 2003a, 2003b, 2004 
and 2005).
Other two subjects of contingent valuation studies of this period are worth 
mentioning. Three papers (Pavlova, et al., 2004; Mataria et al., 2004; Asfaw and von 
Braun, 2004) investigated willingness-to-pay for quality improvement of health 
services in general. Instead of focussing on specific services, these studies assessed 
WTP for several dimensions of quality that could apply to a large variety of medical 
and public health services. Here, rather than providing elements to perform a specific 
cost-benefit analysis, the contingent valuation method allows to provide evidence of 
the people’s willingness to invest for improving the quality of the health care system. 
The other subject that attracted our attention was vaccines (Liu et al., 2000; Morris & 
Hammit, 2001; Arana and Leon, 2002; Bishai et al., 2004; Suraradtecha et al., 2005; 
Liu et al. 2005;). Scholars have investigated hypothetical vaccines to prevent 
HIV/AIDS (Bishai et al., 2004; Suraratdecha et al. 2005), SARS (Liu et al., 2005), 
pneumonia (Morris & Hammit, 2001) and other diseases. It is dubious whether 
contingent valuation can really provide useful insights on programmes so 
hypothetical, although it is useful estimating potential return on investment of 
ambitious research programmes on vaccines. Anyway, these exercises look useful to 
investigate the attitude of respondents towards infectious diseases and towards 
hypothetical and existing prevention measures. In this respect WTP questions on a 
hypothetical vaccine may a part of a larger questionnaire to investigate attitudes and 
behaviour, and may be used to attract the attention of respondents.
3.3.6. Type of welfare measure and types of scenarios presented to 
respondents
As mentioned earlier, willingness-to-pay (WTP) is the maximum amount of money 
that individuals are willing to pay for a set of benefits, while willingness to accept 
(WTA) is the minimum amount of money that individuals are willing to accept as a 
compensation for a set of losses. Out of the 136 studies reviewed, only two papers 
clearly stated to use WTA to measure the value of a healthcare programme (table
3.3). The pilot study by Lindholm et al. (1994) assessed a community-based primary 
prevention programme against cardiovascular disease asking the following questions 
“Do you want the project (in which respondents were involved) to continue or do you 
want to stop, thereby reducing your annual tax by 300 (or 600/900) Swedish 
crowns?” In addition, as indicated by Gafni (1991), the study by Donaldson (1990) on
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continuing care for elderly persons used both WTP and WTA values to measure 
benefits and costs, respectively, of a change in allocation of NHS resources. 
However, Donaldson did not mention in his paper that he was using a WTA measure. 
More recently, Borisova and Goodman (2003) have explicitely measured WTA in 
terms of compensation for reducing travel time to get access to treatment.
WTP and WTA values can be measured in terms of compensating variations or 
equivalent variations. The former assumes that WTP/WTA are measured using the 
starting utility level, while the latter assumes that welfare changes ere measured 
according to the utility level after the decision being evaluated is implemented. 
Unfortunately, only a few papers openly reported whether compensating variation or 
equivalent variation was used. Johannesson et al. (1993) and Golan and Shecther 
(1993) made clear reference to a compensating variation measure, while Chestnut et 
al. (1996) and Stalhammar (1996) clearly stated that the WTP questions were asked 
in an equivalent-variation format. For the remaining papers we tried to identify from 
various elements what kind of measure was used. We reached the conclusion that 
the way the questions were framed and/or the context in which they were answered 
suggest that they all implicitly refer to compensating variations. However, this 
classification has to be considered with caution. More than the classification itself, the 
analysis of the literature on this specific aspect suggests that the distinction between 
compensation variation and equivalent variation is rarely made by researchers in the 
health care field and, probably, that such a distinction is not straightforward when 
conducting empirical studies. This seems to be confirmed by the fact that clear 
statements about the type of variations used are also largely lacking in papers written 
by economists and/or published in economic journals.
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Table 3.3. Contingent valuation studies by type o f welfare measure and type o f scenario presented
(1984-2005)___________________________________________________________________________________
First Author Year
of
Pub.
Purpose 
of the study
Altruistic W TP  
Included?
Ex-ante or ex-post 
evaluation ?
Deterministic or 
probabilistic 
scenarios?
1 Thompson 1984 WTP, CV No Ex-post Deterministic
2 Berwick 1985 WTP,CV No Ex-post Deterministic
3 Fisher 1985 WTP, CV No Ex-ante & ex-post Deterministic
4 Thompson 1986 WTP, CV No Ex-post Deterministic
5 Grimes 1988 CV No Ex-post Not applicable
6 Appel 1990 WTP, CV No Ex-post Not applicable
7 Donaldson 1990 WTP/WTA, CV No Ex-post Not applicable
8 Reis 1990 WTP No Ex-ante Probabilistic
9 Eastaugh 1991 WTP, CV No Ex-post Not applicable
10 Johannesson 1991 WTP, CV No Ex-post Not applicable
11 Pennie 1991 WTP, CV No Not applicable Not applicable
12 Johannesson 1992 WTP, CV No Ex-post Not applicable
13 Golan 1993 WTP, CV Not applicable Not applicable Not applicable
14 Johannesson 1993 WTP, CV No Ex-post Not applicable
15 Johannesson 1993 WTP, CV No Ex-post Not applicable
16 Lindholm 1994 WTP, CV No Ex-post Not applicable
17 Mills 1994 WTP, CV Not applicable Not applicable Not applicable
18 Neumann 1994 WTP, CV Yes Ex-ante & ex-post Probabilistic
19 O’Brien 1994 WTP, CV No Ex-post Probabilistic
20 Donaldson 1995 WTP, CV No Ex-post Probabilistic
21 Eckerlund 1995 WTP, CV Not applicable Not applicable Not applicable
22 Gran berg 1995 WTP, CV No Ex-post Probabilistic
23 Miedzybrodzka 1995 WTP, CV No Ex-post Deterministic
24 O’Brien 1995 WTP, CV No Ex-post Probabilistic
25 Osmond 1995 WTP, CV No Ex-post Not applicable
26 Ross 1995 WTP No Ex-post Not applicable
27 Chestnut 1996 WTP, CV No Ex-post Deterministic
28 Kartman 1996 WTP, EV No Ex-post Deterministic
29 Kartman (a) 1996 WTP, CV No Ex-post Probabilistic
30 Ryan 1996 WTP, CV No Ex-post Deterministic
31 Stalhammar 1996 WTP, CV No Ex-post Deterministic
32 Weaver 1996 WTP, CV No Ex-post Deterministic
33 Asenso-Okyere 1997 WTP,CV No Not applicable Not applicable
34 Kartman 1997 WTP,EV No Ex-post Deterministic
35 Lee 1997 WTP,EV No Ex-post Deterministic
36 O’Conor 1997 WTP,CV No Ex-ante Probabilistic
37 Olsen 1997 WTP,CV Yes Ex-ante Probabilistic
38 Zethreaus 1997 WTP,EV No Ex-post Deterministic
39 Donaldson 1998 WTP,CV No Ex-ante Deterministic
40 Lee 1998 WTP,CV No Ex-ante Probabilistic
41 Mathiyazhagan 1998 WTP,CV No Not applicable Not applicable
42 O’Brien 1998 WTP/WTA,CV No Ex-ante & ex-post Probabilistic
43 Onwujeckwe 1998 WTP,CV No Ex-ante Deterministic
44 Ortega 1998 WTP,CV No Ex-ante & ex-post Deterministic
45 Tambour 1998 WTP,EV No Ex-post Deterministic
46 Chiu 1999 WTP/CV No Ex-post Deterministic
47 Donaldson 1999 WTP, CV Yes Ex-ante Deterministic
48 Dranitsaris 1999 WTP,CV No Ex-ante Probabilistic
49 Matthews 1999 WTP/CV No Ex-post Probabilistic
50 Onwujeckwe 1999 WTP,CV Yes Ex-ante Probabilistic
51 Sorum 1999 WTP/CV No Ex-ante Not applicable
52 Torrance 1999 WTP/CV No Ex-post Not applicable
53 Cho-Min-Naing 2000 WTP,CV No Ex-ante & ex-post Deterministic
54 Clarke 2000 WTP,CV Yes Ex-ante Deterministic
55 Dranitsaris 2000 WTP/CV No Ex-ante Deterministic
56 Estaugh 2000 WTP,CV No Ex-post Deterministic
57 Liu 2000 WTP,CV No Ex-ante Deterministic
58 Narbro 2000 WTP,CV No Ex-post Deterministic
59 Onwujeckwe 2000 WTP,CV No Not applicable Probabilistic
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60 Papatheofanis 2000 WTP.CV No Ex-post Probabilistic
61 Slothus 2000 WTP.CV No Ex-post Deterministic
62 Suh 2000 WTP,CV No Ex-ante and ex-post Probabilistic
63 Thomas 2000 WTP,EV No Ex-post Probabilistic
64 Wagner 2000 WTP,CV No Ex-ante Deterministic
65 Zarkin 2000 WTP,CV Yes Ex-post Deterministic
66 Blumenschein 2001 WTP,CV No Ex-post Deterministic
67 Dalmau-
Matarrodona
2001 WTP,EV No Ex-post Deterministic
68 Gyldmark 2001 WTP,CV No Ex-ante Probabilistic
69 Morris 2001 WTP,CV No Ex-post Probabilistic
70 Onwujekwe 2001 WTP,CV No Ex-post Probabilistic
71 Onwujekwe 2001 WTP,CV No Ex-ante Probabilistic
72 Wagner 2001 WTP/CV No Ex-ante Deterministic
73 Arana 2002 WTP,CV Yes Ex-post Probabilistic
74 Bhatia 2002 WTP,CV No Ex-post Deterministic
75 Clarke 2002 WTP,CV Yes Ex-post Probabilistic
76 Forsythe 2002 WTP,CV No Ex-ante Probabilistic
77 Nocera 2002 WTP,CV Yes Ex-ante Probabilistic
78 Onwujekwe 2002 WTP,CV No Ex-post Deterministic
79 Stewart 2002 WTP,CV Yes Ex-ante Probabilistic
80 Taylor 2002 WTP,CV No Ex-post Probabilistic
81 Wagner 2002 WTP,CV No Ex-ante Deterministic
82 Whittington 2002 WTP,CV No Ex-ante Probabilistic
83 Zillich 2002 WTP,CV No Ex-post Deterministic
84 Bhatia 2003 WTP,CV No Ex-post Deterministic
85 Borisova 2003 WTP/WTA,CV No Not applicable Deterministic
86 Dong 2003 WTP,CV No Not applicable Not applicable
87 Dong 2003 WTP,CV No Not applicable Not applicable
88 Foreit 2003 WTP,CV No Ex-post Deterministic
89 Hammerschmidt 2003 WTP,CV No Ex-post Deterministic
90 Luchini 2003 WTP,CV Yes Ex-ante Probabilistic
91 Onwujekwue 2003 WTP,CV No Ex-ante Probabilistic
92 Shiell 2003 WTP,CV No Ex-ante Probabilistic
93 Tarasiuk 2003 WTP,CV No Ex-post Probabilistic
94 Whynes 2003 WTP,CV No Ex-ante Deterministic
95 Amin 2004 WTP,CV No Ex-ante Deterministic
96 Asgary 2004 WTP,CV No Not applicable Not applicable
97 Bissai 2004 WTP,CV No Ex-ante Probabilistic
98 Bradford 2004 WTP,CV No Ex-post Not applicable
99 Carlsson 2004 WTP,CV Yes Ex-ante Probabilistic
100 Dong 2004 WTP,CV No Not applicable Not applicable
101 Dranitsaris 2004 WTP/CV No Ex-ante Probabilistic
102 Greenberg 2004 WTP,CV No Ex-post Probabilistic
103 Hammerschmidt 2004 WTP,CV No Not applicable Probabilistic
104 Mataria 2004 WTP,CV No Not applicable Deterministic
105 Olsen 2004 WTP,CV Yes Ex-ante Probabilistic
106 Olsen 2004 WTP,CV Yes Ex-ante Probabilistic
107 Onwujekwe 2004 WTP,CV No Ex-ante Probabilistic
108 Onwujekwe 2004 WTP.CV Yes Ex-ante Probabilistic
109 Onwujekwe 2004 WTP,CV No Ex-ante Probabilistic
110 Pavlova 2004 WTP,CV No Not applicable Not applicable
111 Protiere 2004 WTP,CV Yes Ex-ante Probabilistic
112 Rheingans 2004 WTP,CV No Ex-ante Deterministic
113 Ryan 2004 WTP,CV Yes Ex-ante Probabilistic
114 Ryan 2004 WTP,CV No Ex-post Probabilistic
115 Whynes 2004 WTP,CV No Ex-ante Probabilistic
116 Asfaw 2005 WTP,CV No Ex-ante Not applicable
117 Barner 2005 WTP,CV No Ex-ante Probabilistic
118 Bradford 2005 WTP,CV No Ex-ante Not applicable
119 De Ridder 2005 WTP,CV No Ex-ante Deterministic
120 Dong 2005 WTP,CV No Not applicable Not applicable
121 Fautrel 2005 WTP,CV Yes Ex-post Not applicable
122 Finkelstein 2005 WTP,CV No Ex-post Deterministic
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123 Hackl 2005 WTP,CV Yes Ex-ante Deterministic
124 Hamelsky 2005 WTP,CV No Ex-post Probabilistic
125 Ho 2005 WTP,CV No Ex-ante Deterministic
126 Lee 2005 WTP,CV No Ex-ante Deterministic
127 Liu 2005 WTP,CV No Ex-ante Probabilistic
128 Masiye 2005 WTP,CV No Ex-ante Deterministic
129 Olsen 2005 WTP,CV Yes Ex-ante Probabilistic
130 Onwujekwe 2005 WTP,CV No Ex-ante Probabilistic
131 Onwujekwe 2005 WTP,CV Yes Ex-ante Probabilistic
132 Sadri 2005 WTP,CV No Ex-post Deterministic
133 Smith 2005 WTP,CV No Ex-ante Deterministic
134 Suraratdecha 2005 WTP,CV No Ex-ante Probabilistic
135 Takemura 2005 WTP,CV No Ex-post Not applicable
136 Whynes 2005 WTP,CV No Ex-ante Probabilistic
Given the widespread use of public funding for health care services, externalities are 
expected to be of great importance. Actually, as many health services are private 
goods, the “added vale” of using contingent valuation to investigate WTP is strongly 
associated to the existence of caring externalities as they are not easily observable in 
real markets. A correct economic measure of WTP for health care services should 
provide the possibility to detect and measure these externalities. Despite this 
consideration, still few papers attempt to capture them. For the period 1984-1996 
only the Neumann and Johannesson (1994) paper measured the altruistic 
component of WTP. They asked respondents about their WTP for a public 
programme that would have provided an IVF benefit for all Massachusetts residents 
needing treatment. This question was expected to capture altruistic externalities as 
most of respondents were not potential beneficiaries of the programme (see below 
for methods and results of this study). In the period 1997-2005 the number of studies 
designed to capture altruism is significantly higher: twenty out of one-hundred-and 
five (26%).
The demand for a large range of health services is such that people’s welfare is 
increased by the financial risk protection provided by an insurance mechanism. 
Consequently, as Gafni (1991) claims WTP questions should be asked in the context 
of a hypothetical insurance purchasing. However, when we tried to classifiy studies 
according to this dimension we realised that only a limited number of them reflected 
an insurance-based perspective and that it would have been more relevant to 
consider whether respondents experienced the condition for which the intervention 
was suggested before the administration of the survey. According to this new 
classification, the large majority of studies used an ex-post perspective in that 
respondents who answered to CV questions were already in need of the service or 
were instructed to assume to be in that position. Roughly, about 50% of the studies
97
present an ex-post perspective, but the use of an ex-ante perspective, often 
associated with hypothetical interventions, has become more frequent in recent 
years.
The last column of table 3 classifies articles according to the probabilistic or 
deterministic nature of the scenarios that were presented to respondents. Thirty-one 
studies (23%%) were not classified according to this criterion mainly because WTP 
was asked for programmes/interventions whose outcome of interest was not subject 
to uncertainty. Out of the remaining one-hundred-five studies, fifty studies (48%) 
provided deterministic scenarios and fifty-five (52%) allowed for some probabilistic 
elements in the description of the outcome. It appears that studies published more 
recently are more likely to provide respondents with probabilistic information.
3.3.7. Classification of the studies according to survey characteristics
Table 3.4 classifies studies according to the elicitation method used, the mode of 
data collection, sampling procedures followed, sample size and response rate. A 
variety of methods have been used to elicit WTP/WTA. One-hundred-seventy 
different evaluation methods were used in the 136 papers. Open-ended (OE) and 
payment card (PC) were reported in 43 (32%) and 39 (29%) papers, respectively. 
TIOLI was reported in 60 papers (44%) and the bidding game format in 28 (21%). 
Often open-ended questions were asked after another elicitation metod is used.
Open-ended questions were used in twelve studies out of thirty-two (37%) in the 
1984-1996 period and only in six studies out of forty-two in the 2004-05 period (14%). 
Clearly, this method attracts little interest nowadays, probably because it does not 
resemble real market situations. It is worth remembering, however, that Onwujekwe 
and Uzochukwu (2004) argue that open-ended questions may resemble how 
donations occur.
Closed-ended questions have been becoming more popular in recent years: in 2000- 
05 forty-three papers (32%) report to have used this WTP elicitation method. The 
increasing interest in framing questions in a yes/no format probably reflects the 
recognition of respondents’ difficulties in answering open-ended questions and the 
clear preference for this method expressed by the NOAA report (Arrow et al., 1993).
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Nevertheless, the payment card format remains popular (25% of papers published 
since 2000) and economists are still debating on the merits of the different elicitation 
formats (Ryan et al., 2001; Cameron et al., 2002; Hanley et al., 2003; Smith, 2006).
Table 3.4. Contingent valuation studies by value elicitation method, mode of data collection and
sampling characteristics (1984-2005).
First Author Year
of
Publ.
Value elicitation 
method
Mode of data 
collection
Sample and 
sampling 
method
Number 
respondents 
(%  sample size)
1 Thompson 1984 Open-ended Self-administ Patients 36(17%)
2 Berwick 1985 Open-ended Face-to-face Patients 62(100%)
3 Fisher 1985 Payment card Self-administ Patients 165 (92%)
4 Thompson 1986 Open-ended Face-to-face Trial 237 (96%)
5 Grimes 1988 Payment card Self-administ Patients 84 (84%)
6 Appel 1990 Bidding game + open- 
ended
Face-to-face Patients
(random)
95 (95%)
7 Donaldson 1990 Bidding game Face-to-face Patients 107
8 Reis 1990 Open-ended Face-to-face Patients 149(100%)
9 Eastaugh 1991 Open-ended Face-to-face Population 70(100%)
10 Johannesson 1991 Open-ended + TIOLI Mail Patients 322 (66%)
11 Pennie 1991 Payment card Self-administ Benefic 435 (100%)
12 Johannesson 1992 Payment card Face-to-face Trial 61 (95%)
13 Golan 1993 Bidding game Face-to-face Population
(random)
771 (75%)
14 Johannesson 1993 TIOLI Self-administ Patients 336 (65%)
15 Johannesson 1993 TIOLI + open-ended Self-administ Trial 692 (98%)
16 Lindholm 1994 TIOLI Face-to-face+
mail
Patients 407 (77%)
17 Mills 1994 Open-ended Face-to-face Population 97(100%)
18 Neumann 1994 Payment card Self-administ Population 231 (59%)
19 O’Brien 1994 Bidding game Face-to-face Patients 102 (78%)
20 Donaldson 1995 Payment card Mail Trial 260 (75%)
21 Eckerlund 1995 TIOLI Mail Population
(random)
1021 (81%)
22 Gran berg 1995 Open-ended Self-administ Patients 40 (85%)
23 Miedzybrodzka 1995 Open-ended Self-administ Patients 450
24 O’Brien 1995 Open-ended + TIOLI Face-to-face Patients 95 (76%)
25 Osmond 1995 Open-ended Face-to-face Patients 30(100%)
26 Ross 1995 TIOLI Face-to-face Patients
(random)
308 (76%)
27 Chestnut 1996 TIOLI
+open-ended
Face-to-face Patients 50(100%)
28 Kartman 1996 TIOLI Telephone Patients 400 (87%)
29 Kartman 1996 TIOLI Telephone Patients 402 (92%)
30 Ryan 1996 Payment card Mail Patients 294 (42%)
31 Stalhammar 1996 Bidding game Face-to-face Patients 105(100%)
32 Weaver 1996 TIOLI Face-to-face Population 
(quota samp.)
1263 (100%)
33 Asenso-Okyere 1997 Bidding game Face-to-face Population 50
34 Kartman 1997 Open-ended Face-to-face Patients 338
35 Lee 1997 TIOLI Self-administ Patients 235 (44%)
36 O’Conor 1997 TIOLI Mail Patients 148 (69%)
37 Olsen 1997 Payment card Face-to-face Population
(random)
143
38 Zethreaus 1997 TIOLI Face-to-face Patients 104
39 Donaldson 1998 Open-ended Face-to-face Patients 150 (75%)
40 Lee 1998 TIOLI Self-administ Patients 412
41 Mathiyazhagan 1998 Open-ended Face-to-face Population
(random)
918
42 O’Brien 1998 Bidding Game Face-to-face HMO 220
99
enrolees
43 Onwujekwe 1998 Bidding game Face-to-face Population
(random)
1011
44 Ortega 1998 Open-ended Face-to-face + 
telephone
Patients,
population
(random)
150
45 Tambour 1998 TIOLI Self-administ Patients 104
46 Chiu 1999 Payment card, open- 
ended
Face-to-face Patient family 
members
174
47 Donaldson 1999 Open-ended Face-to-face Patients 150 (75%)
48 Dranitsaris 1999 Payment card Telephone Population 100
49 Matthews 1999 Payment card Self-admininst Patients,
employees
41
50 Owujekwe 1999 Open-ended Face-to-face Population
(random)
214
51 Sorum 1999 Open-ended Mail Parents 219(68%)
52 Torrance 1999 Open-ended Self-administ Patients (trial) 240
53 Cho-Min-Naing 2000 Bidding game Face-to face Population 1480
54 Clarke 2000 TIOLI + follow-up Telephone + 
mail
Target
population
(random)
372
55 Dranitsaris 2000 Open ended Telephone Population 80
56 Estaugh 2000 Bidding game Mail Patients 290 (77%)
57 Liu 2000 TIOLI + follow-up Face-to-face Population
(random)
598
58 Narbro 2000 Payment card Self­
administered
Patients 374
59 Onwujekwe 2000 TIOLI + Bidding game Face-to-face Population
(random)
719(89%)
60 Papatheofanis 2000 TIOLI Self-administ Patients 87
61 Slothus 2000 TIOLI + follow-up Face-to-face Patients 179 (67%)
62 Suh 2000 Payment card Self-administ Patients 437 (72%)
63 Thomas 2000 Open-ended Self-administ Patients 1223 (70%)
64 Wagner 2000 Bidding game Telephone Population
(random)
47
65 Zarkin 2000 Payment card Face-to-face Patients
(quota)
393
66 Blumenschein 2001 TIOLI Face-to-face Patients 84
67 Dalmau-
Matarrodona
2001 TIOLI Face-to-face Patients 228 (95%)
68 Gyldmark 2001 Payment card + Open- 
ended
Face-to-face Population
(random)
1349 (70%)
69 Morris 2001 TIOLI + follow-up Telephone Population
(random)
1104 (76%)
70 Onwujekwe 2001 TIOLI + follow-up, 
bidding game
Face-to-face Population
(random)
709 (84%)
71 Onwujekwe 2001 TIOLI + follow-up, 
bidding game
Face-to-face Population
(random)
1908
72 Wagner 2001 Bidding game + open 
ended
Telephone Target pop. 
(random)
1465
73 Arana 2002 TIOLI Face-to-face Population
(random)
539 (77%)
74 Bhatia 2002 Bidding game + open 
ended
Face-to-face Population
(random)
1200 (100%)
75 Clarke 2002 TIOLI Telephone Target pop. 
(random)
372 (81%)
76 Forsythe 2002 Payment card Face-to-face Patients 519(69%)
77 Nocera 2002 TIOLI, Dissonant 
Method, Payment Card
Telephone Populatio
(random)
1240
78 Onwujekwe 2002 Bidding game Face-to-face Population
(random)
719(89%)
79 Stewart 2002 Open-ended Face-to-face Population
(random)
473 (45%)
80 Taylor 2002 Payment card Self-administ Patients 400 (89%)
81 Wagner 2002 Bidding game Telephone Population 1465
100
(random)
82 Whittington 2002 Payment card Face-to-face Population
(quota)
234
83 Zillich 2002 TIOLI Face-to-face Patients 100
84 Bhatia 2003 Bidding game + open- 
ended
Face-to-face Population
(random)
298 (100%)
85 Borisova 2003 Open-ended Self-administ Patients 303 (66%)
86 Dong 2003 TIOLI + bidding game 
+ open-ended
Face-to-face Population
(random)
1108 (86%)
87 Dong 2003 TIOLI + bidding game 
+ open-ended
Face-to-face Population
(random)
2414(90%)
88 Foreit 2003 Bidding games and 
open-ended
Face-to-face
+self-administ
Various About 13,000
89 Hammerschmidt 2003 TIOLI + Payment card Face-to-face Patients 92
90 Luchini 2003 Payment card Face-to-face Population
(random)
163
9I Onwujekwue 2003 Bidding game, TIOLI 
with follow-up and 
structure haggling
Face-to-face Population
(random)
261 (66%), 267 
(75%), 273 
(58.6%)
92 Shiell 2003 Payment card Face-to-face Employees 112(98%)
93 Tarasiuk 2003 Bidding game, open- 
ended
Telephone Patients 252 (92%)
94 Whynes 2003 Open-ended, payment 
card
Self-administ GP patients 2767 (40%)
95 Amin 2004 TIOLI with follow-up Face-to-face Population 324(100%)
96 Asgary 2004 TIOLI, payment card Face-to-face Population
(random)
2139(86%)
97 Bissai 2004 TIOLI Face-to-face Population 1071 (70%)
98 Bradford 2004 TIOLI + follow-up Face-to-face Patients (trial) 126(100%)
99 Carlsson 2004 TIOLI Telephone Population 609 (56%)
100 Dong 2004 TIOLI, bidding game Face-to-face Population
(random)
2414(90%)
101 Dranitsaris 2004 Open-ended Telephone Pharmacists,
nurses
80
102 Greenberg 2004 TIOLI Face-to-face Patients (trial) 1642 (68%)
103 Hammerschmidt 2004 Payment card Face-to face Patients 92(100%)
104 M atari a 2004 Payment card Face-to-face Patients
(random)
499 (64%)
105 Olsen 2004 Payment card Face-to-face Population
(random)
540(100%)
106 Olsen 2004 Payment card Face-to-face Population
(random)
168 (78%)
107 Onwujekwe 2004 TIOLI + follow-up, 
bidding game, structure 
haggling
Face-to-face Population
(random)
528 (59%)
108 Onwujekwe 2004 TIOLI + follow-up, 
open ended
Face-to-face Population
(random)
801 (89%)
109 Onwujekwe 2004 TIOLI + follow-up, 
bidding game, structure 
haggling
Face-to-face Population
(random)
528 (59%)
110 Pavlova 2004 Interval check list and 
open-ended
Face-to-face Population
(random)
990 (91%)
111 Protiere 2004 TIOLI + open-ended Face-to-face Population
(random)
303 (95%)
112 Rheingans 2004 TIOLI Face-to-face Population 583
113 Ryan 2004 Payment card + TIOLI Face-to-face Population 578
114 Ryan 2004 TIOLI Mail Patients 325 (76%)
136 Whynes 2004 Payment card Self-administ Population 1401 +202
115 Asfaw 2005 TIOLI + follow-up Face-to-face Population 550
116 Barner 2005 Payment Card Self-administ Patients 203 (41%)
117 Bradford 2005 TIOLI Self-administ Patients 366
118 De Ridder 2005 Payment card Self-administ Students 110(96%)
119 Dong 2005 TIOLI + bidding game Face-to-face Population
(random)
2414(90%)
120 Fautrel 2005 Payment card Telephone Patients 119(98%)
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121 Finkelstein 2005 Payment card, 
probability statements
Internet-based Population 
(panel quota)
1802(100%)
122 Hackl 2005 TIOLI + follow-up Face-to-face Population 2536(100%)
123 Hamelsky 2005 Payment card Mailed Patients 310(65%)
124 Ho 2005 TIOLI + follow-up Face-to-face Patients 287(100%)
125 Lee 2005 Open-ended Telephone Patients 517(65%)
126 Liu 2005 TIOLI + follow-up Various (mainly 
f-t-f)
Population
(random)
1024 (77%), 
488 (84%)
127 Masiye 2005 Payment card Face-to-face Population 274 (98%)
128 Olsen 2005 Open-ended Face-to-face Population 1240(100%)
129 Onwujekwe 2005 TIOLI + follow-up, 
bidding game, structure 
haggling
Face-to-face Population
(random)
528 (89%)
130 Onwujekwe 2005 TIOLI + follow-up, 
bidding game, structure 
haggling
Face-to-face Population
(random)
321 (71%)
131 Sadri 2005 Payment card Face-to-face Patients 96 (92%)
132 Smith 2005 Open-ended Face-to-face Population 37 (94%)
133 Suraratdecha 2005 TIOLI Face-to-face Population 2524 (78%)
134 Takemura 2005 TIOLI Self-administ Population 152 (100%)
135 Whynes 2005 Payment card Self-administ Population About 3000
136 Whynes 2005 Payment card Self-administ Population 1401 +202
We identified five modes of data collection: self-administered questionnaires, mailed 
questionnaires, telephone interviews, face-to-face interviews and questionnaires 
administered thorugh internet. A large proportion of the surveys (87, 61%) were 
administered face-to-face, and mailed questionnaire (10, 7%) and internet-based 
questionnaire (1, 1%) were seldom used. In the 1984-1996 period self-administered 
questionnaires were used in 7 studies (22%), while questionnaires sent by mail were 
used in four studies (13%). These two modes of data collection present some 
common features as they require reading skills, they avoid interviewer biases and 
they are generally inexpensive. However, they tend to get different response rates: 
they are much higher in the self-administered questionnaires delivered by hand 
probably because respondents are probably more motivated to answer (it mainly 
depends on the way questionnaires are returned). Already in the 1984-1996 period, 
face-to-face interviews was the most common mode of data collection. It was used 
in nineteen studies (59%); in that period only two studies (6%) used telephone 
interviews.
Data from the 1997-2005 period show that face-to-face interviews are now the 
standard approach to conduct contingent valuation surveys: sixty-eight out of one- 
hundred-nine studies (64%) collected data through personal interviews, sometimes 
with the support of visual aids. This method, although expensive, has the advantage 
to maintain high the attention of respondents and to give the interviewer the 
possibility to keep under control the elicitation process. A few studies, mainly
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performed along clinical trials, still use self-administered questionnaires but this 
mode of administration is now less frequent. One paper was based on data collected 
in an internet-based survey conducted in the US (Finkelstein, 2005). This is the first 
internet survey we are aware of in the health care field and it has many features in 
common with the survey presented in the course of the following chapters.
Despite that sampling procedures are of great importance to generalise results and, 
hence, to offer useful material to policy makers, contingent valuation studies have not 
paid attention to this issue for long time. Generally, surveys conducted in the 1980s 
and in the 1990s were based on samples that were arbitrarily chosen from patients of 
a single health care institution. This probably reflected the methodological nature of 
many studies. However, testing the feasibility of using appropriate samples of the 
general population appears an important methodological issue too. In the 1984-1996 
period only four studies elicited WTP from the general population and only two of 
them used a random sampling procedure. Interestingly, these studies did not 
investigate a specific medical treatment, but the size of the health care budget. 
Recent studies show a different picture in this respect. In the 1997-2005 period most 
of the studies are conducted with samples of the general population (56) and 23 of 
them report procedures to assure that they are representative of the adult general 
population living in defined geographical areas. Most of these studies used rigorous 
sampling procedures.
Sample size varies across the studies. In the period 1984-96 nine studies (29%) had 
a sample size of less than one hundred individuals. They generally collected 
information from patients using face-to-face interviews or self-administered 
questionnaires, and reached high response rates. Interestingly, 78% of these studies 
are not methodological and make conclusions of policy or clinical relevance. In the 
1997-2005 peiod only nine studies (8%) were conducted with a sample size of less 
than 100 individuals and most of them were methodological.
During the older period fourteen (44%) studies were based on a sample size 
between 101 and 500 individuals. They were very heterogeneous in terms of mode of 
data collection, sampling method, type of study (methodological or decisional) and 
type of journal where they were published. In 1997-2005 50 studies (52%) have a 
sample size ranging from 101 to 500 individuals. In fact, while in the 1984-1996
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period only 8 studies (25%) had a sample size of more than 500 individuals, in the 
period 2004-05 they were 42 (39%). In the latter period 25 articles reported surveys 
with sample size of more than 1,000 people. It is evident that there has been an 
improvement of contingent valuation studies over time: in more recent surveys 
samples are larger, sampling procedures are more accurate and face-to-face 
interviews are largely preferred over other modes of administration.
The last column of table 3.4 also presents the response rate of each study. The large 
majority of the studies have a high response rate, often above 80%. High response 
rates were high in the older studies mainly because they had a limited size and did 
not involve the general population. Most recent studies present similar high response 
rates, but these are obtained from larger samples and from members of the general 
population, presumably less motivated than patients surveyed on health care 
programmes of their interest.
“Poorly managed surveys can result in a multitude of problems such as falsified or 
incomplete survey forms, biased sampling, lost data, large numbers of people 
refusing to be interviewed or upset by interviewers and field assistants dropping out 
(i.e. the list goes on)” (Nyandieka et al., 2002). It appears that more recent studies, 
especially those conducted in developing countries, are better conducted. Also, 
recent articles report more information about important technicalities related to the 
surveys’ conduction. Yet, however, the contingent valuation method is focused on 
theoretical issues and pays little attention to how the actual collection of data is 
managed. This is an area deserving future investment if the CV method wants to gain 
acceptance in the health policy community.
3.4. Contingent valuation studies on In-Vitro-Fertilisation and other 
Assisted Reproductive Techniques
A few studies have used the contingent valuation method to investigate In-Vitro- 
Fertilisation (IVF) or other Assisted Reproductive Techniques (ARTs). The first study 
was performed by Neumann and Johannesson (1994) and was carried out at the 
Harvard School of Public Health in 1992. The study was very ambitious and tried to 
address several critical issues. It attempted (i) to measure WTP for IVF treatments, 
(ii) to measure WTP to purchase insurance in order to have free access to IVF 
treatments, (iii) to measure WTP for a public IVF insurance programme and (iv) to
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investigate how people trade off the benefit of a public IVF program relative to a 
program which reduces the risk of mortality.
The contingent valuation study was based on 389 self-administered questionnaires 
distributed in classrooms, upon entering a conference or in mailboxes. 
Questionnaires were distributed to: 39 graduate students from the Harvard School of 
Public Health, 274 administrative officers from the Harvard School of Public Health 
and two health service centres at Harvard University, 48 nurses attending a 
conference and 28 physicians attending a seminar in Boston. The questionnaire used 
for the survey was nine pages long and clearly stated in the cover page that 
responses were anonymous and confidential. The first page was on IVF in general as 
it presented the way the procedure is administered and its main side effects. It also 
informed respondents that 10% of all American couples of childbearing are was 
infertile and that IVF was recommended for 5% of couples who seek fertility 
treatment.
In the first section the ex post perspective was explored: childbearing age individuals 
were asked if they would be willing to pay stated amounts for IVF in the event that 
they were infertile. Various assumptions about the probability that the procedure was 
successful were presented (chance of success equal to 0%, 25%, 50% and 100%) in 
separate questions. This section also reported that adoption was an available option 
and cost US $15,000.
Section 2 asked respondents if they would be willing to pay stated amounts for IVF 
insurance, assuming that they did not know their fertility status and that they had 
10% chances to be infertile. This was the ex-ante perspective. Respondents were 
asked to state if they would be willing to pay for a one-time option to purchase 
lifetime insurance against IVF costs. Individuals who were not in childbearing age 
were told to skip this and the previous section.
Section 3 asked respondents if they would be willing to pay stated amounts in taxes 
for a public program consisting in providing free IVF services in Massachusetts. 
Absolute numbers (i.e. 300 expected beneficiaries of the programme) rather that 
percentages were used. Section 4 proposed a referendum on two alternative publicly
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funded programmes: providing IVF or reducing high-way fatalities. Respondents 
were asked to choose between an IVF programme resulting in 300 babies and a 
stated number of deaths avoided by implementing the other programme. Separate 
questions presented different assumptions about the effectiveness of the life saving 
programme (from 1 to 500 deaths avoided). Section 5 asked respondents to provide 
demographic information, an assessment of their (and their spouses) fertility status, 
current and expected household income and opinions about IVF.
The response rate of the survey was just under 60% (231 out of 389). Among 150 
respondents who were potential child bearers, average ex-post WTP (respondents’ 
WTP for the IVF in the event that they were infertile) was $17,730 for a 10% 
probability of having a child, $28,054 for a 25% probability, $43,576 for 50%, and 
63,896 for a 100% probability. Ex-ante WTP (WTP for IVF insurance, assuming 
respondents do not know their fertility status) was $865 for a 10% probability of 
having a child, $1,055 for a 25% probability, $1,456 for 50%, and a $2,006 for a 
100% probability. On average, respondents’ WTP for a public programme with a 10% 
probability of success was $32. For higher probability of success average WTP was 
$38, $46, $62 for 25%, 50% and 100% probability of having a child, respectively.
Analysis of the results of the referendum to choose between IVF and a life-saving 
programme indicates that respondents evaluated that 300 additional IVF babies per 
year were equivalent to 35 prevented deaths. This means that, according to 
respondents’ statements, 8.6 IVF babies were considered equivalent to 1 averted 
death. The implied WTP for a statistical life of the referendum (using the WTP for 
IVF) was $3.44 million.
Table 3.5 shows the marginal WTP per statistical baby that is the implied WTP to 
have a baby assuming that respondents knew to have a probability to be infertile 
equal to that of the overall American population. Obviously, for the ex-post WTP, the 
marginal WTP per statistical baby is equal to the product between WTP for the given 
chance that the treatment is effective and the inverse of this probability (e.g. WTP of 
$17,700 for a chance of 10$ results in marginal WTP equals to $ 17,700/0.1 = $ 
177,000).
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Table 3.5. Marginal willingness-to-pay per statistical baby.
Probability of success (delivered baby following IVF)
10% 25% 50% 100%
Ex-post $ 177,000 $ 68,827 $ 62,088 $ 40,640
Ex-ante $ 1,730,000 $253,333 $ 328,000 $216,000
Public Programme $ 980,000 $ 112,000 $ 100,800 $ 112,000
Source: Neumann and Johannesson, 1994.
Multiple regression analysis was used to test the influence of some demographic, 
clinical, social and attitudinal characteristics of respondents on the amounts that they 
were willing to pay and on results of the referendum questions. Coefficients of the 
regressions generally have the expected sign. Expected income, infertility status, 
inclination to use IVF and the desire to have more children were found to be 
positively associated with WTP (ex ante or ex post). The same variables were also 
negatively associated with the number of IVF babies per averted death.
The survey is presented by the authors as a pilot study to test the feasibility of the 
WTP method in the special context of IVF. The survey was feasible in the sense that 
about 60% of the sample answered to the question in a (presumably) meaningful 
way. However, sampled people, if compared with the general population, had better 
information about IVF, were better educated and were more motivated. Moreover, 
77% of the sample were women and the mean age was 36.
Ex-post WTP for a statistical baby (WTP given that the respondent was told that 
he/she was infertile) was lower than the ex ante WTP (WTP given no information 
about the infertility status). With 10% probability of success at having a baby with 
IVF, the former was $ 177,000 and the latter was $1,130,000. This result is 
consistent with expected utility theory. As shown by Johannesson (1996) ex post 
WTP is a lower bound for ex ante WTP for an individual who is risk averse with 
respect to income. However, a ten fold difference between ex ante and ex post WTP 
for IVF appears too large. It appears exaggerated such a high risk aversion for the 
cost of IVF. In addition, it should be considered that in order to derive WTP values 
per statistical baby it is assumed that respondents understand that the expected 
probability of seeking IVF is 0.005. This value corresponds to the product of the
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probability that the couple is infertile and the conditional probability that IVF is 
recommended given that the couple is infertile. Both these probabilities are stated in 
the survey, but it is not clear whether respondents could really process these 
numbers.
Finally, table 3.5 shows that the ex ante WTP is higher than the WTP for a public 
programme. This conflicts with theoretical expectations. As WTP for a public program 
includes an altruistic component, it should be larger than WTP for an insurance 
programme. This inconsistency may be due to the difficulties that respondents may 
have found in answering questions involving risk evaluation and conditional 
probabilities.
In theory, results of this survey could have been compared to the costs of IVF 
treatments to measure welfare changes attributable to a programme providing this 
technology to infertile couples. However, Neumann and Johannesson (1994) did not 
make this comparison, probably because they were aware that survey results could 
not be generalised given how the sample was chosen. Instead, a straight comparison 
between WTP for IVF and treatment costs was reported by Granberg et al. (1995). 
These researchers from the University of Gotemberg conducted a contingent 
valuation survey with open-ended questions to elicit WTP for IVF among 47 couples 
seeking treatment in two clinics, one public and the other private. The couples were 
asked to state the maximum number of IVF treatments they would be prepared to 
undergo at different price levels. They were also asked their maximum WTP for 
having a child. The article does not report how the questions were administered. It 
seems likely that a self-administered questionnaire was used, even if the possibility 
that couples were interviewed cannot be excluded.
The paper provides few methodological details and results are presented in a very 
concise format. Response rate was 85% and WTP for a child ranged from UK £ 0 to 
£ 25,000. Mean and median WTP are not presented. It is only reported that 22 
couples (54%) were willing to pay UK £ 10,000 or more. The article presents a figure 
illustrating a demand schedule for IVF from which it can be roughly estimated that 
mean WTP for a child was about UK £13,000. The study presents an estimate of the 
costs of the public IVF clinic and used this value to derive the cost per IVF delivered 
baby (dividing total annual costs by the number of babies delivered in one year). The
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cost per delivered baby was estimated at UK £ 9,410, just below the UK £10,000 
WTP expressed by more than half of the couples. By comparing these two values the 
authors came to the conclusion that the benefit to the infertile couples was higher 
than the cost to the NHS. This is a poor quality study, mainly because the methods 
used were not well specified and the results were not clearly and fully presented. 
These deficiencies suggest avoiding comparisons between results obtained in this 
study and those obtained by Neumann and Johannesson (1994).
The third study is based on a survey mailed to 700 women attending a private 
infertility service in Sidney (Ryan, 1996). She investigated Assisted Reproduction 
Techniques (ARTs) from a different perspective to that adopted by the previous 
studies. She investigated whether factors beyond medical definition of success (a 
delivered baby) can explain WTP for ARTs. The survey investigated several factors 
which may be important to users in the provision of ARTs, including psychological 
outcomes, non-health outcomes and attributes of the process of treatment. 
Regarding psychological outcomes, Ryan was interested in feelings such as anxiety 
and stress provoked by the treatment or related to users’ concerns about how the 
community views ARTs. She was also concerned with the feeling of regret. In the 
specific context of ARTs the feeling of regret refers to the fact that these interventions 
can be perceived as an infertile couple’s last chance to have a baby of their own. If 
the opportunity is not taken, regret may be experienced later. As non-health 
outcomes she considered the utility that can be derived from information for its own 
sake, counselling and the provision of follow-up support. Concerning process 
attributes, she wanted to investigate the influence on WTP of factors as such as 
attitude of staff, waiting time, and continuity of contact with same staff.
For each of these factors she designed specific questions aimed at measuring their 
intensity as perceived by respondents. She used 0-10 rating scales (0 completely 
dissatisfied and 10 completely satisfied) or Likert scales from 1 to 5 (1 strongly 
disagree with a statement and 5 strongly agree). The questionnaire also asked 
respondents their maximum WTP for the treatment that they underwent or that they 
were undergoing. The WTP question used a payment card format where 
respondents were presented with a range of monetary amounts and were asked to 
circle the amount that they would be willing to pay. Finally, the questionnaire asked 
respondents to provide information about their age, education, children, household
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income, number of cycles of ART already attempted, whether or not they had left the 
service with a child, and perceptions of their chances of leaving the service with a 
child. Ordinary Least squares (OLS) regression models were used to identify the 
relative importance of attributes presented above, with WTP being the dependent 
variable and attributes hypothesised as significant predictors of WTP being the 
independent variables. A pilot study was carried out on 60 individuals who 
experienced ARTs to assess whether questions where understood and whether 
respondents were willing to answer the WTP questions.
The response rate to the survey was 42% and the item response rate to the WTP 
question was 96%. Twenty-nine percent of respondents had conceived on the 
programme. Respondents’ WTP for an ART cycle ranged from AUS $ 425 to AUS $
20,000 (2.1 AUS$ = 1 £). Mean and median WTP were AUS $2,506 and AUS 
$2,250, respectively. Questions looking at regret clearly indicated that there was 
some perceived benefit from going through the treatment. Of the respondents, 83% 
agreed with the statement “One of the reasons I am trying (or tried) IVF is so that in 
later life I will know that I have tried everything possible to have a child”. Eighty-nine 
percent of respondents also agreed that even if they had left the service childless, 
they still would have been glad they had tried it.
Ryan also reports that respondents overestimated their chances of leaving the 
service with a child. Despite the fact that individuals attending the service were told 
that they had a chance of successful pregnancy between 15% and 25% (according to 
the type of ART used), over 50% of the sample agreed with the statement “when I 
started the programme I was very sure that I would leave it with a child”.
Of the 339 individuals who answered the WTP questionnaire, 289 provided a full data 
set for the regression analysis. Results show that respondents who had a child from 
the programme had a WTP 30% higher than those who had not conceived yet or who 
had left the service childless. Further, the more respondents agreed with the 
statement “Even if I leave (or left) the service childless, I believe I will be (am) glad I 
tried it”, the more they were willing to pay to undertake the service. However, all the 
other variables, including non health outcomes and process attributes, were found 
not to be significant predictors of WTP. Finally, as expected, individuals on higher 
incomes were more willing to pay for ARTs.
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This study is a very interesting attempt to measure WTP beyond a narrow medical 
definition of success. She found some evidence supporting her hypothesis: results 
suggest that there is some value in going through the service, even if the couple 
leaves it childless, However process attributes and non-health outcomes were found 
to be un-correlated with WTP and the only question on psychological outcomes that 
was statistically significant may express the intensity of the desire of having a baby, 
rather than evidence in favour of regret theory. Moreover, the response rate to the 
questionnaire was relatively low and it is possible that respondents differed from non­
respondents in many respects.
Later, Ryan conducted a similar study mailing a questionnaire to all clients 
undergoing IVF treatment at Aberdeen’s Assisted Reproduction Unit (Ryan, 1997; 
Ryan, 1998). Again her main objective was to investigate the importance of 
psychological outcomes when going through ARTs, using the contingent valuation 
method (Ryan, 1998). Nevertheless, results of the WTP survey were also used by 
the author to make recommendations about funding ARTs, although the expression 
cost-benefit analysis was not openly used in the paper.
Although the study was similar to the previous one, its design differed in some 
important elements. First, a closed-ended (also labelled referendum or take-or-leave- 
it) approach was used to estimate WTP. This was in accordance with guidelines 
recommended in environment economics. Choosing this elicitation model requires to 
use logit models to identify the explanatory variables of WTP and to calculate central 
tendency estimates. Simply stated, within the framework of random utility theory, the 
probability that an individual will say “yes” to any given bid is estimated and then 
WTP is derived by integrating the estimated probability function (Ryan, 1998; see 
also chapter 4 of the thesis). Second, the survey included both ex-ante and ex-post 
evaluations. The majority of respondents were still going through the service when 
they were interviewed. According to Ryan’s view they provided an ex-ante 
evaluation. Instead, a smaller fraction of respondents were not users of ARTs 
anymore as they either got a baby or they left the service childless. These patients 
provided an ex-post evaluation as they stated their WTP for a service they had 
already experienced. In addition, as the utility level of these respondents reflected 
their experience with ARTs, WTP measures are to be considered equivalent
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variations (they measure utility changes after the change). On the contrary, in the ex- 
ante evaluation WTP measures were compensating variations because they referred 
to the utility level before the use of ARTs. The ex-post evaluation also allowed 
comparing respondents experiencing positive and negative outcomes. Third, 
psychological outcomes were better specified through the use of two established 
scales to assess the psychological state of respondents: the Satisfaction with Life 
Scale (SWLS) and the Positive Affect Negative Affect Scale (PANAS). The use of 
these scales allowed better testing of Ryan’s hypotheses about the value of 
psychological factors in the provision of ARTs. Particularly, she tested whether 
psychological feelings of “regret” and “disappointment” may explain the motivation to 
seek ARTs and whether these feelings may explain why the axioms of expected 
utility theory are violated. As mentioned earlier, regret theory is based on the premise 
that certain acts are taken to prevent regretting not having taken a given course of 
action later in life (Ryan, 1998). Disappointment is a psychological reaction to the 
results of an event (or a decision) not living up to its expectations. Results of the 
survey support both regret and disappointment arguments. WTP was substantial also 
for people who underwent IVF without success. Ryan argued that respondents felt 
there was a value in using IVF, even if they left the service childless, because of the 
feeling of regret. Support was lent to the importance of the feelings of disappointment 
by the association between WTP and the statement “’’when our first attempt at IVF 
failed I was surprised”. The more the respondent agreed with this statement, the 
higher the WTP. Upon this evidence Ryan argued that the psychological feeling of 
disappointment may be an important factor when looking at total utility from 
undertaking IVF.
In a different paper (Ryan, 1997) the author used the same data to elicit mean WTP 
for a cycle of IVF. Mean WTP was estimated to be in the British £ 5,000-5,100 range 
and evidence was provided of the internal and the theoretical validity of the 
contingent valuation method in the area of reproduction medicine. Estimated average 
WTP of users for ARTs was found substantially higher than current expenditure (£ 
2,700; Ryan and Donaldson, 1995). Based on these results, the author suggests that 
the benefits of providing the service outweight the costs and that public provision of 
the service should be encouraged. It was not openly claimed that this was a cost 
benefit analysis, although both the terms costs and benefits were used in the paper.
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3.5. Elicitation formats, use of internet and zero WTP in Environment
Contingent Valuation studies
In this section we selectively review the contingent valuation literature outside the 
health care field to discuss specific issues of particular importance for the empirical 
study presented in the thesis. This part of the literature review complements what 
was presented in the previous sections and focuses on three major topics: a) the 
WTP elicitation format, b) the use of an electronic panel to administer the survey, c) 
the appropriate econometric techniques in case of zero and negative WTP.
3.5.1 Further considerations on the WTP elicitation format
In section 3.4 we reviewed the main WTP elicitation formats used in CV studies in 
health care. In this sub-section we complement our review with evidence produced 
by environmental studies, where the issue has been investigated more deeply. As 
presented earlier, four types of methods are used to directly ask WTP questions: 
open ended (OE), payment card (PC), take-it-or-leave-it (TIOLI) and bidding games. 
In more recent times, studies in the environment field have investigated a novel 
approach that is still rather uncommon for health care. In this approach respondents 
are provided a list of values and asked to decide among categories that describe the 
extent to which they may be willing to pay the stated amounts (Ready, 1996). 
Typically, respondents are asked if they are “definitely or surely” willing or not willing 
to pay defined amounts and are also let to opt for “do not know”. This approach is 
often labelled as “multiple bounded” (MB) and measures stated preferences in terms 
of a distribution of WTP rather than of point estimates (Welsh and Poe, 1998). Such 
an approach increases the available information about preferences and can 
accommodate TIOLI as a special case.
Even after thousands of journal articles researchers still don’t agree about the 
appropriate form of the valuation question (Whitehead, 2006). How to frame WTP 
questions remains a contested issue attracting several empirical studies with little 
consolidated evidence. Most comparisons (but not all) of TIOLI and OE methods 
performed in the environmental field suggest that TIOLI produce larger estimates 
(Brown et al., 1996). WTP estimates based on TIOLI questions are from 1.1 to 5 
times higher than those based on OE. However, a few studies found TIOLI estimates 
lower and a review by Huang and Smith (1998) that used Monte Carlo simulations
113
found that differences between the two methods are often due to misspecifications of 
the empirical model.
Other studies have compared TIOLI methods with payment card (PC). They have 
found that the TIOLI/PC ratio of the WTP estimates ranges from 2.7 to 4.4 (Cameron 
et al., 2002). Again, TIOLI generally produces much higher estimates and this is 
generally attributed to a “yes” bias (Kanninen, 1995; Holmes and Kramer, 1995).
In general, evidence from environmental economics, in line with that from health 
economics, shows that TIOLI estimates tend to be larger than those based on open 
answers or a range of values. Pair-wise comparisons are clearly useful but only 
signal convergence/divergence of methods. A more systematic approach to confront 
seven different value-elicitation methods was attempted by Cameron et al. (2002). 
The authors identified a common underlying indirect utility function for the identical 
good and compared different methods applied to different samples, pair-wise or 
pooled, across all samples in one unified model. They investigated 1) an actual 
dichotomous choice, 2) a first hypothetical dichotomous choice identical to the 
previous format but without the request to immediately pay for the good, 3) a second 
hypothetical dichotomous choice where different bids were presented to sub­
samples, 4) an open-ended WTP question, 5) a payment card, 6) a multi-bounded 
discrete-choice questionnaire, 7) a conjoint analysis questionnaire.
Overall, this study made use of approximately 7,000 choices concerning 
environmental enhancement interventions and provides some important results 
deserving further investigation. Pooled-data models show that all methods but OE 
and PC appear to have a common underlying preference structure. Actually, findings 
simply show that there is no evidence to reject the hypothesis of identical utility- 
difference functions across the four “discrete” methods and thus further research in 
this vein is required. Nevertheless, these findings are interesting as they support the 
hypothesis initially formulated by Hanneman that the OE and PC methods might lead 
respondents to think about the WTP problem in rather different ways from that of 
discrete choice (Cameron et al., 2002).
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3.5.2 The use of Internet for conducting CV surveys
In our empirical study we tested the use of internet to elicit WTP for funding a health 
care programme. This was the first attempt of this kind as, when we designed the 
survey, we were not aware of any attempt to use internet to elicit WTP in the health 
field. Even now, we are aware of only one study which used internet to administer a 
health care CV study (Finklestein, 2005).
Consequently, we turned to environmental studies and surveys in general to get 
guidance on the pros and cons of using internet. The aim of this section is to present 
the main issues related to the use of internet to administer CV surveys. The lure of 
this mode of administration is strong as the marginal cost of data collection is almost 
nil and the electronic format lends itself to easy data handling (Thurston, 2006). 
Sending some hundred questionnaires through internet saves time and postal costs 
(e.g. letters, envelopes, stamps). Motivating people to answer to internet survey may 
require incentives and specific investments (e.g. training), yet it appears that internet 
surveys tend to be much cheaper than those administered through other types of 
administration. In addition, data collection is much simpler and risk of data input and 
data computation are greatly reduced. Software manages the transfer of data from 
the electronic answer sheet to the databases, where the data is ready to be used by 
any statistical package.
In addition to these simple benefits (costs and data management), unlike with other 
modes of administration, Internet surveys make it possible to enhance the 
respondent’s understanding of the programme in question. For example, it is possible 
to show drawings, photographs and graphs on the survey page; and it is also 
possible to provide links to other pages where additional information is available. The 
virtual nature of websites greatly expands the options to individualise surveys, for 
example by creating articulated pattern of links or by generating a large number of 
variants of the survey.
Web-surveys also make it possible to track the time spent by the respondents when 
pondering questions. Also, when links and other potential information sources are 
offered, it is possible to record what the respondent does so as to use time spent and 
sources accessed as potential explanatory variables. There are endless possibilities
to take advantage of the technology (Thurston, 2006). The respondent can be forced 
in specific patterns (for example can be kept from looking ahead or back), virtual 
interviewers (for example of different races or gender) can be embedded in the page, 
and special aids and tutors can be used to facilitate answering the questions.
In front of the still unexplored wide range of benefits, internet surveys suffer from a 
major problem. Internet users are not representative of the general population. Only 
about 50% of the Italian population has some experience with internet and users and 
non-users tend to different in terms of age, educational status, income and, in Italy, 
even place of residence (urban versus rural and north versus south communities) 
(ISTAT, 2007). Whatever, the advantages of this new form of administration, internet 
surveys are constrained by the survey’s sample and require adequate methods to 
improve representativeness.
In addition, a major problem with internet surveys is that we know very little about 
how they perform (Marta-Pedroso et al., 2007). We have found only one CV study 
that compared Web based to in-person interviews. As expected, the Web study had 
a much lower response rate (5.1% versus 84%). Instead, no significant difference 
was found about the susceptibility to information additivity and proportion of zero 
bids. However, findings of this survey conducted in Portugal indicate that Web based 
surveys generate more conservative estimates than personal interviews, whatever 
the payment vehicle used (taxation or donation). The authors concluded that the use 
of web based surveys is promising in the context of CV, despite the difficulties in 
drawing probability base representative samples (Marta-Pedroso, 2007).
Other studies, although they did not compare web based surveys to more traditional 
approaches, provide evidence of feasibility and show results that are similar to those 
obtained with other methods. For example, various national surveys in the USA 
tested the impact of information about global climate change and the Kyoto protocol 
(Li et al., 2004; Berrens et al., 2004). They found that WTP is associated with 
objective measures of respondents’ effort to understand the issue and that WTP is 
sensible to variations of the Kyoto protocol that should make it more appealing to 
USA residents (Li et al., 2004).
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There is a variety of types of Web surveys; they are summarised in Table 1 and can 
be classified into nonprobability and probability-based methods (Couper, 2001). 
Nonprobability methods recruit survey respondents without particular attention to 
representativeness of the population in question. Type 1 concerns Web surveys as 
entertainment. They cannot be considered a scientific survey and are mainly 
intended for entertainment purpose. These surveys can be launched by associations, 
newspapers and individuals just to collect answers on any type of issue. These 
surveys are generally used to attract attention on a topic and to activate discussions. 
In essence, they openly recognise that samples do not reflect any population and do 
not have any scientific meaning. Self-selected Web survey (type 2) are somehow 
similar as they freely recruit respondents on portals, frequently visited Web sites and 
dedicated sites. Given the recruitment procedures and the lack of any control of 
sample characteristics these surveys cannot reflect the characteristics of the 
population and should be considered very cautiously, even if conducted by 
prestigious institutions.
Table 3.6. Types of Web surveys (Couper, 2001)
Non-probability methods Probability-Based Methods
1. Polls as entertainment
2. Unrestricted self-selected surveys
3. Volunteer opt-in panels
4. Intercept surveys
5. List-based samples
6. Web option in mixed-mode surveys
7. Pre-recruited panels of Internet Users
8. Pre-recruited panels of full population
The third type of Web Surveys concerns volunteer panels of internet users. 
Volunteers are recruited from well-travelled sites to form a database of potential 
respondents for later surveys. Panelists are typically recruited by invitation only and 
access to each survey is controlled through e-mail identifiers and passwords. 
Selection of panellists may be based on various criteria, including quota sampling 
and probability sampling methods. These methods make possible to control for the 
characteristics of respondents. Nevertheless, it should be kept in mind that the initial 
panel is a self-selected sample of volunteers.
The other methods listed in table 1 begin with probability samples of various forms 
(Couper, 2001). Probability sampling greatly improves representativeness of 
samples. Through knowledge of the population from which the sample is drawn and 
information on the process of recruitment, probability sampling permits measurement 
of non-response and thus can contribute to the improvement of survey design. In
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short, probability-based methods do not guarantee representativeness but provide 
valid tools to understand representativeness problems and to suggest improvements. 
There are two main approaches to achieving probability-based Web samples. One 
approach is to restrict the sample to individuals with Web access. The other 
approach is to start for a broader sample of the population so to try to include in the 
sample also individuals who do not have access to the Web.
Intercept surveys concern the first approach and target people visiting a particular 
Web site; they generally use systematic sampling to invite every nth visitor to answer 
to the survey. Clearly, the approach limits generalisation, but it can still be very useful 
to run costumer satisfaction surveys, evaluations and the like (Couper, 2001). A fifth 
approach focuses on specific populations for which web access is universal or quasi- 
universal. Here the limitation to those who are Internet users is not a problem. 
Employees of certain organizations, university students and members of scientific 
communities may constitute populations where Web access is normal. For such 
populations, a list of all individuals may be available so to use probability sampling to 
define the sample of interest. In this type of survey coverage is not a major issue; 
however, nonresponse rate remains a problem as internet surveys tend to have 
response rates lower that those of mail surveys of similar populations.
Web surveys can be combined with other modes of administration. Basically,
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following this approach researchers associate the Web survey to other methods to 
reach the part of the population that does not have access to the Web. This approach 
is popular in panel surveys of establishment (firms, schools, associations), where 
there is a long-term link between researchers and potential respondents (Couper, 
2001). The seventh approach consists in pre-recruiting a panel of internet users and 
it similar to approach type 3. The main difference is that, in contrast with the earlier 
types where the panel was made of volunteers, in this type of survey panel members 
are recruited using probability sampling methods such as Randomized Digital 
Dialing. Through this approach samples should be constructed to be representative 
of those with access to the Web and it is possible to collect demographics and other 
data on Internet users and nonusers (and on those who did not accept to be 
panellists) to help understand the nature of coverage and nonresponse.
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Finally, it is possible to design survey through probability sampling of full populations. 
This approach is similar to type 7 as it starts with a probability sample of the target 
population by using non-Internet approaches. However, while in the previous case 
the final sample was limited to Web users, in this type, researchers try to enrol non- 
Web users as well. Basically, using this approach, respondents are provided the 
necessary equipment and tools to become web users and, possibly, they are 
incentivised to regularly participate to surveys. Clearly, such an approach is costly 
because of high recruitment costs and thus makes economic sense only if it employs 
a panel design (several surveys regularly administered to the same sample). It is also 
the only approach that allows generalisation beyond current internet users and 
shows great promise for replacing probability-base surveys using more traditional 
methods (Cooper, 2001). One limitation of this approach concerns the auto-selection 
of panellists, in the sense that those who are recruited, even if they had no 
experience with the Web, are likely to be different from those who rejected the offer 
to be part of the panel. In addition, it cannot be excluded that becoming Web users 
can induce behavioural and attitudinal changes, thus introducing a new bias.
3.5.3 Appropriate econometric techniques in case of zero and negative WTP
Zero and negative WTP were expected in our study on a publicly funded program for 
IVF. We knew that some respondents were not in the market for private use, even in 
a hypothetical situation, and we suspected that some individuals could have had 
negative WTP for a publicly funded IVF programme. Nevertheless, we could not 
design a survey admitting negative values because it would have required splitting 
the sample according to some initial questions and this was unfeasible because of 
technical and economic constraints. In effect, the optimal strategy to investigate a 
service like IVF that can generate utility losses to some individuals for ethical reasons 
would be to ask an initial question to distinguish those who are in favour from those 
who are against and then to administer two separate sets of WTP questions.
This strategy was not feasible and thus we had to work on the large amount of zero 
WTP stated by the sample. If we limit our discussion to personal use of IVF and 
specific altruism for access to IVF there are three situations that need to be 
discussed. As far as personal use is concerned, there are individuals who have 0 
WTP for IVF. These people are supposed to have a true 0 WTP as in the case of 
individuals that have no interest in a specific public good. They are not damaged by
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it, but they do not derive any benefit either and thus have true zero WTP. For this 
WTP question it does not make sense to investigate negative WTP because people 
who derive negative benefits from IVF simply state out of the market. The situation 
appears more complicated if a programme providing IVF with public funding is 
considered. In this case the good is a public good for some respondents and, likely, a 
public bad for others. In addition, it is also possible that people have a genuine 0 
WTP in the sense that they attribute exact 0 value to such service.
To our knowledge, the issue of zero and negative WTP is unexplored in the field of 
health economics. Instead, in environmental economics it has attracted the attention 
of several scholars and some approaches to deal with the problem have been 
suggested. Starting with the issue of zero WTP, a possible approach in TIOLI 
Contingent Valuation studies is to use a spike model (Kristrom, 1997).
Let’s imagine an individual facing a question to accept or reject a programme for a 
given sum of money A. Following Kristrom (1997) the project concerned the change 
of environmental quality from ZO to Z1. Consequently it is possible to defined WTP 
for this change as
(1) V(y -  WTP, z1) = V(y, z°)
Where V(y, z) is an individual’s indirect utility function and y is income. Suppose that 
the individuals of a population evaluate the project differently. The probability that an 
individual’s WTP is less than A is
(2) prob(WTP < A) = Fwtp(A)
Where Fwtp(A) is a right and non-decreasing function.
The expected value of WTP can be calculated by integration:
(3) E(WTP) = cJ 1 ■ F wtp(A )dA ^ F w rp (A )d A
According to Kristrom (1997), in the spike model the distribution function of WTP 
takes the following form:
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(4) Fwtp(A) = 0 if A < 0
p if A = 0
Gwtp(A) if A > 0
where p should be between 0 and 1 and Gwtp(A) is a continuous function such that 
Gwtp(O) = p and Gwtp(A) = 1 for A that tends to infinity
The previous equation shows the situation where a relevant faction of respondents 
have 0 WTP, which means that they are not in the market. The spike model can also 
be extended to the case where programmes generate both winners and losers. In the 
extended spike model the distribution of WTP can be written as follows:
(5) Fwtp(A) = Hwtp(A)
P 
P
Gwtp(A)
where Hwtp(A) is a continuous and increasing function that has limit equal to zero for 
A that tends to infinity. Hwtp(A) refers to negative WTP, Gwtp(A) refers to positive 
WTP and p is the proportion of 0 WTP.
The models (4) and (5) can be estimated with various approaches. Model (4) can be 
estimated by using parametric maximum likelihood methods. It can also be estimated 
through a non parametric approach as suggested by Kristrom (1990). Similarly, 
model (5) can be estimated through maximum likelihood methods.
In the case of the extended spike model, negative WTP is addressed by formulating 
a questionnaire where both winners and losers can express their WTP for their 
preferred choice. In such a situation, researchers anticipate the presence of both 
winners and losers and prepare an adequate questionnaire.
if A < 0 
if A -+ 0 - 
if A -^ 0 +  
if A > 0
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How to handle negative WTP with TIOLI questions has been investigated extensively 
in the environmental field (Haab and McConnell, 1997; Bohara et al., 2001; Clinch 
and Murphy, 2001). One approach is to make use of Montecarlo simulations (Bohara 
et al., 2001). The study created a “true” distribution of WTP which included negative 
values and then it simulated a contingent valuation study. In short, investigators 
matched individual WTPi’s to a particular randomly drawn bid to create a binary 
response variable Wi, where Wi is a Yes response if WTP > bid, and Wi = 0 is a No 
response if WTP < bid. The study simulated 500 draws for different sample sizes 
(250, 500 and 1000 respondents) and made different assumptions concerning the 
underlying distribution when estimating WTP: normal (that allows for negative 
values), log-normal (that allows for positive values only), Weibull (that allows for 
positive values only) and two mixture models. The simulation was performed on the 
basis of three “true” distributions that varied only in terms of the number of negative 
bids (approximately 2%, 14% and 30%).
Results show that the assumption concerning the distribution is very important. In 
particular, it matters whether the chosen distribution allows for negative values if 
negative values are present. The normal distribution performs better than the other 
distributions as the log-normal and the Weibull inflate mean WTP. The Normal 
distribution also outperforms the Turnbull model, a popular nonparametric approach, 
if negative WTP is rather incidental. Restricting distributions to the positive domain 
significantly biases estimates, especially if the fraction of negative values is relevant. 
If negative WTP is rather frequent among respondents (e.g. more than 20%) neither 
a parametric approach (normal, log-normal, or Weibull distributions) nor the 
nonparametric Turnbull approach reasonably “solve” the problem if negative bids 
were not included.
Another approach, that can extend the solution to negative WTP when only positive 
observations are observed, is based on the analysis of censored data. Basically, in 
addition to assuming a particular distribution for WTP that allows negative values, it is 
assumed that the distribution is censored a zero. Observations at zero include 
negative observations because respondents could not express negative values. One 
way to deal with this case is to use a Tobit model or censored regression models 
(Woldridge, 2006). Open Ended questionnaires and payment cards generate WTP 
values that are normally censored at zero (Seung-Jun et al., 2001). If this is the case,
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OLS estimates are inconsistent. The Tobit model recognises the censoring problem 
but suffers from two limitations concerning the distribution of the errors. If 
heteroskedasticity occurs or there are errors not normally distributed, estimates are 
inconsistent. Therefore, the Tobit model may not solve the problems of OLS. A 
possible solution may be to use a censored regression model as that used by Seung- 
Jun et al. (2001). The authors assumed a Symmetrically-Trimmed Least Square 
(STLS) model. In a left (for example at 0) censored model some of the dependent 
variable yt are not observed if y* < 0. This generates asymmetry in the distribution of 
the error terms. The basic idea of the STLS estimator “is to restore symmetry of the 
error distribution by symmetric trimming in such a way that the uncensored 
observations in the upper tails are replaced by their estimated symmetrically 
censored values”. On one hand this approach addresses the problem of 
heteroskedasticity and non normality of errors; on the other, it also induces a loss of 
informative data concerning the upper tail of the distributions because of the 
trimming.
The issue of zero and negative WTP has not been investigated in the context of 
health care. Basically, health care is often a private good and people who do not 
derive any benefit from it simply decide to stay out of the market. However, for IVF 
the situation may be different because there may be individuals who suffer a welfare 
loss due to the use of the technique by others. We have claimed that this is a special 
case of negative caring externality. As already remarked, we could not design a 
survey that allowed negative WTP. However, we recognised the problem and looked 
for viable approaches in the literature. We found that in the environmental field the 
issues has been investigated and some approaches have been suggested. In the 
previous pages we selectively reviewed these approaches and found that, in order to 
investigate the role of true zero and negative values, we can work with spike or 
censored models.
3.6. The expected contribution of the present study
The study by Ryan appears to be a cost-benefit analysis because it compares the 
costs of providing a good to its value, measured in terms of WTP. ARTs users in 
Aberdeen attributed a value to IVF that outweighs cost. From their point of view the 
use of government resources to fund IVF produces a welfare gain. However, as Ryan 
(1997) recognises, an important question is whose values should be used in health
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care evaluations. As discussed earlier, Gafni (1991) argues that for a choice 
concerning government funding of health services it is the view of the community that 
is relevant. When valuing goods to be funded by the society at large it is important to 
capture whether people consider that those goods deserve to be funded collectively 
rather than privately. Instead, eliciting WTP from users neglects any consideration 
regarding the “social” merits of the goods and ignores the reasons that justify public 
funding.
Let’s imagine that a group of people are invited to a free lunch and then that they are 
asked to state their WTP for the lunch. If we adopt a user perspective to elicit WTP 
we should conclude that the lunch has to be publicly funded if the average WTP 
exceeds its costs (assuming that cost actually refers to the opportunity cost of public 
funds). Basically, this is what Ryan (1997) did in her a cost-benefit analysis. Such an 
approach means to adopt a user perspective for goods that are private (in contrast to 
public goods that are non-rival and non-excludable).
However, for services private in nature, as in the case of most of health services, it 
may be important to include the perspective of non users for at least three main 
reasons. First, it is required in order to capture caring externality (Culyer, 1976) and 
option value (the utility an individual gains from knowing a service is there should 
they want to use it) (Weisbrod, 1964). It appears unlikely that the user of a service 
(e.g. IVF) makes an evaluation with reference to the option of having it in the future 
or to the utility derived by the use of others. Her evaluation is expected to be focused 
on the benefits derived from her immediate and personal use of the service. Second, 
in the case of private goods some members of the community (and thus potential 
payers of government funded programmes) can be non-users because they do not 
derive any utility from the service or may be even against the provision of such 
service. Therefore, surveys that elicit WTP from users depict the perspective of a 
biased sample of the community. By definition, users of a certain private good are not 
a representative sample of the entire community. Third, for private goods, given that 
they are produced and sold in actual markets, it may insufficient to state that 
community WTP outweigh cost to suggest public funding. Individuals should also 
agree with government funding, that is with transferring powers about the provision of 
goods to government decision-making.
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A major problem with eliciting WTP from the community is that the community is 
unlikely to have good knowledge of health care interventions (Ryan, 1997). To inform 
individuals without experience with the good may be difficult and may result in 
information overload. Nevertheless, it appears unreasonable to exclude the 
perspective of non-users to evaluate private goods in order to decide whether they 
should be publicly funded. As cost-benefit analysis tries to offer guidance to public 
decision-making according to a societal perspective it appears appropriate to devise 
welfare measures from all types of members of society, including those who will 
never use IVF but may be required to pay.
The present study tries to go beyond the available evidence on public funding of IVF 
through a contingent valuation survey involving a representative sample of the Italian 
adult population. This sample allows eliciting WTP from non-users of IVF and 
designing welfare measures that reflect the perspective of all the categories of 
individuals directly or indirectly affected by IVF. In particular, the study can provide 
two main tests that are expected to inform the debate about whether ARTs should be 
publicly funded. The first test is partly consistent with the approach used in the 
studies presented above (Neumann and Johannesson, 1994; Ryan, 1996; Ryan, 
1997; Ryan, 1998). In the first part of the survey, respondents are asked to imagine 
being infertile and being suggested the use IVF services. WTP elicited in this 
scenario reflects their ex-ante WTP for an IVF cycle and can be compared to the 
value obtained by Ryan. However, it should be borne in mind that mean WTP in this 
scenario results from all respondents, including those who would have not used IVF if 
they were infertile. Other things being equal, the mean WTP in the present study is 
expected to be lower that mean WTP obtained in the Aberdeen study (Ryan, 1997). 
By definition, the WTP of clients of an Assisted Reproduction Centre does not include 
the perspective of individuals who decide not to use ARTs services because of 
ethical arguments or because they attribute little value to these services. Despite the 
lack of information that the general population has on ARTs or other medical 
treatments, it appears more appropriate to measure welfare gains from a sample of 
the general population rather than from a selected sample of users. According to this 
test a cycle of IVF is worth being publicly funded if mean WTP outweighs its costs.
The second part of the survey attempts to elicit WTP for a publicly funded 
programme providing IVF to infertile couples. Here respondents are not required to
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imagine a hypothetical situation where they are infertile. They are asked to make a 
holistic evaluation of a programme that may be of direct interest only to some of them 
(those young or who are already seeking IVF services) but that it is funded through a 
tax increase. In this case the cost-benefit test is comparing total benefits, measured 
as the extrapolation to the national population of the elicited WTP values, to total 
costs, measured as the total costs of the IVF programme presented to respondents. 
Although, it may be challenging for respondents to process all the relevant 
information presented in the scenario, this approach appears the most consistent 
with an ex-ante, population based evaluation of net benefits of government funded 
programmes.
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Chapter 4
Methods for measuring costs in healthcare
4.1. Introduction
This chapter deals with the costs of providing health services from a methodological 
and pragmatic point of view. It discusses how the cost analysis has been conducted 
in the economic evaluation literature and presents a few basic concepts and methods 
on how to perform sound analysis of costs. Two main conclusions stem from this 
chapter. First, there are various types of cost analyses depending on the decisions 
for which they are performed. Second, when an economic evaluation study is 
performed to decide whether a service should be publicly funded the most 
appropriate cost analysis method is full costing. This is the method used in this study 
to cost In Vitro Fertilisation Services. The aim of this chapter is to provide the 
background and the justification of this choice.
Cost analysis has not received particular attention in economic evaluation literature. 
Economic evaluators have generally preferred to focus on how to measure benefits. 
When they have turned their attention to costs, the main issue of discussion has 
been how to correct prices when they are not supposed to reflect social marginal 
costs. In the healthcare field cost analysis has not received great attention either. 
Major topics of methodological discussions in this field include measurement of 
benefits in CBA, discounting, sensitivity analysis and the use of appropriate statistical 
methods, identification and evaluation of outcomes, equity, and utility assessment. 
Concerning costs, methodological papers have mainly been focused on how to 
measure and evaluate indirect costs (leisure and working time lost, informal care, 
costs related to disability and premature mortality). So far, few authors have 
discussed methodological and practical issues concerning the cost analysis of goods 
and services (Luce and Elixhauser, 1990; Jacobs and Bachynsky, 1996; Graves et 
al., 2002; Wordsworth et al., 2005).
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There are four main reasons suggesting that costing requires more attention in the 
economic evaluation of health care programmes.
i) Both cost-effectiveness and cost-benefit analyses compare costs to 
consequences. The incremental C/E ratio and the present value of net 
benefits are equally dependent on both the elements of the analysis; a 10% 
error in estimating costs has exactly the same impact of a 10% error in 
estimating benefits or effectiveness. Although effectiveness considerations 
may be prominent from the viewpoint of policy, economic results are equally 
sensitive to cost and economic data.
ii) Existing economic evaluation guidelines do not provide clear methodological 
indications or precise rules to evaluate costs. Although the US Public Health 
Service Panel on Cost-Effectiveness in Health and Medicine (Gold et al., 
1996) and the second edition of the popular manual by Drummond and 
colleagues (1997) have made progress, a lot is still unknown and uncertain 
on how concretely to perform cost analysis.
iii) Economic evaluation papers generally use a few lines to explain how the cost 
analysis was performed and the authors often refer to unpublished material 
and personal communications.
iv) In many countries, including the USA, health care services do not have 
efficient prices because of relevant market imperfections and strict 
government regulation. As a consequence, it is rarely acceptable to refer to 
prices as proxies of opportunity costs.
Inaccurate costing may have relevant consequences. For example, in an Italian study 
(Fattore et al., 1997) the congruence between costs and reimbursement in an Italian 
NHS entity was checked. Using a full cost methodology (see below), the authors 
estimated the costs of 17 types of services provided by a Mental Community Service 
in Northern Italy. The results showed that the fee schedule adopted by the NHS to 
fund providers was not realistic. For example, for an outpatient psychiatric visit 
lasting between 20 and 30 minutes, the estimated cost was approximately 100,000 
Italian Liras (€ 51.60). The official reimbursement fee for that type of visit was about
37,000 Italian Liras (€ 19.10). In this setting, using the reimbursement fee would have
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not been a good proxy of the opportunity cost. Nevertheless, the vast majority of 
economic evaluations performed in Italy use reimbursement fees only as a proxy for 
costs.
4.2. The concept of opportunity costs
In general, economic evaluation is based on the economic concept of opportunity 
costs. According to this principle, resources should be valued at an amount equal to 
their best alternative use. This concept is logically straightforward but relatively 
difficult to make operational.
Economic theory shows that if markets are perfectly competitive, then the price of 
products equals its opportunity costs. In such a situation cost analysis is relatively 
simple; prices of health services and other products are used as good proxies of 
opportunity costs. However, when markets do not exhibit the characteristics of a 
perfect competition, prices are no longer suitable guides to the opportunity costs of 
products. In short, these characteristics are the following: information symmetry 
between producers and consumers, the existence of perfect competitive markets for 
all products, the absence of externalities and public goods, and the absence of 
distorting incentives (Stiglitz, 1988). There is large agreement that these 
characteristics do not feature in the health care sector (Le Grand et al., 1992). In 
particular, information imbalances are relevant in both the market providing health 
care services and the insurance market.
In addition, in NHS-type systems, the prices of services are not generally available 
because provision is funded by tax-payers via the State, rather than by consumers. 
In these systems, opportunity costs cannot be measured through prices alone 
because the prices are not available. Recently, however, reforms in various NHS- 
type systems have introduced quasi-markets in the provision of health services. In 
quasi-market systems fee-schedules and other pseudo-prices are gaining ground. 
Italian hospitals (both private and public) are now partially funded through a fee- 
schedule system set at both national and regional level. The British NHS is planning 
to introduce a per case payment for hospital cases (called payment by result) and 
NHS trusts often have “price” lists for products purchased by Health Authorities or 
Primary Care Trusts.
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Do fee-schedules and “price” lists used to regulate financial transactions within the 
public health care systems approximate opportunity costs? It is difficult to know the 
answer to this question, but the little evidence available to suggest that the answer is 
no. It seems unlikely that fees reflect opportunity costs because prices are not 
primarily set according to cost data. This is clearly what the Italian use of the 
Diagnosis Related Groups (DRGs) system shows (Fattore and Torbica, 2006). Ten 
years after their introduction, national and regional tariffs still do not derive from clear 
and transparent algorithms. The government performs costing exercises, but these 
exercises are very rough and tariffs appear subjected to minimally explicit and 
transparent rules. Tariffs are so important that policy makers, at least in Italy, do not 
intend to give up the opportunity to manoeuvre them with a high degree of freedom. 
Similar evidence between costs and tariffs can be found in other EU countries 
(Schreyogg et al., 2006) and was provided in a seminal paper written more than 20 
years ago for the USA (Finkler, 1982).
In conclusion, very often prices cannot be used to costs services simply because 
they are not available in publicly funded healthcare systems. Also, when funding is 
related to activities as it is the case of the Italian National Health Service, charges 
rarely reflect costs because they are used to meet various policy objectives as well 
as to cover production costs. Finally, even when prices formed in the pure private 
market exist, as it is the case of IVF services, market failures (mainly information 
asymmetry) prevent prices to be reasonable proxies for the opportunity cost of 
resources.
4.3. The classification of costs in the economic evaluation literature
Traditionally, costs to be used in economic evaluation studies were classified into 
three general categories: direct, indirect and intangible (Luce and Elixhauser, 1990; 
Drummond et al., 1987). Direct costs concern the value of resources used in the 
provision of an intervention or in dealing with present and future consequences 
attributable to the intervention. Indirect costs on the other hand refer to resources 
whose use is attributable to any consequence of the intervention being evaluated and 
that cannot be counted as direct costs. Most indirect costs generally refer to 
productivity gains and losses attributable to illness or death. Finally, intangible costs
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refer to the monetary value of health losses per se (disutility generated by losses of 
health).
This classification has been criticised by the US Public Health Service Panel on Cost- 
Effectiveness in Health and Medicine (Gold et al., 1996) and by the Drummond et al. 
manual (1997). First, the distinction between direct and indirect costs does not 
appear to be clear. Is the time that an unpaid caregiver spends providing care a 
direct or an indirect cost? According to the definition presented above it is a direct 
cost; however, it is very common to find articles that report this type of cost as 
indirect. The term “direct cost” is not used consistently across the studies, which 
sometimes causes confusion (Drummond et al., 1997). Second, the term “indirect 
costs” is even more confusing as it is defined by difference (indirect costs are costs 
that are not direct). In practice, however, indirect costs generally refer to productivity 
gains or losses. As suggested by Gold et al. (1996), it is therefore more appropriate 
to label these costs as “productivity costs”. Third, as noted by both Gold et al. (1996) 
and Drummond et al. (1997), the term indirect cost has another major interpretation. 
In management accounting an indirect cost is an item of cost that is associated by 
two or more cost objectives jointly but is not directly traced to each objective 
individually (Anthony et al., 1985). Fourth, intangible costs are not economic costs as 
they do not pertain to the use of resources. In addition, they are not strictly intangible 
because they can be measured and evaluated (e.g. using the WTP approach) 
(Drummond et al., 1997). It would be better if “intangible costs” are considered as 
benefits as they pertain to the contribution of health care goods to the utility function 
of individuals.
In this thesis we follow a straight approach as to what costs and benefit are. Benefits 
are monetary measures of changes of the utility function of individuals. The utility 
function of the individual depends on the present and future consumption of goods, 
given a set of characteristics of the individual. It may also include the consumption of 
goods by other people (caring externalities). Costs refer to the use of scarce 
resources that are the time of individuals, land, natural resources and goods/services 
used as means of production (land, natural resources and labour). According to this 
approach, the category of intangible costs does not exist because it pertains to the 
domain of benefits (a variation in people health concerns the utility function rather 
than an automatic use of scarce resources).
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Focusing on costs, different classifications have been suggested. Drummond et al. 
(1997) classify costs according to three sectors: healthcare sector, patient and family, 
and other sectors. The US Panel (Gold et al., 1997, page 179) suggests keeping the 
term direct costs and to include in this category “the value of all the goods, services 
and other resources that are consumed in the provision of an intervention or in 
dealing with the side effects or other current and future consequences linked to it.” As 
a consequence, direct costs encompass all types of resource use, including family, 
volunteer, or patient time. Concerning direct costs, the Panel also suggests to make 
a distinction between health care costs (tests, drugs, health personnel, etc. ), non­
health care costs (transportation, judiciary costs) and patient time costs (time spent 
by the patient seeking or undergoing an intervention). As far as productivity costs are 
concerned, the Panel identifies morbidity costs (costs associated with lost or 
impaired ability to work or to engage in leisure activities due to morbidity) and 
mortality costs (productivity losses due to premature death).
There are very thorny issues concerning costing. The most studied aspects concern 
how to measure working and leisure time spent by patients, productivity costs and 
mortality costs. The chapter discusses a different issue, which is how to cost health 
services when existing prices are not reasonable proxies of opportunity costs. In the 
next sections we present the type of cost information generally available in health 
care organisations and explain why they may or may not be used to cost services in 
cost-effectiveness and cost-benefit studies.
4.4. Accounting information and types of accounting
Decision making requires various kinds of information. Information is data (but also 
facts, perceptions, etc.) that improves knowledge. Information can be either 
qualitative or quantitative. The former type of information is expressed in terms of 
numbers, while the latter is discursive. Accounting information is a subset of 
quantitative information that is generated by an organisation (a company, a 
foundation, a local authority). There is no neat way to define accounting information. 
However, for sake of simplicity we can think of accounting as information expressed 
in monetary terms.
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According to Anthony and colleagues (1985), accounting information can be 
classified in operating information, financial reporting and management accounting. 
Operating information concerns data on operations such as inventory, payroll, 
accounts receivable; they are the basis for the other two types of accounting 
information. Financial reporting requires operating information because financial 
statements are mainly derived by classifying and summarising this type of 
information. For all types of organisations (for-profit, private non profit and 
governmental)1 the main purpose of financial accounting is to provide information to 
outside constituencies (Anthony and Young, 1988). Operating information is also the 
basis of management accounting, which is the function of providing information to 
plan, co-ordinate and control the organisation’s activities (Anthony et al., 1985).
4.4.1. Financial reporting data and its limitations to cost health care services
Financial reporting and management accounting are radically different, although they 
represent areas that overlap. Most organisations (all private and many governmental) 
release financial reports using accrual accounting, that is a system where 
expenditures and revenues are adjusted to find the actual financial position of the 
organisation at the end of the accounting period.2 For example, in income statements 
the cost of acquisition of fixed assets is not recorded; only a portion of them is 
reported (they are called depreciation expenses). Table 4.1 and table 4.2 present the 
balance sheet and the income statement of a hypothetical private infertility centre.
1 Anthony and Young (1988) suggest distinguishing between for profit and non-profit 
organisations. They then categorize non-profit organisations in governmental and private (tax 
exempt). While this classification may be adequate for the USA context and for the purpose of 
their book on management control, we find more useful here to classify organisations in three 
main categories: governmental (somehow controlled by the political system), non profit 
(private with general goals other than producing and distributing profits) and for profit.
Accrual accounting is focused on measuring the cost of resources consumed, rather than 
resources purchased. As a result this type of accounting makes use of accruals that are costs 
which have arisen but for which an invoice has not been received.
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Table 4.1. Balance Sheet of Newborn Fertility Centre (As a December 31 2003 ( ‘000 €).
Assets Liabilities and Equity
Cash.....................................  400 Accounts payable.............. ... 200
Supplies inventory............. 200 Wages payable.................. 100
Equipment: Cost 4,000 Owed to bank.................... ... 4,000
Less: depreciation....200 3,800
Total liabilities......... ... 4,300
Operating equity................ 100
Total assets........................... 4,400 Total liabilities and equity. .. 4,400
Table 4.2. Income Statement of the Newborn Infertility Centre 2003 ( ‘000 €).
Revenues
Patients revenue.......................................................... ......... 1,280
Interests....................................................................... 50
Total revenues.......................................................... 1,330
Expenses
Wage........................................................................... .........  450
Interest........................................................................ ........  200
Rent............................................................................. .......... 150
Utilities....................................................................... ...........  50
Supplies...................................................................... .........  130
Depreciation............................................................... ..........  200
Other expenses........................................................... ......... 50
Total Expenses......................................................... 1,230
Net income.............................................................. 100
The balance sheet is the statement which contains the values of the assets and
liabilities of an entity at a point in time. Table 4.1 reports that the Infertility Centre has 
assets for € 4.4 million and liabilities for € 4.3 million; the difference between assets 
and liabilities, 100,000 €, is its operating equity and corresponds to the net income 
recorded in the Income Statement. It should be noticed that both the statements 
present aggregate data. They provide useful information concerning the overall 
financial position of the company but cannot be used easily to cost products. Only in 
the case of a mono-product company would it be possible to calculate the unit cost of 
the product by dividing total expenses by the number of products. For example, if the 
company provided 1,000 IVF cycles it could be estimated that each cycle cost 
€1,230. However, organisations providing only one type of product are extremely 
rare. It is thus very unlikely that financial statements can provide useful information 
for economic evaluation studies.
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Many governmental organisations still do not produce their financial statements using 
accrual accounting, although this type of accounting is becoming more popular in 
many countries. The main objective of financial accounting differs between private 
and governmental organisations. Outside parties in private organisations are mainly 
interested in having an overall picture of the financial position of the organisation, 
while in governmental organisations they are mainly interested in controlling the 
expenditure process.
Governmental financial accounting varies from one country to another and from one 
type of organisation to another. In Italy, NHS entities (Hospital Trusts and Health 
Authorities) presently use two types of accounting. Accrual accounting has just been 
introduced and (with important exceptions), tends to follow the accounting system of 
for profit organisations (regulated by the Italian Civil Law). The second type of 
accounting, "public accounting" was introduced when the NHS was established in 
1978 and it is derived from the system in which all governmental organisations had to 
prepare their financial reports. In this type of accounting, expenditures are recorded 
at two different stages: i) when the entity becomes obligated to pay a certain amount 
of money and ii) when it actually pays it. Similarly, on the revenues side, amounts are 
recorded when the entity becomes entitled to receive that amount and when it 
actually receives them. Consequently, financial reporting provides two types of 
accounts: the debit/credit account where obligations and entitlements are recorded 
and the cash account where monetary transactions are recorded. Both the accounts 
appear in two documents: the “budget account”, prepared before the beginning of the 
accounting year, and the "final account” prepared after the accounting year has 
ended. Both documents are prepared under the responsibility of the General 
Manager, are approved by the referent political body (the Region for health care 
organisations in Italy) and are subjected to an accounting audit. The most important 
document is the "budget" as it authorises expenditure and allocates funds among 
different types of economic resources (personnel, goods, financial services). Various 
constraints regulate the way the "budget account" is prepared, the main one being 
that total expenditures cannot exceed total revenues.
Public accounting is a system designed to give political bodies control over the 
allocation of resources within the public sector. In contrast with private financial 
accounting, it is not an appropriate system to measure the economic performance of
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the organisation as it is less informative from an economic point of view. For 
example, it records investments for their entire amount and does not provide 
information on depreciation.
At least in Italy, public accounting suffers from severe shortcomings. First, “budget 
accounts” are estimates that can be changed over the accounting period (provided 
that a cumbersome procedure is followed) and "final accounts" are often prepared 
several months or years after the end of the accounting period. Therefore, either they 
do not fully reflect actual expenditures or they lack in timeliness. Second, single 
operations (e.g. wage payment of an employee, purchase of a type of 
pharmaceutical) are aggregated according to the nature of the resources acquired 
(personnel, pharmaceuticals) and not according to the area of intervention 
(prevention, hospital care, out-patient care) or to the organisational structure (hospital 
wards, administrative departments, etc.). Such a type of aggregation makes it difficult 
to extract information to cost products. Third, the system is not an accrual one; it 
produces information that does not reflect the value of the resources used in the 
accounting year. Two examples can explain this point. The system records all 
purchases of pharmaceuticals in a given period; whether the pharmaceuticals are 
used or not is impossible to know from the accounts. It may be the case that the 
organisation decides to purchase a large quantity of some items just to stock them. A 
high value is written in the books, but this does not reflect the use of that item in the 
accounting period. The second example concerns technology and equipment, in 
public accounting records there are two issues to bear in mind: i) the decision to 
purchase the equipment, ii) the corresponding payment/s. It is likely that the 
equipment is a long-lived asset that provides services for several periods after the 
expenditure to acquire it has been made. If in a particular year the organisation 
receives generous funding, its accounts will probably show high expenditures just 
because it used the capacity to spend. But these values have little to do with the use 
of capital equipment and, consequently, with the cost of providing health care 
services.
Both accrual (private) and non accrual (traditional public) accounting are not very 
useful to cost health services. This should not be surprising as they are intended to 
provide information to outside parties. In private organisations outside parties mainly 
consist of investors, creditors and providers. Their main concern is to know the
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overall financial position of the organisation so as to get guidance in their business 
operations. In governmental organisations financial accounting has a different main 
objective: to put allocation of resources under government control. In theory, 
governmental organisations should be interested in producing financial statements 
that justify the use of public money. This might include information on the costs of the 
main products delivered by the organisation. In practice, however, Italian NHS 
financial statements do not provide this data and are not generally useful to 
economic evaluators. Rather, it is management accounting that may prove useful to 
improve costing out products in the economic evaluation.
4.4.2. Types of management accounting
The purpose of management accounting is to provide information for managers in an 
organisation (Anthony and Young, 1988). While financial accounting tends to present 
an underlying unity targeted to outside constituencies, management accounting 
summarises information in different ways and for different purposes (Anthony et al., 
1985). Traditional management accounting suggests three constructions that can be 
applied to costs: i) full accounting, ii) differential accounting and iii) responsibility 
accounting. Table 4.3 presents these types of accounting information and their use.
Table 4.3. Types of cost accounting information and their use (adapted from Anthony et al., 1985)
Cost construction Uses
H is to rica l data Future Estimates
Full Financial reporting 
(inventory and cost of sales) 
Analysis of economic performance 
Cost-type contracts
Programming 
Normal pricing 
decisions
Differential
NONE
Alternative choice 
decisions (e.g. make 
or buy, break even 
analysis)
Responsibility Analysis of managers' performance Budgeting
Source: adapted from Anthony et al., 1985.
4.4.3. Full cost accounting
Full cost accounting aims to estimate the total amount of resources consumed to 
produce a product or another object of interest. It can refer to goods (e.g. 
automobiles, books etc) or services (e.g. university courses, IVF cycles etc). It can 
also refer to different degrees of aggregation; the object of full costing can be the 
simple act of injecting a drug, the surgical operation to re-implant fertilised eggs, or 
the complete sequence of activities required to complete an IVF cycle. The unit of
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measurement chosen to be cost is called cost objective. The full cost of the cost 
objective is the sum of two components: i) the costs directly attributable to the 
objective (direct costs) and ii) a fair share of the costs incurred jointly in providing 
these and others products (indirect costs). Full cost accounting is used for various 
purposes; it provides estimates of the production of goods to be written in the income 
statement, and it may be the basis for contracts where buyers agree to pay the full 
cost of the product plus a negotiated profit margin. Estimates of future full costs can 
be used in long range planning (e.g. to estimate costs of a new hospital) and in 
normal pricing decisions, which is when prices are set according to costs 
disregarding market conditions. In addition, governmental and non-profit 
organisations as well as companies operating in regulated industries (e.g. transport, 
water, electricity etc) are often required to price their products starting from full costs.
In various sectors, many resource providers have published rules for full costing. In 
the USA there are rules set by the Department of Health and Human Services that 
apply to healthcare organisations providing care to patients under Medicare, 
Medicaid and other federal or state programmes. In England, prices agreed between 
NHS Trusts (defined in the contracts/agreements) and Health Authorities had to be 
set on the basis of costs as estimated according to the general criteria defined by the 
Department of Health (NHSME, 1993).3
As it aims to estimate the total amount of resources consumed to produce a product, 
full costing appears an appropriate methodology for costing health services. 
However, before discussing a few details of this methodology it may be useful to 
check if other methodologies may be appropriate.
4.4.4. Differential cost accounting
While the typical question of full cost accounting is "What did it cost?" differential 
accounting tries to answer the question "how will costs change under a proposed set 
of circumstances?" (Anthony and Young, 1985). The most common analyses using 
differential costs are: break-even analysis (estimating the volume of production at
3 The circular provides minimum standards for costing across the NHS in order to improve 
contracting between purchasers and providers. These standards are based upon three basic 
financial principles: i) prices should be based on actual costs; ii) costs should be established 
on a full cost basis; iii) there should be no planned cross subsidisation between specialties, 
procedures or contracts.
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which total revenues equal total costs) and make-or-buy analysis (the search for the 
cheapest option between managing production internally and contracting out). These 
types of analysis are very popular in private and governmental organisations. 
However, differential cost accounting focuses on given problems and thus cost 
estimates depend on the nature of the problem. As there is not a general way of 
labelling a given cost as differential or non-differential, differential cost accounting is 
a technique that varies according to the specificities of the situaions and does not 
make use of regular and systematic reports.
Anthony and colleagues (1985, 1988) state that differential cost accounting regards 
accounting information to be used when making alternative choice decisions. This 
definition is arguable, though. "Alternative choice decisions" is tautological as it is 
difficult to imagine a decision without an alternative. Without choices there are no 
decisions but only obligations. In addition, long-range planning and pricing are 
decisions as any plan or any decided price has at least one alternative. Differential 
cost accounting limits its analysis to costs directly implied by the choice. Therefore it 
needs not to refer to full costing of the alternatives; it focuses on costs that are 
emergent (new because of the decision) and ceasing (avoided because of the 
decision).
In general, differential accounting is not an appropriate cost methodology for cost- 
benefit analysis. However, if the new service to be evaluated requires a marginal 
change in the use of resources and no additional fixed costs, differential accounting 
may be more informative than full cost accounting. In such conditions, the production 
of the service would only imply an increase in variable costs and full costing would 
exaggerate the consumption of resources due to the production of the new service.
4.4.5. Responsibility cost accounting
In responsibility accounting organisations have a structure that defines roles, tasks 
and relationships among their members. This type of accounting refers to the 
organisational structure as it collects and reports accounting information about the 
use of resources and the output of organisational units. The units are generally called 
responsibility centres and are headed by a manager. Responsibility centres of a 
health care organisation may be hospital wards, the departments, the infertility 
centre, the payroll unit, etc.
139
Responsibility accounting interacts with full cost accounting. For example, in order to 
estimate the cost of products, full cost accounting makes use of information provided 
by responsibility centres. But the two types of accounting have different foci. Full cost 
accounting looks at products while responsibility accounting looks at the performance 
of responsibility centres. To a certain extent it can be stated that full cost accounting 
is just a technique while responsibility accounting is the heart of management control, 
which is one of the main management activities performed in an organisation.
4.5. Types of costs in management accounting
Generally, the economic evaluation literature refers to the book by Drummond et al. 
(1997) for categorizing costs. We report here a more sophisticated classification 
following a traditional textbook of cost accounting (Anthony et al., 1985). Table 4.4 
reports a generic summary of cost types classified according to the three different 
accounting sub-systems presented above. Table 4.5 provides examples concerning 
infertility treatments.
Table 4.4. Summary of types of costs.
F u ll Cost Accounting D iffe rentia l Accounting Responsibility Accounting
D irec t: Costs traced to a single 
cost objective
Ind irect: Not-traced to a single 
cost objective; an equitable 
portion is allocated to the cost 
objective (overheads)
F u ll: Direct costs + Indirect costs
Costs incurred in responsibility 
centres.
Contro llable: Manager can 
exercise significant (but not 
necessarily complete) influence 
Non controllable: Other costs, 
including committed and 
allocated costs
Capitalised: Asset to be 
amortised over several future 
periods
Product: Direct + Indirect 
production cost of product 
Period: Expense of current period
Variable: Costs that vary 
proportionately with 
volume
Fixed: Costs that do not 
vary with volume
Engineered: “Right” amount can 
be estimated
Discretionary: Amount subject 
to manager’s discretion; agreed 
on in budget process 
Committed: Will not change in 
the short run (a type of fixed 
cost)
F u ll costs are either h istorica l 
costs o r estimated fu tu re  costs
D iffe ren tia l costs are 
always estimated fu tu re  
costs
Responsibility costs are either 
h is to rica l costs o r estimated 
fu tu re  costs
Source: Anthony et al., 1985.
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Table 4.5. Example of types of cost in an Infertility Centre belonging to an Italian NHS Trust (IVF  
cycle is the cost objective)__________________________________ ______________________________
Full Cost Accounting Differential Accounting Responsibility Accounting
Direct: drug therapy 
Indirect: secretary services
Controllable: lab tests
Non controllable: cleaning the
Centre
Capitalised: most of the 
equipment of the operating room 
Product: the cost of producing an 
IVF cycle
Period: the yearly cost incurred to 
keep an advertisement 
introducing fertility treatments in 
a popular website
Variable: the cost of the 
hormone therapy 
Fixed: the cost of cleaning 
the centre
Engineered: most of lab tests 
Discretionary: employees’ 
participation to conferences and 
seminars
Committed: depreciation on 
equipment and building
Full cost accounting makes use of two classifications. The first refers to the 
traceability to a cost objective; given a cost objective, a direct cost is a cost that can 
be traced to it. Assuming an IVF cycle is a cost objective, the surgeon time spent to 
re-implant retrieved eggs and all pharmacological treatments are direct costs. All 
administrative costs either of the NHS Trust or of the centre are indirect costs. It is 
not possible or feasible to trace them to IVF. The second classification is essential in 
financial accounting; capital expenditures are the costs of the acquisition, 
construction and installation of fixed assets. These costs are recorded in the balance 
sheet, but only depreciation is recorded in the income statement. This is because 
fixed (long-lived) assets make a contribution to production over more than one year 
and thus require having their costs apportioned over various accounting periods. 
Product cost is an expression mainly used in manufacturing companies and refers to 
the costs of producing goods. It therefore excludes marketing, selling, R&D and 
administrative costs. These costs are called period costs. It follows that i) the 
operating room and most of its equipment are capitalised costs, ii) under this 
classification, the “product” cost of IVF cycles exclude the cost of various activities 
not strictly associated with the act of producing, and iii) all administrative support, 
research activities and advertising (i.e. the production and distribution of a leaflet 
explaining IVF to the corhmunity) are period costs.
Differential cost accounting presents a classification very close to that used in 
economics, albeit with important caveats. It refers to the behaviour of costs with 
respect to volume (figure 4.1). An item of cost is variable when its amount varies 
proportionally with volume; an item of cost is fixed when whatever the volume the 
amount of resources remains unchanged. In addition, costs may vary according to 
volume more or less than proportionally and may follow different patterns (quadratic,
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logarithmic, etc.). The two caveats are important; cost behaviour always refers to a 
relevant range that is a range of volume where the behaviour described above is an 
acceptable approximation. The depreciation of the building where the Fertility Centre 
is located is a fixed cost, provided that the number of cycles delivered does not 
increase too much. For example, if the number of cycles more than doubles it will be 
likely that the space available does not suffice and additional space is needed. Either 
the increase in volume is impossible or it is required to acquire new space with 
consequent additional costs. The second caveat concerns time; in the long run many 
fixed costs are variable. When distinguishing between fixed and variable costs it is 
thus important to state the time period the analysis refers to. The cost of cleaning the 
Centre is fixed in the short term (e.g. one year), but becomes variable when the 
arrangement for its provision can be modified.
Figure 4.1. Fixed, variable and total costs in management accounting
Costs
relevant ranee
Total costs
Variable costs
Fixed costs
Actual
volume Volume
Two classifications are useful in responsibility accounting. Costs can be either 
controllable or uncontrollable by the manager of the responsibility centre; 
controllability refers to the amount of resources used by the responsibility centre 
rather than to its unit costs. Lab tests used in an IVF cycle are controllable because, 
although provided by the Laboratory Department, are generally ordered by the 
Fertility Centre. Cleaning services are not controllable as it is very likely that the 
number of hours cleaners spend at the Centre are decided by the Cleaning
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Department of the NHS Trust. According to the second classification costs can be 
engineered, discretionary and committed. Costs are labelled “engineered" when it is 
possible to establish a clear relationship between the amount of resources and the 
volume. Machine time required to perform a lab test is easily predictable; similarly, 
the lab tests required for an IVF cycle are predictable if clinicians follow protocols. 
Discretionary costs refer to resources that do not present a clear relationship with 
products. Their amount is generally decided by the head of the responsibility centre. 
The cost of participating to conferences is an example of discretionary cost. Finally, 
committed costs are those that are inevitable consequences of decisions previously 
made. If the Centre has stipulated a three-year contract with a famous clinician to 
monitor the quality of its activities, then the remuneration of the clinician is a 
committed cost for those three years.
4.6. The estimation of full costs
In one of the few papers reviewing costing methods in the economic evaluation of 
health care programmes Jacobs and Bachynsky (1996) argue that “improvements in 
costing can be made through the use of accepted cost-accounting techniques rather 
than through the continual reinvention of the wheel". They also state that proper 
costing techniques currently exist. However, as shown above, costs can be classified 
in various ways according to the purpose of the accounting system.
Responsibility accounting is nowadays very popular in many health care 
organizations. Under financial pressure, both public and private organizations are 
striving to keep costs under control through making organisational units more 
accountable for their use of resources. Consultants and other managers regularly 
receive reports on the costs of their units. Often, these reports are the basis upon 
which their performance is evaluated. However, these reports do not focus on 
products. Rather, they show actual costs compared with budgeted costs. 
Furthermore, controllability is a key element of this type of accounting. In order to 
make managers accountable, information has to focus on what they can control. The 
general administrative costs of the Health Authority or the costs of the activities 
required by the safety regulation are often disregarded in these reports as they 
concern aspects that are out of the scope of control of the vast majority of 
organisational units.
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The manager of the Infertility centre controls the use of some of the resources 
presented in figure 4.2. Presumably, she has control over the amount of personnel 
time, the consumption of electricity, or the use of lab tests. However, she does not 
control the amount of cleaning services provided to the centre, or the costs of general 
administration. It is thus likely that the report he/she receives provides little 
information about these costs.
Figure 4.2. The step-down method.
Departments Direct and 
indirect costs Cleaning Personnel Laboratory
Total misison 
centre costs
Support Clening 500
Centre
Personnel 100 i 3° i |
Lab tests 500 ! 30 □ 20
Mission
centre
Internal Medicine 2.000 | 200 | 50 | 220 | 2.470
O&G 3.000 | 200 | 50 | 200 | 3.450
Infertility centre 500 I 40 I 10 oCO 680
6.600 500 130 550 6.600
Source: adapted from Anthony and Young, 1985
Although responsibility accounting focuses on people and their organisational roles, it 
may provide useful information to cost products for economic evaluation studies. A 
well prepared cost report shows a detailed synopsis of the controllable costs of the 
responsibility centre. This piece of information may be an important step to estimate 
full or differential costs.
Full cost accounting is not widespread within Italian NHS care organisations. This is 
reasonable as NHS Trusts and HAs determine the prices only of a marginal part of 
their products. Full costing exercises are mainly performed in Italy by the national 
and the regional ministries of health to determine and revise tariffs (Fattore and 
Torbica, 2006; Adduce and Lorenzoni, 2004). On the contrary, British NHS Trusts 
appear to be keener to adopt full cost accounting, possibly because they are pressed 
into it by making sound contracts/agreements with Health Authorities.
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Full cost accounting presents some key features. The first step of the procedures 
consists of assigning costs to the cost centre (the Infertility Centre).4 According to 
Anthony and Young (1985) cost centres “...might be thought of as "buckets” into 
which an organisation’s costs are classified and accumulated for purposes of full-cost 
analysis.” Given the present situation of information systems in NHS Trusts and HAs, 
cost of amortisation of buildings and equipments, personnel, and utilities can be 
easily estimated and assigned to the cost centre. They are direct costs of the 
Infertility Centre as they are easily traceable to it (see above). Cleaning services and 
lab tests are also traceable to the Infertility Centre, although requiring more 
sophisticated information. If the NHS Health Authority has a responsibility accounting 
system, its reporting system will make available the number and the value of lab tests 
used by the Centre. If such a system is not in place, the number of lab tests can be 
estimated by surveying the clinicians working in the Centre. The value of clinical 
services used by the Infertility Centre can also be traced, either by taking advantage 
of responsibility accounting or by collecting information from the Cleaning 
Department. Lastly, figure 4.2 illustrates the fact that general administration, is clearly 
an essential component of the HA, and absorbs resources. Consequently, in order to 
estimate full costs of the Infertility Centre a fair share of general administration costs 
has to be allocated to it. The use of the word “fair” is not casual: there is no objective 
and true way to allocate these costs (Anthony and Young, 1988; Anthony et al., 
1988; Drummond et al., 1997); a fair estimate means that the accounting system 
should try to find an allocation basis (i.e. the number of employees) that it is 
acceptable5 and does not require excessive administrative costs.
The Infertility Centre provides various products; the list may include counselling to 
couples with infertility problems, stimulation therapies and more sophisticated types 
of infertility treatments as such as IVF. For the sake of simplicity, here we exclude the 
instances where the Centre provides products to other departments of the HA (the 
Obstetrics and Gynaecology (O&G) Department may require advise from the 
Infertility Centre) or to other health care organisations (the Centre may serve as
4 According to traditional cost accounting, a cost centre is a cost objective for which costs are 
accumulated. Note that cost centres and responsibility centres may not perfectly overlap. In 
general, most responsibility centres are also cost centres. However, the reverse is not true; 
not all cost centres are responsibility centres. While the distinction between cost centres and 
responsibility centres may be relevant in many organisations, for sake of simplicity it may be 
disregarded in this chapter.
5 The term acceptable may appear too vague. However, the level of precision of the allocation 
basis depends on how cost analysis is used to take decisions and the method, rather than 
being good or bad, it needs to be accepted by organisational actors to be useful.
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semen bank for other centres). Despite this simplification, the Centre is not a mono­
product organisation. It provides various products with different utilisation of 
resources. In order to estimate full costs of IVF cycles it is therefore necessary to 
quantify direct and indirect costs attributable to these specific cost objectives.
While building, personnel, equipment and utilities are traceable to the Infertility 
Centre, their attribution to products cannot be done directly; these items are indirect 
costs to IVF cycles. On the contrary, lab tests, although produced by another 
responsibility centre, can be classified as direct costs since each test can be 
attributed to a specific cost object.
Full cost accounting involves four major difficulties: choosing the allocation basis, 
choosing the allocation method, deciding between a process costing or a job order 
costing approach, and estimating the cost of using capital. We will turn to each of 
these issues in the following sub sections.
4.6.1. The allocation of indirect costs
Before discussing how to allocate indirect costs it is useful to introduce a basic 
distinction made in accounting for service organisations: cost centres can be 
classified in mission centres and support centres. The former (i.e. the Infertility 
Centre) refers to responsibility centres that contribute directly to the objective of the 
organisation, while the latter (i.e. the Personnel Department) contributes to the work 
of other responsibility centres, which may be either mission centres or other support 
centres.
Indirect costs are assigned to cost objectives by means of an overhead rate. 
Assuming that the Infertility Centre delivers only IVF cycles the overhead rate can be 
obtained by dividing total overhead costs by the number of cycles delivered. Since 
responsibility centres usually produce more than one type of product, output volume 
cannot be generally used to calculate the overhead rate. Intuitively, it is probably not 
acceptable to add the number of IVF and the number of counselling sections 
because they absorb different amounts of resources. In manufacturing companies 
the following volume measures are used as overhead allocation bases (Anthony et 
al., 1985): direct labour costs (the costs of the labour directly associated to the
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production of the product), direct labour-hours (the number of hours associated to the 
production of the product), machine-hours (the hours that the machine spent to 
produce the product) and prime costs (the sum of direct labour costs and direct 
material costs). Obviously, each measure results in different full costs and choosing 
the most appropriate allocation basis depends on the specific feature of production 
processes and the purpose of full costing. Given that personnel costs represent 
more than 50% of the overall costs in health care organisations, it appears 
reasonable to allocate overheads by the means of either direct labour costs or direct 
labour-hours.
Drummond et al. (1987) report various methods for allocating overhead costs. The 
simplest method is the direct method; it ignores interaction between support 
departments when any given support department’s costs are allocated to 
departments providing services to final users. Coming back to the example of figure 
4.2, this method means that the costs of the Cleaning Department are allocated to 
O&G, Internal Medicine, the Infertility Centre, but not to the Laboratory Department 
because it is a support centre. This method tends to underestimate costs of 
departments that make higher use of support department services.
The step-down method recognises that there is interaction among support 
departments. The Personnel Department provides administrative services to the 
Cleaning Department; but at the same time the Cleaning Department provides 
cleaning services to the Personnel Department (figure 4.2). In the step-down method 
a sequence of steps is chosen, usually by starting with the support department that 
provides the greatest service (in terms of costs) to the greatest number of other 
support departments (Horgren et al., 1996). The step-down process ends when 
overhead costs of the department that renders the least services to the least number 
of other departments are allocated. Drummond et al. (1997) mention other two 
methods which make full adjustment for interaction among support centres: the step 
down with iteration method where the step-down process is repeated various times to 
eliminate residual unallocated overhead costs, and the simultaneous allocation 
method where full adjustment is assured by solving a set of simultaneous linear 
equations.
147
4.6.2. Process costing and job order costing
There are two extreme approaches to product costing (Horgren et al., 1996): job-
order costing and process costing. The process method is used when products are 
homogenous or when the aim of costing allows to treat products as homogenous. 
The most extreme way of using the process costing method is to consider the entire 
hospital as a mission centre; in its most simplified version it entails two steps to 
estimate the full cost per day: i) calculating all costs for the hospital, ii) dividing them 
by the number of days delivered. This approach may be useful when third-party 
payers reimburse a hospital according to an all-inclusive per diem amount (Anthony 
and Young, 1988) as was the case of private hospitals reimbursed by the Italian NHS 
before the 1992 reform (Fattore 1999; France et al., 2005). However, it is difficult to 
imagine an application of this method to the Infertility Centre for the heterogeneity of 
its products.
By contrast, with the job order method all direct costs are attributed to each specific 
product and an overhead rate is used to apportion indirect costs. Several Italian 
private hospitals use this method as a basis for pricing services delivered to private 
patients. This is also the prevalent method used by lawyers and other professionals 
to charge their clients. According to this method, for each IVF cycle major cost items 
are collected on a record, call job-cost record. For example, the record may collect
health professional and equipment time spent on each cycle.
While the process cost method is too approximate, the job order method is probably 
too costly as it requires close monitoring of equipment and health professionals’ time. 
It appears more suitable to follow a mixed approach which takes advantage of 
standard costing.6 With a standard costing system, each mission centre defines the 
products it provides and the amount of direct labour, machine time and material for 
each treatment. With respect to the Infertility Centre, estimating standard costs 
entails: i) identifying the product objectives (inducement therapy, counselling, IVF 
cycles) ii) estimating the normal amount of labour time cost, equipment cost and lab 
test,7 iii) adding one or more overhead rates.
6 “A standard cost is a measure of how much a cost item should be, as contrasted with a 
record of how much it actually was” (Anthony et al., 1985, page 277)
7 There are two types of standard costing: ideal standard and normal standard. Ideal standard 
costing implies maximum efficiency, while normal standard costing assumes a degree of 
efficiency that can be reasonably expected under prevailing conditions.
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4.6.3. Capital costs
Surprisingly, the US Public Health Service on Cost-Effectiveness (Gold et al., 1996) 
does not discuss how to cost capital. In contrast, Drummond et al. (1997) present 
some basic material and provide practical suggestions. A thorough discussion of the 
theoretical problems associated with costing capital is beyond the scope of this 
chapter. Here, we simply identify some crucial and relevant basic issues.
First, capital costs are fixed costs and refer to expensive long-lived assets that 
contribute to the production of products/services over a period longer than one year. 
They can be either direct or indirect costs to cost objectives (cost centres or 
products). As the use of sophisticated and expensive technologies is increasing in 
health care, how to treat capital costs should be treated as a high priority in the 
research agenda.
Second, there are two main types of capital -  land, building and equipment. Both the 
use of land and the production of building and equipment bring about opportunity 
costs as the land generally has alternative uses and thus the resources used to 
produce equipment and building. However, land, at least to a certain extent, lasts 
forever and without losing its characteristics while equipment has limited useful life. 
Therefore, equipment brings about an additional type of cost related to time and 
utilisation. In accounting, this type of cost is called depreciation. Almost all health 
care programmes require (or impact on) land and equipment. It is therefore essential 
that both “opportunity costs” and “depreciation costs” are properly measured.
Third, there is not a general rule to estimate depreciation costs because each piece 
of equipment has a specific (and uncertain) life span and its rate of utilisation, 
possibly impacting on the life span, is difficult to predict. In addition, obsolescence is 
also difficult to predict. Finally, even if the economic life span of the equipment is 
known, there is not just one way to apportion the economic value according to time. 
In financial accounting at least two general approaches can be followed -  straight 
line depreciation and accelerated depreciation.
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4.7. The role of full costing in the economic evaluation of healthcare 
programmes
One of the basic ideas of cost accounting is that the analysis is dependent on the 
decision that has to be made and on the time framework of interest. Let us assume 
that the Infertility Centre has launched a programme consisting of 10,000 leaflets 
explaining IVF treatments to be distributed to the community. The leaflets are already 
printed and the Centre has to decide whether to post them or to make them available 
in various public places. Does this decision require full costing? Certainly not; what 
matters here is the difference of costs of the two alternatives. Let us now assume 
that the Centre decided to post the leaflet but that a charity has already distributed 
similar leaflets to the same community. Probably, if the Centre had known the 
Charity’s programme it would have not produced the leaflets. But does this mean that 
the programme is now too costly? Probably not; the cost of the production of the 
leaflets is a sunk cost, the decision has to be made only considering the cost of 
delivering the leaflets (and, obviously, the incremental benefit of distributing a second 
leaflet to the community).
Time framework is even more important. Let assume that the Centre increases 
production by 20%. It is likely that in the short-term only lab tests are variable, all 
other resources directly or indirectly involved in the production cannot be varied in 
the short-term. This means that the Centre and the support departments are required 
to increase productivity. However, it is very unlikely that an increase in production 
can be managed with an increase in productivity only. In the long term, unless there 
are permanent productivity gains, a stable increase in production must deal with an 
increase in the resources used. In the long run, even the number of employees of the 
personnel department is expected to be adjusted to the volume of activity of the 
Centre.
The US Public Health Service Panel explicitly recognises that economic evaluation 
(Cost-effectiveness Analysis) is an aid to decision-making. In this part of the chapter 
we have tried to show that organisations take different types of decisions and that 
each type tends to require different definitions of costs and different ways to analyse 
them. As a consequence, it is reasonable to think that there is no right way to 
perform an economic evaluation, but several possible ways depending on the 
specific issue of interest. For example, starting, increasing, decreasing or eliminating
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the provision of a service requires different types of cost analyses and results in 
different cost estimates. The aim of this discussion is not to prove that economic 
evaluation studies are useless in decision-making. Rather, it may help in pointing out 
that there is not “a right” way to do cost analysis and that there are various possible 
approaches that can be followed according to the specific type of decision that has to 
be taken.
There is a particular kind of decision that is attracting growing interest in the health 
care field. This is the decision to provide public coverage for particular treatments. 
Increasingly, health care systems are required to be more explicit about the services 
they provide under public funding. How much of the “basket” of services guaranteed 
to people is explicitly defined according to transparent and consistent rules varies 
from one country to another (Ham and Robert, 2003; Schreyogg et al., 2005). 
Nevertheless, some moves towards “explicit rationing” are made in a few countries 
and economic evaluation is increasingly seen as a possible aid to decision-making 
(Ham and Robert, 2003).
Decisions about public coverage of specific services have two main characteristics 
that are relevant from the point of view of the economic evaluation of healthcare 
programmes. First, they must refer to all organisations actually or potentially 
providing the service. Decision-making about policy is therefore expected to average 
out different situations. In other words, the decision to cover IVF with public funding 
should take into account that there are various types of centres (in terms of volume of 
services provided, degree of specialisation). Second, it seems reasonable to assume 
that policy-making is required to adopt a long-term perspective. Decisions concerning 
the exclusion/inclusion of services are expected to be long lasting and consistent 
over time.
These two characteristics suggest including all the costs that are variable in the long 
run. This is also the recommendation of the US Panel for the Reference Case. In 
effect, recommendation 12 of the cost analysis chapter states that “Costs in CEA 
should reflect the marginal or incremental resources consumed, rather than average 
costs, from a long-run perspective” and recommendation 17 states that “Variable 
costs, reflecting the value of those goods, services, and inputs that change because 
of the intervention being considered, should be included in the CEA, while fixed
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costs, which remain constant in the long run regardless of the level of production, 
should be excluded” (Gold et al., 1996: 209-210).
As shown above, full costing does not make use of the distinction between fixed and 
variable costs. The distinction is irrelevant because no costs are excluded by the 
analysis. Nevertheless, it should be feasible to exclude from full cost accounting 
certain types of costs. It is thus possible to use full cost accounting excluding long 
term fixed costs.
The economic evaluation literature does not provide practical rules to identify long­
term fixed costs. Intuitively, however, in the long run almost all costs are variable. For 
example, administration, information technology equipment, space tend to be 
positively correlated with volume, although not always proportionally. The only 
exception we see concern costs related to the institutional arrangement of health 
care organisations. Whether the volume of production of the Health Authority doubles 
or halves there will be one and only one General Manager, Health Director and 
Administrative Director (to take the Italian case). In effect, these management 
positions exist and have similar costs in both small and large HAs and Hospital 
Trusts. But despite this type of costs, it seems acceptable to assume that virtually all 
costs tend to be variable in the long run and that full costs are an appropriate 
approximation of long run marginal costs.
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Chapter 5
A cost-benefit analysis of In-Vitro-Fertilisation: Methodology and
data
5.1. Introduction
This chapter presents the data and the methodology used to estimate benefits and 
costs of providing In-Vitro-Fertilisation (IVF) services in Italy. The first part of the 
chapter presents and discusses the contingent valuation survey used to estimate the 
monetary values that a sample of the Italian population attributes to the use of IVF 
services. The questions in the survey were framed to elicit two types of values of IVF 
services. People were first requested to give their willingness-to-pay for having 
access to IVF services in case they were infertile and wanted to have a baby. This 
part of the survey measured the use value of IVF, which are the benefits that 
respondents attribute to their personal use of the service. In the second part of the 
survey respondents were asked to state their WTP for a publicly funded programme 
providing IVF to Italian infertile couples desiring to have a baby. The questions of this 
part of the questionnaire elicit WTP for a public programme and thus are expected to 
catch the altruistic component of the programme, which is the WTP for benefits that 
are reaped by other members of the community.
The first section of chapter illustrates how the survey was built and conducted and 
explains the methodologies used to code and analyse the data. Section 5.2 focuses 
on the general characteristics of the survey; section 5.3 lists the socio-demographic 
information collected in the survey. Then a part of the chapter is devoted to the 
analysis of answers on knowledge and attitude towards infertility and Assisted 
Reproduction Technologies (ARTs) (sections 5.4 and 5.5 respectively). The central 
part of the chapter reports on the methods used to analyse the WTP data (sections 
5.6 and 5.7). In addition to the analysis of the determinants of WTP for personal use 
and for the publicly funded programme, we present the models used to estimate 
mean and median WTP (section 5.9 and 5.10) and we detail the methods used to 
test the validity of the methods and to compare the elicitation formats that we used 
(sections 5.11 and 5.12).
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Section 5.13 of the chapter presents the methods and the data used to estimate 
costs. It details how we obtained the full cost per IVF cycle that is used in the cost- 
effectiveness and cost-benefit analysis presented in the next chapter. The rationale 
for using a full costing methodology and details about the source and the type of cost 
data collected are discussed in chapter 4. The final section of the chapters shows 
how benefits and costs were combined to obtain a cost-benefit analysis that can 
inform policy decision-making.
5.2. General characteristics of the survey
The IVF questionnaire was sent through the internet to 6,435 Italian residents in late 
November 1999. These individuals agreed to be part of a panel created by CRA- 
Nielsen that is used for regular surveys on political issues and for marketing 
research. Participants on the panel received at their home computers one or two 
questionnaires each week in the form of an electronic file. They were requested to 
return the files with the answers within one week. Each participant of the Panel was 
equipped with a particular software programme which eases respondent's tasks.
We wanted to investigate WTP of a fairly representative sample of a national 
community. Methodological and practical considerations led us to choose an 
innovative method to interview individuals drawn from the general population: an 
internet-based survey. When the survey was designed very little literature was 
available on the use of internet to collect data from electronic panels. Even now little 
is known about this new method to administrate surveys, as very few studies have 
investigated its validity and reliability (Thurston, 2006).
Internet surveys have several advantages over other more traditional methods to 
administer surveys. In the context of the present survey they reach higher response 
rates, enforce question answering requirement, check errors and force respondents 
to follow predefined rules, allow for random question order, allow for automatic 
coding and data file creation, and ease the control of respondents’ and sample 
characteristics (De Vaus, 2002). The main problem with internet-based surveys is 
that they allow for samples that are unrepresentative and that it is difficult to 
generalize from them. Given the limited and biased penetration of internet access,
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the choice of an adequate sample is critical. This survey used a so called 
“commercially recruited representative sample” (De Vaus, 2002), that is a panel of 
people who agreed to be regularly surveyed for money or in exchange of other 
benefits (e.g. free hardware and software). The survey was built according to a quota 
sampling procedure of the national population. From a list of families located 
according their home telephone number a sample of 5,227 individuals was randomly 
selected, in such a way that a minimum number of people meeting certain 
characteristics were included. These characteristics were gender, age (in 5 years 
brackets till 69 years), education (4 classes), employment status (5 classes), 
geographical area of residence (5 classes) and size of the municipality of residence 
(5 classes). The selection of individuals had to produce a minimum number of cases 
for each category to be included on the panel (even if not in a representative way). 
As a result the sample includes in a known way the characteristics above, so to make 
possible to estimate a weight for each member of the panel and thus to calculate 
statistical measures that are expected to represent the Italian population in respect of 
age, gender, education, employment status, geographical area and municipality size 
of respondent’ residence.
This is by no means a random sample of the Italian population because the basic 
rule of random sampling that each member of the population should have the same 
(greater than 0) probability of being selected is clearly violated (Singleton and Straits, 
1999). The sample was made of individuals who could get access to the URL where 
the survey was posted. There is no doubt that the use of personal computer, even if 
facilitated by another member of the family, may be not independent from the attitude 
towards IVF. However, the sampling procedure guarantees that i) an adequate 
number of respondents are included in each category, ii) the availability of 
information for the calculation of a weighting system to correct collected data. 
Overall, this sample can be considered fairly representative of the Italian adult 
population.
In addition, it is worth mentioning that the Italian ACNielsen/ISPO electronic panel is 
overseen by a prestigious research centre (ISPO) and it is regularly used by the most 
popular Italian newspaper (Corriere della Sera). Obviously, these facts do not prove 
that the sampling method is valid and appropriate for generalization; they only allow 
to state that the surveys obtained from this panel are deemed credible.
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The choice of using a novel model of administration for the CV survey has various 
advantages as illustrated above. The main one is that we could reach a sample of 
the Italian population with a very limited budget. However, the use of a novel model 
of administration and the lack of literature and direct experience with internet surveys 
created a few constraints. The most relevant ones were due to the limited flexibility 
concerning the structure of the survey. We had limitations in terms of the number of 
questions and, more importantly, we had a very limited scope to work on sub­
samples. Had we had more room for action we would have designed sub-samples to 
test various methodological issues. Instead, we could only design four variants to the 
survey and we used this opportunity to implement a TIOLI design.
Given that we also used a modified payment card approach to elicit WTP (see 
below), we could provide the original methodological contributions on the relations 
between the two elicitation methods, on starting bias and on assumptions about the 
probability distributions of WTP. Despite the impediments that we faced, our survey 
also tested relevant methodological issues on the use of CV surveys and provide 
evidence from a large sample of the general population. Our survey is one of the few 
attempts we are aware of that tests a healthcare CV survey on a rather 
representative sample of a national population. Most of the restrictions we faced 
should be seen in this context and may considered the price we had to pay to have a 
sample of the general population at affordable costs.
The survey includes three sets of WTP questions: two Modified Payment Card (MPC) 
questions, one for using IVF in case of infertility and the other for a publicly funded 
programme, and one TIOLI question. For each set we expected a large number o 
non-protest zero, which is a large number of respondents who have no WTP for the 
good under investigation. For the personal use of IVF this is because some people 
clearly think that they would not use IVF even if they would desire a baby. Especially 
in Italy, where the dominant Catholic Church is very influential and openly against 
IVF, people may see it as immoral, would not be in the market as a-priori decision 
and would not accept the good even at zero price. For a publicly funded programme 
the situation is more articulated. Two types of non-positive WTP are present. There 
are people who attribute a positive value to IVF but think that it should not be funded 
with public money. For example, they may argue that IVF satisfies a personal desire 
rather than a medical need (see for example the Dunning (1992) report in this
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respect). Other people could not derive any utility from IVF and would have negative 
WTP, in the sense of attributing a negative value to the fact that others use the good. 
They would suffer a loss in utility because of the use of a private good by other 
individuals. This is a special issue, rather unexplored in contingent valuation studies 
because, so far, negative WTP has been mainly investigated for public goods (Clinch 
and Murphy, 2001) and IVF is a private good and its externalities derive from a moral 
concern rather than from a direct loss of consumption opportunities.
The issue of zero WTP has not been widely discussed in the health economics 
literature, mainly because health services are often private goods and most studies 
have investigated the value perceived by the service user. The issue has been 
investigated in the environmental fields as many interventions (protecting a wild area 
or reducing pollution) have winners and losers, in the sense that interventions or 
goods, in addition to benefit some users and non-users, affect also people who 
directly suffer from the intervention (for example because they face limited 
opportunities to fish or hunt) (Clinch and Murphy, 2001; Bohara et al; 2001). This is 
not generally the case in health care. However, in environmental studies, it is the 
presence of negative effects of the public good to cause utility losses. For example, 
fishermen miss the pleasure of using a lake where fishing is banned and commuters 
suffer from longer journeys because of road-traffic constraints. Typically, in both 
cases some people have negative WTP because they directly suffer from the 
intervention. In our IVF case there is a similar situation in that there are people who 
suffer from the intervention in the sense that they suffer a utility loss if (other) people 
use IVF. To a certain extent this is a case of negative caring externality. In practice, it 
is important to distinguish these individuals from those who have no positive WTP but 
have nothing against IVF per se. We may argue that these people have 0 WTP but 
should not have a negative WTP for IVF because they do not suffer a utility loss from 
others’ use of this technology.
Summing up, the case of IVF presents some peculiarities when measuring the WTP 
of a community. For the personal use of IVF there are people who would be in the 
market and other who would not be in the market even at zero price. For the publicly 
funded IVF programme we can reasonably assume that there are four possible 
categories of respondents: a) those who have zero WTP for the programme (for 
direct interest and for altruistic reasons); b) those who have 0 WTP for personal use,
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in the sense they would never use IVF in case of infertility, but have positive IVF for a 
public programme; these people present a special case of altruism attitude that we 
label here pure altruism as they are willing to pay for a service that they would not 
use even in case of need; c) those who do not have moral arguments about IVF but 
think that it should not be publicly funded (these people should have zero WTP for 
the public programme), d) those who are “morally” against IVF and have negative 
WTP in the sense that they suffer from the fact that other members of the community 
uses it (they procreate new members of the community using this technique); these 
people have negative WTP as they would like to pay not to have an IVF publicly 
funded programme.
In the design of the questionnaire we did not introduce the possibility that 
respondents have negative WTP for a public programme providing IVF to infertile 
couples. This would have required a completely different questionnaire design and 
would have greatly complicated our electronic survey. Nevertheless, we can make 
various assumptions about the error distribution and censoring so to allow that 
patients may have had a negative WTP for the programme even if we did not openly 
design this possibility (Hanemann and Kristrom, 1995; Kristrom, 1997; Seng-Hoon 
and Seng-Jun, 2002). In addition we can detect respondents who have pure altruism 
as we have WTP data about both personal use of IVF and funding a public 
programme.
5.3. Socio-economic questions
The following individual demographic, social and economic information was collected 
in the survey:
• age
• gender
• education (4 classes: less than 8 years of education, between 8 and 13 
years, high school diploma and university degree)
• employment status (7 classes)
• municipality of residence
• marital status
• number of children
• Self-reported socio-economic status (5 classes: low, low-middle, middle, 
middle-upper, upper)
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• Monthly family income after taxes (13 classes from less than approximately 
400 Euros per month to more than approximately 4,000 Euros per month).8
The questionnaire included two specific questions on the economic condition of 
respondents: self-reported socio-economic status and self-reported household 
income. In the first question individuals were asked to attribute their families to five 
social groups (from lower to upper ranks). In the second question, individuals were 
asked to reveal their family monthly income after taxes choosing between 13 
brackets. The question explicitly included a “no answer” option.
5.4. Respondents' knowledge of infertility and Assisted Reproductive 
Techniques (ARTs)
Four questions were designed to collect information on respondents' knowledge 
about infertility and Assisted Reproductive Techniques (ARTs). The first question 
was about respondents’ acquaintance with couples who desire to have babies and 
are unable to do so naturally (table 5.1). The second question investigated whether 
respondents knew IVF and from what sources they had obtained information 
pertaining to it. Then, respondents were asked to rate their knowledge about IVF on 
a five-level scale. Finally, respondents were asked if they had met someone who 
used IVF or other ARTs.
Table 5.1. Questions about respondents’ knowledge about infertility and Assisted Reproductive
Techniques_______________________________________________________________________________
Are you acquainted with any couples who desire to have babies and cannot have them?
Yes
No____________________________________________________________________________________
Did you know about In-Vitro-Fertilisation before?
No, It is the first time I heard of it
Yes, I have heard of it from the TV and/or newspapers
Yes, I have heard of it from relatives/friends
Yes, I have got informed through specialised readings
Yes, I have got informed from the doctor____________________________________________________
How would you rate your knowledge on In-Vitro-Fertilisation?
Very limited 
Relatively limited 
Sufficient 
Relatively wide 
Very wide
Have you ever met someone who used IVF or other ARTs? 
Yes 
No
8 Appendix A reports the questionnaire and the English traslation
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We ran regression analyses to identify the independent variables that explain the 
variability in the answers to the four questions presented above. The statistical 
models included as potential explanatory variables the following characteristics of the 
respondent:
• age (discrete variable ranging from 18 to 69, the age limits of the study);
• fertility age (yes (1) for individual between 18 and 45, no (0) otherwise);
• gender (female = 1, male = 0);
• education (4 classes: less than 8 years of education (1), between 8 and 13 
years (2), high school diploma (3) and university degree (4));
• employed (yes=1, no=0; retired people, students and housewives/husbands 
included in the non employed group)9;
• geographical area of residence (3 groups: northern, central and southern - 
including isles- regions modelled as two dummy variables);
• residence in a city which is ‘‘province capital” (county town)10 (yes=1, no=0);
• marital status (1 if married of living with a partner and 0 otherwise);
• Number of children (discrete variable);
• Socio-economic status (5 classes ordered from 1 to 5 with 5 as the highest 
social economic status);
• Monthly family income after taxes (13 values derived by the classes 
presented in the questionnaire)11.
Three assumptions were made to generate income values from the 13 income 
classes presented in the survey. First, responses indicating classes with defined 
lower and upper limits (e.g. between It Liras 800,000 [€ 413] and It Liras 1,000,000 
[€516]) were set at the mid value of the range (in this case It Liras 900,000 [€465]). 
Second, for the lowest income class (less than It Liras 800.000 [€ 413]) it was 
assumed a value of It Liras 400,000 [€ 207] (half the value of the upper limit). Third, 
for the highest income class (more than It Liras 8 Million [€ 4,132]) the value was set
9 In the empirical study one male respondent stated that he was a “casalinga” which is the 
Italian expression to indicate a person who is fully dedicated to managing the house.
10 Italy has four political tiers directly elected: the State, 20 Regions, 103 provinces and about 
8,000 municipalities. All major Italian cities are province capitals and the smallest ones have 
about 20,000/30,000 inhabitants.
11 See Appendix A for the exact wording of the question on family income.
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at It Liras 16 Million [€ 8,263] (twice the value of the lower limit). These assumptions 
made it possible to use cardinal values in several statistical models presented in the 
thesis.
Most of the independent variables are dichotomous or categorical (without any logical 
order) and were thus transformed into dummy variables. For age, income and 
number of children, that are discrete cardinal variables, we checked normality and 
assessed possible transformations that can improve goodness of fit (R2, Likelihood 
Ratio and prediction value). We also visually checked normality of socio-economic 
status and level of education that present ordered values.
For each dependent variable three dataset were used: i) the “full dataset” including 
all possible independent variables presented above (dataset a), ii) the “full dataset” 
including the variables selected by a backward stepwise regression (dataset a1), iii) a 
model based on the “income dataset” including the variables selected by a backward 
stepwise regression (dataset b). In the “full dataset” all the 5,739 observations 
registered in the empirical study were included, while in the “income dataset” the 933 
respondents who preferred not to state their income were recorded as missing values 
thus resulting in 4,806 useful observations. In regressions a1 and b the stepwise 
procedure starts from the model with all the independent variables and then, step-by- 
step, it removes the independent variables having the least absolute partial 
correlation with the dependent variable, controlling for the other independent 
variables (Agresti and Finlay, 1984). The process continues until each remaining 
independent variable makes a significant partial contribution to explaining the 
variability in the dependent variable. In all the stepwise models a 5% significance 
level for removal of the variables was used.
For the subset of respondents who stated that they had some knowledge of IVF a 
multiple regression model was used to study the effects of demographic, social and 
economic variables on the level of knowledge of IVF, measured according to a 5 
level scale. As ordinary least squares (OLS) estimates of coefficients were not 
efficient in the case of binary variables, a logistic model is used (Maddala, 1983). In 
such a model, generally called logit, it is assumed that errors follow a logistic 
cumulative distribution. For this model, goodness of fit is given by a measure called 
pseudo R2 which is similar to the coefficient of multiple determinations (R2) used in
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multiple regressions. As for R2, pseudo R2 ranges from 0 to 1 with higher values 
reflecting the better overall goodness of fit. The overall significance of the model is 
measured by the likelihood-ratio statistic which follows a x2 distribution. In addition, 
for all logit models we compared observed and predicted values and we calculated 
the Count R2 that is the proportion of correct guesses predicted by the estimated 
model (Long, 1997).
In the logit models, coefficients are expressed as odds ratios, which are ratios 
between the odds of the two groups which characterize the sample (e.g. males and 
females). Odds are derived by probabilities; they are the ratio between the probability 
of the event and its complement to one. If the probability of an event is 0.8, its odds is 
4 (0.8/0.2 = 4). Let’s imagine that the probability of an event varies between males 
and females; it is 0.8 for females and 0.66 for males; thus the odds for females is 4 
(0.8/0.2=4) and for males is 2 (0.66/0.33= 2). As the odds ratio it is simply the ratio of 
the two odds, in this case it would be 2 (4/2). Results of the logistic regressions are 
reported as odds ratios (rather than as coefficient of linear models) as they can be 
easily derived by the likelihood function. For all dependent variables included in the 
model z-scores and their p-values are reported.
5.5. Hypothetical personal use of IVF
Before asking about the WTP for using IVF we asked survey participants if they 
would have personally tried IVF in a hypothetical situation of infertility. More 
specifically, we presented the following question:
“Imagine that you have been married for a few years and you have been 
unsuccessfully trying to have a baby. Imagine you are told to use IVF and that it has 
a 30% chance to be successful. Would you personally try IVF?”
We gave respondents 5 options to this question: “do not know”, “yes, definitely yes”, 
“yes, probably”, “no, probably”, “no, definitely not”. Similarly to the questions on 
attitude towards IVF, we used regression analysis to explain the variability in the 
willingness to try IVF in case of infertility. As the questions were framed with five 
possible answers (“do not know”; “yes, definitely”; “yes, probably”, “no, probably” and 
“no, definitely”) two main measurement strategies could be followed. In the first
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model we computed “do not know” as missing value and we dichotomised the 
remaining 4 answers (yes versus no). In such a model, in addition to treat the 
undecided as missing values, the information on difference between who is probably 
and who is definitely for the two options is lost. The second model tries to exploit the 
full information content of the 5 possible answers. Accordingly, answers are assumed 
to be ordered on a scale from 1 to 5 with “do not know” as the intermediate value (3) 
between “probably not” (2) and “probably yes” (4).
As the dependent variable in the first model is dichotomous we used a logistic 
regression. For the model with 5 ordered levels, measuring the intensity of the 
willingness to try IVF, we ran a multiple regression analysis (i.e. OLS). Similarly to 
the analysis reported in the previous section, for both the models we report results of 
three analyses: i) the “full dataset” including all possible independent variables 
presented above (dataset a), ii) the “full dataset” including the variables selected by a 
backward stepwise regression (dataset a1), iii) a model based on the “income 
dataset” including the variables selected by a backward stepwise regression (dataset 
b).
In addition to demographic (age, fertility age, gender, number of children, marital 
status), geographic (macro area, county town), social (education and employment) 
and economic variables we included the answers to the questions on knowledge 
about infertility and ARTs and on acquaintance with someone who had used IVF.
Coefficients estimated in the regression models can be used to predict the 
dependent variable (willingness to try IVF) for specific values of the dependent 
variables (e.g. income, education, age, etc.). Because in logistic regression the 
dependent variable has binary values (0 and 1), predictions are expressed as 
probabilities of a positive outcome (that is probabilities of willing to try IVF in case of 
infertility). Predictions are generated by the “income dataset” (dataset b) and the 
logistic regression model specified by the backward stepwise procedure.
163
5.6. Willingness to pay for using IVF
A specific question was framed to elicit how much respondents were willing to pay in 
the case they wanted to use IVF. The question was presented on computer screen to 
the survey panel as it approximately appears in table 5.2 (translated into English).
Table 5.2. On screen presentation of the question on willingness-to-pay for IVF
“And, would you try IVF if ........Please, for each alternative indicate yes or not”
I f  it were free □ Yes, I would try IVF
□ No, I would not try IVF
If  it cost £ 1 million (€516) □ Yes, I would try IVF
□ No, I would not try IVF
If  it cost £ 5 million (€ 2,582) □ Yes, I would try IVF
□ No, I would not try IVF
If  it cost £ 10 million (€ 5,165) □ Yes, I would try IVF
□ No, I would not try IVF
If  it cost £ 20 million (€ 10,329) □ Yes, I would try IVF
□ No, I would not try IVF
If  it cost £ 50 million (€ 25,823) □ Yes, I would try IVF
□ No, I would not try IVF
Respondents were presented with 6 values (presented in Italian Lira in the 
questionnaire and shown here also in Euro at the official parity of 1,936.27 It. Liras 
for one Euro).
Two main assumptions can be made about the rationality of respondents (potential 
users of IVF). The first assumption, which reflects standard economic theory, is that 
respondents are not expected to answer “Yes” at any given amount, if for lower 
amounts they have answered “No”. Indeed, it looks irrational to pay a higher price for 
a good for which a lower price is rejected. If we make this rational assumption we can 
also make a consistency check to identify all the answers that violate this 
assumption. However, it is also plausible to assume that for some respondents 
higher prices may reflect higher quality. Given the peculiarity of the good (medical 
interventions aimed at generating babies) some respondents may distrust low prices, 
especially in the case they new market prices, and may be attracted by higher prices 
because they may signal quality. Nevertheless, even if this second assumption of 
rationality is accepted a consistency check can be performed. It would be 
inconsistent to violate twice the rationality rule described above. For example, it 
would be not rational for respondents to state they would not try IVF if it were free, 
then that they would pay It. Liras 1 million, then that they would not pay It. Liras 5 
million and then, finally, that they would pay a higher amount.
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To check whether the “normality” rule was violated twice we designed an algorithm 
that listed all records meeting the criteria shown in table 5.3. The algorithm was then 
translated into instructions to the STATA program to identify records that matched 
the criteria.
Table 5.3. Algorithm used to check the violation of rationality of answers to the questions about WTP 
for personal use___________________________________________________________________________
The question posed 6 bids (£0, 1, 5, 10, 20 and 50 million It Liras). I f  x (normal character) denotes a 
“yes” answer to the bid and x (bold character) a “no” answer, the following pattern of responses were 
identified as a violation of rationality according to the second assumption (see text).
0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50
0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50
0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50 0 1 5 10 20 50
0 1 5 10 20 50
Although the formulation of the WTP questions may appear similar to a payment 
card, it is important to appreciate that respondents provided 6 different answers 
rather than an answer on a single value or a range of values. We have labelled this 
method as “Modified Payment Card” to highlight the fact that it is not a payment card, 
even if the data were analysed according to a method that is similar to that used for 
payment cards. In effect we assigned, each respondent to one value only and this 
value was calculated as the mean between the value for which she stated to be 
willing to pay and the value for which she stated not to be willing to pay.
From the answers to the WTP questions for the use of IVF it is possible to derive a 
demand schedule for IVF. It is worth noting that the demand curve represents the 
relationship between price and "number of consumers". The quantity axis is not the 
number of IVF used by each consumer, but rather the number of consumers using an 
IVF programme. Really, data collected do not define a curve but just 6 points. In 
order to derive a demand curve two assumptions have to be formulated. The first 
concerns the lines between the points. We assumed that demand is linear between 
each consecutive pairs of points. The second assumption, more critical, concerns the 
right tail of the WTP distribution (respondents with the highest WTP values). Five 
hundred individuals answered “yes” to the It Liras 50 million bid (€ 25,823). While 
there is no direct evidence that the respondents would be willing to pay even higher
165
amounts it is very likely that some of them would. To capture this possibility we 
created two different scenarios. In the first one we assumed that It. Lira 50 million is 
the maximum amount that respondents are willing to pay; in the second scenario we 
assumed that the number of respondents willing to pay linearly declines at a constant 
rate. We also assumed that this rate is the same as the one calculated for the decline 
of the positive respondents between the It. Liras 20 million (€ 10,329) and It. Liras 50 
million (€ 25,823). Aggregate measures of WTP can be derived from the demand 
schedule as total WTP is the area beneath the curve and can be calculated 
numerically.
The sample was built to include a minimum number of people in respect of age, 
gender, education, employment status, geographical area and municipality size of 
respondent’ residence. For each stratum the number of people expected to be 
included in a representative sample of the Italian population was used as a basis to 
weight each member of the panel. Simply stated, the members of the panel who 
were part of underrepresented strata (e.g. elderly) were given a high weight while 
those over-represented were given a low weight (low education level). These weights 
were used to calculate mean WTP for personal use of IVF and for a national 
programme providing IVF with public funds.
5.7. Willingness to pay for a publicly funded programme providing IVF to 
infertile couples
WTP for a public programme providing IVF to infertile couples was elicited using two 
approaches: take-it-or-leave-it (TIOLI) and modified payment card (MPC).12 
According to the TIOLI approach, individuals are asked whether they would pay a 
specified amount for a given commodity/programme (Bishop & Heberlein, 1979; 
Ryan, 2004). The specified amount is varied across individuals so that for each 
respondent it is only known whether her/his WTP is above or below the bid offered. 
The PC approach, which was developed by Mitchel and Carson (1981, 1989), is 
based on the presentation of a range of bids; for each bid each respondent is asked 
to state if she/he would be willing to pay that amount for the commodity/programme.
12 In effect the present study adopts a spurious version of dichotomous choice questions as 
respondents could graduate their answers by choosing between “probably" and “definitely” for 
each alternative (“yes” or “no”) and by answering “do not know”. Dichotomous choice 
questions have also been referred to in the literature as take-it-or-leave-it, closed-ended or 
referendum (Ryan et al., 2004). See chapter 2 for a comprehensive discussion of elicitation 
methods.
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This method is more efficient than the DC approach as it collects more precise 
information about each respondent’s WTP.
When we designed the survey CV research was still strongly influenced by the NOAA 
report which clearly stated that OE questions were to be avoided and that the TIOLI 
(Take-lt-Or-Leave-lt) format had to be preferred (Arrow et al., 1993; Smith 2006). 
Given that our survey had several innovative elements we decided to adhere to these 
recommendations and thus we opted for TIOLI without follow-up as our principle 
elicitation format. However, we had to limit the values used in this part of the survey 
to four. We were fully aware that using such a limited number of values is a major 
limitation and produces imprecise estimates, in the sense that the uncertainty around 
the estimates is very large. Nevertheless, we were forced to limit the number of bids 
for two main reasons. The first was mainly technical. The split of the electronic panel 
required the modification of software routines and this would have been too 
expensive for more then four bids. In addition, and more importantly, with only four 
sub-samples it was possible to maintain certain characteristics of each sub-sample 
and thus assure that we could have WTP estimates representative of the adult Italian 
population.
Our main objective was to estimate WTP of the Italian population so to have a 
welfare measure really usable to offer guidance to policy-making. Furthermore, we 
wanted to provide empirical evidence on methodological issues. As far as the 
elicitation methods are concerned, we wanted to use a second elicitation method and 
compare it to TIOLI. We looked at the Payment Card (PC) format, mainly because it 
allowed us to increase the number of values to which the sample could answer. Still 
now PC is a method that attracts a lot of attention, despite serious problems created 
by range biases and prominent numbers (Whynes et al., 2004; Whynes et al., 2005). 
We decided to frame our PC table as a list of values including those used for the 
TIOLI part and thus we added two higher and two lower values.
One special option that electronic surveys makes available is to block respondents if 
they do not answer to questions. Basically, the respondent to the survey can be 
prevented to pass to the successive questions if the answer box is not filled-in. 
Clearly, this is an important feature because it reduces item non-response rate and 
thus reduces the risk of having a biased sample of respondents. On the contrary,
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however, forcing answers may increase the number of protesters thus introducing 
more uncertainty in the estimates and, possibly, other biases. Given the objective of 
the thesis, that was to provide the best possible welfare estimate of a national 
programme publicly funding IVF, we opted for forcing respondents to answer to all 
questions and then checked for protest answers.
The internet-based method provided us with an additional feature that is rather 
unexplored: to randomly generate the sequence of the eight values. In other words, 
the software managing the delivery of the questionnaire could generate, for each 
respondent, a particular order of the values presented. This randomization allowed 
us to limit range bias because respondents do not see the minimum value at first and 
they may not be aware that they had selected the maximum value when checking it. 
In addition, randomization should eliminate the risk that the sequence of questions 
may have any effect on answers.
As a consequence of this feature we also opted for an additional change of the 
standard way in which payment card questions are generally formulated. Instead of 
presenting a list of ranges we opted for asking yes/not questions for specified values. 
Once the respondents are provided a casual order of questions on specific values we 
thought to be more appropriate to use yes/not questions to specific values rather 
than selecting a specific range of values. Our solution is simpler and less cognitively 
demanding. Since this method is different from the standard PC method, we called it 
the modified payment card (MPC).
From the point of the analysis of data, the choice of asking several yes/not questions 
has important implications and casts doubts about the type of elicitation format we 
used. First of all we have 8 observations for each respondents and not only one has 
it is in the standard PC format. This allows us to use the data at least in two ways. 
With the first method we can calculate the number of “yes” respondents for each 
value and estimate a survival function to which derive, parametrically or non 
parametrically, median and mean WTP. The second approach is to derive from each 
respondent the highest WTP and use these values to parametrically or non 
parametrically estimate mean and median WTP. Provided that we use the same 
assumptions about the underlying distribution of data and the algorithms used, we
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expect to obtain similar estimates and to attribute difference to errors and protest 
answers.
Individuals were first presented the TIOLI question. After the question on WTP for 
using IVF it was given a short illustration of a hypothetical referendum on this issue. 
The referendum was illustrated in the following way:
“Imagine that there is a referendum in order to decide whether to fund 
IVF with public money. Each year public funding would be available to 
about 30,000 couples who are advised to use IVF. Out of these couples 
about 10,000 would have a baby. Without public funding, couples 
requiring IVF should spend between It. Liras 5 and It. Liras 15 million for 
the procedure”13.
Then, individuals were asked to state their vote. The total sample was randomly split 
in four sub-samples and for each of them a different annual payment (termed “tax”) 
was proposed. The question was framed as follows:
“Would you vote in favour of funding IVF with public money if you were 
asked an annual payment, that is a tax, of Italian Liras X?””
The following four values were proposed: Italian Liras 5,000 (€ 2.6), It. Liras 10,000 
(€ 5.2), It. Liras 20,000 (€ 10.3) and It. Liras 50,000 (€ 25.8). Respondents could 
choose between five options: yes, definitely; yes, probably; do not know; no, probably 
not; and no, definitively not.
The MPC questions were the same for all respondents and were presented after the 
TIOLI question. Respondents were given 8 values from It. Liras 2,000 (€ 1) to It. Liras
200,000 (€103.3) (table 5.4).
13 Italian Liras 5 and 15 million correspond to € 2,582 and € 7,745, respectively.
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Table 5.4. Modified payment card willingness-to-pay questions.
“How much would you be willing to pay annually? For each alternative, please indicate would you try 
IVF if ........Please, for each alternative indicate yes or no.”
It. Liras 2,000 (€ 1.0) □ Yes, I would pay
□ No, I would not pay
It. Liras 5,000 (€ 2.6) □ Yes, I would pay
□ No, I would not pay
It. Liras 10,000 (€ 2.6) □ Yes, I would pay
□ No, I would not pay
It. Liras 20,000 (€ 10.3) □ Yes, I would pay
□ No, I would not pay
It. Liras 50,000 (€25.8) □ Yes, I would pay
□ No, I would not pay
It. Liras 80,000 (€41.3) □ Yes, I would pay
□ No, I would not pay
It. Liras 100,000 (€ 51.6) □ Yes, I would pay
□ No, I would not pay
It. Liras 200,000 (€ 103.3) □ Yes, I would pay
□ No, I would not pay
Values were presented randomly to each respondent. The values were purposely 
chosen to include the same amounts offered in the TIOLI questions and to cover a 
larger range. For each value respondents were required to choose between yes and 
no, without the “do not knoW' option and the possibility to graduate the answers by 
the use of probably and definitely.
5.8. Demographic and socio-economic determinants of WTP for a 
publicly funded programme providing IVF to infertile couples
We used various regression models to identify significant predictors of WTP for the 
publicly funded programme providing IVF to infertile couples. For the TIOLI format we 
used two types of models. In the first type we computed “do not knoW' as missing 
values and dichotomised the remaining 4 answers (yes versus no). In such a model, 
in addition to treating the undecided as missing values, the information on the 
difference between who is “probably” and who is “definitely” willing to pay the 
proposed amount is lost. This coding strategy allowed us to analyse the data by 
logistic regression (Long, 1997). The second model tried to exploit the full information 
content of the 5 possible answers. Accordingly, answers are assumed to be ordered 
on a scale from 1 to 5 with “do not know” as the intermediate value (3) between 
“probably not' (2), “probably yes" (4) and the two definite answers as extremes (1 
and 5). To analyse this data we used ordered logit models (Long, 1997). In addition 
to demographic and socio-economic variables in these models the value of bids is 
added as one the independent variables.
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Similarly to the regressions presented previously, three specifications are presented:
i) based on the “full dataset” (dataset a) including all possible demographic and 
socio-economic variables, ii) based on the same dataset where variables are 
selected by a backward stepwise procedure (dataset a1), iii) and based on the 
“income dataset” where variables are selected by a backward stepwise procedure 
(dataset b).
We also ran regression analyses for the data collected through the MPC questions. 
Each respondent had to circle whether he/she was or was not willing to pay 8 
different amounts. Answers to these questions were coded as maximum WTP: for 
each respondent it was coded the highest amount for which he/she was providing a 
“yes” answer.
In the presence of censoring OLS estimates are inconsistent (Maddala, 1983). The 
appropriate approach in such circumstances may to estimate a tobit model, 
something referred to as the censored regression model. The tobit model uses all the 
information, including information about the censoring, and provides consistent 
estimates of the parameters through a maximum likelihood (ML) procedure (Long, 
1997). ML estimation for the two-limit tobit model involves dividing the observations 
into three sets. The first set contains uncensored observations, which ML treats in 
the same was as the Linear Regression Model. The other two sets contain censored 
observations. For these observations, we do not know the specific value of the 
dependent variable because of censoring, but can proceed by computing the 
probability of being censored and using this quantity in the likelihood equation.
As for the data generated by the TIOLI question we ran one regression with the 
entire dataset including all the possible demographic and socio-economic variables 
and two backward stepwise regression models, one using the entire dataset and the 
other using the sub dataset containing valid observations of the self reported monthly 
family income after taxes.
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5.9. WTP estimates: the referendum format
As in the tradional referendum (TIOLI) question respondents could graduate their 
answers choosing between definitely and surely and could answer do not know, 
various approaches can be followed to transform data in a binary format and to 
estimate mean and median WTP. Here we present four possible approaches: i) to 
combine definitely and probably answers and treat “do not know” as missing values;
ii) to combine definitely and probably answers and treat “do not know” as negative 
answers; iii) to consider only “yes, definitely” as “yes”, both definitely and probably 
negative answers as “no” and “yes, probably” and “do not know” as missing value; iv) 
to consider only “yes, definitely” as “yes” and all the other answers, including “do not 
know”, as negative answers. Approach i) is the most favourable to the programme; it 
is expected to generate the highest estimates of WTP. On the contrary, approach iv) 
is the most conservative as it assumes that all answers but “yes, definitely” reveal 
negative WTP for the IVF programme. Approaches ii) and iii) are expected to 
produce less extreme estimates. Table 5.5 summarises the assumptions of the four 
scenarios.
Table 5.5. Approaches to estimate willingness to pay for the IVF programme elicited through the 
take-it-or-leave-it format
Assumptions Original answers stated by respondents Formulas to 
calculate WTP
Yes,
definitely
(a)
Yes,
probably
(b)
No,
definitely
(c)
No,
probably
(d)
Do not 
know
(e)
1) Least 
conservative
Yes Yes No No Missing (a+b)/(c+d)
2) intermediate Yes Yes No No No (a+b)/(c+d+e)
3) intermediate Yes Missing No No Missing (a)/(c+d)
4) Most 
conservative
Yes No No No No (a)/(b+c+d+e)
We assumed that the probability that an individual will say “yes” to the WTP question 
follows a logistic distribution (Ryan, 1998 and 2004):
P(yes) = (1 + e -a+b-bid)-1
where a and b are the coefficients of the estimated regression logit equation when 
only the bid amount (bid) is included and P(yes) is the probability of accepting the 
bid. Following Hanemman (1984) and Ryan (1998 and 2004) mean WTP can be
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estimated as the area under this probability function. This area shows the fraction of 
the sample who would consume the good at each price (bid) level. Therefore mean 
WTP can be estimated by integrating the probability function.
u o
E(WTP) = I (1 + e -a+b-bid)-1db - J 1 -  (1 + e -a+b‘bid)-1db
Where U is the upper limit of the integration and L is the lower limit of the integration.
Mean WTP is thus critically dependent on making assumptions about the upper and 
the lower limits of the integral. Assuming that WTP is monotonic these limits should 
correspond to the values for which probability of “yes” is zero (the lower limit) and 
probability of yes is one (the upper limit). Both of them are not observed in the 
present study. As far as the lower limit is concerned, 31.5% of the total sample was 
not willing to pay Italian Liras 5,000 (€ 2.60), the lowest bid offered (see next 
chapter). A lower limit has thus to be assumed. About 41% of respondents were 
definitely willing to pay Italian Liras 50,000 (€ 25.80), the highest bid offered. 
Consequently, imposing this value as the upper limit is conservative and assuming 
higher values may be appropriate.
We made two different assumptions about the upper limit: Italian £ 50,000 (€ 25.80), 
that is the highest value for which some “yes” answers are observed and Italian Liras
200,000 (€ 103.30) that is the highest value offered in the MPC question.14 For 
contingent valuation studies in the healthcare sector zero is generally used as the 
lower limit because it can be assumed that individuals will not use the healthcare 
intervention if they receive disutility from it. This assumption is plausible when 
individual’s utility does not include caring externalities, that is the utility of one person 
is not affected by the consumption of other persons. If the utility of an individual is 
affected by others’ consumption of the good the sign of the contribution cannot be 
assumed a priori. This is because the person whose utility is affected by others’ 
consumption of the good does not control whether the good is used or not (as it is the 
case if he/she is the user of the good). While this argument is often not relevant in
14 It should be noted that the modified payment card questions were presented immediately 
after the TIOLI one that generated the data analysed in this section.
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health care as individuals are not expected to get disutility by the use of health 
services by others, it may be relevant in the case of Assisted Reproductive 
Technologies. Since these technologies manipulate embryos and interfere with 
natural reproduction some people are ethically against them and may suffer utility 
losses from the use of these technologies by other members of the community. 
Following this argument we decided not to completely rule out the possibility of a 
negative lower limit of the integration. We performed the computation of mean WTP 
for IVF according to two lower limit assumptions: 0, the standard assumption in the 
health economics literature and a negative value of It. Liras 50,000 (€ 25.8).
Environmental economics literature suggests that there may be individuals that have 
zero WTP for a public good as they derive no value from consumption of the good. 
Indeed, some individuals may suffer from the provision of specific public goods. We 
designed the survey in such a way that respondents could clearly state that they 
were not in favour of any public funding of IVF. Basically, they could attribute no 
value to a public programme providing IVF and thus it can be assumed that they 
exactly have zero WTP. The presence of these individuals makes critical the use of a 
logistic function to describe respondents’ WTP because, by definition a logistic 
function rules out a nonzero probability of zero WTP (Kristrom, 1997). The function 
assumes that all respondents are in-the-market for a public programme providing 
IVF, but this is not true according to our data and intuition.
To take into account zero WTP we used a basic spike model suggested by Kristrom 
(1997) and also used by Yoo and Kwak (2002).
We assumed that the distribution function of WTP is given by:
Fwtp(A) = 0 if A<0
= p if A=0
= Gwtp(A) if A >0
Where Gwtp(A) is a function such as that Gwtp(0) = p and lim —►00 GwtP(A) = 1.
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Intuitively, WTP has zero probability for negative values, probability p for WTP = 0 
and probability described by Gwtp(A) if WTP is positive.
This model can be estimated through parametrically and non-parametrically 
methods. A non-parametric model was used following the formula suggested by 
Kristrom (1997). In addition we estimated a parametric model under the assumption 
that Gwtp(A) follows a logistic probability distribution. These spike models were 
compared to “traditional” models to check the relevance of different assumptions 
concerning the truncation of the distribution at zero. In the parametric case, under the 
assumption of a logistic distribution, the spike of the distribution can be found at 
1/(1+exp(a), where a is the constant estimated by the maximization of the logit 
function and the mean is log((1+exp(a))/p, where p is the coefficient of the bid term.
5.10. WTP estimates: the modified payment card format
After the referendum question, respondents were asked to state if they were willing to 
pay for the IVF programme 8 different amounts. For each amount, presented in 
random order, respondents were requested to sign “yes” or “no”. To calculate mean 
WTP from these data we adopted a standard procedure which assumes true WTP as 
the mid-point between the amount at which the respondent said “yes” and the 
amount at which he/she said “no” (Cameron, 1987; Ryan, 2004). This approach 
allows WTP to be estimated without regression techniques. Therefore, it does not 
require any hypothesis about the distribution of the underlying probability function. 
However, it requires making assumptions about minimum and maximum WTP. 
Minimum WTP is assumed to be 0; therefore respondents who were not willing to 
pay It. Liras 2,000, the minimum vale offered, were attributed 0 WTP. For the people 
willing to pay It. Liras 200,000 (€ 103.3) it was assumed that this was their maximum 
WTP. Both these assumptions are conservative, as they underestimate true WTP. 
However, 0 minimum WTP rules out the possibility of negative WTP.
The method to calculate mean WTP can be also illustrated graphically and it is 
substantially identical to that used for estimating mean WTP for personal use of IVF. 
Data can be used to present a pseudo-demand schedule for the programme. 
Amounts offered to respondents are presented in the horizontal axis and the number 
of respondents willing to pay those amounts are presented in the vertical axis. For 
the two extreme values it was assumed that minimum and maximum WTP was 0 and
175
It. Liras 200,000, respectively. It was also assumed that demand was linear between 
each consecutive pairs of points. The area below the curve represents the total WTP 
of the entire sample and can be calculated numerically.
5.11. Validity analysis and comparison of the two elicitation methods.
The referendum question was posed before the MPC questions. It is thus possible to 
check whether the answer to the first question had any impact on the answers which 
followed. Since the four groups are not significantly different in their demographic and 
socio-economic characteristics, any difference in mean WTP or other estimates 
derived from results of the MPC should be attributed to the answer to the TIOLI 
question. We compared mean WTP elicited from the four groups. We made two 
comparisons: with all data included to calculate mean WTP and excluding “do not 
know” answers. The two comparisons reflect two different sources of bias. In the 
former comparison, the source would be the value offered; respondents are 
anchored to the value offered in the TIOLI question. In the latter comparison, the 
source of bias would be the decision concerning accepting or rejecting the value 
offered. In this validation check, “do not know” answers would not be a source of bias 
and thus should be excluded by the analysis.
We first compared mean WTP across the two elicitation methods. Then, we 
transformed TIOLI data in MPC data and compared them to the original MPC data. 
As mean WTP generated from TIOLI data requires various assumptions about 
integration limits and the density function of the probability distribution, differences of 
estimates between the two datasets may derive from these assumptions. To 
neutralise the implications of these assumptions, we generated virtual TIOLI data 
from the data collected through the MPC and, in order to calculate mean WTP, we 
made the same assumptions used for the original TIOLI data. In order to do this we 
created a new binary variable (yes and no). For each respondent it was first detected 
to which of the four groups used for the TIOLI question he/she was attributed. Then, 
it was compared the maximum WTP value elicited from MPC data with the bid 
attributed to that group. If the former was equal or larger than the latter the 
respondent was attributed “yes”, otherwise it was attributed “no". For example, if the 
respondent was in the It. Liras “20,000” group he/she was coded as “yes” if in the 
MPC question he/she reported to be willing to pay It. Liras 20,000 or above and 
he/she coded as “no” if his/her stated WTP in the TIOLI was lower than this amount.
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5.12. Methods used to estimate costs of production and cost- 
effectiveness of In-Vitro-Fertilization
Cost data were mainly derived from management accounting documents and were 
complemented by interviews with clinicians and administrative staff employed by two 
Assisted Reproduction (AR) centres based in two major hospitals, one private and 
one run by the Italian NHS. Both of them are located in Lombardy, the largest and 
most populated region in Italy. Data was collected in 1999 and refer to cost and 
activity data in fiscal year 1998. In that year the private and the NHS run centres 
performed 2,257 and 1,116 IVF cycles, respectively.
On the basis of arguments presented in the previous section, we used a full cost 
accounting methodology (Horgren et al., 1996). First, with the help of the 
administrative offices we estimated total annual costs of the organisational units 
managing the assisted reporduction (AR) centres (figure 5.1). Then, we estimated 
the part of these costs that are absorbed to provide IVF cycles as the AR centres 
produce a variety of services in addition to IVF. Finally, we divided the annual costs 
of providing IVF services by the number of cycles delivered.
Figure 5.1. Representation of the methodology used to estimate the average full cost of providing an 
IVF cycles_______________________________________________________________________________
Hospital
costs
Assisted 
Reproduction 
Centre costs
Annual costs 
of providing 
IVF cycles
- Unit 1
- Unit 2
- Unit 3
- IVF cvdes
- semen inseminations
- ICSI services
- infertility counselling - other activities
- Assisted reproduction centre
- Adminstrative departments
- Capital costs
Estimation of costs of the Assisted 
Reproduction Centre
Estimation of costs of the production of IVF Average cost of an IVF cycle 
cycles
Some costs directly attributable (e.g. personnel), Some costs directly attributable to IVF cycles
others (e.g. costs of general hospital management) (e.g. Drugs), others (e.g. the cost of the building of the
need to be allocated on the basis of fair criteria AR centre) need to be apportioned to the various
The average cost of an IVF cycle is 
given by the total annual costs of 
providing IVF cycles divided by the 
number of cycles produced in the yearactivities performed by the AR centre so to estimate 
a share of them to be allocated to IVF cycles
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In both organisations management accounting data attributed only direct costs to the 
AR centres. Indirect costs remain unallocated by the management accounting 
systems in the sense that the organizations do not calculate any apportioning of 
overheads to organizational units. Direct costs consider the personnel working for the 
unit, drugs, medical devices, diagnostic services provided by other departments, use 
of the operating room, ward care (day hospital) and utilities (table 5.6).
Table 5.6. Cost categories and method of estimation
Cost categories Methods of analysis
Personnel Direct estimate based on administrative data (cost of 
labour) and allocation of professional time to the IVF centre
Drugs Direct allocation based on administrative data
Disposables and other material Direct allocation based on administrative data
Equipments (amortization) Direct allocation based on administrative data (private 
centre); estimation based on costs of acquisition and 
straight depreciation (public centre);
Diagnostic services Direct allocation based on administrative data (transfer 
prices)
Operating room Direct allocation based on a hourly cost and the total 
amount of time of operating theatres used by the IVF
Hospital care Direct allocation based on administrative data (average cost 
of day hospital care net of operating theatre, diagnostic and 
drug costs)
Utilities Percentage of total hospital costs
Other Percentage of total hospital costs
Overheads Percentage of total hospital costs
Building (amortization) Direct allocation based on administrative data (private 
centre); estimated on the basis of market rents
For the private infertility centres accounting data also reported the amortization value 
of health technologies used by the AR centre and of the building where the centre is 
located. For the public centre the data was not available and were estimated upon 
qualitative and quantitative information collected during the interviews. The annual 
cost of the building used by the centre was estimated on the basis of market rents of 
buildings for commercial use. The value of health technologies available at the AR 
centre was calculated through a straight depreciation procedure of the acquisition 
costs assuming an average useful life of the technology of 5 years. For both centres 
a fair share of general costs to be attributed to the AR centre was calculated on the 
basis of the ratio between the labour costs of the AR centre and the total labour costs 
of the hospital.
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This is a rather crude method to allocate general overheads but is commonly used in 
many organizations. This method implicitly assumes that the ratio between total 
direct and indirect costs of the AR centre can be approximated by the ratio between 
the value of the labour directly attributable to the AR centre and the total value of the 
labour costs of the hospital. More formally, let CL and 1C the costs of labour and 
indirect costs (the total amount of overheads), respectively. If the AR suffix refers to 
the Assisted Reproduction centre and HOS identifies the entire hospital:
0 = CLar/  C L hos
where 0 is known because both costs are given by the hospitals. The assumption is 
that 0 is also the share of the total general costs that has to be attributed to the AR 
centre. Since 0 and the amount of total hospital costs are known, the amount of 
indirect costs to be attributed to the AR centre is:
IC ar = IC jot * 0
The second step of the procedure is to estimate the part of resources attributed by 
the AR centre that are used to provide IVF service. This is necessary because AR 
centre produces a variety of services in addition of IVF cycles.
In both centres the costs of diagnostic services, drugs, the use of the operating 
theatre and of ward care (the cost of the day hospital for the intervention) could be 
directly attributed to IVF cycles. For these items was thus possible to directly 
calculate the total amount of costs attributable to IVF cycles. For the other cost 
components it was not possible to make a direct allocation. For each category of 
these costs, the percentage of the total consumption of resources that could be 
attributed to IVF cycles was asked to our informants. Basically, for each category of 
costs we estimated the part of them attributable to the production of IVF services. As 
for overheads, capital costs and utilities informants could not provide any reasonable 
answer, we apportioned these costs to IVF on the basis of the average percentage 
estimated for the other categories of indirect costs. For each of the two centres, all 
direct and indirect costs of providing IVF services were added. Then the cost per IVF 
cycle was calculated by dividing this total by the number of cycles provided
These cost estimates do not include the costs of treatment with gonadotrophin- 
releasing hormone (GnRH) and with Follicle-stimulating hormone (FSH). The costs of
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these treatments for each IVF cycle were estimated on the basis of the protocols 
used by the two AR centres.
These calculations were used to estimate the average cost per IVF cycle. However, 
complications associated with the procedure may be a cause of additional costs. 
Infertility treatments may cause severe ovarian hyperstimulation, other major side 
effects (Neumann, et al., 1994) and multiple births (Schenker, 1994; Human 
Fertilisation and Embriology Authority, 2002). Neumann et al. (1994) estimated that 
the additional cost of complications (side effects of treatment, higher rates of difficult 
pregnancies, complications attributable to multiple births) is US $ 1,717 per IVF 
cycle. This value is approximately 20% of the cost of one cycle of IVF (US $ 8,000) 
as estimated by the same authors. This percentage was applied to the cost per IVF 
cycle estimated in our study in order to get an estimate of the expected costs of 
complications for each cycle of treatment.
Given the relevant uncertainty surrounding the data, we performed a sensitivity 
analysis of cost data by using wide range of costs per IVF taken from an Italian study 
that provided estimates for each of the major Italian regions. The minimum and 
maximum regional value of cost per IVF cycle was used to perform a sensitivity 
analysis of the incremental cost-effectiveness ratio (Mantovani et al., 1999).
The attribution of costs of complications to each cycle of treatment, as well as the 
presentation of basic information to the respondents of the IVF survey, require 
estimates of the success rate of IVF. These estimates can be referred to clinical 
pregnancy rates or live birth rates. The cost-benefit analysis presented in this study 
focuses on clinical outcomes and is based on a contingent valuation survey of the 
WTP for procreating babies through IVF. Therefore the relevant measure of success 
is live birth. As Italian data on IVF cycles and outcome was not available at the time 
of the analysis, effectiveness of IVF was derived by the World Register for year 1993 
(De Mouzon and Lancaster, 1995). The register reports the pregnancy rate and the 
delivery rate per egg retrieval. As only a fraction of initiated IVF cycles results on 
successful egg retrieval (Newman et al, 1994), delivery rates reported in the World 
Register were adjusted in order to obtain the probability of live birth per initiated IVF 
cycle.
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Cost and effectiveness data was used to formulate the scenario for the contingent 
evaluation survey and to calculate cost per live birth. Following Neumann et al. 
(1994), it was assumed that the probability of delivery declines one percentage point 
per cycle. This is because the women with the higher potential for fertility are more 
likely to become pregnant early; consequently those women who keep trying IVF 
have a lower probability of becoming pregnant. Consistently with the Italian 
legislation about fertility treatments, a maximum of three IVF cycles were taken into 
consideration and the possibility of freezing eggs was excluded.
The pregnancy rate and delivery rate varies across clients of Assisted Reproduction 
centres. It is thus important to go beyond the analysis to the “average” patient and to 
estimate cost per delivery according to different scenarios. US 1993 data on 31,418 
cycles of IVF were used to estimate delivery rates for four categories of patients: i) 
under 40 with male infertility factor, ii) under 40 without male infertility factor, iii) over 
40 with male infertility factor, iv) over 40 without male infertility factor. Although 
indications of IVF are not analysed in the cost-benefit analysis is worth remembering 
that the rate of success and thus the economic value of the intervention greatly vary 
according to patients’ age and the diagnosis of infertility.
5.13. Cost-benefit analysis
On the basis of estimated costs and benefits we suggest a few analyses that can 
offer guidance to policy making. First, we simply subtract mean WTP for personal 
use of IVF to mean cost, to obtain the net benefits of personal use of IVF. We 
calculated mean WTP per respondent and per user. However, since IVF would 
generate costs only for those willing to use it, the correct cost-benefit analysis should 
exclude non users.
The main goal of this study is to assess the provision of IVF from a societal 
perspective. Therefore, the main cost-benefit analysis is based on the benefits 
perceived by a sample of the national population for a programme providing free 
access to IVF to infertile couples desiring to have a baby. On the basis of the 
scenario presented in the survey and the results of the CV answers, we estimated 
aggregate benefits of a national programme providing publicly funded IVF to 10,000
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infertile couples to obtain 3,000 babies. In order to obtain these estimates we 
extrapolated aggregate WTP of the sample to the entire Italian adult population. 
Then, the national aggregate WTP was compared to total costs of providing IVF to
10,000 couples.
As part of the WTP data was collected according to a referendum format, we also 
present results according to majority decision rules. Give the relevant fraction of the 
population that would never try IVF and the high WTP of a minority of populations, 
mean and media WTP may diverge considerably and an efficient use of economic 
resources may be in contrast with the will of the majority of “voters”.
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Chapter 6
Knowledge, attitude and willingness to pay for In-Vitro-Fertilisation
6.1. Introduction
This chapter analyses data on knowledge of infertility and IVF, acquaintance with 
infertile couples, attitude towards IVF and willingness to pay for the use of IVF and 
for a publicly funded national programme providing IVF. The rationale of 
methodological choices and details about data and methods are presented in the 
previous chapter. Here we report the characteristics of the sample and describe the 
results of all the main answers of the questionnaires. Some of the results of the 
regression analyses are also presented and discussed. The aim of this part of the 
theisis is to understand how respondents’ characteristics influence WTP for IVF.
6.2. Respondents’ socio-economic characteristics
The return rate of the survey was 89.1% (5,739 out of 6,435). As all respondents 
completed the questionnaire in all parts, the return rate coincides with the response 
rate. High response rates are normal in this type of surveys as panel members agree 
in advance to be regularly surveyed and to respond to each questionnaire. It can be 
assumed that most of the people who failed to respond were not in the position to do 
so when the survey was administered (e.g. because they did not have access to the 
computer during the week).
Table 6.1 presents socio-demographic characteristics of respondents broken down 
by gender. The mean age of respondents is 40.1 years; male respondents are 
significantly older than female respondents (41 years vs. 39.2; t=5.06, p- 
value<0.0001). The number of females is slightly higher than the number of men 
(51.3% vs. 48.7%). About 70% of the respondents were either married or cohabiting 
with a partner. Only 8.5% of the sample stated that they had a university degree (at
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least 4 year of university studies after high school)15 and about 10% stated having 
less than 8 years of education, the minimum number of years of schooling required 
by the Italian legislation since 1948. As expected, women were less educated than 
men; fewer women than men had completed high school (at least 13 years of 
schooling) and obtained a university degree.
Table 6.1. Socio-demographic characteristics of survey respondents (n=5,739).
Male Female Total
# % # % # %
Gender
Male
Female
2,792
2,947
48.65
51.35
Age
18-24 392 14.04 469 15.91 861 15.00
25-34 524 18.77 651 22.09 1,175 20.47
35-44 749 26.83 825 27.99 1,574 27.43
45-54 669 23.96 637 21.62 1,306 22.76
55-64 347 12.43 267 9.06 614 10.70
>64 111 3.98 98 3.33 209 3.64
Marital Status
Married (or living with the partner) 1,998 71.56 1,999 67.83 3,997 69.65
Unmarried 794 28.44 948 32.17 1,742 30.35
Education
Less than 8 years 249 8.92 360 12.22 609 10.61
Between 8 and 13 years 1,004 35.96 1,064 36.10 2,068 36.03
High School Diploma 1,289 46.17 1,288 43.71 2,577 44.90
University Degree 250 8.95 235 7.97 485 8.45
Employment
Employed 1,974 70.70 1,204 40.86 3,178 55.38
Unemployed 190 6.81 250 8.48 440 7.67
Housekeeper 1 0.04 899 30.51 900 15.68
Retired 308 11.03 182 6.18 490 8.54
Student 319 11.43 412 13.98 731 12.74
Geographical Area
North-west 677 24.25 686 23.28 1,363 23,75
North-east 384 13.75 423 14.35 807 14.06
Centre 490 17.55 538 18.26 1,028 17.91
South 838 30.01 879 29.83 1,717 29.92
Isles 403 14.43 421 14.29 824 14.36
Size of municipality of residence
< 5,000 inhabitants 403 14.43 440 14.93 843 14.69
5,001-20,000 inhabitants 720 25.79 738 25.04 1,458 25.41
20,001-50,000 inhabitants 453 16.22 484 16.42 937 16.33
50,001-100,000 inhabitants 415 14.86 426 14.46 841 14.65
> 100,000 inhabitants 801 28.69 859 29.15 1,660 28.92
15 As the survey was administered in 2000 no respondents could have got the three year 
Laurea degree introduced by the Italian legislation in accordance with the Bologna 
declaration.
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About 55% of the surveyed individuals were employed, while the retired and 
unemployed accounted for 8.5% and 7.7% of the total sample, respectively. There 
was a 30% absolute difference in the employment rate between males and females 
(70.7% vs. 40.9%). Fewer women than men reported to be retired while more men 
than women reported to be unemployed and students. Almost 29% of the sample 
lived in a municipality with more than 100,000 inhabitants, while almost half of the 
respondents were resident in small-medium size municipalities (from 5,000 to
100,000 inhabitants). There were not significant differences between males and 
females in this respect.
With regard to socio-economic status, seventy percent of respondents reported to be 
in the three central classes (low-middle, middle, middle-upper) of the five classes 
according to which respondents were asked to allocate themselves. As to the request 
to reveal their family monthly income after taxes choosing between 13 brackets, 
approximately sixteen percent of respondents stated that they preferred not to 
answer this question (an option openly given in the questionnaire). Slightly more than 
20% of the total sample responding to this question reported a monthly family income 
(after taxes) of It. Liras 2 million or less (about €1,033)16. About 8.4% of the total 
sample reported an income above It. Liras 5 million (€ 2,582). Females and males 
provided very similar answers. The two questions on the socio-economic status are 
associated (p-value < 0.0001), even if the positive association was not strong (Tau-b 
= 0.0421).
16 In 2002 Liras were converted into Euros at the exchange rate of 1936.27 Liras for one 
Euro.
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Table 6.2. Socio-economic characteristics of survey respondents (n=5,739).
Male Female Total
# % Cum % # % Cum % # % Cum %
Self-reported socio-economic status
Low 601 21.53 21.53 634 21.51 25.24 1,235 21.52 21.52
Low-middle 459 16.44 37.97 483 16.39 37.90 942 16.41 37.93
Middle 840 30.09 68.05 893 30.30 68.20 1,733 30.20 68.13
Middle-upper 682 24.43 92.48 687 23.31 91.52 1,369 23.85 91.98
Upper 210 7.52 100.00 250 8.48 100.00 460 8.02 100.00
Self-reported household monthly income 
(after taxes)
Up to It £800.000 (€413) 21 0.75 0.75 26 0.88 0.88 47 0.82 0.82
It £ 800.001-1.000.000 (€413-516) 30 1.07 1.83 34 1.15 2.04 64 1.12 1.93
It £ 1.000.001-1.500.000 (€516-775) 133 4.76 6.59 139 4.72 6.75 272 4.74 6.67
It £ 1.500.001-2.000.000 (€  775-1.033) 385 13.79 20.38 418 14.18 20.94 803 13.99 20.67
It £ 2.000.001-2.500.000 (€ 1.033-1.291) 436 15.62 36.00 468 15.88 36.82 904 15.75 36.42
It £ 2.500.001-3.000.000 (€ 1.291-1.549) 316 11.32 47.31 336 11.40 48.22 652 11.36 47.78
It £ 3.000.001-3.500.000 (€ 1.549-1.808) 261 9.35 56.66 275 9.33 57.55 536 9.34 57.12
It £ 3.500.001-4.000.000 (€ 1.808-2.066) 274 9.81 66.48 271 9.20 66.75 545 9.50 66.61
It £ 4.000.001-5.000.000 (€ 2.066-2.582) 246 8.81 75.29 256 8.69 75.43 502 8.75 75.36
It £ 5.000.001-6.000.000 (€ 2.582-3.099) 121 4.33 79.62 128 4.34 79.78 249 4.34 79.70
It £ 6.000.001-7.000.000 (€ 3.099-3.615) 41 1.47 81.09 45 1.53 81.30 86 1.50 81.20
It £ 7.000.001-8.000.000 (€ 3.615-4.132) 27 0.97 82.06 21 0.71 82.02 48 0.84 82.04
More than It £ 8.000.000 (€ 4.132) 41 1.47 83.52 57 1.93 83.95 98 1.71 83.74
“ I prefer not to answer” 460 16.48 100.00 473 16.05 100.00 933 16.26 100.00
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6.3. Respondents' knowledge of infertility and Assisted Reproductive 
Techniques (ARTs)
Almost 43% of respondents stated that they knew of couples who have infertility 
problems (table 6.3). Female respondents were more likely to know such couples 
than male respondents (44.7% versus 40.4%, x2 = 10.6, p-value= 0.001).
Only 779 respondents (13.6%) reported that they had never heard of In Vitro 
Fertilisation before. TV programmes and newspapers were the main source of 
information for the vast majority of the sample (72.6%). Only 82 respondents (1.4%) 
stated that they had been informed by doctors; these individuals were likely to have a 
direct personal interest in ARTs. Of the 4,960 respondents who stated having 
previous knowledge of IVF, about 55% reported having limited knowledge. The 
questionnaire did not include a specific question on personal use of IVF or other 
ARTs. However, it asked whether the respondent personally met someone who used 
them. Fifteen percent of the sample provided an affirmative answer to this question. 
For all questions there are significant differences between males and females as the 
latter were more likely to know infertile couples, to know about IVF and to have met 
someone who used IVF or other ARTs. Overall women looked closer than men at the 
issues discussed in this study.
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Table 6.3. Respondents’ knowledge about infertility and Assisted Reproductive Techniques
Males Female X2(p-value) Total
Are you acquainted with any couples who desire to have babies and cannot 
have them?
Yes
No
1,129 (40.44%) 
1,663 (59.56%)
1,317(44.69%)
1,630(55.31%)
10.6019 (p=0.01) 2,446 (42.62%) 
3,293 (57,38%)
Did you know In-Vitro-Fertilisation before?
No, It is the first time I hear of it
Yes, I have heard of it from the Tv and/or newspapers
Yes, I have heard of it from relatives/friends
Yes, I have got informed through specialised readings
Yes, I have got informed from the doctor
406 (14.54%) 
2,058 (73.71%) 
182 (6.52%) 
109 (3.90%)
37 (1.33%)
373 (12.66%) 
2,110(71.60%) 
289 (9.81%) 
130 (4.41%)
45 (1.53%)
24.8121 (p<0.001) 779(13.57%) 
4,168 (72.63%) 
471 (8.21%) 
239(4.16%)
82 (1.43%)
How would you rate your knowledge about In-Vitro-Fertilisation? 
Very limited 
Relatively limited 
Sufficient 
Relatively wide 
Very wide
464 (19.45%) 
947 (39.69%) 
821 (34.41%) 
121 (5.07%) 
33 (1.38%)
408(15.85%) 
916 (35.59%) 
1,064 (41.34%) 
152 (5..91%)
34 (1.32%)
31.8930 (p<0.001) 872 (17.58%) 
1,863 (37.56%) 
1,885 (38.00%) 
273 (5.50%). 
67 (1.35%)
Have you ever met someone who used IVF or other ARTs? 
Yes 
No
354 (12.68%) 
2,438 (87.32%)
537 (18.22%) 
2,410(81.78%)
33.5858 (p<0.001) 891 (15.5%) 
4,848 (84.5%)
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Socio-economic characteristics are expected to explain respondents' knowledge of 
infertility and ARTs. Tables 6.4-6.7 present the results of a few statistical models 
aimed at identifying the impact of demographic, social and economic characteristics 
of respondents on their acquaintance with infertility couples (table 6.4), knowledge of 
IVF (table 6.5 and table 6.6) and acquaintance with someone who used IVF (table 
6.7).
For all cardinal and ordinal variables we visually tested normality and we checked 
transformations. Income, socioeconomic status and years of education have such 
shapes that assuming a Normal distribution appears plausible. Also, when we tested 
non linear forms for these independent variables we have never improved the 
goodness of fit of the model (R2 and likelihood ratios). Consequently, we keep these 
variable untrasformed in all models. Instead, for age of the respondent we 
consistently get better performance with a quadratic transformation, that mean that 
young respondents and old respondents tended to have similar knowledge and 
attitude, significantly different from those of the central cohorts. Consequently, in all 
models we used the following form for the age variable: (B^age) + (322(age)-
Several variables are associated with respondents’ acquaintance with couples with 
infertility problems (table 6.4). The most significant variable is marital status: 
respondents who were married (or live with a partner) have better chances of 
acquainting a couple with infertility problems, which is almost three times more than 
those who were unmarried. Similarly, the odds ratio for respondents being of fertility 
age (18-45) is 1.5. Females, employed and individuals residing outside county 
capitals were more likely to be acquainted with infertile couples. In this respect there 
is also a south-north gradient as southern respondents were more likely than central 
region respondents, who in turn were more likely than northern respondents, to be 
acquainted with infertile couples. None of the tested models show that income or the 
self-reported socio-economic condition had a significant impact on the dependent 
variable. Overall, about 5% of the variability in the dependent variables is explained 
by the explanatory variables. However, the hypothesis that none of the variables has 
an impact on respondents’ acquaintance with couples with infertility problems is 
strongly rejected (p-value of less than 0.0001).
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Table 6.5 presents the logistic regression models used to understand the main 
factors explaining respondents’ knowledge of IVF. The binary variable (yes/no) is the 
answer to the question “Did you know about IVF before (this survey)”? Here the 
overall variability explained by the models is higher (about 7%) although fewer 
variables are statistically significant. In all three models, the level of education is 
highly significant (the higher the level of education, the higher the chance that the 
respondent knows of IVF). Gender and being married are also associated with the 
knowledge of IVF as females and married individuals were more likely to know about 
it. In contrast with the previous set of models (focused on acquaintance with infertile 
couples), age (in a quadratic definition) rather than fertility age (binary variable for 
individuals in their fertility age) is positively associated with the knowledge of IVF.
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Table 6.4. Logistic regression: Acquaintance with infertile couples and socio-economic characteristics (dependent variable: Are you acquainted w ith couples who desire to 
have babies and cannot have them? Yes (1) and No (0)).____________________________________________________________________________________________________
Full dataset:
All dependent variables included
Full dataset:
Stepwise regression model (5% significance level)
Number of observations 5,739 5,739
Likelihood Ratio %2 (p-value) 420.56 (<0.0001) 391.78 (<0.0001)
Pseudo R2 0.0537 0.0500
Count R2 0.629 0.629
Odds Ratio Z (p-value) Odds Ratio Z (p-value)
Age
Bi(age)
B2(age2)
1.089
0.999
4.79 (<0.001) 
-4.59(<0.001)
1.087
0.999
4.72
-4.50
Fertility age* 1.6635 4.87 (0 .0 0 1 ) 1.647 4.96 (<0.001)
Gender 1.310 4.51 (<0.001) 1.128 4.55 (<0.001)
Education** 1.174 4.20 (<0.001) 1.176 4.26 (<0.001)
Employed (yes=l, no=0) 1.239 3.08 (0.002) 1.245 3.17 <0.002)
North (yes=l, no=0) 0.855 -1.95 (0.052)
South (yes=l, no=0) 1.281 3.12(0.002) 1.402 5.93 (<0.001)
County town (yes=l, no=0) 0.795 -3.99 (<0.001) 0.805 -3.77 (<0.001)
Married*** (yes=l, no=0) 1.862 6.73 (<0.001) 2.4688 6.86 (<0.001)
Number of children 0.957 -1.50 (0.134)
Self-reported socio-economic status or monthly net 
income
0.985 -0.67 (0.500)
* from age 18 to age 44
**  Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
* * *  Married include individuals who live with their partners
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Table 6.5. Logistic regression: Knowledge of In-Vitro-Fertilisation and socio-economic characteristics (dependent variable: D id  you know In -V itro -F e rtilisa tion  before? Yes 
(1), No (0))_________________________________________________________________________________
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model 
(5% significance level)
Income dataset: 
stepwise regression model 
(5% significance level)
Number of observations 5,739 5,739 4,806
Likelihood Ratio %2 (p-value) 365.89 (p<0.0001) 362.94 (pO.OOOl) 257.35
Pseudo R2 0.0803 0.0796 0.0719
Count R2 0.865 0.865 0.8774
Odds Ratio Z (p-value) Odds Ratio Z (p-value) Odds Ratio Z(p-value)
Age
Bi(age)
B2(age2)
1.102
0.999
4.29 (<0.001) 
-3.70(<0.001)
1.106
0.999
4.93 (<0.001) 
-4.34(<0.001)
1.159
0.998
9.07 (0 .0 0 1 )  
-7.97(0.001)
Fertility age* 1.120 0.73 (0.532)
Gender 1.342 3.43 (0.001) 1.309 3.36(<0.001) 1.336 3.18(0.001)
Education** 2.330 13.67 (<0.001) 2.369 14.17(0.001) 1.943 9.75 (0 .0 0 1 )
Employed (yes=l, no=0) 1.095 0.91 (0.362)
North (yes=l, no=0) 1.080 0.66 (0.509)
South (yes=l, no=0) 0.840 -1.53 (0.125) 0.776 -3.15 (0.002)
County town (yes=l, no=0) 1.001 0.01 (0.990)
Married*** (yes=l, no=0) 1.265 1.80 (<0.073) 1.6861 2.05(0.041)
Number of children 0.966 -0.81 (0.418)
Self-reported socio-economic status or monthly net 
income ( * * * * )
1.129 3.80 (<0.001) 1.1229 3.71 (0 .0 0 1 ) 1.168 4 .50 (0 .0 01 )
* from age 18 to age 44
**  Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
* * *  Married include individuals who live with their partner 
* * * *  Net income in Million Italian Liras (1€ = 1936.27 Liras)
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About 86% of the sample answered “yes” to the "Did you know about IVF before?” 
question. For these respondents a multiple regression model is used to identify those 
variables which have an effect on the self-reported level of knowledge of IVF (table
6.6). Models based on log and exponential transformations of the dependent variable 
were tested. The models without any transofrmation consistently outperformed the 
others. However, our final the models explain only 4/5% of total variability. Again, 
education gender and marital status are the most significant variables. Males, less 
educated and unmarried individuals tend to have a more limited knowledge about 
IVF.
The last set of models investigates the answer to the question "’’Are you acquainted 
with someone who used In-Vitro-Fertilisation?” (table 6.7). Logistic regression is used 
here to explain the impact of socio-economic characteristics of respondents on the 
variability of the yes/no answer to this question. The three logistic regressions 
present low explanatory power (about 4%). In both the models that resulted from the 
backward stepwise selection being of fertility age, being female, having a higher 
educational level, being married, being employed and living in the central and 
southern part of the country are positively associated with the probability of 
respondent’s acquaintance with someone who used IVF. Neither socio-economic 
status nor income has any significant effect on the dependent variable.
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Table 6.6. Multiple regression: self reported level of Knowledge of In-Vitro-Fertilisation and socio-economic characteristics (dependent variable: You w ou ld  state that your 
level o f  knowledge o f  In -V itro -Fertilisa tion  is: very limited (1), limited (2), intermediate (3), deep (4), very deep (5))_________________________________________________
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model 5% significance level))
Number of observations 4,960 4,960
Fisher test (12,4,947) 19.65 (6, 4,953) 38.55
P-value (p> F) <0.0001 <0.0001
R2 0.0455 0.0446
Coefficient t-student Coefficient t-student
(p-value) (p-value)
Age
Bi(age) 0.01695 2.20 (<0.028) 0.01644 2.17(0.030)
B2(age2) 0.00022 -2.60 (0.009) 0.00023 -2.75 (<0.006)
Fertility age* 0.0435 0.97 (0.332)
Gender 0.1137 4.35 (<0.001) 0.1126 4.32(<0.001)
Education** 0.1943 11.45<0.001) 0.1972 11.79 (0 .0 0 1 )
Employed (yes=l, no=0) -0.0569 -1.86 (0.062) -0.0628- 2.10(0.036)
North (yes= 1, no=0) -0.0166 -0.47 (0.637)
South (yes=l, no=0) -0.0011 -0.03 (0.996)
County town (yes=l, no=0) 0.0250 0.99 (0.324)
Married*** (yes=T, no=0) 0.1168 2.91 (<0.004) 0.1169 2.97 (0.003)
Number of children 0.0191 1.48 (0.139)
Self-reported socio-economic status 0.0043 0.44 (0.663)
Constant 1.3830 8.18(<0.001) 1.4948 26.33 (0 .0 0 1 )
* from age 18 to age 44
**  Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
* * *  Married include individuals who live with their partner
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Table 6.7. Logistic regression: Acquaintance with someone who used In-Vitro-Fertilisation and socio-economic characteristics (dependent variable: Are you acquaint with
someone who used In-Vitro-Fertilisation? Yes (1), No ( 0 ) ) ____________________________________________________________________________ _____
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model (5% significance level)
Number of observations 5,739 5,739
Likelihood Ratio %2 (p-value) 211.19 203.25
Pseudo R2 0.0405 0.0394
Count R2 0.847 0.847
Odds Ratio Z (p-value) Odds Ratio Z (p-value)
Age
Bi(age)
B2(age2)
1.0800
0.99901
2.91 (0.004) 
-3.18(0.001)
1.07591
0.9989
2.72 (0.007) 
-3.37(0.001)
Fertility age* 1.2524 1.63 (0.104)
Gender 1.6592 6.25 (<0.001) 1.7831 6.24 (<0.001)
Education** 1.3080 5.16(<0.001) 1.6576 5.31 (<0.001)
Employed (yes=l, no=0) 0.2112 2.05 (<0.040) 1.2180 2.14 (<0.033)
North (yes=l, no=0) 0.8437 -1.54 (0.123) 0.7880 -3.00 (0.003)
South (yes=l, no=0) 1.1274 1.13 (0.260)
County town (yes=l, no=0) 0.9071 -1.25 (0.210)
Married*** (yes=l, no=0) 1.6634 3.96 (<0.001) 1.7880 4.51 (<0.001)
Number of children 0.9450 -1.43 (0.154)
Self-reported socio-economic status or monthly net 
income
1.0041 0.13 (0.893)
* from age 18 to age 44
**  Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
* * *  Married include individuals who live with their partner
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Results from these regression analyses provide evidence in favour of the validity of 
the survey and are fairly consistent with expectations. Females are closer to the 
issues of infertility and ARTs than men. This is probably due to the fact that women, 
in addition to the issues related to parenthood, feel that they have a more important 
role in procreation. Two sets of regressions refer to acquaintance of the respondents 
with someone affected by infertility and/or who used IVF. For these questions 
respondents are expected to report something stemming from their social life (being 
in touch with other people, being reported such facts by others, being in social 
environments where infertility and the use of IVF are discussed). In the other two sets 
of regressions, instead, the focus is on respondents “knowledge” of IVF that is the 
knowledge that respondents have of a new technology raising difficult scientific and 
ethical issues. In this case it may be expected that both cultural and social factors 
direct affect respondents’ knowledge. Therefore it can be also expected that, 
compared to the former, the latter models (those focused on “knowledge”): i) present 
more overall explanatory power; and ii) have education playing a more significant 
role. Data support both these claims. The pseudo R2 for the models on knowledge of 
IVF (about 0.07) is higher than those for acquaintance with infertility couples (0.05) or 
acquaintance with someone who used IVF (0.04).
Education is a highly significant explanatory variable in all models. However, the 
magnitude of the odd ratios varies significantly across the models (table 6.4, 6.5 and 
6.7). Table 6.8 present a direct comparison of the effects of education on the 
dependent variables investigated in the 3 logistic regressions. For each model the 
fitted values of the regression models are calculated on the basis of the estimated 
coefficients. The table reports means and standard deviations of the probabilities for 
each of the education groups. In the model where the dependent variable is the 
respondent’s acquaintance with infertile couples, the least educated people had a 
probability of 0.34 of having acquaintance with an infertile couple compared to a 
probability of 0.52 of the most educated people. Similarly, acquaintance with 
someone who used IVF is less likely in the least educated respondents (0.09) than in 
the most educated ones (0.23). The magnitude of these differences (0.18 and 0.14, 
respectively) is relevant but smaller than the difference between the two education 
groups with respect to knowledge of IVF (0.73 and 0.97 for a difference of 0.24). 
Indeed, the odds ratio for the education variable in the logistic regression for 
knowledge of IVF is 2.12.
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Table 6.8. Comparison between the coefficients (13) for education on three logistic regression models 
on the knowledge of infertility and IVF (backward stepwise logistic regression on the full dataset of 
5,739 respondents). _____________ _______________________________________________________
Number of 
respondents
Mean probability (standard deviation) fitted by the stepwise 
regression model
Acquaintance with 
infertile couples
Acquaintance with 
someone who used 
IVF
Knowledge of 
IVF
Less than 8 year of 
school
609 0.335 (0.093) 0.090 (0.030) 0.730 (0.059)
Between 8 and 13 
years of school
2068 0.406 (0.115) 0.134 (0.049) 0.824 (0.072)
High school 
diploma
2577 0.446 (0.130 0.173 (0.065) 0.908 (0.043)
University degree 485 0.520 (0.114) 0.232 (0.074) 0.970 (0.014)
Age was expected to be associated with the answers to all these questions. We used 
the age of the respondents in two ways. The first was to use a quadratic expression 
of age as a regressor. Both the coefficients (of the linear and of the quadratic term) 
are significant in all models. Basically, young and old persons are less 
knowledgeable of (and close to) IVF issues than peple in the central part of their life. ; 
The second way to use age as independent variable was to introduce a dummy 
variable to identify individuals presumed to be of “fertility age” (from 18 to 45). This 
dummy is significant in two models. Respondents of fertility age are more likely to be 
acquainted with infertile couples and with people who used IVF. This is probably the 
effect of friendship; people tend to have stronger friendship relationships with people 
of similar age and thus it is more likely that respondents in the age of fertility know 
infertile couples and/or people who used IVF.
For all the questions of this part of the survey it can be observed a curvilinear relation 
with age (figure 6.1). The youngest respondents are acquainted with few people with 
infertility problems and who used IVF; also, they are not very knowledgeable about 
IVF. The peak is in the 35-39 age bracket; then older patients tend to be less 
acquainted with infertile couples and with individuals who used IVF; furthermore, 
people in this age bracket also appear to know less about IVF. These relationships 
make sense as it is reasonable to assume that these are issues for which people in 
their late 30s are the most sensitive. Women, and to a lesser extent men, between 
35 and 45 are the main users of IVF and thus are more likely to be informed about its 
use and about other several related issues.
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Figure 6.1 The curvilinear relation between age and knowledge of infertility and IVF
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6.4. H ypothetica l personal use o f IVF
A specific question asked respondents if they would have personally tried IVF in a 
hypothetical situation of infertility. Almost 20% of the sample (1,119 respondents) 
answered "do not know" (table 6.9). About 34% answered that they would have not 
tried IVF, while 47% answered that they would have tried. Among "yes" answers the 
percentage of "probably" (39.1%) is much higher than that of "definitely" (14.6%), 
while in the “no” answers the two percentages are very similar (17.4% “definitely not” 
and 17.1% “probably not”). If the “do not know” answers are excluded from the 
analysis, individuals willing to try IVF are the majority of the sample (57.2%). Very 
minimal differences between males and females appear in the answers to this 
question.
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Table 6.9. Respondents’ attitude towards IV F  in a hypothetical condition o f infertility. Answers to the question: "Imagine that you have been married for a few years and you
have been unsuccessfully trying to have a baby. Imagine you are told to use IV F  and that it has a 30% chance to be successful. Would you personally try IVF?"_____________
Including "do not know" Excluding "do not know"
# % # %
All Females Males All Males All All Females Males All Males All
Do not know 1,119 537 582 19.5 18.2 20.9
No, definitely not 998 539 459 17.4 18.3 16.4 998 539 459 21.6 22.4 20.8
No, probably not 980 487 493 17.1 16.6 17.7 980 487 493 21.2 20.2 22.3
Yes, probably 1,805 924 881 31.4 31.4 31.6 1,805 924 881 39.1 38.3 39.9
Yes, definitely 837 460 377 14.6 15.6 13.5 837 460 377 18.1 19.1 17.1
Total 5,739 2,947 2,792 100.0 4,620 2,410 2,210 100.0 100.0 100.0
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In the logistic regression models approximately 5% of variability is explained by the 
dependent variables (table 6.10). In the full data set being younger, being employed, 
being married, having less children, being more educated and living in northern 
regions and in county towns are positively associated with the willingness to try IVF. 
However, none of these variables show odds ratios of relevant magnitude (they 
range from 0.9 to 1.3). The only relevant exception is education because the 
coefficient is 1.17 for each of the four levels of education and the p-value of the 
coefficient is less than 0.001. Nevertheless, the most relevant regressors (highest 
odds ratios and Z values) are the answers to the questions presented in the previous 
section. Respondents who are acquainted with infertile couples (OR = 1.42), who 
knew IVF before (OR = 2.01) and who are acquainted with someone who used IVF 
(OR = 1.7) are more likely to provide a positive answer to the question “Would you 
personally try IVF?”
Results of the logistic regression on the income data set are very similar. For all but 
two independent variables coefficients are similar and statistically significant. In the 
income data set the variable “number of children”, which was negatively associated 
with the willingness to try IVF in the full data set, is excluded by the stepwise 
procedure and the variable “income” is included (odds ratio greater than 1).
The explanatory power of multiple regression models is still low (R2 = 0.07) and their 
coefficients are consistent with those obtained in the logistic analyses. In both 
dataset age (-), education (+), employment (+), living in a county town (+) and being 
married (+) are associated with the willingness to try IVF measured on a scale from 1 
to 5. As in the logistic regressions, respondents who reported to be informed about 
IVF and acquainted with people who where infertile and/or used IVF are significantly 
more likely to be in favour of using IVF in case of need. Moreover, if regressions are 
run with the income dataset income shows a positive coefficient (p-value <0.001) and 
the number of children is excluded from the model by the stepwise procedure.
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Table 6.10. Logistic regression: use o f IV F  in case of hypothetical infertility (dependent variable: "Imagine that you have been married for a few years and you have been
unsuccessfully trying to have a baby. Imagine you are told to use IV F  and that it has a 30% chance to be successful. Would you personally try IVF?" Yes (1), No (0))*_______
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model 
(5% significance level)
Income dataset: 
stepwise regression model 
(5% significance level)
Number of observations 4,620 4,620 3,885
Likelihood Ratio y2 (p-value) 328.31 (<0.0001) 323.26 (0 .0001 ) 255.11 (0 .0001 )
Pseudo R2 0.05 0.0512 0.0482
Count R2 0.623 0.622 0.626
Odds Ratio Z (p-value) Odds Ratio Z (p-value) Odds Ratio Z (p-value)
Age
Bj(age)
B2(age2)
1.0551
0.9992
2.72 (0.007) 
-3.57(<0.001)
1.0587
0.9992
4 .10 (0 .001 ) 
-5.08 (0 .0 01 )
1.0600
0.9992
3.82 (0 .0 0 1 )  
-4 .66(0.001)
Fertility age** 1.0775 0.66 (0.506)
Gender (female=l, male=0) 0.9693 -0.47 (0.640)
Education*** 1.1689 3.64 (0 .0 0 1 ) 1.1894 4 .16 (0 .0 01 ) 1.1903 3.72 (0 .0 0 1 )
Employed (yes=l, no=0) 1.0547 0.69 (0.488) 2.04 (0.041)
North (yes=l, no=0) 0.9595 -0.46 (0.643)
South (yes=l, no=0) 1.0781 0.85 (0.398)
County town (yes=l, no=0) 1.2994 4.09 (0 .0 0 1 ) 1.2918 3.99 (0 .0 0 1 ) 1.2418 3.14(0.002)
M arried**** (yes=l, no=0) 1.0108 0.10(0.917)
Number of children 0.9036 -3.05 (0.002) 0.9207 -2.94 (0.003)
Self-reported socio-economic status or monthly net 
income * * * * *
1.0251 0.98 (0.357) 1.0788 3.31 (0.001)
Acquaintance with infertile couples (yes=l, no=0) 1.4064 5.11 (0 .0 0 1 ) 1.4227 5.34 (0 .0 0 0 ) 1.4025 4.67 (0 .0 0 1 )
Knowledge of IVF (yes= 1, no=0) 1.9739 6.43 (0 .0 0 1 ) 2.0000 6.40 (0 .0 0 0 ) 1.9830 5.68 (0 .0 0 1 )
Acquaintance with someone who used IVF (yes=l, 
no=0)
1.7024 5.86 (0 .0 0 1 ) 1.7016 5.87 (0 .0 0 0 ) 1.6468 5.07 (0 .0 0 1 )
* “do not know” answers excluded from the analysis 
* *  from age 18 to age 44
* * *  Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
* * * *  Married includes individuals who live with their partner 
* * * * *  Net income in Million Italian Liras ( 1 € = 1936.27 Liras)
201
Table 6.11. Multiple regression: use o f IV F  in case o f hypothetical infertility (dependent variable: "Imagine that you have been married for a few years and you have been
unsuccessfully trying to have a baby. Imagine you are told to use IV F  and that it has a 30% chance to be successful. Would you personally try IV F?”)______________________
Full dataset:
All dependent variables 
included
Full dataset:
stepwise regression model 
(5% significance level))
Income dataset: 
stepwise regression model 
(5% significance level))
Number of observations 5,739 5,739 4,806
Fisher test (14; 5,724) (8; 5,730) (9; 4,796)
P-value (p> F) <0.0001 <0.0001 <0.0001
R2 0.0662 0.0666 0.0664
Dependent variable: yes definitely (5), yes probably (4), do not know (3), no probably (2), no definitely (1)
Coefficient t-student
(p-value)
Coefficient t-student
(p-value)
Coefficient t-student
(p-value)
Age
Bi(age)
B2(age2)
0.01962
-0.00034
2.72 (0.007) 
-3.57(0.001)
0.02762
-0.00043
3.78 (<0.001) 
-5.01 (<0.001)
0.02739
-0.00043
3.43 (<0.001) 
-4.57 (<0.001)
Fertility age* 0.0387 0.62 (0.533)
Gender -0.0184 -0.11 (0.915)
Education** 0.0784 3.57 (0.000) 0.0888 3.84 (<0.001) 0.0875 3.37(0.001)
Employed (yes=l, no=0) 0.0522 2.46 (0.014)
North (yes=l, no=0) -0.0410 -0.83 (0.937)
South (yes=l, no=0) 0.0028 4 .18 (0 .001 )
County town (yes=l, no=0) 0.1465 2.73 (0.006) 0.1436 4.13 (<0.001) 0.1037 2.73 (0.006)
Married*** (yes=l, no=0) 0.0425 0.76 (0.446) -
Number of children -0.0511 -2.83 (0.005) -0.4445 -2.52 (0.012) 0.0384 -2.01 (0.036)
Self-reported socio-economic status or monthly net 
income****
0.01683 1.22 (0.221) 0.0542 4.32 <(0.001)
Acquaintance with infertile couples (yes=l, no=0) 0.2173 5.95 (0 .0 0 1 ) 0.2243 6.06 (<0.001) 0.2154 5.31 (<0.001)
Knowledge of IVF (yes=l, no=0) 0.3236 6.30 (0 .0 0 1 ) 0.3329 6.30 (<0.001) 0.3250 5.58 (0 .0 0 1 )
Acquaintance with someone who used IVF (yes=l, 
no=0)
0.3936 7.88 (0 .0 0 1 ) 0.3947 7.93 (<0.001) 0.3653 6.74 (<0.001)
Constant 2.1929 9.66 (0 .0 0 ) 2.1207 13.52 (<0.001) 1.9736 11.44 (<0.001)
* from age 18 to age 44
**  Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
* * *  Married includes individuals who live with their partner; * * * *  Net income in Million Italian Liras (1€ = 1936.27 Liras)
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Coefficients estimated in the regression models were used to predict the probability 
that the respondent was willing to try IVF in case of infertility for specific values of the 
dependent variables (e.g. income, education, age, etc.). Predictions were generated 
by the income data set and by the logistic regression model specified by the 
backward stepwise procedure. The predicted probability that an individual of the 
sample is willing to try IVF is 0.57. Although their coefficients are statistically 
significant, some variables do not predict substantial differences (table 6.12). Marital 
status and place of residence are not relevant predictors. The role of employment 
status is more important; while unemployed respondents have a probability of 0.51 
those who are employed have a probability of 0.61. Education is the most important 
predictor. There is almost an absolute 30% difference between the most educated 
individuals, those who hold a University degree (probability = 0.67), and the least 
educated (probability = 0.39). Income is also important: for respondents in the low 
income brackets the probability of trying IVF is below 0.5, while for high-income 
respondents the probability ranges from 0.6 to 0.65. Overall, however, education is 
much more important than income in explaining the variability of the attitude towards 
the use of IVF.
The logistic regression model predicts that the highest probability of trying IVF can be 
found in the 30 year old respondents (probability = 0.62). As age increases, the 
probability of the willingness to try IVF declines this is up to the value of 0.36 for 
respondents who are over 64. However, the relationship between age and attitude 
towards IVF is not linear because respondents in their twenties show a lower 
probability than those in their thirties.
The probability of a “yes” answer to the question “Would you try IVF?’’ is higher if the 
respondents are acquainted with infertile couples (0.64), if they knew IVF before the 
survey (0.59) and if they are acquainted with someone who used IVF (0.72). 
Individuals who reported all three characteristics (i.e. being acquainted with infertile 
couples, knowing about IVF, and being acquainted with couples who tried IVF) show 
a probability of 0.74. Those who lack all the three characteristics have a probability of 
0.34. These “soft” characteristics are by far the most important predictors of the 
attitude towards the use of IVF.
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Table 6.12. Factors explaining willingness to try IVF: predictions from the logistic regression (Income dataset; dependent variable: "Imagine that you have been married fo r
a few years and you have been unsuccessfully trying to have a baby. Imagine you are told to use IV F  and that it has a 30% chance to be successful. Would you personally try
IV F ? " )_______________________________________________________________________________________________________________________________________________________
Respondents characteristics # o f
observations
Expected 
probability of 
trying IVF
Respondents’ characteristics # o f
observations
Expected 
probability of 
trying IVF
Age
18-24 714 0.56
Monthly Family Income* 
700.000 (€ 362) 47 0.47
25-29 418 0.60 900.000 (€ 465) 64 0.49
30-34 546 0.62 1.250.000 (€ 646) 272 0.48
35-39 702 0.62 1.750.000 (€904) 803 0.53
40-44 640 0.60 2.250.000 (€ 1,162) 904 0.55
45-49 582 0.57 2.275.000 (€ 1,175) 652 0.57
50-54 518 0.53 3.250.000 (€ 1,678) 536 0.57
55-59 321 0.49 3.750.000 (€ 1,937) 545 0.61
60-64 186 0.43 4.500.000 (€ 2,324) 502 0.60
>64 179 0.36 5.500.000 (€ 2,841) 249 0.61
Education 6.500.000 (€ 3,357) 86 0.65
Less than 8 years of education 482 0.39 7.500.000 (€ 3,873) 48 0.60
Between 8 and 13 years of education 1,727 0.53 8.500.000 (€ 4,390) 98 0.65
High School Diploma (at least 13 years of 
education)
University Degree
2,191
406
0.61
0.67
Employed
Yes 2,671 0.61
Acquaintance with infertile couples 
Yes 2,049 0.64
No 2,135 0.51 No 2,757 0.51
County town 
Yes 1,929 0.59
Knowledge of IVF  
Yes 4,216 0.59
No 2,877 0.55 No 590 0.36
Married Acquaintance with someone who used IVF
Yes 3,376 0.57 Yes 759 0.72
No 1,430 0.54 No 4,047 0.54
* Net of income taxes
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6.5. Variables explaining willingness to pay for personal use of IVF and 
for a publicly funded programme
Three questions were framed to elicit willingness to pay for IVF. First, a question was 
presented to elicit how much respondents were willing to pay in the case they wanted 
to use IVF. Respondents were presented 6 values and for each of them they were 
asked to choose between “yes” and “no”. Then, we administered the WTP question 
for a national programme providing public funding for IVF according to a referendum 
format. The take-it-or-leave-it question was presented with four different values by 
splitting the total sample into four sets. Each sub sample consisted of about 1,400 
individuals. Finally, all respondents were requested to answer to a series of modified 
payment card WTP questions about the national programme.
We ran a set of regressions for each of the three WTP questions as dependent 
variables, using basic socio-demographic characteristics as independent variables. 
For the WTP for personal use of IVF we censored data at both extremes values 
presented in the modified payment card. As linear regression models may not be 
appropriate we also used a doubled censored Tobit model, with censoring at the 
lower (€ 0) and upper (€ 25,823) values proposed to respondents The log 
transformation of stated WTP values presented higher pseudo R2 (about 0.03 versus 
0.01) and higher likelihood ratios than untransformed WTP values. Consequently, we 
used the log specification to report regression results (table 6.13 and 6.14).
The model based on the income data set presents the best goodness of fit values 
and the expected signs for the independent variables. Income and education are 
positively associated to the stated WTP for personal use of IVF. On the contrary, 
older and northern respondents present lower WTP. In this survey residing in a 
northern region is regularly associated with a weaker preference for IVF; likely, this is 
due to social characteristics and traditions of northern regions differentiating them 
from the central and, especially, the southern ones. Both coefficients of age are 
significant, suggesting that the relationaship between WTP and age is indeed 
quadratic, with WTP relatively low and increasing in the twenties and thirties, at its 
peak in the early fourtys and decreasing since then.
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Table 6.13. Tobit regression models o f willingness to pay for per personal use o f IV F  in case o f infertility: modified payment card data (dependent variable: 6 values ranging
from It. Liras 0 to It. Liras 50.00.000 (€ 25,823); dependent variable = log(W TP+l) and censored at 0 and log (50.000). W TP data in thousand Italian Liras._________________
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model 
(5% significance level)
Income dataset: 
stepwise regression model 
(5% significance level)
Number of observations 5,739 5,739 4,806
Likelihood Ratio %2 (p-value) 226.05 (<0.0001) 2.16.76 (0 .0001 ) 1009.56 (0 .0001 )
Pseudo R2 0.0093 0.0089 0.010
2,612 left-censored observations; 
500 right-censored observations
3,174 left-censored observations; 
500 right-censored observations
2,623 left-censored observations 
422 right-censored observations
Coefficient t-student
(p-value)
Coefficient t-student
(p-value)
Coefficient t-student
(p-value)
Age
Bi(age)
B2(age2)
0.29030
-0.00391
3.63 (0 .0 0 1 )  
-4.39(0.001)
0.3952
-0.00520
3.63 (0 .0 0 1 )  
-4.39(0.001)
0.37875
-0.000722
6.29 (0 .0 0 1 )  
-7 .18 (0 .001 )
Fertility age (1= age from 18 to 44, 0 otherwise) 0.5457 1.16(0.245)
Gender (female=l, male=0) 0.2735 1.16(0.316)
Education* 1.2775 7 .19 (0 .001 ) 1.3331 7.71 (0 .0 0 1 ) 1.0004 5.20 (0 .0 0 1 )
Employed (yes=l, no=0) 0.4203 1.32 (0.188)
North (yes=l, no=0) -0.8288 -2.24 (0 .0 2 5 ) -0.9765 -3.64 (0 .0 2 5 ) -1.3177 -4.47 (0 .0 0 1 )
South (yes=l, no=0) 0.2419 0.66 (0.508)
County town (yes=l, no=0) 0.9016 3.41 (0.001) -0.8459 3.23 (0 .0 0 1 )
Married** (yes=l, no=0) 0.6436 1.53 (0 .1 2 5 )
Number of children -0.3795 -2.77 (0.006) -0.4202 -3.11 (0.006) -0.3621 -2.50(0.012)
Self-reported socio-economic status or monthly net 
income***
0.16568 1.59 (0.111) 0.6106 6.41 (0 .0 0 1 )
Constant -6.7210 -3.90 (0 .0 0 1 ) -6.885 -5.63 (0 .0 0 1 ) -6.7455 -5 .16 (0 .001 )
Sigma 8.84 8.85 8.68
* Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
**  Married includes individuals who live with their partner
* * *  Monthly net income reported in Million Italian Liras (1 Euro -  1,937 Italian Liras)
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Table 6.14. Linear regression models o f willingness to pay for per personal use o f IV F  in case o f infertility: modified payment card data (dependent variable: 6 values
ranging from It. Liras 0 to It. Liras 50,000,000 (€ 25,823); dependent variable -  log(W TP+l) and censored at 0 and log (50.000.000). W TP data in thousand Italian Liras
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model 
(5% significance level)
Income dataset: 
stepwise regression model 
(5% significance level)
Number of observations 5,739 5,739 4,806
Likelihood Ratio (p-value) F(11, 5726)= 19.57 
(Pr>F <0.0001)
F(11,5726)= 19.57 
(Pr>F <0.0001)
F(6, 4799) = 34.47 
(Pr>F <0.0001)
R2 0.0394 0.0380 0.0413
Coefficient t-student
(p-value)
Coefficient t-student
(p-value)
Coefficient t-student
(p-value)
Age
Bj(age)
B2(age2)
0.12926
0.00166
3.60 (<0.001) 
-4.21 (<0.001)
0.18044
-0.00217
7.17(<0.001) 
-7.22 (<0.001)
0.16959
-0.00228
7 .1 7 (0 .0 01 )  
-7.22 (0 .0 0 1 )
Fertility age (1= age from 18 to 44, 0 otherwise) 0.3993 1.85 (0.065) 0.4516 2.12(<0.034)
Gender (female=l, male=0) 0.0963 0.70 (0.486)
Education* 0.4772 5.16 (<0.00 ) 0.6455 8 .10 (0 .001 ) 0.5043 5.59 (0 .0 0 1 )
Employed (yes=l, no=0) 0.2096 1.28 (0.201)
North (yes=l, no=0) -0.55106 -2.97 (<0.001) -0.4399 -3.55 (0 .0 0 1 ) -0.6087 -4.40 (0 .0 0 1 )
South (yes=l, no=0) 0.1000 0.54 (0.672)
County town (yes=l, no=0) 0.2685 2.80 (0.005) 0.3719 3.06 (0.002)
Married** (yes=l, no=0) 0.2707 1.26 (<0.207)
Number of children -0.1450 -2.10(0.036) -0.1882 -3.01 (<0.003) -0.17364 -2.56 (0 .0 1 0 )
Self-reported socio-economic status or monthly net 
income***
0.2605 1.97 (0.049) 0.27951 6.26 (0 .0 0 1 )
Constant -0.502 0.64 (0.525) -0.1169 -0 .18(0 .854 ) 0.5490 0.92 (<0.357)
* Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
**  Married includes individuals who live with their partner
* * *  Monthly net income reported in Million Italian Liras (1 Euro = 1,937.27 Italian Liras)
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Tobit and regression models present coefficients with the same sign and similar 
magnitude. However, their predictions should be taken cautiously, as the 
assumptions about the tails of the distribution significantly influences mean values. 
For example, in both models the income coefficient is significantly positive and 
suggests that about € 500 increase in income is associated to an increase by 30- 
60% of the WTP for private use of IVF. However, both sets of models greatly 
underestimate mean WTP (see later).
Table 6.15 reports the results of the three regression models using the answers to 
the TIOLI questions on WTP for a publicly funded programme (full data set with all 
possible independent variables, full data set and backward stepwise selection, and 
data set containing information about family income and backward stepwise 
selection). For all models, all but three variables are significant at the 5% level. The 
variable with the highest absolute Z score is the value of the bid (OR: 0.98; z= -8.8). 
As expected, the higher the value of the bid, the lower the probability of a “yes” 
answer. The other significant variables, retained by the stepwise procedure with both 
datasets, are age and number of children, with the negative sign, and education, 
employment status, living in a southern region, living in a county town and being 
married, with the positive sign. Although the explanatory power of the model is limited 
(R2 around 0.03), its regressors have the expected signs and are generally 
consistent with regression models tested in the previous sections.
The ordered logistic regressions are expected to capture the intensity of the 
preference of respondents (table 6.15). Virtually all the regressors identified in the 
logit binary model are also significant in the ordered logistic regressions. The only 
marginal difference concerns the two dummy variables for the three macro 
geographic areas (north, centre and south). While in the binary logit the “South” 
dummy is significant with the positive sign (people residing in the southern regions 
were more likely to be willing to pay for the IVF programme), in the ordered logit the 
dummy for the northern regions is significantly negative.
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Table 6.15. Logistic regression of the willingness to pay for a publicly funded IVF programme for infertile couples: referendum data (dependent variable: Yes definitely or 
probably (=1) and No definitely or probably (=0) to the question “ Would you vote in fa vo u r o ffund ing  IV F  w ith pub lic  money i f  you were asked an annual payment, that is a 
tax, o f  Ita lian  £ X ?  bids -  It Liras 5,000 (€ 2.6), 10,000 (€ 5.2), 20,000 (€ 10.3) and 50,000 (€ 25.8))__________________________ ________________________________
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model 
(5% significance level)
Income dataset: 
stepwise regression model 
(5% significance level)
Number of observations 4,838 4,838 4,071
Likelihood Ratio %2 (p-value) 214.01 (<0.0001) 212.31 187.41
Pseudo R2 0.0327 0.0324 0.0341
Odds Ratio Z (p-value) Odds
Ratio
Z (p-value) Odds Ratio Z(p-value)
Bid* 0.9852 -8.85 (<0.001) 0.9852 -8.85 (<0.001) 0.9840 -8.84 (0 .0 0 1 )
Age
Bi(age)
B2(age2)
1.052
0.99928
3.60 (<0.001) 
-4.21 (<0.001)
1.060
-0.00327
4.17 (<0.001) 
-4.52 (<0.001)
1.0470
-0.99931
3.22 (0.001) 
-4.03 (<0.001)
Fertility age (1= age from 18 to 44, 0 otherwise) 1.1235 1.07 (0.284)
Gender (female=l, male=0) 0.9950 -0.08 (0.936)
Education** 1.1691 3.80 (<0.001) 1.1705 3.83 (<0.001) 1.0978 2.01 (0.045)
Employed (yes=l, no=0) 1.1629 2.18(0.029) 1.1681 2.37(0.018) 1.1745 2.23 (0.026)
North (yes=l, no=0) 0.9354 -0.77 (0.441)
South (yes=l, no=0) 1.0979 1.08 (0.280) 1.1515 2.25 (0.024) 1.1813 2.34(0.019)
County town (yes=l, no=0) 1.1404 2.12(0.034) 1.1515 2.25 (0.024) 1.1952 2.65 (0.008)
Married*** (yes=l, no=0) 1.5824 5.51 (0.017) 1.1450 2.20 (0.028) 1.5069 4.56(<0.001)
Number of children 0.9150 -2.76 (0.006) 0.9134 -2.83 (0.011) 0.9008 -2.96 (0.003)
Self-reported socio-economic status or monthly net 
income****
1.0661 2.63 (0.09) 1.0657 2.62 (0.009) 1.0903 3.70 (0 .0 0 1 )
* (It Liras 5,000 (€ 2.6), 10,000 (€ 5.2), 20,000 (€ 10.3) and 50,000 (€ 25.8))
**  Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
* * *  Married includes individuals who live with their partner
* * * *  Monthly net income reported in Million It. Liras (1 Euro = 1,936.27 Italian Liras)
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Table 6.16. Ordered Logistic regression o f the willingness to pay for a publicly funded IV F  programme for infertile couples: referendum data (dependent variable: no,
definitely not (1); no, probably not (2), do not know (3); yes, probably (4); yes, definitely (5) to the question “Would you vote in favour offunding IV F  with public money i f
you were asked an annual payment, that is a tax, o f Italian £  X? Bids = It. Liras 5,000 (€ 2.6), 10,000 (€ 5.2), 20,000 (€ 10.3) and 50,000 (6 25.8))._____________________
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model 
(5% significance level)
Income dataset: 
stepwise regression model 
(5% significance level)
Number of observations 5,739 5,739 4,806
Likelihood Ratio x2 (p-value) 271.39 (<0.0001) 268.36 238,75
Pseudo R2 0.0149 0.0147 0.0157
Odds Ratio Z (p-value) Odds
Ratio
Z (p-value) Odds Ratio Z (p-value)
Age
Bi(age)
B2(age2)
1.035
0.99928
3.83 (<0.001) 
-4.56(<0.001)
1.045
-0.99971
3.97 (0 .0 0 1 )  
-4.02 (0 .0 0 1 )
1.0470
-0.99954
3.62 (0.001) 
-3.95 (0 .0 0 1 )
Fertility age (1= age from 18 to 44, 0 otherwise) 1.1526 1.65 (0.100)
Gender (female=l, male=0) 1.0183 0.36(0.715)
Education** 1.1601 4.55 (0 .0 0 1 ) 1.1633 4.66 (0 .0 0 1 ) 1.1121 2.91 (<0.004)
Employed (yes=l, no=0) 1.1876 3.14(0.002) 1.1843 3.27 (0 .0 0 1 ) 1.1645 2.67 (<0.008)
North (yes=l, no=0) 0.8843 -1.83 (0.068) 0.8727 -2.75 (0.006) 0.8700 -2.53 (0.011)
South (yes=l, no=0) 1.0214 0.31 (0.754)
County town (yes=l, no=0) 1.1380 2.64 (0.068) 1.1339 2.60 (0.009) 1.1354 2.40 (0.016)
Married*** (yes=l, no=0) 1.4582 5 .78 (0 .001 ) 1.4911 6.25 (0 .0 0 1 ) 1.4610 5 .39 (0 .0 01 )
Number of children 0.9198 -3.33 (0.001) 0.9170 -3.48 (0 .0 0 1 ) 0.9175 -3.17 (0 .0 0 2 )
Self-reported socio-economic status or monthly net 
income****
1.0487 2.50(0.012) 1.0472 2.43 (0.015) 1.0856 4 .5 9 (0 .0 0 1 )
* (It. Liras 5,000 (€ 2.6), 10,000 (€ 5.2), 20,000 (€ 10.3) and 50,000 (€ 25.8))
**  Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
* * *  Married includes individuals who live with their partner
* * * *  Monthly net income reported in Million Italian Liras (1 Euro = 1,936.27 Italian liras)
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Regression analysis models of the MPC data support the theoretical validity of the 
WTP elicitation method. In all models education is a significant predictor of the 
magnitude of willingness to pay for the IVF programme. In the full dataset stepwise 
regression model one class difference in education (respondents are classified 
according to 4 classes) is associated with an expected increase in willingness to pay 
for the programme of It. Liras 9,600 (€ 5) (table 6.16). The expected difference in the 
WTP between the least educated (less that 8 years of education) and the most 
educated (university degree) is almost € 15. In the analysis performed on the sub 
dataset reporting income values the coefficient of education is smaller (6.6 versus
9.6). However, income looks a better explanatory variable than the socio-economic 
status. For an increase of the net monthly income of € 500 it is expected an increase 
in WTP of about € 2.50, holding all the other variables constant. Married individuals 
(including those living with their partner) have higher WTP for the IVF programme 
ranging from € 6 to € 8 depending on the model specification. Unemployed 
individuals (including retired people) and those residing in northern regions present 
lower WTP for the IVF programme than those employed and residing in central and 
southern regions. Although the Likelihood Ratio tests suggest that we can reject the 
hypothesis that all coefficients are 0, it should be noted that the explained variability 
of the models is low (Pseudo R2=0.03).
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Table 6.17. Tobit regression models o f willingness to pay for a publicly funded IV F  programme for infertile couples: modified payment card data (dependent variable: 8
values ranging from It. Liras 2,000 (Euro 1) to It. Liras 200,000 (€ 103.3); dependent variable censored at It. Liras 0 and Italian Liras 200,000).____________________________
Full dataset:
all dependent variables included
Full dataset:
stepwise regression model 
(5% significance level)
Income dataset: 
stepwise regression model 
(5% significance level)
Number of observations 5,739 5,739 4,806
Likelihood Ratio x2 (p-value) 136.55 (<0.0001) 120.20 116.56
Pseudo R2 0.032 0.031 0.033
Coeff. t-student
(p-value)
Coeff. t-student
(p-value)
Coeff. t-student
(p-value)
Age
Bi(age)
B2(age2)
321.56
-7.22
0.37(0.718) 
-0.73 (<0.464)
439.35
-10.73
Fertility age (1= age from 18 to 
44, 0 otherwise)
10.4010 1.97 (0.049) 16.86 5.13 (<0.001)
Gender (female=l, male=0) 5.7430 1.89 (0.059)
Education* 9.0150 4.54 (0 .0 0 1 ) 9.5695 4.89 (<0.001) 6.5966 2.99 (0.003)
Employed (yes=l, no=0) 10.0375 3.00 (0.003) 8.0386 2.54 (0.011) 8.5498 2.47 (0.013)
North (yes=l, no=0) -14.9271 -3.60 (0 .0 0 1 ) -15.4242 -5.13 (<0.001) -19.0558 -5.74 (0 .0 01 )
South (yes^l, no=0) 1.9233 0.47 (0.639)
County town (yes=l, no=0) 7.6121 2.56(0.011) 7.5348 2.56 (0.011)
Married** (yes=T, noO ) 14.0424 3.50(0.001) 12.4714 3.56 (0 .0 0 1 ) 16.2373 3.78 (0 .0 0 1 )
Number of children -2.1108 -1.37(0.169)
Self-reported socio-economic 
status or monthly net income***
2.3840 2.04 (0.041) 2.3771 2.04 (0.042) 4.8999 4 .56 (0 .0 01 )
Constant -15.7656 -1.15 (0.250) -31.1966 -4.51 (0 .0 0 1 )
Sigma 101.487 100.786 100.076
* Education is classified in 4 classes: less than 8 years of education (1), between 8 and 13 years (2), high school diploma (3) and university degree (4) 
**  Married includes individuals who live with their partner
* * *  Monthly net income reported in Million Italian Liras (1 Euro = 1,936.27 Italian Liras).
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Chapter 7
A cost-benefit analysis of In-Vitro-Fertilisation
7.1. Introduction
In this chapter we present the analysis of benefits and costs data that we obtained 
from the empirical study. The rationale of methodological choices and details about 
the data are presented in Chapters 4 and 5. Here, we first analyse the answers to the 
WTP questions and then provide estimates of mean WTP for hypothetical personal 
use of IVF (section 7.2) and for an Italian national programme providing IVF to Italian 
infertile couples who desire to have a baby (sections 7.3-7.7). WTP data collected 
according to two elicitation methods (take-it-or-leave-it and a modified version of 
payment card) are used to make some validity checks (section 7.8) and comparisons 
(section 7.9).
Section 7.10 presents the data obtained in the cost analysis conducted in two Italian 
hospitals. Results presented in the previous sections are then used to estimate the 
incremental cost-effectiveness ratio of IVF and to present a cost-benefit analysis of a 
national programme providing IVF (7.11 and 7.12). Overall, results show that 
providing IVF to infertile couples should imply a welfare gain.
7.2. Willingness to pay for hypothetical personal use of IVF
A specific question was framed to elicit how much respondents were willing to pay in 
case they wanted to use IVF. Respondents were presented 6 values and for each of 
them they were asked to choose between “yes” and “no”. As detailed in Chapter 5, 
two main assumptions can be made about the rationality of respondents (potential 
users of IVF). The first assumption, which reflects standard economic theory, is that 
respondents are not expected to answer “yes” at any given amount if for lower 
amounts they have answered “no”. The second assumption accepts that respondent 
can violate the assumption, but only once.
Under the first assumption, there is an inconsistency when a respondent states “yes” 
to a value that it is higher than a value for which he/she stated “no”. According to this
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definition of inconsistency, for the total sample of 5,739 individuals there are 504 
inconsistencies to this part of the questionnaire (table 7.1). As each respondent was 
presented 6 bids, the maximum possible number of inconsistencies is 34,434. 
Therefore, only 1.5% of the answers can be deemed invalid under this rational 
assumption. For several respondents there were more than one inconsistency and 
for few of them there is a pattern suggesting protest answers (see below). It is 
calculated that 207 respondents present at least one inconsistency to the answer to 
the willingness to pay for IVF. Accordingly, 3.6% of respondents provided an invalid 
answer to this question if the standard assumption of the positive correlation between 
price and willingness to pay is assumed.
If it is assumed that an answer is inconsistent only if the “normality” rule is violated 
twice, very few answers are void. Sixteen answers meet these criteria (0.3% of the 
sample). These answers are null even if a wide concept of rationality is assumed; it is 
also very likely that they express protest.
Overall this check corroborates the validity of this part of the questionnaire. If we 
impose a standard notion of rationality, 3.6% of respondents provided invalid 
answers; however, if the rationality assumption is relaxed only 0.3% respondents 
provided clearly void answers. Overall, it appears that this part of the questionnaire 
was comprehended and provoked very few protests.
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Table 7.1. Willingness-to-pay for the use of IVF: analysis of inconsistent answers (under the assumption that the probability of stating the use of IVF increases as the prices 
increase)._____________________________________________________________________________
Willing to Pay 
£ 0 million
Willing to Pay 
£ 1 million
Willing to Pay 
£ 5 million
Willing to Pay 
£ 10 million
Willing to Pay 
£ 20 million
Willing to Pay 
£ 50 million
Total 1* Total 2 **
No Willing to Pay £ 0 X 51 29 33 26 24 163 5
No Willing to pay £ 1 mln X 34 35 24 22 115 1
No Willing to pay £ 5 mln X 50 35 33 118 5
No Willing to pay £ 10 mln X 32 38 70 10
No Willing to pay £ 20 mln X 38 38 38
No Willing to pay £ 50 mln X
Total 504 59
* Total 1 reports the number of inconsistent answers; the grand total is the total number of inconsistencies to the question on willingness to pay for using IVF
* Total 2 reports the minimum number of respondents who provided one or more inconsistencies
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Table 7.2 summarises the main results. Out of the 5,739 respondents, 3,040 (53.0%) 
stated to be willing to use IVF if it were free. Therefore, 47% of respondents 
attributed no value to IVF and would not use it even in the case it were free. 2,482 
(43.2%) of the respondents were willing to pay Italian Liras 1 million (€ 516), this was 
558 less than those who were willing to use it if it were free. For higher prices the 
number of respondents willing to pay for IVF drops further; for the highest value 
(Italian Liras 50 million that it is about € 25,800) the number of “users” is 500, about 
8.7% of the total number of respondents. Overall, as predicted using standard 
economic theory, the higher the bid the fewer the number of respondents willing to 
pay.
Table 7.2. Willingness to pay for using IVF in case of infertility (yes/no answers to 6 bids).
Willing to Pay No Willing to Pay
Bid # (%) # (%)
It. Liras 0 3.040 (53.0) 2.699 (47.0)
It. Liras 1 million (€516) 2.482 (43.2) 3.257(56.8)
It. Liras 5 million (€ 2,582) 1.895 (33.0) 3.844 (67.0)
It. Liras 10 million (€ 5,165) 1.309 (22.8) 4.430 (77.2)
It. Liras 20 million (€ 10,329) 879 (15.3) 4.860 (84.7)
It. Liras 50 million (€ 25,823) 500 (8.7) 5.239 (91.3)
On the basis of the data generated by these answers we graphed the basis of a 
demand schedule of IVF for personal use (figure 7.1). As we only observed 6 points 
of the curve, we assumed that demand is linear between each consecutive pairs of 
points and we created two scenarios: one with the maximum WTP set at Italian Lira 
50 million (€ 25,823) and the other assuming that the number of respondents willing 
to pay linearly declines at a constant rate. Visual representations of the demand 
schedule for personal use of IVF for the two scenarios are presented in figure 7.2. 
and figure 7.3.
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Figure 7.1. Number of respondents willing to pay for IVF at different bids
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Figure 7.2. Demand schedule for IVF 
(assuming no respondent is willing to pay more than Italian 50 Million - Euro 25,823 )
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Figure 7.3. Demand schedule for IVF 
(assuming linear decrease in the number of respondents)
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Total WTP is the area beneath the curve. If it is assumed that It. Liras 50 Million (€ 
25,823) is the maximum WTP value, the aggregate WTP of the sample is It. Liras 
52,980 Million (€ 27.4 Million), that is It. Liras 9.23 Million (€ 4,767) per respondent 
and It. Liras 17.43 Million (€ 8,999) per user (respondent willing to use IVF). Linder 
the other assumption (linear decrease of the number of persons willing to pay more 
that It Liras 50 million) total WTP is It. Liras 61,025 million (€ 31.5 million) and the 
WTP per respondents and per user are It. Liras 10.6 million (€ 5,474) and It. Liras 
20.1 Million (€10,381), respectively.
In summary, this part of the survey shows that the mean willingness to pay for IVF of 
those respondents who would use IVF in case of need would range from € 9.000 to € 
10.381. This is the value attributed to an IVF package providing up to 3 IVF cycles 
with an overall probability of success (life birth) of 30%.
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7.3. Willingness to pay for a publicly funded programme providing IVF to 
infertile couples
We first administered the TIOLI questions by splitting the total sample into four sets. 
Each sub-sample consisted of about 1,400 individuals (minimum 1,384 and 
maximum 1,490 (table 7.3). Respondents who chose the option “Do not know” to the 
TIOLI question were about 15% of the sample. In the “It. Liras 5,000” (€ 2.6) sub­
sample, 29% of respondents were definitely willing to pay for the programme. For the 
same amount another 25.2% of respondents were probably willing to pay. Overall 
“yes” answers in this sub-sample accounted for 54.2% of respondents. For the 
highest bid, that is It. Liras 50.000 (€ 25.8), the proportion of respondents willing to 
pay was 41.1% (26.3% probably and 14.8% definitely). The proportion of “Yes, 
definitely” answers is strictly decreasing and the proportion of “No, definitely not” 
answers is strictly increasing. However, both probably answers are not monotone 
and as a consequence both overall “yes” and “no” are not monotone as well. The 
proportion of respondents willing to pay It. Liras 10,000 (€ 5.2) is 55.2%, a little 
higher than 54.2% that is the proportion willing to pay It. Liras 5,000 (€ 2.6).
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Table 7.3. Willingness-to-pay for a publicly funded programme providing IVF to infertile couples: referendum format (each bid presented to one of the four sub-samples)
Bid in Italian Liras (€)
It Liras 5,000 (€2.6) It. Liras 10,000 (€ 5.2) It. Liras 20,000 (€ 10.3) It. Liras 50,000 (€ 25.8) All bids
# % # % # % # % # %
Do not know 213 14,30% 202 14,03% 275 19,87% 211 14,81% 901 15,70%
Yes, probably 376 25,23% 418 29,03% 407 29,41% 374 26,25% 1575 27,44%
Yes, definitely 432 28,99% 377 26,18% 254 18,35% 211 14,81% 1274 22,20%
No, probably not 213 14,30% 189 13,13% 199 14,38% 303 21,26% 904 15,75%
No, definitely not 256 17,18% 254 17,64% 249 17,99% 326 22,88% 1085
Yes (probably or definitely) 808 54,23% 795 55,21% 661 47,76% 585 41,05% 2849 49,64%
No (probably or definitely) 469 31,48% 443 30,76% 448 32,37% 629 44,14% 1989 34,66%
Total 1490 1440 1384 1425 5739
“Do not know” excluded Bid in Italian Liras (€)
It Liras 5,000 (€ 2.6) It. Liras 10,000 (€5.2) It. Liras 20,000 (€ 10.3) It. Liras 50,000 (€ 25.8) All bids
# % # % # % # % # %
Yes, probably 376 29,44% 418 33,76% 407 36,70% 374 30,81% 1575 32,55%
Yes, definitely 432 33,83% 377 30,45% 254 22,90% 211 17,38% 1274 26,33%
No, probably not 213 16,68% 189 15,27% 199 17,94% 303 24,96% 904 18,69%
No, definitely not 256 20,05% 254 20,52% 249 22,45% 326 26,85% 1085 22,43%
Yes (probably or definitely) 808 63,27% 795 64,22% 661 59,60% 585 48,19% 2849 58,89%
No (probably or definitely) 469 36,73% 443 35,78% 448 40,40% 629 51,81% 1989 41,11%
Total 1277 1238 1109 1214 4838
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This unexpected pattern is due to very few cases and may be attributable to chance. 
Nevertheless, it is inconsistent with standard economic theory that assumes that the 
higher the price the fewer the number of consumers. The results of this part of the 
survey do not fully support the validity of the TIOLI format. In addition, while the 
highest bid (It. Liras 50,000) is 10 times the lowest one (It. Liras 5.000) the proportion 
of yes answers (probably and definitely) drops only by an absolute 13% (from 54.2% 
to 41.1%). Respondents do not appear to be very sensitive to the value of the bid so 
that it may be argued that the TIOLI questions produce inaccurate estimates.
Mean WTP values calculated according to different hypotheses are presented later in 
this chapter. In the meanwhile it can be noted that if this data derived from a real 
referendum and a strict majority rule applied (absolute majority of voters), a tax of It. 
Liras 10,000 (€ 5.2) to fund IVF would have been approved. If a relative majority 
sufficed to approve the proposal (a less stringent rule), a tax of It. Liras 20,000 (€ 
10.3) would have been approved.
The modified payment card (MPC) questions were the same for all respondents and 
followed the TIOLI questions. Respondents were presented 8 values, from It. Liras
2,000 (€ 1) to It. Liras 200,000 (€ 103.3). Values were presented randomly to each 
respondent. For each value respondents were required to choose between yes and 
no without the “do not know/1 option and the possibility to graduate the answers by 
the use of probably and definitely.
Out of the 5,739 returned questionnaires 581 (10.1%) were deemed inconsistent as 
they reported “yes” to bids that were higher of bids for which they reported “no”. This 
relatively high number of inconsistent answers is probably due to the random 
presentation of bids. As respondents faced 8 unordered values unintentional 
mistakes are likely and may reflect uncertainties and difficulties of the cognitive 
processes. Eight-nine questionnaires (1.5% of the total) twice violated the positive 
association between price and willingness to pay (that is a sequence no-yes-no-yes 
to increasing values of willingness to pay). This value is significantly higher than 
those observed in the MPC questions for private use of IVF. This may due to the 
higher number of values offered (8 compared to 6 in the part on personal use of IVF) 
or by the fact that the part of the questionnaire on WTP for the publicly funded 
programme was administered at the end, when respondents were probably more 
tired and less concentrated.
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All 5,739 answers, including those inconsistent were kept in the data set to be 
analysed in the next sections. While there is uncertainty about how to treat 
apparently invalid data, we preferred not to exclude any observation in order to fully 
reflect what respondents answered. Almost 56% of respondents stated to be willing 
to pay at least It. Lira 2,000 (Euro 1) (table 7.4). This percentage drops for higher 
values: it is about 53% for It Lira 10,000 (€ 5.2), 32% for It. Lira 50,000 (€ 25.8) and 
10.2% for It. Lira 200.000 (€ 103.3).
Table 7.4. Willingness-to-pay for a publicly funded programme providing IVF to infertile couples:
modified payment card format (all bids presented to the entire sample)
Willingness-to-Pay
Yes Not
Bid values # % # %
It. Liras 2,000 (€ 1.0) 3,192 55,62% 2,547 44,38%
It. Liras 5,000 (€ 2.6) 3,168 55,20% 2,571 44,80%
It. Liras 10,000 (€5.2) 3,043 53,02% 2,696 46,98%
It. Liras 20,000 (€ 10.3) 2,632 45,86% 3,107 54,14%
It. Liras 50,000 (€ 25.8) 1,845 32,15% 3,894 67,85%
It. Liras 80,000 (€41.3) 1,291 22,50% 4,448 77,50%
It. Liras 100,000 (€51.6) 1,127 19,64% 4,612 80,36%
It. Liras 200,000 (€ 103.3) 590 10,28% 5,149 89,72%
For the maximum value offered (€ 103.3) 590 respondents, that is about 10.3% of the 
sample, stated to be willing to pay. Such a large number of respondents for the 
highest value offered is unexpected and suggests that the sample may be censored. 
It is likely that a significant number of respondents would have been willing to pay 
more that € 103; consequently, to set this value as the upper WTP limit may 
underestimate the maximum willingness to pay of many respondents.
On the other side 44.3% of the sample stated they were not willing to pay even € 1, 
the minimum value offered. We attributed 0 WTP to these individuals. However, it is 
plausible that some of these patients may have a negative willingness to pay for a 
publicly funded IVF programme as ARTs present controversial ethical issues. 
Therefore, it looks appropriate to assume that there is a spike at zero or that 
observations are left-censored because the latent dependent variable may assume 
negative values.
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7.4. WTP estimates elicited from the referendum format
As detailed in the previous chapter, we assumed that the probability that an individual 
will say “yes” to the WTP question follows a logistic distribution and we estimated 
mean WTP as the area under the probability function. This area shows the fraction of 
the sample who would consume the good at each price (bid) level. Therefore mean 
willingness to pay can be estimated by integrating the probability function.
u o
E(WTP) = J (1 + e -a+b*bid)-1db - lJ 1 -  (1 + e -a+b*bid)-1db
Where a and b are the coefficients of the estimated regression logit equation when 
only the bid amount (bid) is included, U is the upper limit of the integration and L the 
lower limit of the integration. Table 7.5 presents the coefficients and the limits used 
for the integrations used in the different scenarios.
Table 7.5. Logit regression results of the take-it-or-leave-it data and estimates of mean willingness to
pay.
A B C D
Lower Limit € 0 € 0 €-25.8 €-25.8
Upper Limit €25.8 €103.3 €25.8 € 103.3
Mod. No/Yes Const. B coeff. Mean willingness to pay
1 1989/2849 0.67409 -0.01475 € 19.04 € 89.77 €8.06 € 78.80
2 2890/2849 0.25089 -0.01264 € 16.96 € 82.22 €3.64 €68.89
3 1989/1274 0.13940 1-0.00218 € 14.16 r € 60.73 €0.99 €47.56
4 4465/1274 -0.8818 -0.01916 € 10.39 €71.54 €-10.06 €51.09
LL = lower limit of the integration; UL = upper limit of the integration; It L. 50,000 = € 25.8, It L. 
200,000 = € 103.3.
The four rules for reducing to a binary format the answers collected in the 
questionnaire produce different mean WTP (see section 5.7). If the limits of the 
integration are those corresponding to the lowest and the highest bids offered to 
respondents (0 and It. Liras 50,000), mean WTP is about € 19 for model 1 (“do not 
know” treated as missing, “yes, definitely” and “yes, positively” treated as “yes” and 
“no, definitely not” and “no, positively not” treated as “no”) and is € 10.40 for the 
most conservative scenario (model 4 in which only “yes, definitely” is treated as “yes” 
and all the other answers are treated as “no”). As expected, for larger integration 
intervals mean WTP estimates are larger; if the probability function is integrated
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between negative Italian Liras 50,000 (€ 25.80) and Italian Liras 200,000 model 1 
and model 4 produce mean WTP equal to € 78.80 and to € 51.10, respectively.
The assumptions about the integration limits are crucial. In model 1 results vary more 
than tenfold, from € 8.10 to € 89.80; in model 4, the most conservative, they vary 
from a negative value of € 10.10 to a positive value € 71.50. It is important to 
investigate why the integration limit assumptions are so important. Almost 1/3 of 
respondents refused to pay the lowest value offered. In a previous section of the 
questionnaire it was revealed that 47% of respondents were not willing to pay 
anything for IVF in case of infertility. These respondents would not have used IVF 
even if it were completely free of charge. Although altruistic feelings may cause some 
of these respondents to be willing to pay a positive amount even if they excluded 
their personal use (see below), it looks very likely that many respondents who are not 
willing to pay € 2.60 (the lowest value offered) have no willingness to pay for the 
publicly funded IVF programme. Moreover, it is also likely that some people do not 
derive any utility from the programme. These arguments suggest setting the lower 
integration limit at 0.
However, as mentioned in the previous chapter, the case of ARTs is so peculiar that 
some individuals may experience disutility as a result of the publicly funded 
programme providing IVF. Therefore, for this specific question negative WTP is 
possible and thus setting a negative lower integration limit may be plausible. 
However, it should be made clear that the setting of such a value would be arbitrary 
as no evidence was collected on the magnitude of the disutility of the IVF programme 
for any respondent.
Table 7.5 clearly shows that the assumptions about the lower integration limits have 
a great impact on results. In model 1 changing the lower integration limit from 0 to 
negative It. Liras 50,000 (€ -25.80) implies a reduction in mean WTP from € 19 to € 
8.10 if the upper bound is It. Liras 50,000 (€ 25.80) and a reduction in mean WTP 
from € 89.80 to € 78.80 if the upper bound is Liras 200,000 (€ 103.30). In model 4, 
the very conservative one, mean WTP for the IVF programme is negative if the upper 
value is It. Liras 50,000 (€ 25.80) and the lower value is It. Liras 50,000 (€ -25.80) 
(see column c in table 7.5).
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The assumption about the upper integration limit is crucial as well. Out of the 1,425 
respondents to the It. Liras 50,000 (€ 25.80) group, 374 and 211 were probably and 
definitely willing to pay, respectively. Almost 15% of the sub-sample stated to be sure 
to be willing to pay the highest amount offered. It is thus very likely that some of them 
would have been probably (and even definitely) willing to pay higher amounts. This 
justifies the hypothesis of the upper bound set at It. Liras 200,000 (€ 103.30). Such a 
hypothesis has a great impact on results. In model 1 raising the upper limit of the 
integration raised mean WTP from € 19 to € 79.80 if the lower integration limit is 0, 
and from € 8.10 to € 78.60 if the limit is It. Liras -50,000.
The referendum format questions used to elicit willingness to pay required a few 
assumptions about how to treat “do not know” answers, how to code the distinction 
between “definitely” and “probably” answers and about the minimum and the 
maximum willingness-to-pay admissible. Our results show that this last set of 
assumptions, that is the definition of the upper and the lower limits of the distribution 
are more relevant than those related to coding. However, it should be clear that the 
high sensitivity of results to the assumption of minimum and maximum WTP derives 
from the very limited number of bids used in the present survey (only four in this part 
of the questionnaire) and the limited sensitivity of respondents to the range of value 
offered. Excluding “do not know”, the percentage of respondents willing to pay varies 
from 63.3% for the lowest value offered (€ 2.60) to 48.2% for the highest one (€ 
25.80). Consequently, the survey was not very informative. It provided limited 
information on the 36.7% of respondents whose WTP is less than € 2.60 and on the 
48.2% of respondents whose WTP is likely to be higher than € 25.80.
Keeping in mind these limitations, results presented here can be also interpreted 
according to a policy perspective. Depending of the referendum rules, the survey 
reveals different implications. If the proposal had to be approved by the absolute 
majority of voters, a tax of € 5.20 to fund IVF would have been approved while taxes 
of higher values would have been rejected. Results are more favourable to the IVF 
programme if a less stringent majority rule is used. If the proposal had to be 
approved by the majority of those expressing a yes/no vote (thus excluding “do not 
know” from computation) a clear majority of 58.9% of votes would have been in 
favour of raising a tax of € 10.30 to fund IVF. However, the referendum logic
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neglects the intensity of preferences. Instead, the cost-benefit analysis needs benefit 
measures reflecting the magnitude of utility generated by public choices. According 
to a cost-benefit perspective it is thus more relevant to calculate mean WTP than the 
WTP of the median voter.
We think that model 1 under the hypothesis a) is the most plausible. Model 1 uses 
both the “probably” and the “definitely” answers respecting the sign (yes and no) and 
integrate the probability function between two limits that are directly observed. The 
use of these limits may inflate mean WTP as the lower limit excludes the possibility of 
negative WTP but, at the same time, reduces mean WTP as many respondents may 
be willing to pay amounts that are much higher than those offered in the survey. 
According to these assumptions, mean WTP is about € 19. If different assumptions 
are made about coding of “do not know” and “yes, probably” answers, but the 
integration limits are not varied, mean WTP ranges from € 10.40 to € 17. In section 
6.13 we compare these benefits to estimates of cost for producing IVF services.
7.5. Spike models
A major characteristic of our dataset is that a large number of respondents answered 
“no” to any proposed value. From this we can draw the conclusion that most of these 
individuals were not in the market in the sense that attributed zero value to the public 
programme. If this is so, it may be inappropriate to assume that the probability that a 
respondent is willing to pay a certain amount is given by a logistic probability 
function. It is likely that a more articulated assumption about the probability 
distribution is needed. One option, following Kristrom (1997), consists of assuming 
that the panel is split in two parts, one for whom the programme provides benefits 
(even if marginal) and the other for whom the programme does not produce any 
benefit. As presented earlier, for such a model we have to estimate parameters from 
a composite function: In essence, the model first describes whether the respondent is 
willing to pay any amount for the programme and then estimates the parameters of 
the probability distribution function of willing to pay as a function of the proposed bid. 
Table 6 presents the results of these analyses.
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Table 7.6. Parametric estimates o f mean WTP: the effects o f zero WTP
Logit
Lower limit 
Upper limit
-QO 
+  00
Spike Logit 
Lower limit 0 
Upper limit + oo
No/Yes Const. B coeff. Mean
Willingness 
to Pay (€)
Const. B coeff. Mean
Willingness 
to Pay (€)
1 1989/2849 0,67409 -0,01475 23.60 0.09668 0.14752 26.00
2 2890/2849 0,25088 -0,01264 10.25 0.08799 0.12645 30.34
3 1989/1274 0,01394 -0,02284 0.31 0.65798 0.02284 16.80
4 4465/1274 0,01394 -0,01916 -23,77 0.96697 0.01915 20.10
Estimates on WTP through a parametric logit model are regularly below those having 
a spike at zero. This is because the full parametric model requires the integration of 
the overall function in the real domain, including negative values. Therefore, zero 
values are understood by the model as truncated observations on negative values. 
Consequently, the entire distribution of WTP, compared to the spike models, is 
shifted towards left and consequently mean WTPs are lower. The spike model 
estimates that about 27% of observations are true zero WTP (this is approximately 
the percentage of respondents that were against any funding of a public programme 
providing IVF) and provide WTP estimates between €16 and € 31.
It is important to note that the two main methodological issues are crucial here: the 
form of the probability distribution function and the limits of integration. We only 
proposed positive values; however, we have used the answer to another question to 
detect respondents who have true WTP for the programme. This data can be used 
according to a large variety of assumptions about the distribution of probability (here 
the distribution of interest is the probability of providing yes to a specific bid). If we 
use a logistic distribution we implicitly recognize that the probability distribution 
function may be positive (with probability greater than zero) also for negative WTP 
values. Instead, by using the spike model we assume that the negative realm is 
excluded and that a relative large amount of respondents have zero WTP.
The other relevant issue is the interval of integration. If we use a parametric 
approach, this interval should be drectly identified by the probability distribution 
function; otherwise the mathematical result has unclear statistical interpretation 
(Hanemann and Kanninen; 1996). Consequently, in the parametric model without
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any spike the integration linterval covers negative values and thus mean WTP results 
lower. What drives down mean WTP in the model without spike is the number of 
observations at zero. Results of assumption 4 (table 7.6) presents the largest 
difference between the model with and without the spike because the large number 
of zero generate a high number of negative WTP value in the former and zero WTP 
in the latter. The higher the number of observations at zero (as in assumption 4) the 
larger the fraction of observations that contribute differently to the shape of the 
distribution and thus to the mean value (but not to the median values).
7.6. WTP estimates elicited from the modified payment card format
Table 7.6 presents data and calculations to obtain total sample and mean WTP from 
the modified payment card data. Respondents are attributed to the value that they 
reported as the maximum WTP. For each value it is also presented the value used to 
calculate WTP (the mid-point between the amount at which the respondent said “yes” 
and the amount at which he/she said “no”).
Table 7.7. Total and mean WTP for a public programme funding IVF to infertile couples of the total 
sample (5,739 respondents). ___________________________________________________________
Amount offered Mid-range 
value (*)
Number of respondents 
willing to pay
Total Willingness to 
pay
It. Liras 0 0 2,057 € 0
It. Liras 2.000 (€ 1) € 1.80 109 € 196
It. Liras 5.000 (€ 2.60) €3.90 251 € 979
It. Liras 10.000 (€5.20) €7.80 474 € 3,697
It. Liras 20.000 (€ 10.30) € 18.10 869 € 15,728
It. Liras 50.000 (€ 25.80) €33.60 561 € 18,849
It. Liras 80.000(6 41.30) €46.50 251 € 11,420
It. Liras 100.000 (€ 51.60) € 77.50 577 €44,717
It. Liras 200.000 (€ 103.30) € 103.30 590 € 60,947
Total WTP (€) €156,536
Mean WTP per respondent (€) €27.28
(*) Maximum WTP = 0 for respondents not willing to pay It. Liras 2,000 and maximum WTP = 
200,000 for those willing to pay It. Liras 200,000.
The sample has a total WTP of about € 156,536. The highest valued offered (€ 
103.30) contributes to total WTP for almost 40% of the total. As in the referendum 
question, the high number of respondents willing to pay the highest amount offered 
has a decisive impact on the WTP estimate and raises the issue of the WTP amount 
to be attributed to those willing to pay the maximum value proposed. A consistent 
minority (about 10% of the sample) is probably willing to pay amounts higher than 
those presented in the questions and strongly influences the sample mean value.
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Mean WTP, estimated as the ratio between total WTP and total number of 
respondents (5,739), is € 27.28. This means that, on average, respondents of this 
survey are available to pay € 27.28 to fund a national programme providing free IVF 
to infertile couples.
The survey over represent some population groups (e.g. the well educated) and 
under represent other groups (e.g. the elderly). In order to have results more 
representative of the Italian population each respondent was assigned a weight to 
adjust his/her relative importance in the sample. Table 7.8 reports total and mean 
WTP of the weighted sample. Also, it reports the average weight of the respondents 
for each of the 8 values offered. The weighting procedure has a limited impact on 
results: total WTP is € 152,580 (it is € 156,536 if data are not weighted) and mean 
WTP is € 26.59, about € 0.70 less than the value obtained without weighting.
Table 7.8. Total and mean WTP for a public programme funding IVF to infertile couples of a sample 
representative of the Italian population in respect of age, gender, education, employment status, 
geographical area and municipality size of respondent’ residence.________________________________
Amount offered Mid-range 
value (*)
Number of 
respondents willing 
to pay
Average
weight
Total willing to 
pay
It. Liras 0 0 2,057 1.174901 € 0
It. Liras 2.000 (€ 1) € 1.80 109 1,224666 € 240
It. Liras 5.000 (€2.60) €3.90 251 0.985312 € 964
It. Liras 10.000 (€5.20) €7.80 474 0.896577 € 3,315
It. Liras 20.000 (€ 10.30) € 18.10 869 0.919385 € 14,460
It. Liras 50.000 (€25.80) €33.60 561 1.282328 €24,171
It. Liras 80.000 (€41.30) €46.50 251 1.083753 € 12,377
It. Liras 100.000 (€51.60) €77.50 577 0.896416 €40,085
It. Liras 200.000 (€ 103.30) € 103.30 590 0.934676 € 56,966
Total WTP (€) €152,580
Mean WTP per respondent (€) €26.59
(*) Maximum WTP = 0 for respondents not willing to pay It. Liras 2,000 and maximum WTP = 
200,000 for those willing to pay It. Liras 200,000.
These values are substantially lower than the estimates obtained from the 
referendum questions (about € 70-80) if the upper integration limit is set at Italian Lire
200,000 (€ 103.30). However, if the integration limit is set at the highest bid proposed 
in the TIOLI questions (Italian Liras 50,000 that corresponds to € 25.80), the estimate 
derived from the MPC questions are substantially higher (€ 27.28 compared to € IQ- 
20).
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7.7. Egoistic and altruistic willingness to pay
We estimated that, in a hypothetical case of infertility, respondents willing to try IVF 
(potential users of IVF) have a mean willingness to pay of about € 9-10,000 for 3 
cycles of IVF. Then, from other questions of the survey we estimated that mean WTP 
for a national programme providing free IVF to infertile couples is likely to be in a € 
10-30 range.
The first estimate (€ 9-10,000) refers to the use of IVF and thus reflects WTP for the 
personal use of the intervention. This estimate should only include what the person is 
willing to pay in the case he/she needs the intervention. Therefore, this value does 
not include any option value and any altruistic component. It does not include any 
option value because respondents are presented an ex-post situation (..imagine that 
you are infertile...) and it does not include any altruistic component because the 
question referred to WTP for the personal use of the service with no reference to any 
collective scheme of funding.
The second WTP value, elicited through the take-it-or-leave-it and the modified 
payment card formats, refers to a publicly funded programme providing IVF to 
infertile Italian couples. This WTP value should include WTP for personal use, WTP 
for the option of having WTP in case of need and WTP for making it freely available 
to other members of the community. Therefore, this WTP value is expected to 
capture the altruistic component of IVF.
Unfortunately, a direct comparison between the two estimates cannot be performed. 
Respondents were not given their probability of being infertile and did not have 
enough information to make an estimate of expected probability of using IVF. The 
provision of this information would have made the questionnaire too complicated and 
to cognitively difficult. In addition, about 40% of respondents were not of fertility age 
and even those who were of fertility age had different probability of being infertile due 
to their specific age.
Despite the missing link between the two WTP estimates it is possible to further 
investigate the data in order to understand the magnitude of the altruistic component 
of WTP. As one question asked whether the respondents would have used IVF in
case of infertility, it is possible to provide separate WTP estimates for potential user 
and non users of IVF (table 7.9).
Table 7.9. Personal use of IVF and willingness-to-pay for a national programme funding IVF to 
infertile couples_________ ___________________________________________________________
“ Imagine you are in fertile  and you desire a baby. Would you try  IV F ? "
Do
not
know
No,
definitely
not
No,
probabl 
y not
Yes,
probably
yes
Yes,
definitely
yes
Not Yes
Amount offered Number of respondents willing to pay
It. LO 552 733 488 211 73 1221 284
It. L 2.000 (€ 1) 23 18 21 37 10 39 47
It. L 5.000 (€2.60) 55 41 57 60 38 98 98
It. L 10.000(6 5.20) 106 36 78 191 63 114 254
It. L 20.000 (€ 10.30) 134 69 118 419 129 187 548
It. L 50.000 (€25.80) 76 26 82 250 127 108 377
It. L 80.000 (€41.30) 38 18 26 118 51 44 169
It. L 100.000 (€51.60) 69 25 66 269 148 91 417
It. L 200.000 (€ 103.30) 66 32 44 250 198 76 448
Total respondents 1.119 998 980 1.805 837 1.978 2.642
Mean WTP per 
respondent
17.83 8.68 16.94 38.68 49.59 12.77 42.13
% of respondents having 
positive WTP
50.7
%
26.6% 50.2% 88.3% 91.3% 65.5% 83.8%
Using the non-parametric approach to estimate the WTP from the MPC data, the 
mean WTP for the publicly funded IVF programme is much larger among users of 
IVF (€ 42.13) than among non users (€ 12.77). Moreover, the mean WTP is higher 
among those being definitely in favour of using IVF (€ 49.59) than among those being 
probably in favour (€ 38.68); on the contrary, respondents that were definitely against 
the use of IVF have a lower WTP (€ 8.68) than those who were probably against its 
use (€ 16.94).
These results were expected because respondents who would not use IVF, and thus 
have 0 WTP for personal use of IVF, should state a lower WTP for a publicly funded 
programme. This is because for the respondents who are against personal use of 
IVF the entire value of the programme is generated by altruism. Almost two-thirds of 
the respondents who were not in favour of using IVF would have paid something for 
a public programme providing IVF to infertile couples. Mean WTP of these 
respondents (those who would not use IVF), provides an estimate of the altruistic 
component of total WTP. The approximate mean WTP of € 12.77 for these
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respondents can be used as a proxy of the altruistic component of WTP for the 
programme (about 50% of mean WTP of the entire sample).
The fact that almost two-thirds of the sample with no intention to use IVF would have 
paid something for IVF and that their mean WTP is substantial provide an important 
indication that altruism is a relevant determinant of willingness-to-pay for a public 
programme in the area of assisted reproduction.
7.8. Validity considerations
As respondents were split into four groups according to the amount offered in the 
TIOLI question, we could check if different amounts have an impact on the answer to 
the MPC question (see previous chapter). Estimates of mean WTP ranges from € 
25.50 € to € 29.40 and tend to be positively associated to the value offered in the 
TIOLI question (table 7.8). The higher the value offered, the higher the mean WTP 
elicited from modified payment card data. In a linear regression where the dependent 
variable is mean WTP, the coefficient of the value offered in the TIOLI question is 
significantly positive (t=2.50, p=0.012). It can be stated that the TIOLI question had 
an impact on the WTP elicited from the MPC questions. The magnitude of the impact 
is significant but not large: mean WTP for the respondents attributed to the lowest 
value offered (about € 2.50) is about € 4 less than the mean WTP for the 
respondents attributed to the highest value (€ 25.80). This absolute variation is about 
15% of the total sample mean and suggests the existence of an anchoring effect. 
Once respondents are given an amount to decide whether they are willing to pay, 
they are influenced by that amount when answering to additional questions.
Table 7.10. Mean WTP from the modified payment card (MPC) data: comparison of the four sub 
groups used in the take-it-or-leave-it question._________________________________________________
Sub-group Mean WTP (including do not 
know to the TIOLI question) (a)
Mean WTP (excluding do not 
know to the TIOLI question) (b)
It. Liras 5,000 (€ 2.60) It. Liras 46.470 (€ 24.00) It. Liras 55.310 (€28.60)
It. Liras 10,000 (€5.20) It. Liras 51.311 (€26.50) It. Liras 60.772 (€ 31.40)
It. Liras 20,000 (€ 10.60) It. Liras 51.698 (€26.70) It. Liras 61.551 (€31.80)
It. Liras 50,000 (€ 25.80) It. Liras 54.021 (€ 27.90) It. Liras 61.452 (€31.70)
All sub groups It. Liras 52.821 (€27.30) It. Liras 59.696 (€ 30.80)
The last column of table 7.9 reports the same analysis for a smaller dataset: all “do 
not know” answers to the TIOLI questions are excluded. Mean WTP is higher for
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respondents who were attributed to higher bids even if “do not know” respondents 
are excluded, although the magnitude of the effect appears slightly smaller.
The exclusion of undecided respondents is associated with higher mean WTP (€
30.80 versus € 27.30). In other words, if respondents who did not know whether they 
were willing to pay certain amounts for a publicly funded IVF programme in the TIOLI 
question are not included to calculate mean WTP from MPC data, the estimate is 
higher. This suggests that the inclusion of the “do not know” option is not neutral and 
tend to capture more “yes” respondents than “no” respondents. Therefore, including 
“do not know” makes the WTP elicitation method more conservative.
7.9. A comparison between the two elicitation methods.
We compared the TIOLI and the MPC elicitation methods in various ways. According 
to the standard procedure presented above mean WTP from MPC data is estimated 
to be € 27.28. As the MPC format did not allow the possibility of negative WTP, a 
meaningful comparison of mean WTP from the two formats must exclude negative 
integration limits for the analysis of TIOLI data. If the lower integration limit is 
assumed to be 0, mean WTP calculated from TIOLI data ranges from € 10.40 to €
89.80 (table 7.5). As reported above, mean WTP estimates derived from TIOLI data 
are sensitive to the integration limits and coding of “do not know”, “probably” and 
“definitely” answers. If the upper integration limit is Italian Liras 200,000 (€ 103.30), 
the highest value offered in the MPC approach, mean WTP calculated from the TIOLI 
data varies from € 60.7 to € 80.8. These values are substantially higher than the 
mean WTP derived from MPC data (€ 27.30).
While this comparison assumes that the upper integration limit to calculate mean 
WTP is equal to the highest value offered in the MPC, a similar comparison can be 
conducted by calculating mean WTP from the MPC data including only answers to 
the value that were also used in the TIOLI question. This implies calculating mean 
WTP assuming that yes/no answers are available only for 4 values offered to 
respondents (It Liras 5,000, 10,000, 20,000 and 50,000). According to this 
assumption, mean WTP for the MPC data is €10.70, a value that is smaller than 
those derived from the TIOLI data. Only if a very conservative assumption is made, 
which consists in assuming that only “definite yes” reveal that respondents are willing 
to pay and that all the other answers (including “yes, probably”) reveal that they are
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not, mean WTP derived from TIOLI data is similar to mean WTP derived from MPC 
data. However, if model 1, 2 or 3 are assumed (table 7.5), it clearly appears that 
TIOLI data produce larger estimates of mean WTP.
Finally, we simulated TIOLI data from those elicited with the MPC method and made 
a comparison between actual and simulated data (table 7.11). Simulated TIOLI data 
are very similar to those observed. If “do not know” answers are excluded, as they 
cannot be simulated, the percentage of total “yes” answers is very similar between 
observed and simulated data (58.8% and 58.7%, respectively). In the simulated data 
the percentage of “yes” to the highest bid (Italian Liras 50,000 - € 25.88) is slightly 
higher; on the contrary, the percentages of observed “yes” for the lower bids are 
higher than those calculated from the simulated data.
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Table 7.11. Data collected from the T IO L I question and data generated by simulating T IO L I data from the answers to the modified payment card questions.
Bid Observed TIOLI data Simulated TIOLI data (including “Do not 
know” respondents to TIOLI question)
Simulated T IO LI data (excluding “Do not 
know” respondents to the T IO LI question)
Willing to Pay No Willing to Pay Willing to Pay No Willing to Pay Willing to Pay No Willing to Pay
# (%) # (%) # (%) # (%) # (%) # (%)
It. Liras 5,000 (€ 2.60) 808 (63.27) 469 (36.76) 893 (59.93) 597 (40.07) 830 (65.00) 447 (35.0)
It. Liras 10,000 (€ 5.20) 795 (64.22) 443 (35.78) 873 (60.63) 567 (39.38) 812(65.59) 430 (65.59)
It. Liras 20,000 (€ 10.60) 661 (59.60) 448 (40.40) 721 (52.10) 663 (47.90) 657 (59.24) 452 (40.76)
It. Liras 50,000 (€ 25.80) 585 (48.19) 629 (51.81) 586 (41.12) 839 (58.88) 541 (44.56) 673 (55.44)
Total 2,849 (58.89) 1,989 (41.11) 3,073 (53.55) 2,666 (46.45) 2,686 (58.70) 2,152 (41.30)
Logit estimates (constant and 
bid coefficient)
a = 0.67409 
b = -0.01475
a = 0.52002 
b = -0.01790
a = 0.77392 
b = -0.01973
Mean WTP It. Liras 36,866 (€ 19.04) It Liras 38,821 (€20.04) It Liras 36,083 (€ 19.00)
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For both the simulations the same assumption used for the original TIOLI data were 
made concerning the distribution of the probability that an individual will say “yes” to 
the WTP question. It was assumed that it follows a logistic distribution:
P(yes) = (1 + e - a+b*bid)-1
As shown above, mean WTP can be calculated from the probability function by 
integration. The comparison of the original and simulated data is based on the 
assumptions that the minimum WTP is 0 and that the maximum is It. Liras 50,000 (€ 
51.60). Therefore:
50
E(WTP) = i  (1 + e -a+ b*b id )',db
Results derived from observed and simulated data are strikingly similar. Simulated 
TIOLI data generate WTP estimates ranging from €19 to € 20. Based on the same 
assumptions mean WTP from the observed data is € 19.04. If data collected from the 
modified payment card approach are transformed in TIOLI data, the distribution of 
“yes” in the simulated data is similar to the distribution of original TIOLI data. WTP 
estimates are also very similar. Two main reasons may drive these results. First, 
estimates from MPC data may be higher than those derived from TIOLI data because 
of the assumptions concerning the probability function needed to calculate mean 
WTP. The second reason why actual and simulated data are similar may derive from 
the sequence of the questions. Respondents answered the TIOLI question before the 
MPC one. Thus it is plausible that they have anchored their answers to the second 
question to the first one. In other words, simulated and actual TIOLI data are similar 
because respondents wanted to be consistent across the two questions.
7.10. Cost estimates
In this section we present the results of cost analysis. The justification of the general 
approach adopted is presented in Chapter 4 and details about the source of data and 
the methods used are described in Chapter 5.
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Before presenting the results of the cost analysis it is important to underline the 
general approach which was followed. We used a full costing methodology as we 
estimated the cost of IVF cycle as the sum of direct and indirect costs. Direct costs 
refer to those resources that are unequivocally attributable to the object of the 
analysis (the drug administered to the patient or the time spent by the doctor to 
implant the embryos are unequivocally attributable to the IVF cycle). Indirect costs 
refer to the share of costs that pertain to the general functioning of the organization 
or the unit and that cannot be directly attributed to the cost objective (e.g. the cost of 
the administrative personnel or for the maintenance of the technological equipments 
if the cost object is the IVF cycle). To perform a full costing analysis we identified all 
the costs of the organizational unit delivering IVF services (the AR centre) and then 
we apportioned its costs to IVF treatment. In this sense, we used a top-down 
approach as we started from aggregated costs. However, we use detailed 
information collected in the two organizations two estimate direct costs attributable to 
IVF cycles and to identify drivers for the allocation of indirect costs.
The AR centre run by the NHS cost about € 5.2 million in 1998 (table 7.12). A part of 
these costs refer to services that are attributed to the AR centre but technically 
produced by other organizational units of the hospital. Costs for the operating room, 
ward care and diagnostic services are attributed to the AR centre but concern other 
hospital’s departments. For these cost items it was possible to make a direct 
attribution to thethe AR centre.
The AR centre employed 8 full time equivalent workers: 2 biologists, 2 physicians, 2 
secretaries and 4 nurses/technicians. The physicians and the biologists spent only a 
part of their working time in the AR centre. According to our estimates, total direct 
costs (directly attributable) amounted to € 3.7 million and indirect costs to € 1.7 
million. The private centre presented lower costs for virtually all items and provided 
fewer IVF cycles. The overall distribution of costs is similar, although it appears less 
labour intensive in the private hospital. It is likely that this is due to the way personnel 
time is allocated to the organizational units in the two hospitals.
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Table 7.12. Costs o f Assisted Reproduction centre (year 1998)
Cost categories Public Assisted 
Reproduction Centre (€)
Private Assisted Reproduction 
Centre (€)
Personnel 637,426 206,626
Drugs 118,925 68,463
Disposables and other material 199,760 89,008
Equipments (amortization) 219,317 73,630
Diagnostic services 416,588 180,657
Operating room 918,007 337,765
Hospital care 1,212,647 815,490
Total d irect costs 3,722,669 1,771,638
Utilities 21,296 22,558
Other 22,908 30,500
Overheads 1,370,684 505,505
Building (amortization) 69,958 51,006
Total indirect (allocated) costs 1,484,845 609,568
Grand Total 5,207,514 2,381,207
Original data were expressed in Italian Lira; here they are reported in Euro at the parity rate of 1936.27 
Liras for 1 €.
In addition to IVF services the AR centres provided other services to infertile couples 
and dedicated a substantial part of their resources to other units of the maternity 
department (table 7.13). Our informants estimated that the percentage of the time 
spent by the personnel of the AR centre for IVF services accounted to about 60% 
and 50% of the total in the NHS and in the private hospital, respectively. Similar 
percentages were found for drugs and disposables. However, in both centres it was 
estimated that most of the equipment costs had to be attributed to IVF. As operating 
room and hospital care costs were almost totally attributed to IVF, about 80% of total 
direct costs were attributed to IVF services. This percentage was used to allocate 
indirect costs.
Table 7.13. Parameters used to allocate costs of the Assisted Reproduction Centres
Cost categories Estimated % of costs attributed to IVF procedures
Public Assisted 
Reproduction Centre
Private Assisted Reproduction 
Centre
Personnel 60 .50
Drugs 60 .50
Disposables and other material 50 .50
Equipments (amortization) 80 .70
Diagnostic services directly allocated directly allocated
Operating room directly allocated directly allocated
Hospital care directly allocated directly allocated
Utilities 78 83
Other 78 83
Overheads 78 83
Building (amortization) 78 83
These allocation procedures allowed us to estimate that the total costs of providing 
2,257 IVF cycles in the NHS AR centre amounted to € 4.2 million (table 7.14). To
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provide 1,116 IVF cycles in the private centre the estimated cost amounted to € 1.9 
million. These data result in a cost per IVF intervention of € 1,849 and € 1,742 in the 
NHS and in the private AR centre, respectively. To obtain the total cost per IVF cycle, 
the cost of treatment with gonadotrophin-releasing hormone (GnRH) and with follicle- 
stimulating hormone (FSH) need to be added to this value. Treatment costs vary 
across the two centres because in the private one the dosage of FSH reported in the 
protocol is significantly lower. Overall, including GnRH and FSH treatments, the total 
cost per IVF cycle amounted to € 2,732 and € 2,487, in the NHS and in the private 
centre, respectively. In the base case for the cost-effectiveness and cost-benefit 
analysis the average of these two values was used as the cost of one IVF cycle.
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Table 7.14. Costs o f providing In Vitro Fertilization Services and cost per IV F  cycle
Cost categories Public Assisted 
Reproduction Centre (€)
Private Assisted 
Reproduction Centre (€)
Personnel 382,456 103,313
Drugs 71,355 34,232
Disposables and other material 99,880 44,504
Equipments (amortization) 175,453 51,541
Diagnostic services 393,270 174,525
Operating room 752,327 304,711
Hospital care 1,107,806 733,373
Total d irect costs 2,982,547 1,446,199
Utilities 17,062 18,414
Other 18,354 24,897
Overheads 1,098,171 412,647
Building (amortization) 56,049 41,636
Total ind irect (allocated) costs 1,189,635 497,594
Grand Total 4,172,182 1,943,793
Number of IVF cycles provided in 1998 2,257 1,116
Cost of IVF per cycle 1,849 1,742
Cost of treatments with GnRH and FSH 
per cycle 883 745
Total cost of care per IVF cycle 2,732 2,487
On the basis of the analysis conducted by Newman et al. (1994) (see also section 
5.12) we estimated that the average cost of adverse event per IVF cycle is € 522. 
Consequently, the total cost per IVF cycle is € 3,131 (€ 1,765 for the provision of the 
IVF cycle, €814 for drug treatment and €522 for the adverse events).
7.11. Cost-effectiveness of In-Vitro-Fertilisation
In the base scenario used to calculate the cost-effectiveness ratio of IVF the delivery 
rate per initiated cycle is estimated at 12.90% (table 7.15). Assuming that at each 
successive cycle the marginal probability of success declines of 1%, cumulative 
delivery rate is 23.3% after two cycles and 31.6% after three cycles. In other words, 
according to our base case almost one couple out of three will leave IVF with one (or 
more) baby after a maximum of three cycles.
Table 7.15. Effectiveness of IVF (marginal and cumulative delivery rates)
Marginal probability 
of success
Cumulative probability 
of success
1st cycle 2nd cycle 3rd cycle 2nd cycle 3r cycle
Base case 12.9% 11.9% 10.9% 23.3% 31.6%
Women < 40 without male infertility 
factor
18.8% 17.8% 16.8% 33.3% 44.5%
Women > 40 without male infertility 
factor
6.7% 5.7% 4.7% 12.0% 16.2%
Women < 40 with male infertility factor 14.7% 13.7% 12.7% 26.4% 35.7%
Women > 40 with male infertility factor 5.5% 4.5% 3.5% 9.8% 12.9%
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The cumulative probability of leaving the service with a child greatly varies according 
to the age of the woman and the presence of male infertility factor. In the worst 
scenario (woman older than 40 with male infertility factor) the probability of success 
after three cycles is only 12.9%. On the contrary, younger women have much higher 
chances (35% or 45% according to whether the male infertility factor is present).
From an economic perspective the key question is to measure value for money that 
is the cost of gaining the expected outcome. As pointed out earlier, in the context of 
IVF an appropriate outcome measure is the delivery rate (called by some authors the 
maternity rate or live birth rate). Therefore, cost effectiveness analysis takes the form 
of the cost per delivery that is the expected cost of obtaining a “statistical” baby from 
IVF.
Under the assumptions of the base case, the first cycle of IVF costs € 3,131 (if the 
costs of side and adverse events are included) and has an estimated probability of 
success of 12.9%; consequently, the first cycle presents an incremental cost- 
effectiveness ratio of € 24,274 (table 7.16). The cost per delivery increases at 
successive attempts; at the second cycle is € 26,314 and at the third is € 28,728. 
This is because with each failed cycle the probability that the next cycle will be 
successful is revised downward. The raw data of the base scenario can be also used 
to estimate the incremental cost effectiveness ratio of an IVF programme consisting 
of a maximum of three cycles. A couple entering such a programme would expect to 
incur costs for € 8,618 and to have a probability of 31.6% to leave the service with a 
child. This programme would have a cost per delivery of € 27,246. These estimates 
were used to present cost and effectiveness information in the contingent valuation 
survey.
Table 7.16. Cost-effectiveness Analysis for the base scenario (World Register Data) (expected cost per 
delivery)___________________________________________________________________ _____________
At 1st cycle At 2nd cycle At 3rd 
cycle
After the 2nd 
cycle
After the 
3 rd cycle
Incremental costs (€) 3,131 3,131 3,131 5,859 8,618
Incremental effectiveness 12.9% 11.9% 10.9% 23.3% 31.6%
Incremental cost- 
effectiveness ratio (€) 24,274 26,314 28,728 25,183 27,246
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Sensitivity analysis assesses the robustness of results and provides interval 
estimates of the measures (table 7.17). Clearly, the incremental cost effectiveness 
ratio is sensitive to the assumptions about the probability of success of IVF. In turn, 
this is very sensitive to the age of the woman. Cost per delivery ranges from € 16,000 
to € 24,000 for women under 40 to more than € 70,000 for women above 40. The 
cost-effectiveness ratio is also sensitive to the cost of IVF. Using the range of median 
prices of the IVF procedures and of treatments observed in 8 Italian regions in 1998 
(Mantovani et al, 1999), the cost per delivery ranges from about € 16,000 to € 
67,000.
Table 7.17. Cost-effectiveness analysis: sensitivity analysis
Incremental cost-effectiveness ratio (€)
At 1st At 2nd At 3rd After 2nd After 3rd
cycle cycle cycle cycle cycle
Base scenario 24,274 26,314 28,728 25,183 27,246
Women < 40 without male infertility factor 16,656 17,592 18,639 17,063 18,549
Women > 40 without male infertility factor 46,737 54,937 66,626 50,366 55,753
Women < 40 with male infertility factor 21,302 22,857 24,657 21,991 23,800
Women > 40 with male infertility factor 56,935 69,587 89,469 62,451 70,335
Upper limit of cost per IVF cycle (€ 1,1 A l) 60,053 65,100 71,072 62,302 67,405
Lower limit of cost per IVF cycle (€ 1,859) 14,413 15,624 17,057 14,952 16,177
The cost and cost-effectiveness estimates obtained in this study are higher than to 
those of the Italian study. Mantovani et al. (1999) estimated that the cost per delivery 
ranges from € 11,100 to € 19,500. These ratios derive from different assumptions 
about effectiveness. Cost of initial consultations, laboratory tests, egg retrieval game 
culturing and embryo transfers and drug treatments are very similar in the two 
studies (around € 3,000 per cycle). Instead, the probability of success assumed in 
the two studies greatly differ; while in the present study the cumulative effectiveness 
after three cycles is 31.6%, in the study by Mantovani et al. (1999), it ranges from 
50% to 62.2% depending on the drug used for the hormone stimulation.
Estimates of effectiveness used in this study are similar to those presented by 
Neumann et al. (1994) and Ryan and Donaldson (1996) (about 12%). However, in 
these studies the cost of a successful delivery appears higher, especially in the 
American one. This is because the cost per initiated cycle in the US study was 
estimated at $ 8,000 (€ 9,528), a value which is more than three times the Italian 
estimate presented above. The British estimate of the cost per delivery appears close
242
to the value obtained in this study. Based on charges to health boards who 
purchased IVF for the financial year 1991/1992 and including estimates for costs due 
to multiple births and to treating side effects for women, Ryan and Donaldson 
obtained that the cost per delivery (maternity) of IVF was UK £ 22,491 (€ 32,758). 
This value is about 20% higher than the cost per delivery obtained for Italy. Given 
important differences between the two countries (organization of labour, prevailing 
prices) and the band of variation of exchange rates this difference appears modest 
and seem to provide a test of convergent validity of the costing methodologies used 
in the two studies.
7.12. Cost-benefit analysis
First of all, cost data can be related to the WTP for the personal use of IVF. As 
calculated in the previous section, the expected cost of three cycles of IVF is 
estimated to be € 8,618 (including collateral cost of IVF as the costs of more 
complicated pregnancies). The cost of IVF is an issue for 53% of respondents; the 
remaining 47% would not try IVF even if it were free. This means that for these 
respondents the value of IVF is 0 (if not even negative). For these individuals the 
user value component of an IVF programme does not generate any welfare 
improvement. Out of the 3,040 individuals willing to use IVF, 2,161 were willing to 
pay an amount that was insufficient to cover the cost of IVF (table 7.2). In a real 
market, and provided that individuals acted as they stated in the survey, these 
respondents would be willing to pay an insufficient amount to purchase the 
intervention. In a real (not subsidized) market they would not use IVF. Only 879 
individuals (15.3% of the total sample and almost 30% of those who would use IVF) 
would be willing to pay at least the cost, of the procedure. Therefore, out of 100 
individuals with infertility problems about 15 would use IVF if its cost had to be 
completely covered by consumers. Government funding would make possible the 
access to the procedure to an additional 38%.
Data on WTP for private use can be used to make a cost-benefit analysis that 
neglects benefits due to altruism. Such an analysis measures only whether total 
benefits of the users of the programme outweigh costs. Mean WTP for personal use 
of IVF is € 4,767 and € 5,474, according to the way to treat the responders who 
stated to be willing to pay the maximum value presented. The former is based on the 
assumption that maximum WTP is the value of the highest bid, while the latter is
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based on the extrapolation of maximum WTP. As respondent were provided with the 
information that IVF would have been effective with a probability of 0.3, the correct 
cost value to include in the analysis is that of three cycles (that has a cumulative 
effectiveness of 0.316). Data presented in the previous sections allow estimating the 
mean cost of providing three cycle of IVF to be € 8,618.
According to this special type of cost-benefit analysis, IVF would present negative net 
benefits: mean WTP does not cover mean cost; this is due to the fact that a large 
fraction of the sample would never use IVF and thus does not assign any value to the 
procedure. Results change if we include only respondents who are willing to pay for 
IVF. Mean WTP for personal use of IVF of this fraction of the sample varies from €
9,000 to € 10,381; these values are greater than the mean cost (€ 8,618). Therefore, 
if we include in the analysis only respondents who are willing to use IVF, benefits 
exceed costs.
In our opinion, these partial cost-benefit analyses should be undertaken cautiously. A 
full understanding of the value that people attach to IVF to overcome infertility must 
include altruistic considerations. Indeed, our results show that they are very 
important. Nevertheless, if we limit benefits to those stemming from personal use, the 
analysis should be limited to users, thus excluding respondents who state that they 
would not use IVF even if it were free. To understand if the IVF programme produces 
positive benefits we should compare the cost of providing the service to the benefits 
of its use. Consequently, mean cost of IVF should be compared to the mean WTP of 
users. Those who have zero WTP for IVF would not use the service and thus would 
not generate any cost.
From a societal perspective total benefits attributable to the programme can be 
measured as the aggregate WTP for the programme. If the possibility that 
respondents have negative WTP for the programme is ruled out, mean WTP for the 
IVF programme calculated from TIOLI data varies from a minimum of € 10.40 to a 
maximum of € 78.80, depending on the assumptions about the minimum and 
maximum admissible WTP that individuals can have. If it assumed that 0 is the 
minimum WTP and It Liras 50,000 (€ 25.80) is the maximum WTP, mean WTP varies 
from € 10.40 to € 19. According to the estimate derived from the MPC questions, 
mean WTP is € 27.30.
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These estimates can be used to calculate aggregate WTP of the Italian population. 
Census data of year 2001 report that people over 18 years amounted to 47,162,576 
units (ISTAT, 2005). If the estimates derived from the contingent valuation survey 
can be extrapolated to the Italian population, aggregate WTP for the IVF programme 
varies from € 483 million to € 1,431 Million (table 7.18).
The cost of a programme providing IVF to Italian infertile couples can be derived from 
the estimates of the costs of the programme (see previous section). In the 
questionnaire it was suggested that the programme would allow about 10,000 
infertile couples to have a baby. Cost per successful delivery with IVF varies 
depending on the cycle (subsequent cycles have higher cost per successful delivery), 
the age of the woman and the cause of infertility. According to cost and effectiveness 
data presented in the previous chapter, the average cost per successful delivery with 
IVF is about It. Liras 46 million (€ 23,752). Consequently, the cost of an IVF 
programme that would procreate 10,000 babies from infertile couples would amount 
to It. Liras 460 billion (€ 238 million).
Table 7.18. Cost-benefit analysis of a programme providing IVF to Italian infertile couples (10,000 
babies bom from IVF)_____________________________________________________________________
Assumptions on WTP 
estimates
Mean WTP per 
survey respondents 
(€)
Aggregate 
WTP 
(benefits in 
million €)
Total costs of the 
programme 
(costs in million €)
Net benefits 
(million €)
TIOLI data (model 1) 19.04 898.08 237.52 660.56
TIOLI data (model 2) 16.96 799.88 237.52 562.36
TIOLI data (model 3) 14.16 667.82 237.52 430.30
TIOLI data (model 4) 10.39 490.02 237.52 252.50
Modified payment card 
data (un-weighted) 27.28 1,286.32 237.52 1,048,80
TIOLI data, Logit no 
spike (model 1) 23.60 1,113.04 237.52 875.52
TIOLI data, Logit with 
spike (model 1) 26.00 1,226,27 237.52 988.71
TIOLI data, Logit no 
spike (model 2) 10.25 483.42 237.52 245.90
TIOLI data, Logit with 
spike (model 2) 30.34 1,430.91 237.52 1193.40
Modifie payment card 
data (weighted) 26.59 1,253.79 237.52 1,016,27
245
For all the scenarios total benefits greatly exceed total costs. Even if WTP is derived 
from a very conservative hypothesis which assumes that only “yes, definitely” 
responses reveals WTP and all other possible responses (including “yes, probably” 
and “do not know”) reveal that respondents are not willing to pay, aggregate benefits 
are more than the double of total costs. In the most conservative scenario, that 
assumes that only respondents with “yes, definitely” answers are willing to pay for the 
programme costs are about 50% of benefits. Only if we assume that a substantial 
fraction of respondents have negative WTP the programme results as having 
negative benefits.
According to cost-benefit analysis principles, a programme makes a positive 
contribution to the welfare of the population if benefits expressed in monetary terms 
exceed costs. It is thus possible to calculate the minimum value of mean WTP that 
would suffice to cover the costs of the programme. This corresponds to total costs 
divided by the number of individuals being part of the population (in this case the 
adult Italian population). About a mean WTP of € 5.04 per member of the population 
would suffice to cover the cost of an IVF programme generating 10,000 babies from 
infertile couples.
TIOLI data may be used as they resulted from a real referendum. As mentioned 
earlier, if a strict majority rule applied (absolute majority of voters), a tax of It. Liras
10,000 (€ 5.20) to fund IVF would have been approved. Had a less stringent rule 
adopted “voters” would have approved a higher tax. If a relative majority sufficed to 
approve the proposal (the number of "yes” greater than the number of “no”) a tax of 
It. Liras 20,000 (€ 10.30) would have been approved.
Welfare estimates (those based on mean WTP) and decisions based on majority 
rules applied to TIOLI data are in favour of publicly funding IVF to infertile couples. 
Overall, our cost-benefit analysis of IVF in Italy for couples with infertile problems 
shows that it would imply a welfare gain.
246
Chapter 8
Conclusions
8.1. Introduction
The research presented in this thesis makes a number of main contributions, some 
methodological and some substantive. The methodological contributions concern the 
feasibility and the validity of cost-benefit analysis and contingent valuation in the area 
of reproductive medicine. Cost-benefit analysis plays a pivotal role in normative 
economics as it is expected to offer guidance to decision makers about the allocation 
of economic resources. Intuitively, doing a cost-benefit analysis means clearly 
identifying the object of the evaluation (the programme) and to compare costs (use of 
scarce resources) to benefits (contribution to the wellbeing of people) attributable to 
the programme; when benefits exceed costs the programme is valuable, and thus it 
is worth being funded. Not surprisingly, there are a large variety of techniques which 
are consistent with this basic idea of cost-benefit analysis. National governments, 
international institutions (e.g. UN agencies) and organizations (e.g. World Bank) and 
non governmental organizations have their own way of doing cost-benefit analysis. 
Although these methodologies may significantly vary in several respects, what they 
have in common is their attempt to use a logical framework to provide actual 
guidance to decision-making.
Our research started from a similar stance. We wanted to use cost-benefit analysis to 
provide an answer to a precise policy question. The question was: Should the Italian 
government fund IVF treatment for infertile couples? This policy issue has driven the 
choice of the conceptual framework, the research design and the investigation 
methods. Within this policy perspective, in the first part of this concluding chapter we 
review the major methodological issues addressed in the research and provide some 
critical insights.
The other major contribution is strictly connected to the methodology and refers to 
the policy implications of the results of the study. Overall, results support the 
inclusion of IVF (and to a certain extent of other Assisted Reproductive
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Technologies) in the basic package offered by the Italian National Health Service. 
This is an important outcome of the research and it is worth discussing in the light of 
the recent Italian policy of being more transparent and explicit in the rationing 
process, and in the light of the regulation of reproductive medicine. In addition, 
results of the study have implications beyond the decision of whether to include IVF 
in the national guarantees as they help understanding how Italian citizen view 
reproductive medicine and the place it should have in the healthcare system in 
general. These themes are discussed in the second part of this chapter.
In summary the thesis shows that:
- An IVF programmme providing free IVF to infertile couples implies a welfare 
improvement for the Italian society because benefits (€ 400-1,300 millions) 
exceed costs (€ 240 million);
- Altruism is an important driver of this result as respondents are willing to pay 
substantial amounts of money even if they do not need IVF and, more 
importantly, even if they would never personally use IVF in a hypothetical 
situation of infertility;
Societal benefits are mainly attributable to a minory of respondents with very 
high WTP; while cost-benefit analysis fully appreciates the intensity of 
preferences, democratic processes (like referendums) do not; according to 
our survey only 55% of Italians would have approved a tax of € 5.20 
hypothecated to a national programme costing € 5.02 per person.
8.2. Testing actionable cost-benefit analysis
Governments and other organizations acting for the public interest need to be guided 
by economic methods. Clearly, in order to be useful these methods have to be 
feasible and valid. They have to be feasible in that it has to be possible to conduct 
studies in the context of actual decision-making. Typically, in real contexts resources 
and time are limited. Validity refers “to the extent of matching, congruence, or 
“goodness of fit” between an operational definition and the concept it is purported to 
measure” (Singleton and Straits, 1993: 114). In other words, the method is valid if it 
really measures what it intends to measure. The main challenge of the thesis was to 
measure the net benefit of providing IVF treatment to infertile couples. Consequently,
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to discuss the validity of the method requires checking whether it really measured the 
net benefit of such a programme. In turn, to establish the validity of the cost-benefit 
method used in this study a conceptual definition of net benefit is required. Without 
an appropriate theoretical framework, it would be difficult (if not impossible) to assess 
the validity of the method. The theoretical framework adopted in the study is that of 
welfare economics.
Although it would be possible to have a physical measure of the benefits of IVF (that 
is births or pregnancies), we preferred using the notion of value (Williams, 1983) and 
to refer to the willingness-to-pay approach. This
“..approach is derived directly from welfare economics theory and hence 
is generally recognized to be conceptually appropriate for establishing 
individuals’ values from a welfarist perspective" (Birch and Donaldson,
2003: 1121).
A number of authors argue that this should be the preferred approach to be used for 
evaluation health care programmes (Pauly, 1995; Johannesson, 1996a; Birch and 
Donaldson, 2003). In addition, in the area of reproductive medicine other economic 
methods may be inappropriate or of limited scope. It would be possible to use cost- 
effectiveness analysis to calculate the cost per life gained (generated) of IVF. Indeed, 
in Chapter 7 we present this calculation. However, cost-effectiveness analysis of IVF 
cannot be used to make allocative choices because the benefit of a new life cannot 
be compared to the cost of a life saved. The outcome of IVF and other ARTs is such 
that cost-effectiveness analysis is of little help to decide government funding.
Cost-utility analysis is increasingly gaining acceptance in the health care sector. 
While it tries to capture both quality and quantity of life gains of health services, it 
also tries to estimates “benefits" consistently with the axioms of utility theory under 
uncertainty. In theory, cost-utility analysis could be used to assess the benefits of 
IVF. In practice, however, it would be very difficult to elicit the utility of an IVF baby 
through standard-gamble and time-trade-off exercises and, as far as we know, it has 
never been attempted. Both cost-effectiveness and cost-utility analysis do not appear 
the appropriate methods to assess the economic value of IVF. The appropriate 
analysis to measure benefits of IVF is cost-benefit analysis that is the analysis where 
the value of the service is measured in monetary terms and compared to its cost.
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8.2.1. How to measure benefits of an IVF programme
The theoretical base for the measurement of benefits is the concept of consumer 
surplus (Hicks, 1941; Johannesson and Johnson 1990). In principle, the 
measurement of consumer surplus can make use of the willingness-to-pay or the 
willingness-to-accept approach. In the former case the maximum that an individual is 
willing to pay in order to obtain the good is measured, in the latter the minimum 
he/she is willing to accept as a compensation for losing the good is measured. A 
major problem of theoretically grounded cost-benefit analysis is how to estimate WTP 
or WTA. One possibility is to make inferences from actual behaviour of individuals 
(revealed preferences). However, for many goods, especially those for which we are 
interested in performing cost-benefit analysis, actual transactions do not exist or do 
not take place in competitive markets so that market signals are lacking, distorted or 
difficult to capture and interpret.
Given its flexibility, the CV method can be used to measure WTP or WTA. In 
practice, however, WTA is rarely used when the respondent does not have the good 
being valued. In such a case the question is cognitively difficult because the 
respondents should first imagine having the good and then they should formulate the 
compensation of having it taken away. The willingness to pay questions are easier to 
understand, especially if the respondent is not familiar with the good. Therefore, we 
performed the cost-benefit analysis making WTP questions aimed at measuring the 
compensating variation (the amount of money willing to pay for the benefit) for an IVF 
programme.
The CV method is a powerful approach to be used for priority setting and to offer 
guidance to the allocation of resources in publicly funded health care systems. 
Depending on the decision-making context, various approaches can be followed. A 
major choice concerns whether one programme at a time is evaluated or several 
programme simultaneously are evaluated (Olsen et al., 2005). Both approaches 
present strengths and weaknesses. Although a thorough theoretical discussion of 
each of them is beyond the scope of this thesis, it is important to outline some major 
methodological issues.
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On one hand, the focus on a single programme allows the respondent to be more 
informed about the programme. In addition, this approach mimics purchase decisions 
and voting in referendum, in that in real life decisions regard one thing at a time 
(even if people make trade off in their minds). On the other hand, this approach has 
been criticized by Olsen and Smith (2001) to be of no aid to decision-makers if the 
healthcare system operates under a global budget.
It is argued that even if WTP for a new programme exceeds its marginal social costs, 
it is not guaranteed that it provides a welfare improvement. Welfare gains require that 
marginal benefit equals marginal cost for all existing programmes and this is 
unknown unless all health services already funded are investigated. In addition, if 
budget is fixed it is necessary to rank programmes to the extent of their net benefit so 
that total net benefits are maximised under the funding constraint (that may 
insufficient to fund all services with benefits greater than costs). Hence, Olsen and 
Smith (2001) conclude that: “a partial valuation is not an aid to decision-makers, if 
money is to be taken from a given health care budget”. This critique is a serious 
concern for cost-benefit analysis and it is a thorny issue in welfare economics as it 
calls for “second best” solutions.
In this study we did not frame the WTP scenario and questions on the basis of the 
assumptions that the budget is given. Indeed, it was clearly stated in the 
questionnaire that additional taxes were raised to fund the IVF programme. If the 
welfare function is separable in respects of the programmes funded by the given 
budget, cost-benefit analysis of one programme at a time may provide useful results. 
If the WTP for a new programme exceeds its marginal social costs and its provision 
is funded outside the given budget, the addition of the new programme improves 
social welfare. Notice that the opposite is not true. If WTP does not exceed social 
costs it cannot be assumed that the programme has to be rejected. Furthermore, 
there is the possibility that some programmes are inefficient and would thus make it 
possible to free resources that would have been used for the rejected programme.
If it is possible to add resources for new programmes, evaluating one programme at 
a time is theoretically sound. In addition, strategy of evaluating more programmes 
together may be hindered by practical concerns. It is difficult to survey respondents 
on different programmes at the same time. An adequate description of the
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programme being evaluated is essential to make the survey valid, especially if many 
respondents are not familiar with the good that is being evaluated as it is the case 
with IVF. Had we described one or two programmes in addition to IVF, in the survey 
we would have probably reduced the attention and comprehension of respondents of 
the IVF programme.
As discussed in Chapter 3, WTP estimates of health benefits are often made through 
contingent valuation (CV) surveys where direct WTP questions asked. More recently 
a new approach, called Discrete Choice Experiments (DCE), has been used for 
estimating benefits of health care programmes (McIntosh et al., 1999; Ryan, 2004). 
Here respondents are asked to choose between alternatives, described in terms of a 
graduated set of attributes (including price). Then, econometric methods (variations 
of logit and probit models) are used to estimate WTP for marginal changes in 
attributes and overall welfare measures (Hanley et al., 2003).
The use of the DCE approach in health care is still experimental and debated (Bryan 
and Dolan, 2004; Cairns et al., 2002; Cairns and van der Pol, 2004; Lancsar and 
Donaldson, 2005). One major issue concerns the cognitive burden associated with a 
full DCE survey as it must include several questions with different levels of the 
attributes. We believe it would have been too cognitively demanding to conduct a 
WTP survey with several questions having different levels of the attributes of the IVF 
programme. The “traditional” CV approach was deemed more viable. It is worth 
noting that one of the very few studies comparing the two methods is on ARTs. Ryan 
(2004) conducted two studies with the same users of IVF in an Assisted 
Reproductive Unit at Aberdeen and found that the welfare estimates derived from the 
two methods were not significantly different.
Our survey provides some evidence that contingent valuation is feasible and valid. 
This is the first large CV study in Italy and the first attempt to survey WTP for IVF of a 
sample of the general population. Other studies (Ryan 1996, 1997, 1998 and 2004; 
Neumann and Johannesson, 1994) have either surveyed people attending ART 
centres or convenient samples of students and health professionals. Our survey 
involved individuals of all ages and of a large variety of socio-economic conditions. 
The low number of inconsistent answers, the extremely low number of answers that 
can be considered as “protest” answers, the positive correlation between socio­
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economic measures and WTP and the consistency of results across elicitation 
methods are all elements in favour of the validity of the survey. This study shows that 
asking the general population WTP questions is feasible and provides internally valid 
answers.
A widely debated issue in CV research concerns the elicitation method. The 
guidelines of the National Oceanic and Atmospheric Administration (NOAA) of the 
US government (Arrow et al., 1993) have had a strong influence in this respect, 
including our research. They strongly argued in favour of a referendum format where 
respondents are asked to answer yes or no and are allowed to refuse to answer. We 
followed this recommendation as we randomly split our random sample in 4 groups 
and to each we submitted a different value. In addition, we included the “do not 
know" option. We also articulated both “yes” and “no” answers to get additional 
information on the strength of preferences. Respondents could choose between 
probably and definitely (“yes” or “no”). Given that we had a tight constraint on the 
number of questions, we did not follow the standard of framing a “yesTno” question 
first, and then asked respondents how much they were sure about their answers. 
Rather, we opted for only one question with 5 options (“yes, definitely”, “yes, 
probably,” “no, probably”, “no, definitely” and “do not know”). We are aware that the 
two approaches are not equivalent as they are associated with different cognitive 
processes. However, the relative advantages and disadvantages of the various 
approaches to sequence questions are presently unclear, at least to our knowledge.
As we were aware that to use only four values would have produced estimates with 
large confidence intervals for the entire sample we included a subsequent series of 
yes/no questions to a larger number of values. While this method is similar to the 
MPC as far as the calculations to estimate WTP are concerned, it is not a proper 
MPC because it presented 8 different specific values and asked respondents to state 
yes or not to each one. The list of values included the four values used for the 
referendum format and other four values so to offer respondents the possibility to 
choose from It Liras 2,000 (€ 1) to It Liras 200,000 (€ 103). Hence it was possible to 
compare the answers of the two questions’ formats and to undertake a convergence 
validity test. Obviously, a major limitation of this check is that it cannot be assumed a 
priori that the answers of the questions are independent.
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8.2.2. Eliciting WTP for an IVF programme: Whose value?
Although IVF appears a popular topic for the CV literature, probably because of the 
limitations of cost-effectiveness studies in the area of reproductive medicine, we are 
aware of only two studies that draw clear policy conclusions from a cost-benefit 
analysis of IVF (Granberg et al., 1995; Ryan, 1997). These studies were discussed 
earlier (Chapter 2 and 3); it is worth mentioning here that they are based on 
surveying IVF users and thus that policy implications do not derive from the 
perspective of those funding such a programme in a public system.
Granberg et al. (1995) concluded that, according to their study conducted in one 
centre in Goteborg, the benefit to the infertile couples (those treated in the Centre) 
was higher than the cost to the Swedish NHS. They did not state that this result 
implied that public funding was warranted, although it is implicitly suggested. On the 
basis of cost data obtained in Scotland (Ryan and Donaldson, 1996) and WTP data 
from 466 IVF users of the Aberdeen’s Assisted Reproduction Unit (Ryan, 1997; 
Ryan, 1999) a more explicit conclusion was drawn: “The results suggest that the 
benefits of providing the service outweigh the costs, and that public provision of the 
service should be encouraged” (Ryan, 1997: 842).
Our survey asked respondents their WTP for personal use of IVF. This way we 
measured the hypothetical user value of IVF and could obtain a measure partly 
comparable to that obtained by the above-mentioned studies. Obviously, a major 
difference is that our respondents were asked to imagine a hypothetical situation, 
while in Granberg et al (1995) and Ryan (1997) studied patients who actually 
experienced infertility and went through IVF. In both surveys it was performed an ex- 
ante evaluation of the programme with the aim of measuring the user value of IVF. 
Hence, our survey allows making a cost-benefit analysis similar to that proposed by 
Ryan, but based on the preferences of the general population rather than of the 
actual users of IVF. Although hypothetical situations may be associated with special 
validity and reliability problems, this approach allows the measure of welfare gains 
from the point of view of those who are requested to pay for the publicly funded 
programme.
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In our sample, it would have been useful to compare WTP between those who 
experienced infertility and IVF those who did not. However, no question was asked 
about the personal infertility problems and the use of ARTs. Such questions were not 
asked to avoid making the survey too sensitive to emotional issues. Ex-post, we think 
that we should have included a specific question concerning the personal experience 
of the respondent with infertility and IVF. However, it is worth noting that the two 
questions asking for the acquaintance of respondents with people with infertility 
problems or who experienced IVF may serve, to a certain extent, as proxies.
Whilst there is no doubt that user value is an argument of the utility function of 
individuals, the issue of whether other arguments may be included is still debated. 
Birch and Donaldson (2003, 1122), following Culyer (1991), argue that assuming that 
“ i) social welfare is a function of individual utilities and ii) individual utilities are a 
function of the commodities (i.e. goods and services) consumed by those individuals” 
are restrictive assumptions that, at least partly, can be relaxed without violating the 
general axioms of welfare economics. The issue of values other than those derived 
from the personal use of the good has been discussed in health economics in the 
context of whose values CV studies should be elicited (Hanley et al., 2003). Two 
other sources of value are deemed relevant: “caring externality” (utility derived from 
knowing that someone else is using the good) (Culyer, 1976; Ryan, 1996; McIntosh, 
1999; Hanley et al. 2003) and “option value” (utility derived from knowing that a good 
is available for future use given demand uncertainty) (Weisbrod, 1964; Ryan, 1996; 
McIntosh, 1999; Hanley et al. 2003).
The “caring externality” reflects an altruistic feeling while “option value” reflects a 
personal interest in having a sure access to a good whose demand is uncertain, and 
it is associated to the value of an insurance product. Both these non-user values can 
be captured in a survey of the general population if the programme being evaluated 
is the provision of IVF services to infertile couples with public funding.
In this respect our study provides new evidence. We used a national sample to elicit 
total WTP for a programme providing IVF to infertile couples with public funds and, at 
the same time, WTP for a hypothetical personal use of the service. Our estimates of 
WTP for personal use of IVF is not a component of total WTP because survey 
panellists were presented with an ex-post scenario in which they had to imagine
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being infertile and willing to have a baby. If we had only formulated the demand as a 
probabilistic ex-ante scenario, WTP for using IVF would have had to be smaller than 
total WTP. Nevertheless, our study provides new evidence on the existence of a pure 
altruistic component of WTP. About two-thirds of respondents who would have not 
used IVF were willing to pay something for a publicly funded programme. WTP of 
these individuals is purely altruistic because the programme would not be used by 
the respondents even if it were free. It is worth noting that these respondents stated 
that they were not willing to pay in a hypothetical situation. For them, altruism goes 
beyond the concept of fair innings. They would be paying to make something 
available to others that holds no value for them, even in a hypothetical situation. This 
finding is new in the area of IVF and ARTs and shows that procreation is conceived 
by people as an area for solidarity of funding arrangements.
The particular way we framed the questions allowed us to make a distinction 
between two kinds of altruism that may deserve attention in future studies. Normal 
altruism refers to the willing to pay for something that is not used but would have 
been used by the subject if he/she were in a different condition. Pure altruism refers 
to the situation where a person is willing to pay for something he/she would never 
use under any condition. This form of altruism reflects a combination of solidarity and 
freedom, as it expresses the willingness of individuals to help others to make 
different choices. It seems to us that donating in order to let others have the same 
goods we have is profoundly different from donating to let others have a good we do 
not want to have. The latter, at least in some circumstances, reveals a larger scope 
for solidarity.
8.2.3. Eliciting WTP for an IVF programme: using Internet
The idea of surveying the general public on IVF was tested in a study performed in 
Boston at the Harvard School of Public Health (Neumann and Johannesson, 1994). 
The authors used a convenience (clearly unrepresentative) sample and consequently 
did not draw policy conclusions from their analysis. They also clearly stated with 
reference to IVF that “to use results for policymaking, it will be important to use a 
representative sample of the population in future studies”.
From the beginning our study wanted to provide a picture of the WTP for an IVF 
programme of an entire population, so to provide an analysis that could really offer
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guidance to policy making. We reviewed the major methods of administration of CV 
questionnaires and found that they were either inappropriate (it would be difficult to 
present IVF and to make WTP questions in a telephone interview) or too costly (face- 
to-face interviews are appropriate but were unaffordable given the budget). These 
constraints led us to test a new method to administer CV surveys: internet. When we 
designed the survey no scientific literature was available to understand its pros and 
cons and very few scientific studies had been conducted. Nevertheless, this method 
was appealing to us because it was seen innovative, and thus represented an 
opportunity for testing a new method, and was affordable.
We described how the survey worked and the characteristics of the panel that we 
used in Chapter 5. Here we simply summarise the potential benefits of the method: it 
reaches high response rates, it introduces flexibility in the questionnaire design and 
eases the control of respondents’ and sample characteristics. In our opinion these 
advantages justified the test presented in this thesis.
Our survey performed well and gave results consistent with surveys administered by 
telephone, face-to-face or by post. The number of respondents whose answers were 
inconsistent is limited (3-5%) and the number of answers that could be clearly 
detected as “protest” was about 20 (about 0.5%). It appears that the survey panel 
took the questionnaire seriously. Results of regression analyses appear consistent 
with a priori expectations. More importantly, the income of the respondent (or the 
self-attributed socio-economic class) is positively associated to WTP for IVF and, in 
the referendum format the higher the value offered the smaller the fraction of 
respondents willing to pay. These basic validity checks show that this method to 
administer the survey did not present any special problem and performed similarly to 
the others.
Further evidence in favour of this new method of collecting CV data come from two 
problems often encountered in the CV literature, that have also been detected in this 
survey . First, the WTP estimates derived from the referendum format exceeded the 
estimates derived from the modified payment card (MPC) format. Second, we 
detected a relevant anchor biases in the WTP answers. Respondents appear 
influenced by the value given in the referendum format when answering to the MPC 
questions. Both these problems are largely known in the CV literature. To detect
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them in a large internet based survey confirm their presence across any type of 
survey method.
Overall, this study presents important evidence in favour of using internet to survey 
people for eliciting WTP. Despite the lack of experience in designing internet surveys 
and little help from the literature, it appears that the survey worked well and that 
respondents had “normal” reactions to the stimuli of this method of administration of 
the questionnaire. We could not detect anything seriously abnormal in the survey. 
We do think that this attempt to use internet to elicit WTP for a health care 
programme has been positive. Given the potential benefits of the method, internet 
surveys should deserve more attention by the health economics scientific community.
At the moment, an internet survey cannot be fully representative of the general 
population. The older and less educated are seriously underrepresented in the sub­
population of internet users. This is a serious issue that may undermine the utility of 
the method. However, age and education may introduce biases also with the other 
methods and, given the large amount of information that can be collected on survey 
panellists, post survey corrections can be used to make the sample more 
representative. In effect, we adjusted estimates obtained from the survey to make it 
more representative of the Italian population.
Finally, we also want to highlight that the use of an electronic panel established and 
administered by an independent institution significantly limited the room we had to 
design our study. We had a restricted number of questions that we could administer, 
we had to avoid highly sensitive questions and, more importantly, we had very limited 
room to produce different versions of the questionnaire to submit to sub-samples. In 
this respect we paid a relevant price for the use of this novel method of survey 
administration. The possibility to collect data from a sample of the entire Italian 
population costed us a sub-optimal design of the questionnaire. Having said that 
however, we want to underline that CV is a sophisticated and complex technique to 
gather relevant information and that, unavoidably, conducting a good study means to 
decide about trade-offs and to find a balance between different instance that 
contribute to the quality of the study (sampling, framing of the questions, 
methodological tests).
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8.2.4. Eliciting WTP for an IVF programme: Which elicitation method?
In many respects we tried to follow the NOAA panel recommendations for conducting 
contingent valuation studies of environmental goods. We tried to follow these 
recommendations also in respect of the elicitation format. For environmental goods, 
the NOAA panel strongly criticized the use of open-ended questions and 
recommended that “the valuation questions should be posed as a vote on a 
referendum” (Arrow et al., 1993). We framed the first question concerning the IVF 
programme for IVF exactly according to these guidelines. However, we were allowed 
to split the sample into only four groups. Given the size of the sample, this made 
precise estimates for each value but collected limited information about how WTP 
varies for different values. Indeed we only collected information on whether 
respondents were willing to pay four values: approximately € 2.60, €5.30, €10, and 
€25.80. Results clearly show that our measurement instrument was not sensitive 
enough; the difference in overall “yes” answers was only 13% between the lowest 
and the highest bid. As we anticipated this result, we added a modified payment card 
(MPC) with 8 different values to all respondents. In effects, the MPC method was 
more informative as for the highest bid (€ 103.30) “yes” were 55.6% and for the 
lowest bid “yes” were 10.3%. A similar degree of sensitivity was found in the survey 
for personal use of IVF.
Overall both the elicitation methods that we used appeared feasible and easily 
understandable to the respondents. In the referendum format “yes, definitely” 
answers were strictly declining, but “yes” answers (sum of “definitely” and “probably”) 
where not strictly declining because the fraction of “yes” respondents for Italian Liras 
5,000 was lower that the fraction of “yes” for Italian Liras 10,000 (about 1% 
difference). In the modified payment card question, where values where presented 
randomly to each respondent, we found a limited number of inconsistencies and a 
very few answers that may be considered “protest”.
The main purpose of this survey was not to test the CV method in general and thus it 
cannot provide strong arguments in favour of its validity and reliability. Nevertheless, 
it gave apparently reasonable results and did not show any strong evidence 
supporting the claim the method had serious validity problems. Really, the use of two
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elicitation methods in the same survey provided material to test the convergent 
validity of the methods and to detect anchor biases. The evidence on convergent 
validity is equivocal. The two methods produce different WTP estimates. If the 
possibility of negative WTP is excluded, TIOLI estimates results higher than the MPC 
estimates. Consistently with other studies (Ryan, 2004) and the position of the NOAA 
panel (Arrow et al., 1993), we found that TIOLI may overstate true WTP. However, 
surprisingly we found that the answers of the questions in the two formats were 
strikingly consistent. The elicitation methods are not convergent but respondents are 
consistent in providing their answers across the two methods. This suggests that the 
difference in WTP values may derive from the assumption used to make the 
estimates and, particularly, those determining the WTP of the respondents with the 
highest WTP. Definitely, this issue deserves more attention in future specific studies.
The evidence in favour of an anchoring effect is solid. Respondents are significantly 
influenced by an initial value, even if it stated in a different question. The direction of 
this bias is expected: the higher the initial value, the higher the estimate derived from 
the following MPC questions. Is this bias disturbing? Yes, to a certain extent it is. It 
would be much better to have a measurement system that it is insensitive to 
contingent elements. However, it is naive to think that such a method can exist. A 
major learning that economists got from psychology is that preferences are 
responses to stimuli and hence cannot be investigated as they were an object 
independent by the context and the observer.
Social sciences refer to two main concepts of validity: criterion-related validity and 
content validity (Straits and Singleton, 1999). We have evidence on both concepts in 
our study. Criterion-related validity concerns the degree to which the concept under 
consideration enables one to predict the value of some other concepts that 
constitutes the criterion. In this study criterion-related validity is provided by the 
association between answers to the WTP questions. Construct validity is to be tested 
at theoretical level and requires a consistent pattern of relationships. Our study 
provides evidence in this respect in that some variables have the expected 
association with WTP. First of all, income and socio-economic status measures are 
significant regressors of WTP in virtually all models. Once the effects of other 
variables are controlled, people with higher income (or better socio-economic status) 
have higher WTP. This is a standard requirement in WTP studies that is fully
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respected in this study. In addition, most of the variables that were expected to 
explain variability of WTP have statistical significance and present the expected sign. 
Respondents who are employed, are more educated and live in larger municipalities 
show higher WTP for IVF, even after controlling for income. These results are 
consistent with expectations as IVF is a sophisticated technology that requires 
knowledge to be comprehended and that help couples who may have delayed 
procreation because of studies (Italians complete university studies later in their life 
than other Europeans) and professional expectations. To a certain extent, IVF and 
other ARTs are goods for the middle urban classes, rather than for the very rich 
(difficult to fully represent in such a survey) and the lowest social classes. When the 
models included all these variables, it also appeared that southern respondents are 
different from northern ones in that the former have higher WTP. Other things being 
equal, it appears that southern people’s preference for IVF is stronger. This result is 
expected as it is consistent with southern values and traditions which favour large 
families and tend to blame childless couples.
In the case of IVF a relevant part of the population may attribute zero value to a 
public programme. Some individuals simply do not see any benefit in the programme 
and thus they have a zero WTP. The possibility of zero WTP is particularly important 
when the TIOLI format is used. Basically, in this method the answer to the yes/no 
question reveals minimum/maximum values of the WTP distribution. For example, if 
the lower value offered is € 5, no-respondents are only signalling that are not willing 
to pay that amount. How this information is used to estimate the WTP distribution or 
only a value of the central tendency depend on the assumptions about the probability 
distribution function, if a parametric or a semi-parametric approach is followed, or the 
algorithm used to calculate mean or median WTP if a non parametric approach is 
followed. The crucial point here is that the issue of zero WTP may require using a 
semi-parametric approach so to better model the characteristics of the preferences to 
be elicited. In the thesis we tested a particular semi-parametric model labelled “spike- 
model”. Simply, the model is based on the combination of two probability density 
functions, one concerning whether the individual has zero or positive WTP, the other 
reflecting the probability that individuals with positive WTP accept different values. 
Intuitively, this method assigns zero WTP to a part of the sample and, compared to a 
“normal” logit model, preclude negative observations.
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Results of the various models we used are consistent with expectations and confirm 
that the assumptions about the probability distribution function significantly matter. 
The case of IVF clearly suggests that it really matters whether it is assumed that 
individuals may have negative WTP for the programme. Provided that negative WTP 
is excluded, whether a spike or another model is used does not have any large effect 
because the left tail of the WTP distribution contributes little to the mean WTP. The 
relevant issue is how to model the right tail of the distribution because the mean WTP 
is substantially determined by the (relative) modest part of the sample that is willing 
to pay the highest amount.
The survey presented in the thesis was designed as a part of a full actionable cost- 
benefit analysis. Methodological choices were mainly based in the attempt to follow 
best practices. Nevertheless, it provides some important contributions that are worth 
being summarised. First, this was the first survey administered to a sample of the 
general population on infertility and IVF. It proved to be feasible and results appear 
valid. This shows that contingent valuations, even on a critical issue as IVF in Italy, 
can be conducted on samples of the general population. Second, a few 
methodological tests were made possible by the survey design. All of them appear 
consistent with previous studies. This is very important because they provide 
evidence in favour of the major methodological contribution of our survey. This is the 
first attempt that we are aware of that estimated WTP from the general population 
through an internet survey. We have collected evidence that the internet may be a 
valid mode to administer CV survey. This result is of paramount importance because 
an internet survey may present several advantages over the traditional methods, 
including costs, time, flexibility and control over respondents.
8.2.5. Costing methods
Although the fact that both costs and benefits have similar impact of results of cost- 
benefit analysis is rather obvious, researchers often pay very little attention on how to 
estimate costs. In this study we spent a fair amount of time and energy to produce 
good estimates of costs of providing IVF in Italy. First, we selected the procedure to 
calculate costs on the basis of a review of the possible methods available and of a 
basic understanding of cost accounting, the management discipline dealing with 
costs and their use for decision making. Second, we selected two Assisted 
Reproduction centres and performed a micro-costing study. Basically, we collected
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data and information about the two centres and used them to estimate the full costs 
of an IVF cycle. Therefore, our cost-benefit analysis is based on a specific costing 
study, based on pondered methodological choices.
In Chapter 4 we argue that full costing is the most appropriate procedure when cost- 
benefit analysis should inform the inclusion of an item in the basic package of the 
services to be provided with public funding. We think that this is the appropriate 
approach because it approximates long-run marginal costs. In the long run, if the 
decision is whether or not to provide the service with public funds, all categories of 
costs tend to vary and thus appropriate measures of costs should include a fair share 
of overheads.
In the empirical part of the study we were consistent with the full costing 
methodology, despite the difficulties of obtaining appropriate data. Therefore, this 
study was based on the collection of original data on both sides of the economic 
analysis (benefits and costs). As we have pointed out that costing is often overlooked 
in cost-benefit analysis, we think that a major contribution of this study is the 
illustration of an example of how data, generally available in health care 
organisations, can be used to estimate costs for cost-benefit studies.
8.3. Limitations of the study
Had we the opportunity to re-start the project we would make some different 
methodological choices. First, testing and piloting was insufficient. We were under 
time pressure because the use of the ACNielsen-ISPO panel was possible in a 
certain period only and could not delayed. For this reason we tested a hard copy of 
the questionnaire with a small convenience sample of colleagues and three 
experienced professional pollsters provided some useful comments. Had we carried 
out a better pilot we would have probably used more informative bids in the 
referendum questions and more appropriate values for modified payment card 
questions. Better planning could have allowed us to improve the survey. However, 
the issue of piloting internet survey through commercial panels is particularly critical 
as costs of pilots may be relevant, compared to the overall costs of the survey, and 
may interfere with the sampling procedures. Having said that however, after a few 
years since the survey was conducted the scenario descriptions appear clear and
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effective (see Appendix) and we do not have serious regrets about how we framed 
the questions.
Second, in addition to performing a full cost-benefit analysis we could have 
investigated more methodological issues. The substantive aim was overriding and 
distracted us from using the survey to test some methodological issues that were 
unexplored when the survey was designed (autumn 2000) and are still debated. 
These issues include sensitivity to the scope of the programme (e.g. by providing 
them different scenario in terms of beneficiaries and/or probability of success), 
sequencing of questions and a better design of the relationship between WTP for 
personal IVF use and WTP for the publicly funded programme.
Third, there are other two specific choices that may be disputed. We did not 
randomly select the bids for the referendum questions as we did not randomly select 
the values for the MPC questions. Random selection of bids was not recommended 
by the NOAA panel but has been used in a few studies, including one on IVF (Ryan, 
2004). Lack of randomisation of bids was also found to be source of relevant biases. 
Our bids and values were purposely selected. For the referendum format, we think 
that if we had done a random selection we could have selected bids of limited 
informative values (e.g. to covering a limited range). The main problem in this respect 
was the limited number of bids that we used in the referendum format, rather than the 
way we selected the value. It is worth reminding that this is due to lack of flexibility in 
managing the electronic panel and to assure that each sub-sample was 
representative of the Italian population. Nevertheless, we could have randomly 
selected the values used in the MPC questions. The other contestable choice 
regards the lack of any follow-up questions. We were aware that this is an important 
limitation but, again, the inclusion of an open-ended question in the electronic 
questionnaire was not possible for technical reasons.
As mentioned earlier we did not include any question on personal experience of 
surveyed individuals with infertility and IVF services because they were deemed too 
sensitive. Probably, the inclusion of such questions would have caused some 
concern to a few respondents and, maybe, would have induced more protest 
answers. However, information about the direct experience of respondents with
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infertility and IVF would have substantially enriched the survey and would have made 
possible to investigate WTP for personal use of IVF services.
The fifth limitation is probably the most important. We did not address the issue of 
negative values. That is, we did not expect the possibility of hostility towards IVF. 
This issue was not addressed in the past, at least for what we know, and was not 
sufficiently addressed in this study. Really, this is probably the most relevant issue 
differentiating IVF from other health care programmes; it deserves attention from a 
theoretical, methodological perspective as it also relevant from policy perspectives. In 
many phases of this investigation we felt it would have been appropriate to analyze 
the possibility and the implications of measuring negative WTP for IVF, but we could 
not adequately frame the issue and we did not include any question on this issue. Ex­
post, we regret not being more courageous in this respect. We strongly encourage 
research on negative WTP values because we do think that if we include caring 
externalities to capture altruistic feelings we should also investigate whether funding 
programmes that are deemed against personal values may have a negative impact 
on individuals’ utilities and thus social welfare.
8.4. Policy implications
This is the first study that tried to provide an answer to the question “IVF should be 
publicly funded?” by investigating WTP of a national representative sample. Results 
clearly provide a positive answer to the question. Our WTP estimates per Italian 
resident, ranging from €10 to € 70, are much higher than the expected per capita 
costs of providing IVF to 30,000 couples to procreate 10,000 babies (between € 4.70 
and € 5.20). Our results appear robust as they hold under several circumstances. As 
stated above, the only major challenge to our net benefit estimate is that our results 
hold but we do not admit that some people may experience disutility due to public 
funding of technologies for assisting reproduction.
This study was designed to capture the perspective of Italians. There are no doubts 
that countries may have relevant specificities in respect of ARTs, as they touch 
critical cultural, social, religious and ethical themes. Overall, however, we think that 
these results can have some value for other European countries. After all, religious 
arguments are very important in this area of medicine and the fact that Italy is a
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catholic country with an influential role of the Roman Church should bias against 
rather than in favour of public funding of IVF.
Interestingly, while we used a referendum format to elicit WTP for publicly funding 
IVF (the questionnaire was administered in year 2000), in June 2005 Italy had a 
popular referendum to abolish the new legislation restricting the use of ARTs. 
Reproductive medicine is one of the most divisive issues that Italian society has 
experienced since the end of WWII.
Legislation permitting and regulating abortion was passed by the Parliament and 
resisted a popular referendum in the early 80s. The Catholic Church, fiercely against 
this legislation, obtained the support of the largest Italian political party (Christian 
Democrats). The fact that about 80% of Italians went to the polls and a neat 
(although limited) majority voted for maintaining the legislation had important 
implications for the Italian society and politics. In the following 20 years ARTs was 
the new terrain of confrontation between the Catholic Church and a large variety of 
social and political groups. Up until 2005 Italy had been without relevant legislation 
about ARTs. Several attempts failed in the 90s. Once, despite a bi-partisan 
agreement, legislation that was killed by parliament members that claimed that for 
such a sensitive issue they had to follow their moral values and thus could not obey 
to the indications of their parties. Only in 2004 was a national law on ARTs approved 
by the Parliament. The law was passed because of the large majority of the 
Berlusconi government in both branches of the Italian Parliament and the strong 
support of the Catholic Church. The new legislation permits IVF and other ARTs, but 
only with couples’ genetic material. In addition to forbidding heterologous ARTs, the 
legislation bans freezing embryos and limits the number of embryos that can be 
implanted in the woman’s womb to three. This is one the most restrictive legislation 
that major European countries have on ARTs and is reported to cause migrations to 
other countries to circumvent it.
The national referendum, called by two million Italians who wished to abolish this 
legislation, failed because only 34% of adult Italians (automatically registered to vote) 
went to the polls. Basically, those who favoured the approved legislation campaigned 
against going to the polls so that, despite a swiping majority among voters, 
abolishers did not reach the quorum of the majority of Italians registered to vote and
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thus the legislation was not abolished. Likely, if the decision had been taken on the 
basis of the intensity of preferences, as cost-benefit analysis does, the outcome 
would have been different.
Whilst limiting access to ARTs services, the legislation enacted in 2004 (L. 40/2004) 
provided public coverage to ARTs and created a hypothecated annual funding line of 
€ 6.8 Million aimed at “facilitating” access to fertility services. This funding is very 
limited, as it will cover about 3,000 IVF cycles (if a full costing method is used and 
costs of stimulation treatments are included). However, it signals the decision to 
include ARTs in the Italian basic package (Torbica and Fattore, 2005).
In the 1990s IVF was a preferred target of explicit rationing exercises. The Dutch 
committee on choices in health care (Dunning, 1992) used the IVF to exemplify how 
certain services could be excluded from basic coverage on the ground that they are 
not a medical necessity. The basic health plan proposed by the first Clinton 
Administration in the US did not include IVF and the Oregon list ranked IVF at the 
very bottom (Spar, 2006). In 1994 almost a quarter of English Health Authorities 
decided not to purchase IVF (Wiles and Patel, 1995). About ten years later the 
situation appears to be different. Over time IVF and other sophisticated ARTs have 
gained acceptance and have been increasingly funded with public money, as it 
shows the English NHS (NICE, 2005).
The availability of IVF services under the NHS still greatly varies across the country 
(NICE, 2005). IVF is a classic example of rationing by postcode: in some Health 
Authorities it is available and in others, it is not, without any clear rationale. In such 
situations, the National Institute for Health and Clinical Excellence (NICE) was asked 
to issue a guideline on assessment and treatment of people with fertility problems. 
The guideline was published in February 2004 and included indications about the use 
of IVF services. Basically, it suggested that up to three cycles should be offered to 
couples in which the woman is aged 23-39 years and who have identified cause for 
their fertility problems or who have infertility of at least 5 years’ duration. When the 
guideline was released John Reid, the Secretary of State for Health of England, 
announced that all Primary Care Trusts that were not currently offering IVF should be 
in the position to offer 1 cycle to those eligible, with the longer-term aim for full 
implementation and 3 cycles for patients eligible for treatment.
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Briefly, on the basis of clinical evidence and cost-effectiveness studies NICE 
suggested the inclusion of IVF in the package of services that the English NHS 
should offer to citizens (NICE, 2005). This policy is consistent with the results of our 
study in Italy. However, it does not appear that cost-benefit studies have been used 
to prepare the NICE guideline. In our opinion, cost-benefit analysis should be openly 
used to provide evidence by authorities in charge of summarising evidence to be 
used in policy making. Cost-benefit analysis is significantly different from ACE and 
ACU because it is the only valuation technique that ha no need to provide anchor 
points as a means of interpreting values (Fox-Rushby, 1993). In addition, there are 
circumstances in which cost-effectiveness and cost-utility are inappropriate, for 
example because the outcome of the intervention cannot be measured in terms of 
years of life gained or the process of going through the service may produce 
important welfare gains. In such cases, cost-benefit analysis is the preferred method 
of economic evaluation. Reproductive medicine is surely such a case and we suspect 
that emerging areas of medicine may pose similar problems and may require cost- 
benefit analysis rather than cost-effecttiveness and cost-utility analysis (e.g. genetic 
testing and cosmetic surgery).
In general, IVF and other Assisted Reproductive Techniques are now part of the 
normal coverage of statutory systems in Europe. Evidence on effectiveness and cost- 
effectiveness has probably favoured this. Whatever the strength of this evidence it 
would never suffice to give an answer to the question of whether the benefits of IVF 
outweigh its costs. Only cost-benefit analysis can do it. Therefore, we strongly 
encourage that NICE and other agencies in charge of giving direction on the content 
of coverage of statutory systems accept the framework of cost-benefit analysis and 
use sound cost-benefit studies when making recommendations.
As mentioned earlier, this study provides evidence in favour of funding IVF services 
to infertile couples. Our analysis shows that, following a series of reasonable 
assumptions, benefits greatly outweigh costs. Interestingly, however, our data clearly 
shows that in a real referendum a new tax sufficient to cover the costs would be 
approved with a very tiny majority, if any. As a consequence, while cost-benefit 
analysis is strongly in favour of the programme, popular voting for the programme 
might give a different result. Mathematically, this derives from the fact that the mean 
value is much larger than the median value given the large number of “0” WTP and
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the significant number of respondents willing to pay the maximum amount offered. 
Concretely, the issue concerns the impact that a limited number of respondents with 
a very high WTP have on results. About 600 respondents (10% of the total sample) 
revealed to be willing to pay € 200 or above for the programme. According to the 
conservative assumption that € 200 is the maximum amount that these respondents 
are willing to pay, about 40% of total WTP derives from the answer of these 
respondents. This minority of the sample determines the results of the cost-benefit 
analysis!
Basically, in cost-benefit analysis WTP amounts are similar to a weighing system of 
the voting procedure. Each respondent expresses a position that can be interpreted 
in terms of being in favour or against the programme and the extent of the stated 
WTP weights the position. To a certain extent contingent valuation can be 
assimilated to a procedure to measure the intensity for public choices. Indeed, WTP 
is a metric of preferences.
In terms of policy implications, however, aggregating individual WTP to derive a 
mean WTP to be compared to costs presents a major problem: the weighing system 
favours the opinions of the most affluent. As they have more resources available, 
they have higher WTP to state in contingent valuation surveys. This means that the 
point of view of the most affluent individuals count more than that of the less affluent. 
In this respect cost-benefit analysis violates the “one head -one vote” principle of 
modern democracy.
In our study the minority strongly in favour of the sample is also overrepresented of 
affluent and well educated individuals. Although sufferance due to infertility hits 
people across social groups and conditions, our data shows that the higher socio­
economic groups are also those that are more acquainted with infertility and IVF. 
Likely, postponing parenthood and thus being at higher risk of infertility, is mainly an 
issue among highly educated professionals and middle-class couples.
The assumption underlying this research is that sound economic analysis can 
provide guidance to policymaking. Consistently, we used cost-benefit analysis to 
provide original evidence about the desirability of a publicly funded programme
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providing IVF to Italian infertile couples. Our data robustly indicates that such 
programme would imply a welfare gain for Italians. This is the main message for 
policy maker. Nevertheless, evidence-based policymaking cannot be based on naive 
assumptions about the neutrality of theories and research methods. A major issue to 
be taken into consideration in cost-benefit studies based on stated or revealed 
preferences is that aggregate benefits measures give a louder voice to affluent 
individuals so creating important equity concerns.
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Appendix A
Questionnaire and coding 
(Original answers version)
g  Domanda 1: Lei conosce delle coppie che desiderano avere dei bambini e non 
riescono ad averli?
V71
Print Format: Fl 
Write Format: Fl
Value Label
1 s i '
2 no
g  Domanda 2: Lei era a conoscenza della Fertilizzazione in Vitro?
V72
Print Format: Fl 
Write Format: Fl
Value Label
1 e' la prima volta che ne sento parlare
2 si', ne ho sentito parlare e\o letto sui giornali
3 si', ne ho sentito parlare da amici\conoscenti\parenti
4 si', mi sono informatoXa attraverso letture specializzate
5 si', mi sono informatoXa dal medico
g  Domanda 3: Lei direbbe che le sue conoscenze sulla Fertilizzazione sono: 
(esclusi coloro che hanno risposto 'e la prima volta che ne sento parlare' 
codice 1 a dom. 2)
V7 3
Print Format: Fl 
Write Format: Fl
Value Label
1 molto scarse
2 abbastanza scarse
3 sufficienti
4 abbastanza approfondite
5 molto approfondite
g  Domanda 4: Lei conosce qualcuno che abbia utilizzato la Fertilizzazione in 
Vitro o altre terapie finalizzate a permettere a coppie non fertili di avere 
bambini?
V74
Print Format: Fl
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Write Format: Fl
Value Label
1 s i '
2 No
g  Domanda 5: Immagini di essere in una situazione in cui e sposato/a da
qualche anno e in cui, malgrado desiderandoli, non riesca ad avere dei 
bambini. Immagini che le venga indicata la Fertilizzazione in Vitro e che le 
venga prospettata una probability del 30% di riuscire ad avere un bambino. 
Lei personalmente proverebbe la fertilizzazione in Vitro:
V7 5
Print Format: Fl 
Write Format: Fl
Value Label
0 Non so
1 Sicuramente no
2 Probabilmente no
3 Probabilmente si'
4 Sicuramente si'
g  Do m a n d a 6: E, Lei proverebbe la Fertilizzazione in vitro se...
Per ciascuna delle seguenti alternative, indichi, per favore, se si o se no, 
tenendo presente che:
- se fosse gratuita... 
V7 6.1
Print Format: Fl 
Write Format: Fl
Value Label
1 si 1, proverei la Fertilizzazione in Vitro
2 no, non proverei la fertilizzazione in Vitro
- se le fosse chiesto di pagare 1 milione...
V7 6.2
Print Format: Fl 
Write Format: Fl
Value Label
1 si', proverei la Fertilizzazione in Vitro
2 no, non proverei la fertilizzazione in Vitro
- se le fosse chiesto di pagare 5 milioni...
V7 6.3
Print Format: Fl 
Write Format: Fl
Value Label
1 si', proverei la Fertilizzazione in Vitro
2 no, non proverei la fertilizzazione in Vitro
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- se le fosse chiesto di pagare 10 milioni..
V7 6. 4
Print Format: Fl 
Write Format: Fl
Value Label
1 si', proverei la Fertilizzazione in Vitro
2 no, non proverei la fertilizzazione in Vitro
- se le fosse chiesto di pagare 20 milioni...
V7 6.5
Print F o r m a t : Fl 
Write Format: Fl
Value Label
1 si', proverei la Fertilizzazione in Vitro
2 no, non proverei la fertilizzazione in Vitro
- se le fosse chiesto di pagare 50 milioni...
V7 6. 6
Print F o r m a t : Fl 
Write Format: Fl
Value Label
1 si', proverei la Fertilizzazione in Vitro
2 no, non proverei la fertilizzazione in Vitro
SPLIT 4 CAM PIONI
flp Domanda 7: Immagini ora che in Italia si decida di fare un referendum per
decidere se finanziare la Fertilizzazione in Vitro con soldi pubblici. Ogni 
anno il finanziamento sarebbe disponibile per circa 10.000 coppie alle quali 
questa terapia viene indicata. Di queste coppie circa 3.000 riuscirebbero ad 
avere un bambino. Senza il finanziamento pubblico ogni coppia dovrebbe 
spendere dai 5 ai 15 milioni.
Campione 1 - Lei voterebbe a favore del programma di finanziamento pubblico se 
le chiedessero un pagamento annuale, una tassa di 5.000 lire?
V771
Print Format: Fl 
Write Format: Fl
Value Label
0 non so
1 sicuramente no
2 probabilmente no
3 probabilmente si'
4 sicuramente si'
Campione 2 - Lei voterebbe a favore del programma di finanziamento pubblico se 
le chiedessero un pagamento annuale, una tassa di 10.000 lire?
V772
Print Format: Fl 
Write Format: Fl
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Value Label
0 non so
1 sicuramente no
2 probabilmente no
3 probabilmente si'
4 sicuramente si'
Campione 3 - Lei voterebbe a favore del programma di f inanziamento pubblico se 
le chiedessero un pagamento annuale, una tassa di 20.000 lire?
V I 13
Print Format: Fl 
Write Format: Fl
Value Label
0 non so
1 sicuramente no
2 probabilmente no
3 probabilmente si'
4 sicuramente si'
Campione 4 - Lei voterebbe a favore del programma di finanziamento pubblico se 
le chiedessero un pagamento annuale, una tassa di 50.000 lire?
V774
Print Format: Fl 
Write Format: Fl
V a l u e Label
0 non so
1 sicuramente no
2 probabilmente no
3 probabilmente si'
4 sicuramente si'
A TU TTI
flj Do m a n d a 8: Ma, quanto sarebbe il contributo annuale che lei personalmente
sarebbe disposto a pagare? Per ciascuna delle seguenti alternative, indichi, 
per favore, se si o se no, tenendo presente che:
- 2.000 lire
V8.1
Print Format: Fl 
Write Format: Fl
Value Label
1 si'
2 no
- 5.000 lire 
V8.2
Print F o rmat: Fl 
Write Format: Fl
Value Label
1 s i '
2 no
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- 10.000 lire
V8.3
Print Form a t : Fl 
Write Format: Fl
Value Label
1 si'
2 no
- 20.000 lire 
V8 . 4
Print Format: Fl 
Write Format: Fl
Value Label
1 si'
2 no
- 50.000 lire 
V8 .5
Print Format: Fl 
Write Format: Fl
Value Label
1 s i '
2 no
- 80.000 lire 
V 8 . 6
Print Format: Fl 
Write Format: Fl
Value Label
1 s i '
2 no
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- 100.000 lire
V8 . 7
Print Format: Fl 
Write Format: Fl
Value Label
1 si ’
2 no
- 200.000 lire 
V8.8
Print Format: Fl 
Write Format: Fl
Value Label
1 s i '
2 no
fl? Domanda 9: 
FIVET:
Ma, Lei sarebbe favorevole al finanziamento pubblico della
Value Label
1 Si,
2 Si, ma solo per le fasce a basso reddito
3 Si, ma con una compartecipazione a carico delle famiglie
4 No
QP Variabili strutturali
PM6 PANELMEMBER
Print Format: F7 
Write Format: F7
SEQUENZA PROGRESSIVO FISSO 
Print Format: F2 
Write Format: F2
UNIVOCO DENTIFICATIVO DI CASO (pm6 *100000 +sequenza:
Print Format: F16 
Write Format: F16
ETACON (eta continua)
Print Format: F 8 .2 
Write Format: F 8 .2
ETA E T A 1 (per classi)
Print Format: Fl 
Write Format: Fl
Value Label
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ETACL2
SESSO
2 18-29 anni
3 30-39 anni
4 40-49 anni
5 50-59 anni
6 60 e oltre
ETA' i(classi d ’ eta
Print Format: F3
Write Format: F3
Value Label
1 18-24 anni
2 25-2 9 anni
3 30-34 anni
4 35-39 anni
5 40-44 anni
6 45-49 anni
7 50-54 anni
8 55-59 anni
9 60-64 anni
10 >64 anni
SESSO
Print Format: F2 
Write Format: F2 
Missing Values: 0
Value Label
maschio 
femmina
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ISTR2
C0NPR0F3
C0NPR0F7
MCR
MCR2
SCOLARITA'
Print Format: F2 
Write Format: F2 
Missing Values: 0
Value Label
1 no tit/lic. elem.
2 lie. media inf.
3 d i p l . media sup.
4 laurea
CONDIZIONE PROFESSIONALE 
Print Format: F2 
Write Format: F2 
Missing Values: 0
Value Label
1 Occupato
2 In cerca lavoro
3 Non forze lavoro
CONDIZIONE PROFESSIONALE 
Print Format: F2 
Write Format: F2
Value Label
1 lav.auton.
2 lav.dip.
3 operaio
4 casa-linga
5 stu-dente
6 pensio-nato
7 in cerca occup.
MACROAREA 
Print Format: F2 
Write Format: F2
Value Label
1 nord-ovest
2 nord-est
3 centro
4 sud e isole
MACROAREA 
Print Format: F6 
Write Format: F6
Value Label
1 Nord ovest
2 Nord est
3 Centro
4 Sud
5 Isole
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AMPC AMPIEZZA CENTRO 
Print Format: F2 
Write Format: F2
Value Label
1 <=5000
2 5001-20000
3 20001-50000
4 50001-100000
5 >100000
CODREGI REGIONE
Print F o r m a t : F3
Write F o r m a t : F3
Value Label
1 Piemonte
2 Valle d'Aosta
3 Lombardia
4 Trentino Alto Adige
5 Veneto
6 Friuli Venezia Giulia
7 Liguria
8 Emilia Romagna
9 Toscana
10 Umbria
11 Marche
12 Lazio
13 Abruzzo
14 Molise
15 Campania
16 Puglia
17 Basilicata
18 Calabria
19 Sicilia
20 Sardegna
CODPROV Codice Istat provincia 
Print Format: F2 
Write F o r m a t : F2
Value Label
1 Torino
2 Vercelli
3 Novara
4 Cuneo
5 Asti
6 Alessandria
7 Aosta
8 Imperia
9 Savona
10 Genova
11 La Spezia
12 Varese
13 Como
14 Sondrio
15 Milano
16 Bergamo
17 Brescia
18 Pavia
19 Cremona
20 Mantova
21 Bolzano
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22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
Trento
Verona
Vicenza
Belluno
Treviso
Venezia
Padova
Rovigo
Udine
Gorizia
Trieste
Piacenza
Parma
Reggio Emilia
Modena
Bologna
Ferrara
Ravenna
Forli
Pesaro
Ancona
Macerata
Ascoli Piceno
Massa Carrara
Lucca
Pistoia
Firenze
Livorno
Pisa
Arezzo
Siena
Grosseto
Perugia
Terni
Viterbo
Rieti
Roma
Latina
Frosinone
Caserta
Benevento
Napoli
Avellino
Salerno
L 'Aquila
Teramo
Pescara
Chieti
Campobasso
Foggia
Bari
Taranto
Brindisi
Lecce
Potenza
Matera
Cosenza
Catanzaro
Reggio Calabria
Trapani
Palermo
Messina
Agrigento
Caltanissetta
Enna
Catania
Ragusa
Siracusa
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AMPC2
CETOVEN
AMFTE02
CAPOLUO
QUOTIDIA
90 Sassari
91 Nuoro
92 Cagliari
93 Pordenone
94 Isernia
95 Oristano
AMPIEZZA CENTRO 
Print F o rmat: FI 
Write Format: FI
Value Label
1 <=5000
2 5001-20000
3 20001-50000
4 50001-100000
5 >100000
6 Capoluogo
LIVELLO SOCIO ECONOMICO 
Print Format: F6 
Write Format: F6 
Missing Values: 0
Value Label
1 Basso
2 Medio basso
3 Medio
4 Medio alto
5 Alto
AMPIEZZA FAMIGLIA 
Print Format: F2 
Write Format: F2
Value Label
1 1 componente
2 2 componenti
3 3 componenti
4 4 componenti
5 5 o piu' componenti
Comune capoluogo 
Print Form a t : FI 
Write Format: FI
Value Label
0 No
1 Si
LETTURA QUOTIDIANI 
Print F o rmat: FI 
Write Format: FI
Value Label
1 tutti i giorni
2 spesso
3 saltuariamente
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4 raramente/mai
RESP
QUAFAM
CAPOF
RESP. ACQUISTI
Print Format: FI
Write Format: FI
Value Label
0 No
1 Si'
Qualifica familiare
Print F o rmat: F8
Write Format: F8
Value Label
1 marito/partner
2 moglie/partner
3 figlio/figlia
4 fratello/sorella
5 zio/zia
6 cugino/cugina
7 nipote
8 nonno/nonna
9 genero/nuora
10 cognato/cognata
11 suocero/suocera
12 Single
13 Altro parente
14 Padre/madre
Ruolo individuo 
Print Format: FI 
Write Format: FI 
Missing Values: 0
Value Label
1 Capofamiglia
2 Non capofamiglia.
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ETACL4 Eta a 6 classi
Print Format: F3 
Write Format: F3 
Missing Values: 99
ue Label
1 18-24 anni
2 25-34 anni
3 35-44 anni
4 45-54 anni
5 55-64 anni
6 >64 anni
ELE96PTO VOTO PROPORZIONALE (ricordo+rilevato) 
Print Format: F3
Write Format: F3
Value Label
1 FI
2 AN
3 CCD,CDU
4 Pannell
5 PDS
6 RC
7 Verdi, Rete
8 Dini, Segni, SI, AD
9 Po p o l - U .d e m . + L a b u r .
10 Lega Nord
11 Altri
12 Non Voto
ELE96M VOTO MAGGIORITARIO (rilevatoSO) 
Print Format: F2 
Write Format: F2
Value Label
1 CENTRO-DESTRA
2 CENTRO-SINISTRA
3 Lega Nord
4 Pannell
5 Altri
6 Non voto
MESSA Esclusi i matrimoni e i funerali, con quale frequenza partec 
Print F o r m a t : FI 
Write Format: FI
Value Label
1 Mai
2 1-2 volte l'anno
3 Piu' volte l'anno
4 1 volta al mese circa
5 2-3 volte al mese
6 Ogni settimana
7 Piu' volte la settimana
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RMESSA
RV6
RV9
FREQUENZA ALLA MESSA 
Print Format: F8 
Write Format: F8
Value Label
1 mai
2 1\2 volte anno
3 piu' volte anno
4 1\3 volte mese
5 ogni sett.
SCELTA ATTUALE DI VOTO (con non voto) 
Print Format: F 8 .2 
Write Format: F 8 .2
Value Label
3,00 Forza Italia
4, 00 A l l .Naz
5, 00 CCD
6, 00 Lista-Pannel.
7, 00 UDR
8,00 Dem. di Sinis.
9,00 R i f .Com
10, 00 Com. d'Italia
11, 00 Verdi
12, 00 Rinnov.Ital.
13,00 Ulivo
14, 00 L'ltal.dei Val
15, 00 PPI
16,00 Lega - Nord
17,00 MS Fiam. Tricol
18, 00 Social-Italian
19, 00 Patto Segni
20, 00 Altri
21, 00 Bianca/nulla/N.V
VOTO MAGGIORITARIO ATTUALE (con non voto) 
Print Format: F 8 .2 
Write Format: F 8 .2
Value Label
1, 00 Polo-Liberta1
2, 00 L'Ulivo
3, 00 R i f .Com.
4, 00 Lega-Nord
5, 00 Lista Pannel.
6, 00 Altro
7, 00 Bianca/nulla/N.V
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V5R2 Autocollocazione (con non so) 
Print Format: F 8 .2 
Write Format: F 8 .2
PA13
DATANAS
PES04
PES04C1
PES04C2
PES04C3
PES04C4
NFIGLI
Value Label
1,00 sini-stra
2, 00 centro-sin.
3,00 centre
4,00 centro-destra
5,00 destra
6,00 non so
INTERESSE ALLA POLITICA 
Print Format: F 8 .2
Write Format: F8.2
Value Label
,00 non so
M
1
O O per nulla
2,00 poco
3,00 abbastanza
4, 00 molto
Datanasci aa.mm.gg. 
Print Format: EDATE8 
Write Format: EDATE8
peso senza politiche 
Print Format: F13.10 
Write Format: F13.10
peso senza politiche (campione 1) 
Print Format: F13.10 
Write Format: F13.10
peso senza politiche (campione 2) 
Print Format: F13.10 
Write Format: F13.10
peso senza politiche (campione 3) 
Print Format: F13.10 
Write Format: F13.10
peso senza politiche (campione 4) 
Print Format: F13.10 
Write Format: F13.10
Numero di figli 
Print Format: F4 
Write Format: F4
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V5 In politica di solito si parla di 'SINISTRA', 'CENTRO' e 'DE
Print Format: F2 
Write Format: F2
V6 Se oggi ci fossero delle nuove elezioni, quale partito votera
Print Format: F2 
Write Format: F2
Value Label
3 Forza Italia (Berlusconi)
4 Alleanza Nazionale (Fini)
5 CCD (Casini)
6 Lista Pannella (Pannella)
7 UDR (Cossiga-Mastella)
8 Democratici di Sinistra (ex PDS-Veltroni)
9 Rifondazione Comunista (Bertinotti)
10 Comunisti d'Italia (Cossutta)
11 Verdi (Manconi)
12 Rinnovamento Italiano (Dini)
13 l'Ulivo (Prodi)
14 Italia dei valori (Di Pietro)
15 PPI (Marini)
16 Lega Nord (Bossi)
17 Movimento Sociale - Fiamma Tricolore (Rau
18 Socialisti Italiani di Boselli
19 Patto Segni (Segni)
20 altri
21 scheda bianca
22 scheda nulla
23 non andrei a votare
V9 Se oggi ci fossero delle nuove elezioni, lei quale coalizion
Print Format: FI 
Write Format: Fl
Value Label
1 Polo per le Liberta'
2 L'Ulivo
3 Rifondazione Comunista
4 Lega Nord
5 Lista Pannella
6 altro
7 scheda bianca
8 scheda nulla
9 non andrei a votare
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Questionnaire 
(English translation)
3  QUESTION 1: Are you acquainted with any couples who desire to have babies and cannot have them?
Yes
No
3  QUESTION 2: Did you know In-Vitro-Fertilisation before?
No, It is the first time I hear of it
Yes, I have heard of it from the Tv and/or newspapers
Yes, I have heard of it from relatives/friends
Yes, I have got informed through specialised readings
Yes, I have got informed from the doctor
3  QUESTION 3: How would you rate your knowledge about In-Vitro-Fertilisation?
Very limited 
Relatively limited 
Sufficient 
Relatively wide 
Very wide
3  QUESTION 4: Have you ever met someone who used IVF or other ARTs?
Yes
No
3  QUESTION 5: Imagine that you have been married for a few years and you have been unsuccessfully 
trying to have a baby. Imagine you are told to use IVF and that it has a 30% chance to be successful. 
Would you personally try IVF?
Do not know 
No, definitely not 
No, probably not 
Yes, probably 
Yes, definitely
3  QUESTION 6: Would you personally try IVF if  it were free?
Yes
No
3  QUESTION 6a : Would you personally try IVF i f  you had to pay 1 M illion  Italian Liras?
Yes
No
3  QUESTION 6b : Would you personally try IVF if  you had to pay 5 Million Italian Liras? 
Yes 
No
3  QUESTION 6c : Would you personally try IVF if  you had to pay 10 Million Italian Liras? 
Yes 
No
3  QUESTION 6d : Would you personally try IVF if  you had to pay 20 Million Italian Liras? 
Yes 
No
304
flp QUESTION 6e: Would you personally try IVF if  you had to pay 50 Million Italian Liras? 
Yes 
No
Sample splitted into 4 sub-samples
fljl QUESTION 7: Imagine that there is a referendum in order to decide whether to fund IVF with public 
money. Each year public funding would be available to about 30,000 couples who are advised to use 
IVF. Out of these couples about 10,000 would have a baby. Without public funding, couples requiring 
IVF should spend between It. Liras 5 and It. Liras 15 million for the procedure.
Sub-sample 1 -  Would you vote in favour of funding IVF with public money i f  you were asked an
annual payment, that is a tax, of Italian Liras 5,000?
Do not know 
No, definitely not 
No, probably not 
Yes, probably 
Yes, definitely
Sub-sample 2 -  Would you vote in favour of funding IVF with public money if  you were asked an
annual payment, that is a tax, of Italian Liras 10,000?
Do not know 
No, definitely not 
No, probably not 
Yes, probably 
Yes, definitely
Sub-sample 3 -  Would you vote in favour of funding IVF with public money i f  you were asked an
annual payment, that is a tax, of Italian Liras 20,000?
Do not know 
No, definitely not 
No, probably not 
Yes, probably 
Yes, definitely
Sub-sample 4 -  Would you vote in favour of funding IVF with public money if  you were asked an 
annual payment, that is a tax, of Italian Liras 50,000?
Do not know 
No, definitely not 
No, probably not 
Yes, probably 
Yes, definitely
All
Question 8: And, would you try IVF if. Please, for each alternative indicate yes or not
- 2.000 liras
- 5,000 liras
- 10,000 liras
- 20,000 liras
- 50,000 liras
- 80,000 liras
- 100,000 liras
- 200,000 liras
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g  QUESTION 9: But, would you in favour to a public program providing IVF to infertile couples? 
Yes
Yes, but only for low incombe couplet 
Yes, but with a co-payment 
No
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